ID	Gene Name	Species	BBID	BIOCARTA	COG_ONTOLOGY	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	SMART	UP_KEYWORDS	UP_SEQ_FEATURE
NT5C2	5'-nucleotidase, cytosolic II(NT5C2)	Homo sapiens				GO:0006195~purine nucleotide catabolic process,GO:0016310~phosphorylation,GO:0016311~dephosphorylation,GO:0017144~drug metabolic process,GO:0046040~IMP metabolic process,GO:0046085~adenosine metabolic process,	GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0008253~5'-nucleotidase activity,GO:0046872~metal ion binding,GO:0050146~nucleoside phosphotransferase activity,	IPR008380:HAD-superfamily hydrolase, subfamily IG, 5'-nucleotidase,IPR016695:Purine 5'-nucleotidase,IPR023214:HAD-like domain,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa00760:Nicotinate and nicotinamide metabolism,hsa01100:Metabolic pathways,	613162~Spastic paraplegia 45, autosomal recessive,	PIRSF017434:cytosolic purine 5'-nucleotidase,		3D-structure,Allosteric enzyme,Alternative splicing,Complete proteome,Cytoplasm,Hereditary spastic paraplegia,Hydrolase,Magnesium,Metal-binding,Neurodegeneration,Nucleotide metabolism,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	active site:Nucleophile,active site:Proton donor,binding site:Allosteric activator 1,binding site:Allosteric activator 1; via carbonyl oxygen,binding site:Allosteric activator 2,chain:Cytosolic purine 5'-nucleotidase,compositionally biased region:Asp/Glu-rich (acidic),helix,metal ion-binding site:Magnesium,metal ion-binding site:Magnesium; via carbonyl oxygen,modified residue,region of interest:Substrate binding,sequence variant,strand,turn,
AKT1	AKT serine/threonine kinase 1(AKT1)	Homo sapiens	104.Insulin_signaling,105.Signaling_glucose_uptake,106.Glycogen_synthase-synthesis,107.mRNA_translation-protein_synthesis,108.Regulating_glucose_transport,37.Akt-PKB_Effector_of_P13K_in_Vivo,83.Growth_factors_Survival_factors_Mitogens,	h_achPathway:Role of nicotinic acetylcholine receptors in the regulation of apoptosis,h_aktPathway:AKT Signaling Pathway,h_badPathway:Regulation of BAD phosphorylation,h_bcellsurvivalPathway:B Cell Survival Pathway,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_crebPathway:Transcription factor CREB and its extracellular signals,h_edg1Pathway:Phospholipids as signalling intermediaries,h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,h_erk5Pathway:Role of Erk5 in Neuronal Survival,h_gcrpathway:Corticosteroids and cardioprotection,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,H_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages,h_hcmvPathway:Human Cytomegalovirus and Map Kinase Pathways,h_hdacPathway:Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK),h_igf1mtorPathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway,h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il4Pathway:IL 4 signaling pathway,h_longevityPathway:The IGF-1 Receptor and Longevity,h_mtorPathway:mTOR Signaling Pathway,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_no1Pathway:Actions of Nitric Oxide in the Heart,h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,h_plcPathway:Phospholipase C Signaling Pathway,h_ptdinsPathway:Phosphoinositides and their downstream targets.,h_ptenPathway:PTEN dependent cell cycle arrest and apoptosis,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_rasPathway:Ras Signaling Pathway,h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality,h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,h_trkaPathway:Trka Receptor Signaling Pathway,		GO:0000060~protein import into nucleus, translocation,GO:0001649~osteoblast differentiation,GO:0001893~maternal placenta development,GO:0001934~positive regulation of protein phosphorylation,GO:0001938~positive regulation of endothelial cell proliferation,GO:0005978~glycogen biosynthetic process,GO:0005979~regulation of glycogen biosynthetic process,GO:0006006~glucose metabolic process,GO:0006412~translation,GO:0006417~regulation of translation,GO:0006464~cellular protein modification process,GO:0006468~protein phosphorylation,GO:0006469~negative regulation of protein kinase activity,GO:0006809~nitric oxide biosynthetic process,GO:0006924~activation-induced cell death of T cells,GO:0006954~inflammatory response,GO:0006974~cellular response to DNA damage stimulus,GO:0006979~response to oxidative stress,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007281~germ cell development,GO:0007568~aging,GO:0008283~cell proliferation,GO:0008286~insulin receptor signaling pathway,GO:0008637~apoptotic mitochondrial changes,GO:0009408~response to heat,GO:0010507~negative regulation of autophagy,GO:0010629~negative regulation of gene expression,GO:0010748~negative regulation of plasma membrane long-chain fatty acid transport,GO:0010763~positive regulation of fibroblast migration,GO:0010765~positive regulation of sodium ion transport,GO:0010907~positive regulation of glucose metabolic process,GO:0010951~negative regulation of endopeptidase activity,GO:0010975~regulation of neuron projection development,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0015758~glucose transport,GO:0016310~phosphorylation,GO:0016567~protein ubiquitination,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0021510~spinal cord development,GO:0030030~cell projection organization,GO:0030154~cell differentiation,GO:0030163~protein catabolic process,GO:0030168~platelet activation,GO:0030212~hyaluronan metabolic process,GO:0030307~positive regulation of cell growth,GO:0030334~regulation of cell migration,GO:0031018~endocrine pancreas development,GO:0031295~T cell costimulation,GO:0031641~regulation of myelination,GO:0031659~positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0031999~negative regulation of fatty acid beta-oxidation,GO:0032079~positive regulation of endodeoxyribonuclease activity,GO:0032094~response to food,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032287~peripheral nervous system myelin maintenance,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032869~cellular response to insulin stimulus,GO:0032880~regulation of protein localization,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0034405~response to fluid shear stress,GO:0035556~intracellular signal transduction,GO:0035655~interleukin-18-mediated signaling pathway,GO:0035924~cellular response to vascular endothelial growth factor stimulus,GO:0038128~ERBB2 signaling pathway,GO:0042593~glucose homeostasis,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043488~regulation of mRNA stability,GO:0043491~protein kinase B signaling,GO:0043536~positive regulation of blood vessel endothelial cell migration,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045600~positive regulation of fat cell differentiation,GO:0045725~positive regulation of glycogen biosynthetic process,GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway,GO:0045792~negative regulation of cell size,GO:0045861~negative regulation of proteolysis,GO:0045907~positive regulation of vasoconstriction,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046326~positive regulation of glucose import,GO:0046329~negative regulation of JNK cascade,GO:0046777~protein autophosphorylation,GO:0046889~positive regulation of lipid biosynthetic process,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0050999~regulation of nitric-oxide synthase activity,GO:0051000~positive regulation of nitric-oxide synthase activity,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051146~striated muscle cell differentiation,GO:0060416~response to growth hormone,GO:0060644~mammary gland epithelial cell differentiation,GO:0060709~glycogen cell differentiation involved in embryonic placenta development,GO:0060716~labyrinthine layer blood vessel development,GO:0070141~response to UV-A,GO:0071260~cellular response to mechanical stimulus,GO:0071364~cellular response to epidermal growth factor stimulus,GO:0071380~cellular response to prostaglandin E stimulus,GO:0071407~cellular response to organic cyclic compound,GO:0071456~cellular response to hypoxia,GO:0072655~establishment of protein localization to mitochondrion,GO:0072656~maintenance of protein location in mitochondrion,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,GO:0090201~negative regulation of release of cytochrome c from mitochondria,GO:0097011~cellular response to granulocyte macrophage colony-stimulating factor stimulus,GO:0097194~execution phase of apoptosis,GO:0099565~chemical synaptic transmission, postsynaptic,GO:0100002~negative regulation of protein kinase activity by protein phosphorylation,GO:1900182~positive regulation of protein localization to nucleus,GO:1901215~negative regulation of neuron death,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1901976~regulation of cell cycle checkpoint,GO:1902176~negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,GO:1990090~cellular response to nerve growth factor stimulus,GO:1990418~response to insulin-like growth factor stimulus,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005819~spindle,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0015630~microtubule cytoskeleton,GO:0031982~vesicle,GO:0036064~ciliary basal body,GO:0043234~protein complex,GO:0098794~postsynapse,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0005080~protein kinase C binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0016301~kinase activity,GO:0019899~enzyme binding,GO:0030235~nitric-oxide synthase regulator activity,GO:0032794~GTPase activating protein binding,GO:0042802~identical protein binding,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,GO:0051721~protein phosphatase 2A binding,GO:0071889~14-3-3 protein binding,	IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR001849:Pleckstrin homology domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011993:Pleckstrin homology-like domain,IPR017441:Protein kinase, ATP binding site,IPR017892:Protein kinase, C-terminal,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04210:Apoptosis,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04370:VEGF signaling pathway,hsa04380:Osteoclast differentiation,hsa04510:Focal adhesion,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04611:Platelet activation,hsa04620:Toll-like receptor signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04668:TNF signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04728:Dopaminergic synapse,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04922:Glucagon signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa04973:Carbohydrate digestion and absorption,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	114480~Breast cancer, somatic,114500~Colorectal cancer, somatic,167000~Ovarian cancer, somatic,176920~Proteus syndrome, somatic,181500~Schizophrenia, susceptibility to,615109~Cowden syndrome 6,		SM00133:S_TK_X,SM00220:S_TKc,SM00233:PH,	3D-structure,Acetylation,Alternative splicing,Apoptosis,ATP-binding,Carbohydrate metabolism,Cell membrane,Complete proteome,Cytoplasm,Developmental protein,Disease mutation,Disulfide bond,Glucose metabolism,Glycogen biosynthesis,Glycogen metabolism,Glycoprotein,Isopeptide bond,Kinase,Membrane,Neurogenesis,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Serine/threonine-protein kinase,Sugar transport,Transferase,Translation regulation,Transport,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:RAC-alpha serine/threonine-protein kinase,domain:AGC-kinase C-terminal,domain:PH,domain:Protein kinase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,strand,turn,
AKT2	AKT serine/threonine kinase 2(AKT2)	Homo sapiens				GO:0001934~positive regulation of protein phosphorylation,GO:0005978~glycogen biosynthetic process,GO:0006006~glucose metabolic process,GO:0006417~regulation of translation,GO:0006464~cellular protein modification process,GO:0006915~apoptotic process,GO:0007165~signal transduction,GO:0008286~insulin receptor signaling pathway,GO:0008643~carbohydrate transport,GO:0010748~negative regulation of plasma membrane long-chain fatty acid transport,GO:0010907~positive regulation of glucose metabolic process,GO:0018105~peptidyl-serine phosphorylation,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0031340~positive regulation of vesicle fusion,GO:0032000~positive regulation of fatty acid beta-oxidation,GO:0032287~peripheral nervous system myelin maintenance,GO:0032869~cellular response to insulin stimulus,GO:0035556~intracellular signal transduction,GO:0045444~fat cell differentiation,GO:0045725~positive regulation of glycogen biosynthetic process,GO:0046326~positive regulation of glucose import,GO:0060644~mammary gland epithelial cell differentiation,GO:0065002~intracellular protein transmembrane transport,GO:0071156~regulation of cell cycle arrest,GO:0072659~protein localization to plasma membrane,GO:0090314~positive regulation of protein targeting to membrane,GO:0090630~activation of GTPase activity,GO:2000147~positive regulation of cell motility,GO:2001275~positive regulation of glucose import in response to insulin stimulus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005769~early endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0032587~ruffle membrane,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR001849:Pleckstrin homology domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011993:Pleckstrin homology-like domain,IPR017441:Protein kinase, ATP binding site,IPR017892:Protein kinase, C-terminal,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04210:Apoptosis,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04370:VEGF signaling pathway,hsa04380:Osteoclast differentiation,hsa04510:Focal adhesion,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04611:Platelet activation,hsa04620:Toll-like receptor signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04668:TNF signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04728:Dopaminergic synapse,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04922:Glucagon signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa04973:Carbohydrate digestion and absorption,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	125853~Diabetes mellitus, type II,240900~Hypoinsulinemic hypoglycemia with hemihypertrophy,		SM00133:S_TK_X,SM00220:S_TKc,SM00233:PH,	3D-structure,Acetylation,Alternative splicing,Apoptosis,ATP-binding,Carbohydrate metabolism,Cell membrane,Complete proteome,Cytoplasm,Developmental protein,Diabetes mellitus,Disease mutation,Disulfide bond,Endosome,Glucose metabolism,Glycogen biosynthesis,Glycogen metabolism,Glycoprotein,Isopeptide bond,Kinase,Membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Serine/threonine-protein kinase,Sugar transport,Transferase,Translation regulation,Transport,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:RAC-beta serine/threonine-protein kinase,domain:AGC-kinase C-terminal,domain:PH,domain:Protein kinase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,strand,turn,
AMER1	APC membrane recruitment protein 1(AMER1)	Homo sapiens				GO:0016055~Wnt signaling pathway,GO:0031398~positive regulation of protein ubiquitination,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0048856~anatomical structure development,GO:0060348~bone development,GO:0060612~adipose tissue development,GO:0060828~regulation of canonical Wnt signaling pathway,GO:0072161~mesenchymal cell differentiation involved in kidney development,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1903364~positive regulation of cellular protein catabolic process,GO:1904885~beta-catenin destruction complex assembly,GO:1904886~beta-catenin destruction complex disassembly,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0008013~beta-catenin binding,GO:1904713~beta-catenin destruction complex binding,	IPR019003:Uncharacterised protein family FAM123,		300373~Osteopathia striata with cranial sclerosis,			3D-structure,Acetylation,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Lipid-binding,Membrane,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Wnt signaling pathway,	chain:Protein FAM123B,compositionally biased region:Glu-rich,compositionally biased region:Poly-Glu,compositionally biased region:Pro-rich,modified residue,sequence variant,splice variant,
APC	APC, WNT signaling pathway regulator(APC)	Homo sapiens	84.Ubiquitination_Pathways_Cell_Cycle,90.IB_and-cat-Arm_processing_of_Ci,97.Immune_injury_MS-lesions_MS_antigen,	h_alkPathway:ALK in cardiac myocytes,H_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages,h_pitx2Pathway:Multi-step Regulation of Transcription by Pitx2,h_ps1Pathway:Presenilin action in Notch and Wnt signaling,h_tgfbPathway:TGF beta signaling pathway,h_wntPathway:WNT Signaling Pathway,		GO:0000281~mitotic cytokinesis,GO:0001708~cell fate specification,GO:0006461~protein complex assembly,GO:0006921~cellular component disassembly involved in execution phase of apoptosis,GO:0006974~cellular response to DNA damage stimulus,GO:0007026~negative regulation of microtubule depolymerization,GO:0007050~cell cycle arrest,GO:0007094~mitotic spindle assembly checkpoint,GO:0007155~cell adhesion,GO:0007389~pattern specification process,GO:0008285~negative regulation of cell proliferation,GO:0016055~Wnt signaling pathway,GO:0016477~cell migration,GO:0030178~negative regulation of Wnt signaling pathway,GO:0030335~positive regulation of cell migration,GO:0031274~positive regulation of pseudopodium assembly,GO:0032886~regulation of microtubule-based process,GO:0043065~positive regulation of apoptotic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045595~regulation of cell differentiation,GO:0045732~positive regulation of protein catabolic process,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0051988~regulation of attachment of spindle microtubules to kinetochore,GO:0060070~canonical Wnt signaling pathway,GO:0070830~bicellular tight junction assembly,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:1904885~beta-catenin destruction complex assembly,GO:1904886~beta-catenin destruction complex disassembly,	GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005874~microtubule,GO:0005881~cytoplasmic microtubule,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0005913~cell-cell adherens junction,GO:0005923~bicellular tight junction,GO:0016328~lateral plasma membrane,GO:0016342~catenin complex,GO:0030027~lamellipodium,GO:0030877~beta-catenin destruction complex,GO:0032587~ruffle membrane,GO:1990909~Wnt signalosome,	GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008017~microtubule binding,GO:0019887~protein kinase regulator activity,GO:0019901~protein kinase binding,GO:0045295~gamma-catenin binding,GO:0045296~cadherin binding,GO:0051010~microtubule plus-end binding,	IPR000225:Armadillo,IPR009223:Adenomatous polyposis coli protein, cysteine-rich repeat,IPR009224:SAMP,IPR009232:EB-1 binding,IPR009234:Adenomatous polyposis coli protein basic domain,IPR009240:Adenomatous polyposis coli protein, 15 residue repeat,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR026818:Adenomatous polyposis coli (APC)  family,IPR026831:Adenomatous polyposis coli domain,IPR026836:Adenomatous polyposis coli,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04810:Regulation of actin cytoskeleton,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05206:MicroRNAs in cancer,hsa05210:Colorectal cancer,hsa05213:Endometrial cancer,hsa05217:Basal cell carcinoma,	114500~Colorectal cancer, somatic,114550~Hepatoblastoma, somatic,135290~Desmoid disease, hereditary,175100~Adenomatous polyposis coli,175100~Brain tumor-polyposis syndrome 2,175100~Gardner syndrome,613659~Gastric cancer, somatic,Adenoma, periampullary, somatic~Adenoma, periampullary, somatic,		SM00185:ARM,	3D-structure,Acetylation,Alternative splicing,Cell junction,Cell membrane,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Membrane,Microtubule,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Tumor suppressor,Ubl conjugation,Wnt signaling pathway,	chain:Adenomatous polyposis coli protein,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Leu-rich,compositionally biased region:Ser-rich,helix,modified residue,mutagenesis site,region of interest:Highly charged,region of interest:Responsible for down-regulation through a process mediated by direct ubiquitination,repeat:ARM 1,repeat:ARM 2,repeat:ARM 3,repeat:ARM 4,repeat:ARM 5,repeat:ARM 6,repeat:ARM 7,sequence conflict,sequence variant,short sequence motif:PDZ-binding,splice variant,turn,
ARID1B	AT-rich interaction domain 1B(ARID1B)	Homo sapiens				GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0007270~neuron-neuron synaptic transmission,GO:0007399~nervous system development,GO:0016569~covalent chromatin modification,GO:0048096~chromatin-mediated maintenance of transcription,GO:0060996~dendritic spine development,GO:0097026~dendritic cell dendrite assembly,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016514~SWI/SNF complex,GO:0071565~nBAF complex,GO:0090544~BAF-type complex,	GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,	IPR001606:ARID/BRIGHT DNA-binding domain,IPR011989:Armadillo-like helical,IPR021906:Protein of unknown function DUF3518,		614562~Mental retardation, autosomal dominant 12,		SM00501:BRIGHT,	3D-structure,Acetylation,Alternative splicing,Chromatin regulator,Complete proteome,DNA-binding,Mental retardation,Methylation,Neurogenesis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Triplet repeat expansion,	chain:AT-rich interactive domain-containing protein 1B,compositionally biased region:Ala-rich,compositionally biased region:Gln-rich,compositionally biased region:Gly-rich,compositionally biased region:His-rich,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,domain:ARID,helix,modified residue,sequence conflict,sequence variant,short sequence motif:LXXLL,splice variant,
ARID2	AT-rich interaction domain 2(ARID2)	Homo sapiens				GO:0006337~nucleosome disassembly,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0008285~negative regulation of cell proliferation,GO:0016569~covalent chromatin modification,GO:0030336~negative regulation of cell migration,	GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0090544~BAF-type complex,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001606:ARID/BRIGHT DNA-binding domain,IPR003150:DNA-binding RFX-type winged-helix domain,IPR007087:Zinc finger, C2H2,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR016024:Armadillo-type fold,				SM00501:BRIGHT,	Acetylation,Alternative splicing,Chromatin regulator,Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:AT-rich interactive domain-containing protein 2,compositionally biased region:Gln-rich,domain:ARID,modified residue,sequence conflict,short sequence motif:LXXLL,splice variant,zinc finger region:C2H2-type,
ATM	ATM serine/threonine kinase(ATM)	Homo sapiens		h_atmPathway:ATM Signaling Pathway,h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,H_cdc25Pathway:cdc25 and chk1 Regulatory Pathway in response to DNA damage,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_g2Pathway:Cell Cycle: G2/M Checkpoint,h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,h_p53Pathway:p53 Signaling Pathway,h_plk3Pathway:Regulation of cell cycle progression by Plk3,h_rbPathway:RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage,		GO:0000077~DNA damage checkpoint,GO:0000723~telomere maintenance,GO:0000724~double-strand break repair via homologous recombination,GO:0000729~DNA double-strand break processing,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0001666~response to hypoxia,GO:0001756~somitogenesis,GO:0002331~pre-B cell allelic exclusion,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006468~protein phosphorylation,GO:0006974~cellular response to DNA damage stimulus,GO:0006975~DNA damage induced protein phosphorylation,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007004~telomere maintenance via telomerase,GO:0007050~cell cycle arrest,GO:0007094~mitotic spindle assembly checkpoint,GO:0007131~reciprocal meiotic recombination,GO:0007165~signal transduction,GO:0007420~brain development,GO:0007507~heart development,GO:0008340~determination of adult lifespan,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0010212~response to ionizing radiation,GO:0010506~regulation of autophagy,GO:0016572~histone phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0030889~negative regulation of B cell proliferation,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0033129~positive regulation of histone phosphorylation,GO:0033151~V(D)J recombination,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0036289~peptidyl-serine autophosphorylation,GO:0042159~lipoprotein catabolic process,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator,GO:0043525~positive regulation of neuron apoptotic process,GO:0045141~meiotic telomere clustering,GO:0046777~protein autophosphorylation,GO:0048599~oocyte development,GO:0051402~neuron apoptotic process,GO:0051726~regulation of cell cycle,GO:0051972~regulation of telomerase activity,GO:0071044~histone mRNA catabolic process,GO:0071480~cellular response to gamma radiation,GO:0071481~cellular response to X-ray,GO:0071500~cellular response to nitrosative stress,GO:0072434~signal transduction involved in mitotic G2 DNA damage checkpoint,GO:0090399~replicative senescence,GO:0097694~establishment of RNA localization to telomere,GO:0097695~establishment of macromolecular complex localization to telomere,GO:1900034~regulation of cellular response to heat,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1904262~negative regulation of TORC1 signaling,GO:1904354~negative regulation of telomere capping,GO:1904358~positive regulation of telomere maintenance via telomere lengthening,GO:1904884~positive regulation of telomerase catalytic core complex assembly,	GO:0000781~chromosome, telomeric region,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,GO:1990391~DNA repair complex,	GO:0003677~DNA binding,GO:0004674~protein serine/threonine kinase activity,GO:0004677~DNA-dependent protein kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0016740~transferase activity,GO:0032403~protein complex binding,GO:0046983~protein dimerization activity,GO:0047485~protein N-terminus binding,	IPR000403:Phosphatidylinositol 3-/4-kinase, catalytic domain,IPR003151:PIK-related kinase, FAT,IPR003152:PIK-related kinase, FATC,IPR011009:Protein kinase-like domain,IPR014009:PIK-related kinase,IPR015519:ATM/Tel1,IPR016024:Armadillo-type fold,IPR018936:Phosphatidylinositol 3/4-kinase, conserved site,IPR021668:Telomere-length maintenance and DNA damage repair,	hsa04064:NF-kappa B signaling pathway,hsa04068:FoxO signaling pathway,hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa04210:Apoptosis,hsa05166:HTLV-I infection,hsa05202:Transcriptional misregulation in cancer,hsa05206:MicroRNAs in cancer,	114480~Breast cancer, susceptibility to,208900~Ataxia-telangiectasia,Lymphoma, B-cell non-Hodgkin, somatic~Lymphoma, B-cell non-Hodgkin, somatic,Lymphoma, mantle cell~Lymphoma, mantle cell,T-cell prolymphocytic leukemia, somatic~T-cell prolymphocytic leukemia, somatic,		SM00146:PI3Kc,SM01342:SM01342,SM01343:SM01343,	Acetylation,ATP-binding,Cell cycle,Complete proteome,Cytoplasmic vesicle,Disease mutation,DNA damage,DNA-binding,Kinase,Neurodegeneration,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Tumor suppressor,	chain:Serine-protein kinase ATM,domain:FAT,domain:FATC,domain:PI3K/PI4K,modified residue,mutagenesis site,region of interest:Interaction with ABL1,sequence conflict,sequence variant,splice variant,
ATP2B3	ATPase plasma membrane Ca2+ transporting 3(ATP2B3)	Homo sapiens				GO:0006810~transport,GO:0006874~cellular calcium ion homeostasis,GO:0034220~ion transmembrane transport,GO:0070588~calcium ion transmembrane transport,GO:1903779~regulation of cardiac conduction,	GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,GO:1903561~extracellular vesicle,	GO:0005388~calcium-transporting ATPase activity,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0030165~PDZ domain binding,GO:0046872~metal ion binding,	IPR001757:Cation-transporting P-type ATPase,IPR004014:Cation-transporting P-type ATPase, N-terminal,IPR006068:Cation-transporting P-type ATPase, C-terminal,IPR006408:Calcium-transporting P-type ATPase, subfamily IIB,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR022141:Calcium transporting P-type ATPase, C-terminal, plasma membrane,IPR023214:HAD-like domain,IPR023298:P-type ATPase,  transmembrane domain,IPR023299:P-type ATPase, cytoplasmic domain N,	hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04970:Salivary secretion,hsa04972:Pancreatic secretion,	302500~Spinocerebellar ataxia, X-linked 1,		SM00831:SM00831,	Alternative splicing,ATP-binding,Calcium,Calcium transport,Calmodulin-binding,Cell membrane,Coiled coil,Complete proteome,Disease mutation,Hydrolase,Ion transport,Magnesium,Membrane,Metal-binding,Neurodegeneration,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Plasma membrane calcium-transporting ATPase 3,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Pro,metal ion-binding site:Magnesium,modified residue,region of interest:Calmodulin-binding subdomain A,region of interest:Calmodulin-binding subdomain B,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ATR	ATR serine/threonine kinase(ATR)	Homo sapiens		h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_g2Pathway:Cell Cycle: G2/M Checkpoint,h_plk3Pathway:Regulation of cell cycle progression by Plk3,		GO:0000077~DNA damage checkpoint,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007275~multicellular organism development,GO:0008156~negative regulation of DNA replication,GO:0018105~peptidyl-serine phosphorylation,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0034644~cellular response to UV,GO:0036297~interstrand cross-link repair,GO:0042493~response to drug,GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator,GO:0046777~protein autophosphorylation,GO:0070198~protein localization to chromosome, telomeric region,GO:0071480~cellular response to gamma radiation,GO:0090399~replicative senescence,GO:0097694~establishment of RNA localization to telomere,GO:0097695~establishment of macromolecular complex localization to telomere,GO:1900034~regulation of cellular response to heat,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1904884~positive regulation of telomerase catalytic core complex assembly,	GO:0000784~nuclear chromosome, telomeric region,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005794~Golgi apparatus,GO:0016605~PML body,	GO:0003677~DNA binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0032405~MutLalpha complex binding,GO:0032407~MutSalpha complex binding,	IPR000403:Phosphatidylinositol 3-/4-kinase, catalytic domain,IPR003151:PIK-related kinase, FAT,IPR003152:PIK-related kinase, FATC,IPR011009:Protein kinase-like domain,IPR011989:Armadillo-like helical,IPR011990:Tetratricopeptide-like helical,IPR012993:UME,IPR014009:PIK-related kinase,IPR016024:Armadillo-type fold,IPR018936:Phosphatidylinositol 3/4-kinase, conserved site,IPR021133:HEAT, type 2,IPR026683:Serine/threonine-protein kinase TOR/Smg1,	hsa03460:Fanconi anemia pathway,hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa05166:HTLV-I infection,	210600~Seckel syndrome 1,614564~Cutaneous telangiectasia and cancer syndrome, familial,		SM00146:PI3Kc,SM00802:UME,SM01343:SM01343,	Alternative splicing,ATP-binding,Chromosome,Complete proteome,Disease mutation,DNA damage,DNA repair,DNA-binding,Dwarfism,Kinase,Manganese,Mental retardation,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Serine/threonine-protein kinase,Transferase,	chain:Serine/threonine-protein kinase ATR,domain:FAT,domain:FATC,domain:PI3K/PI4K,modified residue,mutagenesis site,repeat:HEAT 1,repeat:HEAT 2,sequence conflict,sequence variant,splice variant,
ATRX	ATRX, chromatin remodeler(ATRX)	Homo sapiens				GO:0006281~DNA repair,GO:0006306~DNA methylation,GO:0006310~DNA recombination,GO:0006334~nucleosome assembly,GO:0006336~DNA replication-independent nucleosome assembly,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007283~spermatogenesis,GO:0010571~positive regulation of nuclear cell cycle DNA replication,GO:0016569~covalent chromatin modification,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0030900~forebrain development,GO:0031297~replication fork processing,GO:0032206~positive regulation of telomere maintenance,GO:0032508~DNA duplex unwinding,GO:0035128~post-embryonic forelimb morphogenesis,GO:0035264~multicellular organism growth,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060009~Sertoli cell development,GO:0070198~protein localization to chromosome, telomeric region,GO:0072520~seminiferous tubule development,GO:0072711~cellular response to hydroxyurea,GO:1900112~regulation of histone H3-K9 trimethylation,GO:1901581~negative regulation of telomeric RNA transcription from RNA pol II promoter,GO:1901582~positive regulation of telomeric RNA transcription from RNA pol II promoter,GO:1904908~negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005720~nuclear heterochromatin,GO:0005721~pericentric heterochromatin,GO:0016605~PML body,GO:0031933~telomeric heterochromatin,GO:0070603~SWI/SNF superfamily-type complex,GO:1990707~nuclear subtelomeric heterochromatin,	GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003682~chromatin binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0015616~DNA translocase activity,GO:0035064~methylated histone binding,GO:0042393~histone binding,GO:0046872~metal ion binding,GO:0070087~chromo shadow domain binding,	IPR000330:SNF2-related,IPR001650:Helicase, C-terminal,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR025766:ADD domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		300448~Alpha-thalassemia myelodysplasia syndrome, somatic,301040~Alpha-thalassemia/mental retardation syndrome,309580~Mental retardation-hypotonic facies syndrome, X-linked,Mental retardation, X-linked 52~Mental retardation, X-linked 52,		SM00487:DEXDc,SM00490:HELICc,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Chromatin regulator,Chromosome,Coiled coil,Complete proteome,Disease mutation,DNA damage,DNA repair,DNA-binding,Helicase,Hydrolase,Isopeptide bond,Mental retardation,Metal-binding,Methylation,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Telomere,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Transcriptional regulator ATRX,compositionally biased region:Poly-Asp,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Ser,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEGH box,short sequence motif:PxVxL motif,splice variant,strand,turn,zinc finger region:GATA-type; atypical,zinc finger region:PHD-type,
BAP1	BRCA1 associated protein 1(BAP1)	Homo sapiens				GO:0001558~regulation of cell growth,GO:0006464~cellular protein modification process,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0008285~negative regulation of cell proliferation,GO:0016579~protein deubiquitination,GO:0035520~monoubiquitinated protein deubiquitination,GO:0035522~monoubiquitinated histone H2A deubiquitination,GO:0051726~regulation of cell cycle,GO:0071108~protein K48-linked deubiquitination,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0035517~PR-DUB complex,	GO:0003682~chromatin binding,GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0008233~peptidase activity,	IPR001578:Peptidase C12, ubiquitin carboxyl-terminal hydrolase 1,		614327~Tumor predisposition syndrome,			Chromatin regulator,Coiled coil,Complete proteome,Cytoplasm,Hydrolase,Nucleus,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Thiol protease,Ubl conjugation,Ubl conjugation pathway,	chain:Ubiquitin carboxyl-terminal hydrolase BAP1,modified residue,mutagenesis site,region of interest:Interaction with BRCA1,sequence variant,
BRIP1	BRCA1 interacting protein C-terminal helicase 1(BRIP1)	Homo sapiens				GO:0000077~DNA damage checkpoint,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0006139~nucleobase-containing compound metabolic process,GO:0006260~DNA replication,GO:0006302~double-strand break repair,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008285~negative regulation of cell proliferation,GO:0032508~DNA duplex unwinding,GO:0071295~cellular response to vitamin,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0031965~nuclear membrane,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0046872~metal ion binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR006554:Helicase-like, DEXD box c2 type,IPR006555:ATP-dependent helicase, C-terminal,IPR010614:DEAD2,IPR013020:DNA helicase (DNA repair), Rad3 type,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014013:Helicase, superfamily 1/2, ATP-binding domain, DinG/Rad3-type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03460:Fanconi anemia pathway,	114480~Breast cancer, early-onset,609054~Fanconi anemia, complementation group J,		SM00487:DEXDc,SM00488:DEXDc2,SM00491:HELICc2,	3D-structure,4Fe-4S,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Direct protein sequencing,Disease mutation,DNA damage,DNA repair,Fanconi anemia,Helicase,Hydrolase,Iron,Iron-sulfur,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Fanconi anemia group J protein,domain:Helicase ATP-binding,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Interaction with BRCA1,sequence conflict,sequence variant,short sequence motif:DEAH box,short sequence motif:Nuclear localization signal,splice variant,
BRCA1	BRCA1, DNA repair associated(BRCA1)	Homo sapiens		h_atmPathway:ATM Signaling Pathway,h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_bard1Pathway:BRCA1-dependent Ub-ligase activity,h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor,h_g2Pathway:Cell Cycle: G2/M Checkpoint,	Signal transduction mechanisms,	GO:0000724~double-strand break repair via homologous recombination,GO:0000729~DNA double-strand break processing,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006301~postreplication repair,GO:0006302~double-strand break repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006310~DNA recombination,GO:0006349~regulation of gene expression by genetic imprinting,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006359~regulation of transcription from RNA polymerase III promoter,GO:0006633~fatty acid biosynthetic process,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007098~centrosome cycle,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0009048~dosage compensation by inactivation of X chromosome,GO:0010212~response to ionizing radiation,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0010628~positive regulation of gene expression,GO:0016567~protein ubiquitination,GO:0016925~protein sumoylation,GO:0030521~androgen receptor signaling pathway,GO:0031052~chromosome breakage,GO:0031398~positive regulation of protein ubiquitination,GO:0031572~G2 DNA damage checkpoint,GO:0033147~negative regulation of intracellular estrogen receptor signaling pathway,GO:0035066~positive regulation of histone acetylation,GO:0035067~negative regulation of histone acetylation,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptotic process,GO:0043009~chordate embryonic development,GO:0043627~response to estrogen,GO:0044030~regulation of DNA methylation,GO:0045717~negative regulation of fatty acid biosynthetic process,GO:0045739~positive regulation of DNA repair,GO:0045766~positive regulation of angiogenesis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046600~negative regulation of centriole replication,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0051572~negative regulation of histone H3-K4 methylation,GO:0051573~negative regulation of histone H3-K9 methylation,GO:0051574~positive regulation of histone H3-K9 methylation,GO:0051865~protein autoubiquitination,GO:0070512~positive regulation of histone H4-K20 methylation,GO:0071158~positive regulation of cell cycle arrest,GO:0071356~cellular response to tumor necrosis factor,GO:0071681~cellular response to indole-3-methanol,GO:0085020~protein K6-linked ubiquitination,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2000378~negative regulation of reactive oxygen species metabolic process,GO:2000617~positive regulation of histone H3-K9 acetylation,GO:2000620~positive regulation of histone H4-K16 acetylation,	GO:0000151~ubiquitin ligase complex,GO:0000794~condensed nuclear chromosome,GO:0000800~lateral element,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0008274~gamma-tubulin ring complex,GO:0016021~integral component of membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0031436~BRCA1-BARD1 complex,GO:0043234~protein complex,GO:0070531~BRCA1-A complex,	GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0015631~tubulin binding,GO:0016874~ligase activity,GO:0019899~enzyme binding,GO:0031625~ubiquitin protein ligase binding,GO:0044212~transcription regulatory region DNA binding,GO:0050681~androgen receptor binding,	IPR001357:BRCT domain,IPR001841:Zinc finger, RING-type,IPR011364:Breast cancer type 1 susceptibility protein (BRCA1),IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,IPR018957:Zinc finger, C3HC4 RING-type,IPR025994:BRCA1, serine-rich domain,IPR027370:RING-type zinc-finger, LisH dimerisation motif,	hsa03460:Fanconi anemia pathway,hsa04120:Ubiquitin mediated proteolysis,hsa04151:PI3K-Akt signaling pathway,hsa05206:MicroRNAs in cancer,	604370~Breast-ovarian cancer, familial, 1,614320~Pancreatic cancer, susceptibility to, 4,	PIRSF001734:transcriptional regulator, BRCA1 type,	SM00184:RING,SM00292:BRCT,	3D-structure,Acetylation,Activator,Alternative initiation,Alternative splicing,Cell cycle,Chromosome,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,DNA damage,DNA recombination,DNA repair,DNA-binding,Fatty acid biosynthesis,Fatty acid metabolism,Isopeptide bond,Ligase,Lipid biosynthesis,Lipid metabolism,Membrane,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Transferase,Transmembrane,Transmembrane helix,Tumor suppressor,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Breast cancer type 1 susceptibility protein,compositionally biased region:Poly-Lys,domain:BRCT 1,domain:BRCT 2,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:RING-type,
BRCA2	BRCA2, DNA repair associated(BRCA2)	Homo sapiens		h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,		GO:0000722~telomere maintenance via recombination,GO:0000724~double-strand break repair via homologous recombination,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0000910~cytokinesis,GO:0001556~oocyte maturation,GO:0001833~inner cell mass cell proliferation,GO:0006289~nucleotide-excision repair,GO:0006302~double-strand break repair,GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:0007141~male meiosis I,GO:0007283~spermatogenesis,GO:0007420~brain development,GO:0007569~cell aging,GO:0008585~female gonad development,GO:0010165~response to X-ray,GO:0010225~response to UV-C,GO:0010332~response to gamma radiation,GO:0030097~hemopoiesis,GO:0031052~chromosome breakage,GO:0032465~regulation of cytokinesis,GO:0033600~negative regulation of mammary gland epithelial cell proliferation,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0043966~histone H3 acetylation,GO:0043967~histone H4 acetylation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045931~positive regulation of mitotic cell cycle,GO:0048478~replication fork protection,GO:0051298~centrosome duplication,GO:0070200~establishment of protein localization to telomere,GO:1990426~mitotic recombination-dependent replication fork processing,	GO:0000784~nuclear chromosome, telomeric region,GO:0000800~lateral element,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0016021~integral component of membrane,GO:0030141~secretory granule,GO:0033593~BRCA2-MAGE-D1 complex,GO:0043234~protein complex,	GO:0002020~protease binding,GO:0003697~single-stranded DNA binding,GO:0004402~histone acetyltransferase activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0010484~H3 histone acetyltransferase activity,GO:0010485~H4 histone acetyltransferase activity,GO:0043015~gamma-tubulin binding,	IPR002093:BRCA2 repeat,IPR012340:Nucleic acid-binding, OB-fold,IPR015187:BRCA2, oligonucleotide/oligosaccharide-binding 1,IPR015188:BRCA2, oligonucleotide/oligosaccharide-binding 3,IPR015205:Tower,IPR015252:DNA recombination/repair protein BRCA2, helical domain,IPR015525:Breast cancer type 2 susceptibility protein,	hsa03440:Homologous recombination,hsa03460:Fanconi anemia pathway,hsa05200:Pathways in cancer,hsa05212:Pancreatic cancer,	114480~Breast cancer, male, susceptibility to,155255~Medulloblastoma,176807~Prostate cancer,194070~Wilms tumor,605724~Fanconi anemia, complementation group D1,612555~Breast-ovarian cancer, familial, 2,613029~Glioblastoma 3,613347~Pancreatic cancer 2,	PIRSF002397:DNA recombination repair protein, BRCA2 type,	SM01341:SM01341,	3D-structure,Cell cycle,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,DNA damage,DNA recombination,DNA repair,DNA-binding,Fanconi anemia,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Tumor suppressor,Ubl conjugation,	chain:Breast cancer type 2 susceptibility protein,helix,modified residue,region of interest:Interaction with FANCD2,region of interest:Interaction with PALB2,repeat:BRCA2 1,repeat:BRCA2 2,repeat:BRCA2 3,repeat:BRCA2 4,repeat:BRCA2 5,repeat:BRCA2 6,repeat:BRCA2 7,repeat:BRCA2 8,sequence conflict,sequence variant,turn,
BUB1B	BUB1 mitotic checkpoint serine/threonine kinase B(BUB1B)	Homo sapiens			General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair,	GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0007091~metaphase/anaphase transition of mitotic cell cycle,GO:0007093~mitotic cell cycle checkpoint,GO:0007094~mitotic spindle assembly checkpoint,GO:0008283~cell proliferation,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0034501~protein localization to kinetochore,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0051301~cell division,GO:0051436~negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,	GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000778~condensed nuclear chromosome kinetochore,GO:0000940~condensed chromosome outer kinetochore,GO:0005680~anaphase-promoting complex,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,GO:0051233~spindle midzone,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR011009:Protein kinase-like domain,IPR013212:Mad3/BUB1 homology region 1,IPR015661:Mitotic checkpoint serine/threonine protein kinase Bub1/Mitotic spindle checkpoint component Mad3,	hsa04110:Cell cycle,hsa05166:HTLV-I infection,	114500~Colorectal cancer, somatic,176430~Premature chromatid separation trait,257300~Mosaic variegated aneuploidy syndrome 1,		SM00777:Mad3_BUB1_I,	3D-structure,Acetylation,Alternative splicing,Apoptosis,ATP-binding,Cell cycle,Cell division,Centromere,Chromosome,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Kinase,Kinetochore,Mitosis,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Tumor suppressor,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Mitotic checkpoint serine/threonine- protein kinase BUB1 beta,compositionally biased region:Poly-Glu,domain:CD1,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Necessary for interaction with CASC5,sequence conflict,sequence variant,short sequence motif:D-box,short sequence motif:Nuclear localization signal,site:Cleavage; by caspase-3,splice variant,
BLM	Bloom syndrome RecQ like helicase(BLM)	Homo sapiens				GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000724~double-strand break repair via homologous recombination,GO:0000729~DNA double-strand break processing,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0000733~DNA strand renaturation,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0010165~response to X-ray,GO:0016925~protein sumoylation,GO:0031297~replication fork processing,GO:0032508~DNA duplex unwinding,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045910~negative regulation of DNA recombination,GO:0048478~replication fork protection,GO:0051259~protein oligomerization,GO:0051782~negative regulation of cell division,GO:0071479~cellular response to ionizing radiation,GO:0072711~cellular response to hydroxyurea,GO:0072757~cellular response to camptothecin,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0000228~nuclear chromosome,GO:0000781~chromosome, telomeric region,GO:0000800~lateral element,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0016605~PML body,	GO:0000405~bubble DNA binding,GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0009378~four-way junction helicase activity,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016887~ATPase activity,GO:0036310~annealing helicase activity,GO:0043140~ATP-dependent 3'-5' DNA helicase activity,GO:0051880~G-quadruplex DNA binding,	IPR001650:Helicase, C-terminal,IPR002121:HRDC domain,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR004589:DNA helicase, ATP-dependent, RecQ type,IPR010997:HRDC-like,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR012532:BDHCT,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR018982:RQC domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03440:Homologous recombination,hsa03460:Fanconi anemia pathway,	210900~Bloom syndrome,		SM00341:HRDC,SM00487:DEXDc,SM00490:HELICc,SM00956:SM00956,	3D-structure,Acetylation,ATP-binding,Complete proteome,Disease mutation,DNA replication,DNA-binding,Dwarfism,Helicase,Hydrolase,Isopeptide bond,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Bloom syndrome protein,compositionally biased region:Poly-Asp,compositionally biased region:Poly-Ser,domain:Helicase ATP-binding,domain:Helicase C-terminal,domain:HRDC,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,short sequence motif:DEAH box,short sequence motif:Nuclear localization signal,
CXCR4	C-X-C motif chemokine receptor 4(CXCR4)	Homo sapiens	14.chemokine_receptor-ligand,15.T-cell_polarization-chemokine_receptors,	h_ccr5Pathway:Pertussis toxin-insensitive CCR5 Signaling in Macrophage,h_cxcr4Pathway:CXCR4 Signaling Pathway,h_nktPathway:Selective expression of chemokine receptors during T-cell polarization,h_vifPathway:HIV-1 defeats host-mediated resistance by CEM15,		GO:0000187~activation of MAPK activity,GO:0001666~response to hypoxia,GO:0002407~dendritic cell chemotaxis,GO:0006915~apoptotic process,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0009615~response to virus,GO:0019064~fusion of virus membrane with host plasma membrane,GO:0019722~calcium-mediated signaling,GO:0030260~entry into host cell,GO:0030334~regulation of cell migration,GO:0043217~myelin maintenance,GO:0048714~positive regulation of oligodendrocyte differentiation,GO:0050920~regulation of chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0071345~cellular response to cytokine stimulus,	GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030054~cell junction,GO:0031252~cell leading edge,GO:0031410~cytoplasmic vesicle,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0003779~actin binding,GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,GO:0015026~coreceptor activity,GO:0016494~C-X-C chemokine receptor activity,GO:0019955~cytokine binding,GO:0031625~ubiquitin protein ligase binding,GO:0032027~myosin light chain binding,GO:0043130~ubiquitin binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR001277:CXC chemokine receptor 4,IPR017452:GPCR, rhodopsin-like, 7TM,IPR022726:CXC chemokine receptor 4 N-terminal domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04144:Endocytosis,hsa04360:Axon guidance,hsa04670:Leukocyte transendothelial migration,hsa04672:Intestinal immune network for IgA production,hsa05200:Pathways in cancer,	193670~WHIM syndrome,Myelokathexis, isolated~Myelokathexis, isolated,			3D-structure,Alternative splicing,Cell junction,Cell membrane,Complete proteome,Disulfide bond,Endosome,G-protein coupled receptor,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Lysosome,Membrane,Phosphoprotein,Proteoglycan,Receptor,Reference proteome,Sulfation,Transducer,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:C-X-C chemokine receptor type 4,disulfide bond,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (Xyl...) (chondroitin sulfate),modified residue,mutagenesis site,short sequence motif:Important for signaling,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CEBPA	CCAAT/enhancer binding protein alpha(CEBPA)	Homo sapiens		h_keratinocytePathway:Keratinocyte Differentiation,h_mapkPathway:MAPKinase Signaling Pathway,		GO:0000050~urea cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001889~liver development,GO:0001892~embryonic placenta development,GO:0006091~generation of precursor metabolites and energy,GO:0006351~transcription, DNA-templated,GO:0006360~transcription from RNA polymerase I promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007005~mitochondrion organization,GO:0007219~Notch signaling pathway,GO:0008203~cholesterol metabolic process,GO:0008285~negative regulation of cell proliferation,GO:0016032~viral process,GO:0019221~cytokine-mediated signaling pathway,GO:0030099~myeloid cell differentiation,GO:0030225~macrophage differentiation,GO:0030324~lung development,GO:0030851~granulocyte differentiation,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0042593~glucose homeostasis,GO:0045444~fat cell differentiation,GO:0045600~positive regulation of fat cell differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045945~positive regulation of transcription from RNA polymerase III promoter,GO:0048469~cell maturation,GO:0048839~inner ear development,GO:0050872~white fat cell differentiation,GO:0050873~brown fat cell differentiation,GO:0055088~lipid homeostasis,GO:0071285~cellular response to lithium ion,GO:0071356~cellular response to tumor necrosis factor,GO:0071407~cellular response to organic cyclic compound,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001013~RNA polymerase I regulatory region DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019900~kinase binding,GO:0042803~protein homodimerization activity,GO:0044212~transcription regulatory region DNA binding,	IPR004827:Basic-leucine zipper domain,IPR016468:CCAAT/enhancer-binding,	hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05221:Acute myeloid leukemia,	601626~Leukemia, acute myeloid,601626~Leukemia, acute myeloid, somatic,	PIRSF005879:CCAAT/enhancer-binding protein,	SM00338:BRLZ,	Acetylation,Activator,Alternative initiation,Complete proteome,Developmental protein,Disease mutation,DNA-binding,Host-virus interaction,Isopeptide bond,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:CCAAT/enhancer-binding protein alpha,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,DNA-binding region:Basic motif,domain:Leucine-zipper,modified residue,sequence conflict,
CTCF	CCCTC-binding factor(CTCF)	Homo sapiens		h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,	General function prediction only,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006306~DNA methylation,GO:0006349~regulation of gene expression by genetic imprinting,GO:0006366~transcription from RNA polymerase II promoter,GO:0007059~chromosome segregation,GO:0010216~maintenance of DNA methylation,GO:0010628~positive regulation of gene expression,GO:0016569~covalent chromatin modification,GO:0016584~nucleosome positioning,GO:0031060~regulation of histone methylation,GO:0035065~regulation of histone acetylation,GO:0040029~regulation of gene expression, epigenetic,GO:0040030~regulation of molecular function, epigenetic,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0070602~regulation of centromeric sister chromatid cohesion,GO:0071459~protein localization to chromosome, centromeric region,	GO:0000775~chromosome, centromeric region,GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0043035~chromatin insulator sequence binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,		615502~Mental retardation, autosomal dominant 21,		SM00355:ZnF_C2H2,	3D-structure,Acetylation,Activator,Alternative splicing,Centromere,Chromatin regulator,Chromosome,Chromosome partition,Complete proteome,Direct protein sequencing,Disease mutation,DNA-binding,Isopeptide bond,Mental retardation,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Tumor suppressor,Ubl conjugation,Zinc,Zinc-finger,	chain:Transcriptional repressor CTCF,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),helix,modified residue,sequence variant,strand,turn,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11; atypical,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
CNOT3	CCR4-NOT transcription complex subunit 3(CNOT3)	Homo sapiens				GO:0000288~nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0001829~trophectodermal cell differentiation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0017148~negative regulation of translation,GO:0031047~gene silencing by RNA,GO:2000036~regulation of stem cell population maintenance,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005829~cytosol,GO:0030014~CCR4-NOT complex,GO:0030015~CCR4-NOT core complex,	GO:0005515~protein binding,	IPR007207:Not CCR4-Not complex component, N-terminal,IPR007282:NOT2/NOT3/NOT5,IPR012270:CCR4-NOT complex, subunit 3/ 5,	hsa03018:RNA degradation,		PIRSF005290:CCR4-NOT complex, subunits 3 and 5,		3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Developmental protein,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,RNA-mediated gene silencing,Transcription,Transcription regulation,Translation regulation,	chain:CCR4-NOT transcription complex subunit 3,compositionally biased region:Gly/Ser-rich,compositionally biased region:Pro-rich,modified residue,splice variant,
CD79A	CD79a molecule(CD79A)	Homo sapiens	5.B7_CD40_B-cell_activa,79.B_cell_Activation,	h_bcrmolecule:B Cell Receptor Complex,h_bcrPathway:BCR Signaling Pathway,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,		GO:0002250~adaptive immune response,GO:0030183~B cell differentiation,GO:0042100~B cell proliferation,GO:0042113~B cell activation,GO:0050853~B cell receptor signaling pathway,	GO:0005737~cytoplasm,GO:0005771~multivesicular body,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0019815~B cell receptor complex,GO:0045121~membrane raft,	GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,	IPR003110:Phosphorylated immunoreceptor signaling ITAM,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,	hsa04662:B cell receptor signaling pathway,hsa05340:Primary immunodeficiency,	613501~Agammaglobulinemia 3,		SM00077:ITAM,SM00408:IGc2,SM00409:IG,	3D-structure,Adaptive immunity,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Membrane,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:B-cell antigen receptor complex- associated protein alpha chain,disulfide bond,domain:Ig-like C2-type,domain:ITAM,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,sequence conflict,signal peptide,site:Required for binding to BLNK,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CD79B	CD79b molecule(CD79B)	Homo sapiens		h_bcrmolecule:B Cell Receptor Complex,h_bcrPathway:BCR Signaling Pathway,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,		GO:0002250~adaptive immune response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0030183~B cell differentiation,GO:0050853~B cell receptor signaling pathway,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0019815~B cell receptor complex,GO:0070062~extracellular exosome,	GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,	IPR003110:Phosphorylated immunoreceptor signaling ITAM,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04662:B cell receptor signaling pathway,	612692~Agammaglobulinemia 6,		SM00077:ITAM,SM00409:IG,	3D-structure,Adaptive immunity,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Membrane,Phosphoprotein,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:B-cell antigen receptor complex- associated protein beta chain,disulfide bond,domain:Ig-like V-type,domain:ITAM,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CYLD	CYLD lysine 63 deubiquitinase(CYLD)	Homo sapiens				GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007049~cell cycle,GO:0007346~regulation of mitotic cell cycle,GO:0010803~regulation of tumor necrosis factor-mediated signaling pathway,GO:0016055~Wnt signaling pathway,GO:0016579~protein deubiquitination,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032480~negative regulation of type I interferon production,GO:0042347~negative regulation of NF-kappaB import into nucleus,GO:0045087~innate immune response,GO:0070266~necroptotic process,GO:0070423~nucleotide-binding oligomerization domain containing signaling pathway,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0070536~protein K63-linked deubiquitination,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:1902017~regulation of cilium assembly,GO:1990108~protein linear deubiquitination,GO:2001238~positive regulation of extrinsic apoptotic signaling pathway,GO:2001242~regulation of intrinsic apoptotic signaling pathway,	GO:0005813~centrosome,GO:0005819~spindle,GO:0005829~cytosol,GO:0005874~microtubule,GO:0005881~cytoplasmic microtubule,GO:0030496~midbody,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0036064~ciliary basal body,GO:0048471~perinuclear region of cytoplasm,GO:0097542~ciliary tip,	GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0019901~protein kinase binding,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,GO:0061578~Lys63-specific deubiquitinase activity,GO:0070064~proline-rich region binding,	IPR000938:CAP Gly-rich domain,IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,	hsa04380:Osteoclast differentiation,hsa04622:RIG-I-like receptor signaling pathway,	132700~Cylindromatosis, familial,601606~Trichoepithelioma, multiple familial, 1,605041~Brooke-Spiegler syndrome,		SM01052:SM01052,	3D-structure,Alternative splicing,Cell cycle,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Hydrolase,Immunity,Innate immunity,Membrane,Metal-binding,Microtubule,Phosphoprotein,Protease,Proteomics identification,Reference proteome,Repeat,Thiol protease,Tumor suppressor,Ubl conjugation pathway,Wnt signaling pathway,Zinc,	chain:Probable ubiquitin carboxyl-terminal hydrolase CYLD,domain:CAP-Gly 1,domain:CAP-Gly 2,helix,modified residue,mutagenesis site,region of interest:Interaction with NEMO,region of interest:Interaction with TRAF2,region of interest:Interaction with TRIP,sequence variant,splice variant,strand,turn,
CBLB	Cbl proto-oncogene B(CBLB)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0006508~proteolysis,GO:0006607~NLS-bearing protein import into nucleus,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007175~negative regulation of epidermal growth factor-activated receptor activity,GO:0023051~regulation of signaling,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0045121~membrane raft,	GO:0001784~phosphotyrosine binding,GO:0004842~ubiquitin-protein transferase activity,GO:0004871~signal transducer activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0017124~SH3 domain binding,GO:0030971~receptor tyrosine kinase binding,GO:0061630~ubiquitin protein ligase activity,	IPR000980:SH2 domain,IPR001841:Zinc finger, RING-type,IPR003153:Adaptor protein Cbl, N-terminal helical,IPR009060:UBA-like,IPR011992:EF-hand-like domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR014741:Adaptor protein Cbl, EF hand-like,IPR014742:Adaptor protein Cbl, SH2-like,IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote,IPR017907:Zinc finger, RING-type, conserved site,IPR024159:Adaptor protein Cbl, PTB domain,IPR024162:Adaptor protein Cbl,	hsa04012:ErbB signaling pathway,hsa04120:Ubiquitin mediated proteolysis,hsa04144:Endocytosis,hsa04910:Insulin signaling pathway,hsa05100:Bacterial invasion of epithelial cells,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05220:Chronic myeloid leukemia,			SM00165:UBA,SM00184:RING,	3D-structure,Alternative splicing,Calcium,Complete proteome,Cytoplasm,Ligase,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	binding site:Phosphotyrosine,chain:E3 ubiquitin-protein ligase CBL-B,compositionally biased region:Pro-rich,domain:CBL N-terminal,domain:EF-hand-like 1,domain:EF-hand-like 2,domain:SH2; atypical,domain:UBA,helix,modified residue,mutagenesis site,region of interest:4H,region of interest:Interaction with SH3KBP1,region of interest:Interaction with VAV1,region of interest:Linker,sequence conflict,sequence variant,splice variant,turn,zinc finger region:RING-type,
DDX3X	DEAD-box helicase 3, X-linked(DDX3X)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007059~chromosome segregation,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0009615~response to virus,GO:0010501~RNA secondary structure unwinding,GO:0010628~positive regulation of gene expression,GO:0016055~Wnt signaling pathway,GO:0017148~negative regulation of translation,GO:0030307~positive regulation of cell growth,GO:0030308~negative regulation of cell growth,GO:0031333~negative regulation of protein complex assembly,GO:0032508~DNA duplex unwinding,GO:0032728~positive regulation of interferon-beta production,GO:0034063~stress granule assembly,GO:0035556~intracellular signal transduction,GO:0042256~mature ribosome assembly,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0045070~positive regulation of viral genome replication,GO:0045087~innate immune response,GO:0045727~positive regulation of translation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045948~positive regulation of translational initiation,GO:0071243~cellular response to arsenic-containing substance,GO:0071470~cellular response to osmotic stress,GO:0071651~positive regulation of chemokine (C-C motif) ligand 5 production,GO:0097193~intrinsic apoptotic signaling pathway,GO:0098609~cell-cell adhesion,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,GO:1903608~protein localization to cytoplasmic stress granule,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005741~mitochondrial outer membrane,GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0005913~cell-cell adherens junction,GO:0010494~cytoplasmic stress granule,GO:0016607~nuclear speck,GO:0022627~cytosolic small ribosomal subunit,GO:0070062~extracellular exosome,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003924~GTPase activity,GO:0004003~ATP-dependent DNA helicase activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0008143~poly(A) binding,GO:0008190~eukaryotic initiation factor 4E binding,GO:0016887~ATPase activity,GO:0017111~nucleoside-triphosphatase activity,GO:0031369~translation initiation factor binding,GO:0035613~RNA stem-loop binding,GO:0043024~ribosomal small subunit binding,GO:0043273~CTPase activity,GO:0044822~poly(A) RNA binding,GO:0048027~mRNA 5'-UTR binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04622:RIG-I-like receptor signaling pathway,hsa05161:Hepatitis B,hsa05203:Viral carcinogenesis,	300958~Mental retardation, X-linked 102,		SM00487:DEXDc,SM00490:HELICc,	3D-structure,Acetylation,Alternative splicing,Apoptosis,ATP-binding,Chromosome partition,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,DNA-binding,Helicase,Host-virus interaction,Hydrolase,Immunity,Innate immunity,Isopeptide bond,Membrane,Mental retardation,Methylation,Mitochondrion,Mitochondrion outer membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribosome biogenesis,RNA-binding,Transcription,Transcription regulation,Translation regulation,Ubl conjugation,	chain:ATP-dependent RNA helicase DDX3X,compositionally biased region:Gly/Ser-rich,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Necessary for interaction with XPO1,sequence conflict,sequence variant,short sequence motif:DEAD box,short sequence motif:Q motif,strand,
DNMT3A	DNA methyltransferase 3 alpha(DNMT3A)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000278~mitotic cell cycle,GO:0006306~DNA methylation,GO:0006346~methylation-dependent chromatin silencing,GO:0006349~regulation of gene expression by genetic imprinting,GO:0007283~spermatogenesis,GO:0007568~aging,GO:0009636~response to toxic substance,GO:0010212~response to ionizing radiation,GO:0010288~response to lead ion,GO:0010424~DNA methylation on cytosine within a CG sequence,GO:0010468~regulation of gene expression,GO:0010942~positive regulation of cell death,GO:0030182~neuron differentiation,GO:0032355~response to estradiol,GO:0033189~response to vitamin A,GO:0042220~response to cocaine,GO:0042493~response to drug,GO:0043045~DNA methylation involved in embryo development,GO:0043046~DNA methylation involved in gamete generation,GO:0044027~hypermethylation of CpG island,GO:0045814~negative regulation of gene expression, epigenetic,GO:0046498~S-adenosylhomocysteine metabolic process,GO:0046499~S-adenosylmethioninamine metabolic process,GO:0071230~cellular response to amino acid stimulus,GO:0071361~cellular response to ethanol,GO:0071456~cellular response to hypoxia,GO:0090116~C-5 methylation of cytosine,GO:0097284~hepatocyte apoptotic process,	GO:0000775~chromosome, centromeric region,GO:0000791~euchromatin,GO:0001741~XY body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005720~nuclear heterochromatin,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003886~DNA (cytosine-5-)-methyltransferase activity,GO:0005515~protein binding,GO:0009008~DNA-methyltransferase activity,GO:0042802~identical protein binding,GO:0045322~unmethylated CpG binding,GO:0046872~metal ion binding,GO:0051718~DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates,	IPR000313:PWWP,IPR001525:C-5 cytosine methyltransferase,IPR018117:DNA methylase, C-5 cytosine-specific, active site,IPR025766:ADD domain,	hsa00270:Cysteine and methionine metabolism,hsa01100:Metabolic pathways,hsa05206:MicroRNAs in cancer,	615879~Tatton-Brown-Rahman syndrome,		SM00293:PWWP,	3D-structure,Alternative promoter usage,Alternative splicing,Chromatin regulator,Complete proteome,Cytoplasm,Disease mutation,DNA-binding,Mental retardation,Metal-binding,Methylation,Methyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,S-adenosyl-L-methionine,Transferase,Ubl conjugation,Zinc,Zinc-finger,	chain:DNA (cytosine-5)-methyltransferase 3A,domain:PWWP,helix,modified residue,mutagenesis site,region of interest:Interaction with DNMT1 and DNMT3B,region of interest:Interaction with the PRC2/EED-EZH2 complex,splice variant,strand,turn,zinc finger region:ADD-type,
POLE	DNA polymerase epsilon, catalytic subunit(POLE)	Homo sapiens				GO:0000082~G1/S transition of mitotic cell cycle,GO:0000722~telomere maintenance via recombination,GO:0000731~DNA synthesis involved in DNA repair,GO:0006260~DNA replication,GO:0006270~DNA replication initiation,GO:0006272~leading strand elongation,GO:0006281~DNA repair,GO:0006287~base-excision repair, gap-filling,GO:0006297~nucleotide-excision repair, DNA gap filling,GO:0045004~DNA replication proofreading,GO:0048568~embryonic organ development,GO:0090305~nucleic acid phosphodiester bond hydrolysis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0008622~epsilon DNA polymerase complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0008270~zinc ion binding,GO:0008310~single-stranded DNA 3'-5' exodeoxyribonuclease activity,GO:0008408~3'-5' exonuclease activity,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR006133:DNA-directed DNA polymerase, family B, exonuclease domain,IPR006134:DNA-directed DNA polymerase, family B, multifunctional domain,IPR006172:DNA-directed DNA polymerase, family B,IPR012337:Ribonuclease H-like domain,IPR013697:DNA polymerase epsilon, catalytic subunit A, C-terminal,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,hsa03030:DNA replication,hsa03410:Base excision repair,hsa03420:Nucleotide excision repair,hsa05166:HTLV-I infection,	615083~Colorectal cancer, susceptibility to, 12,615139~FILS syndrome,		SM00486:POLBc,SM01159:SM01159,	4Fe-4S,Complete proteome,Direct protein sequencing,Disease mutation,DNA damage,DNA repair,DNA replication,DNA-binding,DNA-directed DNA polymerase,Iron,Iron-sulfur,Metal-binding,Nucleotidyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,Zinc,Zinc-finger,	chain:DNA polymerase epsilon catalytic subunit A,modified residue,sequence conflict,sequence variant,zinc finger region:C4-type,
ERCC2	ERCC excision repair 2, TFIIH core complex helicase subunit(ERCC2)	Homo sapiens				GO:0000717~nucleotide-excision repair, DNA duplex unwinding,GO:0001666~response to hypoxia,GO:0001701~in utero embryonic development,GO:0006139~nucleobase-containing compound metabolic process,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006289~nucleotide-excision repair,GO:0006293~nucleotide-excision repair, preincision complex stabilization,GO:0006294~nucleotide-excision repair, preincision complex assembly,GO:0006295~nucleotide-excision repair, DNA incision, 3'-to lesion,GO:0006296~nucleotide-excision repair, DNA incision, 5'-to lesion,GO:0006361~transcription initiation from RNA polymerase I promoter,GO:0006362~transcription elongation from RNA polymerase I promoter,GO:0006363~termination of RNA polymerase I transcription,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006370~7-methylguanosine mRNA capping,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0006979~response to oxidative stress,GO:0007059~chromosome segregation,GO:0007568~aging,GO:0008283~cell proliferation,GO:0009650~UV protection,GO:0009791~post-embryonic development,GO:0016032~viral process,GO:0021510~spinal cord development,GO:0030198~extracellular matrix organization,GO:0030282~bone mineralization,GO:0032289~central nervous system myelin formation,GO:0033683~nucleotide-excision repair, DNA incision,GO:0035264~multicellular organism growth,GO:0035315~hair cell differentiation,GO:0040016~embryonic cleavage,GO:0043249~erythrocyte maturation,GO:0043388~positive regulation of DNA binding,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048820~hair follicle maturation,GO:0060218~hematopoietic stem cell differentiation,GO:0070911~global genome nucleotide-excision repair,GO:1901990~regulation of mitotic cell cycle phase transition,	GO:0000439~core TFIIH complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005669~transcription factor TFIID complex,GO:0005675~holo TFIIH complex,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0019907~cyclin-dependent protein kinase activating kinase holoenzyme complex,GO:0071817~MMXD complex,	GO:0003677~DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004672~protein kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0008094~DNA-dependent ATPase activity,GO:0008353~RNA polymerase II carboxy-terminal domain kinase activity,GO:0043139~5'-3' DNA helicase activity,GO:0046872~metal ion binding,GO:0047485~protein N-terminus binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR001945:Xeroderma pigmentosum group D protein,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR006554:Helicase-like, DEXD box c2 type,IPR006555:ATP-dependent helicase, C-terminal,IPR010614:DEAD2,IPR010643:Domain of unknown function DUF1227,IPR013020:DNA helicase (DNA repair), Rad3 type,IPR014013:Helicase, superfamily 1/2, ATP-binding domain, DinG/Rad3-type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03022:Basal transcription factors,hsa03420:Nucleotide excision repair,	278730~Xeroderma pigmentosum, group D,601675~Trichothiodystrophy 1, photosensitive,610756~Cerebrooculofacioskeletal syndrome 2,		SM00488:DEXDc2,SM00491:HELICc2,	3D-structure,4Fe-4S,Alternative splicing,ATP-binding,Cataract,Chromosome partition,Cockayne syndrome,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Deafness,Disease mutation,DNA damage,DNA repair,DNA-binding,Dwarfism,Helicase,Host-virus interaction,Hydrolase,Ichthyosis,Iron,Iron-sulfur,Magnesium,Metal-binding,Nucleotide-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,Xeroderma pigmentosum,	chain:TFIIH basal transcription factor complex helicase subunit,domain:Helicase ATP-binding,metal ion-binding site:Iron-sulfur (4Fe-4S),mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,short sequence motif:DEAH box,short sequence motif:Nuclear localization signal,
ERCC3	ERCC excision repair 3, TFIIH core complex helicase subunit(ERCC3)	Homo sapiens		h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor,h_hSWI-SNFpathway:Chromatin Remodeling by hSWI/SNF ATP-dependent Complexes,h_rarrxrPathway:Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells,		GO:0000717~nucleotide-excision repair, DNA duplex unwinding,GO:0001666~response to hypoxia,GO:0006265~DNA topological change,GO:0006281~DNA repair,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006289~nucleotide-excision repair,GO:0006293~nucleotide-excision repair, preincision complex stabilization,GO:0006294~nucleotide-excision repair, preincision complex assembly,GO:0006295~nucleotide-excision repair, DNA incision, 3'-to lesion,GO:0006296~nucleotide-excision repair, DNA incision, 5'-to lesion,GO:0006361~transcription initiation from RNA polymerase I promoter,GO:0006362~transcription elongation from RNA polymerase I promoter,GO:0006363~termination of RNA polymerase I transcription,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006370~7-methylguanosine mRNA capping,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0006979~response to oxidative stress,GO:0008104~protein localization,GO:0009411~response to UV,GO:0009650~UV protection,GO:0016032~viral process,GO:0033683~nucleotide-excision repair, DNA incision,GO:0035315~hair cell differentiation,GO:0043065~positive regulation of apoptotic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048568~embryonic organ development,GO:0070911~global genome nucleotide-excision repair,GO:1901990~regulation of mitotic cell cycle phase transition,	GO:0000439~core TFIIH complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005669~transcription factor TFIID complex,GO:0005675~holo TFIIH complex,	GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004386~helicase activity,GO:0004672~protein kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0008022~protein C-terminus binding,GO:0008094~DNA-dependent ATPase activity,GO:0008134~transcription factor binding,GO:0008353~RNA polymerase II carboxy-terminal domain kinase activity,GO:0016887~ATPase activity,GO:0032564~dATP binding,GO:0042277~peptide binding,GO:0043138~3'-5' DNA helicase activity,GO:0047485~protein N-terminus binding,	IPR001161:Helicase Ercc3,IPR001650:Helicase, C-terminal,IPR006935:Helicase/UvrB domain,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03022:Basal transcription factors,hsa03420:Nucleotide excision repair,	610651~Xeroderma pigmentosum, group B,616390~Trichothiodystrophy 2, photosensitive,		SM00487:DEXDc,SM00490:HELICc,	3D-structure,ATP-binding,Cockayne syndrome,Complete proteome,Deafness,Disease mutation,DNA damage,DNA repair,DNA-binding,Dwarfism,Helicase,Host-virus interaction,Hydrolase,Ichthyosis,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Xeroderma pigmentosum,	chain:TFIIH basal transcription factor complex helicase XPB subunit,compositionally biased region:Asp/Glu-rich (acidic),domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,short sequence motif:DEVH box,short sequence motif:Nuclear localization signal,
ERCC4	ERCC excision repair 4, endonuclease catalytic subunit(ERCC4)	Homo sapiens				GO:0000712~resolution of meiotic recombination intermediates,GO:0000723~telomere maintenance,GO:0000724~double-strand break repair via homologous recombination,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006289~nucleotide-excision repair,GO:0006293~nucleotide-excision repair, preincision complex stabilization,GO:0006295~nucleotide-excision repair, DNA incision, 3'-to lesion,GO:0006296~nucleotide-excision repair, DNA incision, 5'-to lesion,GO:0009411~response to UV,GO:0009650~UV protection,GO:0032205~negative regulation of telomere maintenance,GO:0033683~nucleotide-excision repair, DNA incision,GO:0034644~cellular response to UV,GO:0036297~interstrand cross-link repair,GO:0070911~global genome nucleotide-excision repair,GO:1901255~nucleotide-excision repair involved in interstrand cross-link repair,	GO:0000109~nucleotide-excision repair complex,GO:0000110~nucleotide-excision repair factor 1 complex,GO:0000781~chromosome, telomeric region,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005669~transcription factor TFIID complex,GO:0070522~ERCC4-ERCC1 complex,	GO:0000014~single-stranded DNA endodeoxyribonuclease activity,GO:0001094~TFIID-class transcription factor binding,GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003697~single-stranded DNA binding,GO:0004519~endonuclease activity,GO:0004520~endodeoxyribonuclease activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0043566~structure-specific DNA binding,GO:0047485~protein N-terminus binding,	IPR006166:ERCC4 domain,IPR006167:DNA repair protein,IPR010994:RuvA domain 2-like,IPR011335:Restriction endonuclease  type II-like,IPR020819:DNA repair nuclease, XPF-type/Helicase,	hsa03420:Nucleotide excision repair,hsa03460:Fanconi anemia pathway,	278760~Xeroderma pigmentosum, group F,278760~Xeroderma pigmentosum, type F/Cockayne syndrome,610965~XFE progeroid syndrome,615272~Fanconi anemia, complementation group Q,		SM00891:SM00891,	3D-structure,Acetylation,Alternative splicing,Cockayne syndrome,Complete proteome,Disease mutation,DNA damage,DNA repair,DNA-binding,Dwarfism,Endonuclease,Fanconi anemia,Hydrolase,Magnesium,Nuclease,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Xeroderma pigmentosum,	chain:DNA repair endonuclease XPF,domain:ERCC4,domain:Leucine-zipper 1,domain:Leucine-zipper 2,helix,modified residue,region of interest:Interaction with EME1 and ERCC1,sequence variant,short sequence motif:Nuclear localization signal,strand,
ERCC5	ERCC excision repair 5, endonuclease(ERCC5)	Homo sapiens				GO:0006281~DNA repair,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006293~nucleotide-excision repair, preincision complex stabilization,GO:0006294~nucleotide-excision repair, preincision complex assembly,GO:0006295~nucleotide-excision repair, DNA incision, 3'-to lesion,GO:0006296~nucleotide-excision repair, DNA incision, 5'-to lesion,GO:0009411~response to UV,GO:0009650~UV protection,GO:0010225~response to UV-C,GO:0033683~nucleotide-excision repair, DNA incision,GO:0043066~negative regulation of apoptotic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005662~DNA replication factor A complex,GO:0005675~holo TFIIH complex,GO:0016021~integral component of membrane,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,	GO:0000405~bubble DNA binding,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0004518~nuclease activity,GO:0004520~endodeoxyribonuclease activity,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0047485~protein N-terminus binding,	IPR001044:XPG/Rad2 endonuclease, eukaryotes,IPR006084:XPG/Rad2 endonuclease,IPR006085:XPG N-terminal,IPR006086:XPG-I domain,IPR008918:Helix-hairpin-helix motif, class 2,IPR019974:XPG conserved site,IPR020045:5'-3' exonuclease, C-terminal domain,	hsa03420:Nucleotide excision repair,	278780~Xeroderma pigmentosum, group G,278780~Xeroderma pigmentosum, group G/Cockayne syndrome,616570~Cerebrooculofacioskeletal syndrome 3,		SM00279:HhH2,SM00484:XPGI,SM00485:XPGN,	3D-structure,Acetylation,Alternative splicing,Cockayne syndrome,Complete proteome,Deafness,Disease mutation,DNA damage,DNA repair,DNA-binding,Dwarfism,Endonuclease,Hydrolase,Magnesium,Membrane,Metal-binding,Nuclease,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Xeroderma pigmentosum,	chain:DNA repair protein complementing XP-G cells,metal ion-binding site:Magnesium 1,metal ion-binding site:Magnesium 2,modified residue,region of interest:I-domain,region of interest:Interaction with PCNA,region of interest:N-domain,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,
FBXW7	F-box and WD repeat domain containing 7(FBXW7)	Homo sapiens		h_fbw7Pathway:Cyclin E Destruction Pathway,		GO:0000209~protein polyubiquitination,GO:0001944~vasculature development,GO:0006974~cellular response to DNA damage stimulus,GO:0007062~sister chromatid cohesion,GO:0010868~negative regulation of triglyceride biosynthetic process,GO:0010883~regulation of lipid storage,GO:0016032~viral process,GO:0016567~protein ubiquitination,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0031398~positive regulation of protein ubiquitination,GO:0032876~negative regulation of DNA endoreduplication,GO:0032880~regulation of protein localization,GO:0034644~cellular response to UV,GO:0045741~positive regulation of epidermal growth factor-activated receptor activity,GO:0045746~negative regulation of Notch signaling pathway,GO:0050821~protein stabilization,GO:0051443~positive regulation of ubiquitin-protein transferase activity,GO:0055088~lipid homeostasis,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:1901800~positive regulation of proteasomal protein catabolic process,GO:1902806~regulation of cell cycle G1/S phase transition,GO:1903146~regulation of mitophagy,GO:1903378~positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,GO:1903955~positive regulation of protein targeting to mitochondrion,GO:2000060~positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:2000346~negative regulation of hepatocyte proliferation,GO:2000639~negative regulation of SREBP signaling pathway,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0019005~SCF ubiquitin ligase complex,GO:0043234~protein complex,GO:1990452~Parkin-FBXW7-Cul1 ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0030332~cyclin binding,GO:0030674~protein binding, bridging,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0050816~phosphothreonine binding,GO:0097027~ubiquitin-protein transferase activator activity,	IPR001680:WD40 repeat,IPR001810:F-box domain, cyclin-like,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	hsa04120:Ubiquitin mediated proteolysis,			SM00256:FBOX,SM00320:WD40,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Host-virus interaction,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Ubl conjugation,Ubl conjugation pathway,WD repeat,	chain:F-box/WD repeat-containing protein 7,domain:F-box,helix,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,sequence variant,splice variant,strand,turn,
FBXO11	F-box protein 11(FBXO11)	Homo sapiens			Inorganic ion transport and metabolism,	GO:0006464~cellular protein modification process,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007605~sensory perception of sound,GO:0016567~protein ubiquitination,GO:0035246~peptidyl-arginine N-methylation,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016274~protein-arginine N-methyltransferase activity,	IPR001810:F-box domain, cyclin-like,IPR003126:Zinc finger, N-recognin,IPR006626:Parallel beta-helix repeat,IPR006633:Carbohydrate-binding/sugar hydrolysis domain,IPR007742:Periplasmic copper-binding protein NosD, beta helix domain,IPR011050:Pectin lyase fold/virulence factor,IPR012334:Pectin lyase fold,IPR022441:Parallel beta-helix repeat-2,				SM00256:FBOX,SM00396:ZnF_UBR1,SM00710:PbH1,SM00722:CASH,	Alternative splicing,Chromosome,Complete proteome,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:F-box only protein 11,domain:F-box,repeat:PbH1 1,repeat:PbH1 10,repeat:PbH1 11,repeat:PbH1 12,repeat:PbH1 13,repeat:PbH1 14,repeat:PbH1 15,repeat:PbH1 16,repeat:PbH1 17,repeat:PbH1 18,repeat:PbH1 19,repeat:PbH1 2,repeat:PbH1 3,repeat:PbH1 4,repeat:PbH1 5,repeat:PbH1 6,repeat:PbH1 7,repeat:PbH1 8,repeat:PbH1 9,sequence conflict,sequence variant,splice variant,zinc finger region:UBR-type,
FAT1	FAT atypical cadherin 1(FAT1)	Homo sapiens				GO:0007015~actin filament organization,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007163~establishment or maintenance of cell polarity,GO:0007267~cell-cell signaling,GO:0009653~anatomical structure morphogenesis,GO:0016337~single organismal cell-cell adhesion,GO:0016477~cell migration,	GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030027~lamellipodium,GO:0030175~filopodium,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001791:Laminin G domain,IPR001881:EGF-like calcium-binding,IPR002126:Cadherin,IPR013032:EGF-like, conserved site,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR015919:Cadherin-like,IPR018097:EGF-like calcium-binding, conserved site,IPR020894:Cadherin conserved site,				SM00112:CA,SM00179:EGF_CA,SM00181:EGF,SM00282:LamG,	Calcium,Cell adhesion,Cell membrane,Complete proteome,Cytoplasm,Disulfide bond,EGF-like domain,Glycoprotein,Membrane,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Protocadherin Fat 1,disulfide bond,domain:Cadherin 1,domain:Cadherin 10,domain:Cadherin 11,domain:Cadherin 12,domain:Cadherin 13,domain:Cadherin 14,domain:Cadherin 15,domain:Cadherin 16,domain:Cadherin 17,domain:Cadherin 18,domain:Cadherin 19,domain:Cadherin 2,domain:Cadherin 20,domain:Cadherin 21,domain:Cadherin 22,domain:Cadherin 23,domain:Cadherin 24,domain:Cadherin 25,domain:Cadherin 26,domain:Cadherin 27,domain:Cadherin 28,domain:Cadherin 29,domain:Cadherin 3,domain:Cadherin 30,domain:Cadherin 31,domain:Cadherin 32,domain:Cadherin 33,domain:Cadherin 34,domain:Cadherin 4,domain:Cadherin 5,domain:Cadherin 6,domain:Cadherin 7,domain:Cadherin 8,domain:Cadherin 9,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3,domain:EGF-like 4,domain:EGF-like 5,domain:Laminin G-like,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
FAT4	FAT atypical cadherin 4(FAT4)	Homo sapiens				GO:0001658~branching involved in ureteric bud morphogenesis,GO:0003007~heart morphogenesis,GO:0007009~plasma membrane organization,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007219~Notch signaling pathway,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0021987~cerebral cortex development,GO:0022008~neurogenesis,GO:0035329~hippo signaling,GO:0043931~ossification involved in bone maturation,GO:0048565~digestive tract development,GO:0060122~inner ear receptor stereocilium organization,GO:0072137~condensed mesenchymal cell proliferation,GO:0072307~regulation of metanephric nephron tubule epithelial cell differentiation,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0045177~apical part of cell,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001791:Laminin G domain,IPR001881:EGF-like calcium-binding,IPR002126:Cadherin,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR013032:EGF-like, conserved site,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR015919:Cadherin-like,IPR018097:EGF-like calcium-binding, conserved site,IPR020894:Cadherin conserved site,		615546~Van Maldergem syndrome 2,616006~Hennekam lymphangiectasia-lymphedema syndrome 2,		SM00112:CA,SM00179:EGF_CA,SM00181:EGF,SM00282:LamG,	Alternative splicing,Calcium,Cell adhesion,Complete proteome,Deafness,Disease mutation,Disulfide bond,EGF-like domain,Glycoprotein,Membrane,Mental retardation,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Protocadherin Fat 4,disulfide bond,domain:Cadherin 1,domain:Cadherin 10,domain:Cadherin 11,domain:Cadherin 12,domain:Cadherin 13,domain:Cadherin 14,domain:Cadherin 15,domain:Cadherin 16,domain:Cadherin 17,domain:Cadherin 18,domain:Cadherin 19,domain:Cadherin 2,domain:Cadherin 20,domain:Cadherin 21,domain:Cadherin 22,domain:Cadherin 23,domain:Cadherin 24,domain:Cadherin 25,domain:Cadherin 26,domain:Cadherin 27,domain:Cadherin 28,domain:Cadherin 29,domain:Cadherin 3,domain:Cadherin 30,domain:Cadherin 31,domain:Cadherin 32,domain:Cadherin 33,domain:Cadherin 34,domain:Cadherin 4,domain:Cadherin 5,domain:Cadherin 6,domain:Cadherin 7,domain:Cadherin 8,domain:Cadherin 9,domain:EGF-like 1,domain:EGF-like 2; calcium-binding,domain:EGF-like 3; calcium-binding,domain:EGF-like 4,domain:EGF-like 5,domain:EGF-like 6,domain:Laminin G-like 1,domain:Laminin G-like 2,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
FANCA	Fanconi anemia complementation group A(FANCA)	Homo sapiens		h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_bard1Pathway:BRCA1-dependent Ub-ligase activity,		GO:0006281~DNA repair,GO:0006461~protein complex assembly,GO:0007140~male meiosis,GO:0008584~male gonad development,GO:0008585~female gonad development,GO:0036297~interstrand cross-link repair,GO:0042127~regulation of cell proliferation,GO:0045589~regulation of regulatory T cell differentiation,GO:0050727~regulation of inflammatory response,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,GO:2000348~regulation of CD40 signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0043240~Fanconi anaemia nuclear complex,	GO:0005515~protein binding,	IPR003516:Fanconi anaemia group A protein,	hsa03460:Fanconi anemia pathway,	227650~Fanconi anemia, complementation group A,			Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,DNA damage,DNA repair,Fanconi anemia,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,	chain:Fanconi anemia group A protein,modified residue,sequence variant,short sequence motif:Nuclear localization signal,splice variant,
FANCC	Fanconi anemia complementation group C(FANCC)	Homo sapiens		h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_bard1Pathway:BRCA1-dependent Ub-ligase activity,		GO:0006281~DNA repair,GO:0006289~nucleotide-excision repair,GO:0006461~protein complex assembly,GO:0034599~cellular response to oxidative stress,GO:0036297~interstrand cross-link repair,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0043240~Fanconi anaemia nuclear complex,	GO:0005515~protein binding,	IPR000686:Fanconi anaemia group C protein,	hsa03460:Fanconi anemia pathway,	227645~Fanconi anemia, complementation group C,	PIRSF018417:Fanconi anemia group C protein,		Complete proteome,Cytoplasm,Disease mutation,DNA damage,DNA repair,Fanconi anemia,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:Fanconi anemia group C protein,sequence conflict,sequence variant,
FANCD2	Fanconi anemia complementation group D2(FANCD2)	Homo sapiens		h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_bard1Pathway:BRCA1-dependent Ub-ligase activity,		GO:0006281~DNA repair,GO:0007129~synapsis,GO:0007276~gamete generation,GO:0010332~response to gamma radiation,GO:0034599~cellular response to oxidative stress,GO:0036297~interstrand cross-link repair,GO:0045589~regulation of regulatory T cell differentiation,GO:0048854~brain morphogenesis,GO:0050727~regulation of inflammatory response,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,GO:0097150~neuronal stem cell population maintenance,GO:2000348~regulation of CD40 signaling pathway,	GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0070182~DNA polymerase binding,		hsa03460:Fanconi anemia pathway,	227646~Fanconi anemia, complementation group D2,			Alternative splicing,Cell cycle,Complete proteome,Disease mutation,DNA damage,DNA repair,Fanconi anemia,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Fanconi anemia group D2 protein,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,mutagenesis site,region of interest:Interaction with BRCA2,region of interest:Interaction with FANCE,sequence conflict,sequence variant,splice variant,
FANCE	Fanconi anemia complementation group E(FANCE)	Homo sapiens		h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_bard1Pathway:BRCA1-dependent Ub-ligase activity,		GO:0036297~interstrand cross-link repair,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0043240~Fanconi anaemia nuclear complex,		IPR021025:Fanconi Anaemia group E protein, C-terminal,	hsa03460:Fanconi anemia pathway,	600901~Fanconi anemia, complementation group E,			3D-structure,Complete proteome,Disease mutation,DNA damage,DNA repair,Fanconi anemia,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Ubl conjugation,	chain:Fanconi anemia group E protein,helix,modified residue,region of interest:Interaction with FANCC,sequence variant,strand,
FANCF	Fanconi anemia complementation group F(FANCF)	Homo sapiens		h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_bard1Pathway:BRCA1-dependent Ub-ligase activity,		GO:0001541~ovarian follicle development,GO:0006974~cellular response to DNA damage stimulus,GO:0007283~spermatogenesis,GO:0016567~protein ubiquitination,GO:0036297~interstrand cross-link repair,	GO:0005654~nucleoplasm,GO:0043240~Fanconi anaemia nuclear complex,	GO:0005515~protein binding,GO:0061630~ubiquitin protein ligase activity,		hsa03460:Fanconi anemia pathway,	603467~Fanconi anemia, complementation group F,			3D-structure,Complete proteome,Direct protein sequencing,DNA damage,DNA repair,Fanconi anemia,Nucleus,Polymorphism,Reference proteome,	chain:Fanconi anemia group F protein,helix,mutagenesis site,sequence variant,strand,turn,
FANCG	Fanconi anemia complementation group G(FANCG)	Homo sapiens		h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_bard1Pathway:BRCA1-dependent Ub-ligase activity,		GO:0000075~cell cycle checkpoint,GO:0001541~ovarian follicle development,GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0007005~mitochondrion organization,GO:0007286~spermatid development,GO:0009314~response to radiation,GO:0036297~interstrand cross-link repair,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005886~plasma membrane,GO:0043240~Fanconi anaemia nuclear complex,	GO:0003684~damaged DNA binding,GO:0005515~protein binding,	IPR011990:Tetratricopeptide-like helical,IPR019734:Tetratricopeptide repeat,	hsa03460:Fanconi anemia pathway,	614082~Fanconi anemia, complementation group G,		SM00028:TPR,	Complete proteome,Cytoplasm,Disease mutation,DNA damage,DNA repair,Fanconi anemia,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,TPR repeat,	chain:Fanconi anemia group G protein,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,sequence variant,
FAS	Fas cell surface death receptor(FAS)	Homo sapiens	38.Cell_cycle_arrest_and_apoptosis_ceramide,39.Deg_of_Chromosomal_DNA,46.P13K_PTEN,58.(CD40L)_immnosurveillance,72.IAP_interaction_with_cell_death_pathways,97.Immune_injury_MS-lesions_MS_antigen,	h_asbcellPathway:Antigen Dependent B Cell Activation,h_bbcellPathway:Bystander B Cell Activation,h_ctlPathway:CTL mediated immune response against target cells ,h_fasPathway:FAS signaling pathway ( CD95 ),h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_hsp27Pathway:Stress Induction of HSP Regulation,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_keratinocytePathway:Keratinocyte Differentiation,h_pmlPathway:Regulation of transcriptional activity by PML,h_tcapoptosisPathway:HIV Induced T Cell Apoptosis,		GO:0002377~immunoglobulin production,GO:0003014~renal system process,GO:0006461~protein complex assembly,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006924~activation-induced cell death of T cells,GO:0006925~inflammatory cell apoptotic process,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007420~brain development,GO:0007623~circadian rhythm,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0009636~response to toxic substance,GO:0010467~gene expression,GO:0019724~B cell mediated immunity,GO:0032464~positive regulation of protein homooligomerization,GO:0032496~response to lipopolysaccharide,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043281~regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043410~positive regulation of MAPK cascade,GO:0045060~negative thymic T cell selection,GO:0045619~regulation of lymphocyte differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0048536~spleen development,GO:0050869~negative regulation of B cell activation,GO:0051260~protein homooligomerization,GO:0051384~response to glucocorticoid,GO:0070230~positive regulation of lymphocyte apoptotic process,GO:0071260~cellular response to mechanical stimulus,GO:0071285~cellular response to lithium ion,GO:0071455~cellular response to hyperoxia,GO:0097049~motor neuron apoptotic process,GO:0097190~apoptotic signaling pathway,GO:0097191~extrinsic apoptotic signaling pathway,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:0097284~hepatocyte apoptotic process,GO:0097296~activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,GO:0097527~necroptotic signaling pathway,GO:1902041~regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2001241~positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031264~death-inducing signaling complex,GO:0031265~CD95 death-inducing signaling complex,GO:0043005~neuron projection,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0004871~signal transducer activity,GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0005031~tumor necrosis factor-activated receptor activity,GO:0005515~protein binding,GO:0019900~kinase binding,GO:0042802~identical protein binding,	IPR000488:Death domain,IPR001368:TNFR/NGFR cysteine-rich region,IPR008063:Fas receptor,IPR011029:Death-like domain,	hsa04010:MAPK signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,hsa04115:p53 signaling pathway,hsa04210:Apoptosis,hsa04650:Natural killer cell mediated cytotoxicity,hsa04668:TNF signaling pathway,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa04940:Type I diabetes mellitus,hsa05010:Alzheimer's disease,hsa05142:Chagas disease (American trypanosomiasis),hsa05143:African trypanosomiasis,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05168:Herpes simplex infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05320:Autoimmune thyroid disease,hsa05330:Allograft rejection,hsa05332:Graft-versus-host disease,	601859~Autoimmune lymphoproliferative syndrome,601859~Autoimmune lymphoproliferative syndrome, type IA,Squamous cell carcinoma, burn scar-related, somatic~Squamous cell carcinoma, burn scar-related, somatic,		SM00005:DEATH,SM00208:TNFR,	3D-structure,Alternative splicing,Apoptosis,Cell membrane,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Tumor necrosis factor receptor superfamily member 6,disulfide bond,domain:Death,glycosylation site:N-linked (GlcNAc...),helix,modified residue,region of interest:Interaction with HIPK3,repeat:TNFR-Cys 1,repeat:TNFR-Cys 2,repeat:TNFR-Cys 3,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
GNA11	G protein subunit alpha 11(GNA11)	Homo sapiens		h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,		GO:0001501~skeletal system development,GO:0001508~action potential,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007213~G-protein coupled acetylcholine receptor signaling pathway,GO:0007507~heart development,GO:0007603~phototransduction, visible light,GO:0009649~entrainment of circadian clock,GO:0030168~platelet activation,GO:0045634~regulation of melanocyte differentiation,GO:0048066~developmental pigmentation,GO:0060158~phospholipase C-activating dopamine receptor signaling pathway,GO:0071467~cellular response to pH,	GO:0001750~photoreceptor outer segment,GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005525~GTP binding,GO:0019001~guanyl nucleotide binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0031826~type 2A serotonin receptor binding,GO:0046872~metal ion binding,	IPR000654:G-protein alpha subunit, group Q,IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04540:Gap junction,hsa04725:Cholinergic synapse,hsa04730:Long-term depression,hsa04911:Insulin secretion,hsa04912:GnRH signaling pathway,hsa04925:Aldosterone synthesis and secretion,hsa05142:Chagas disease (American trypanosomiasis),hsa05146:Amoebiasis,hsa05200:Pathways in cancer,	145981~Hypocalciuric hypercalcemia, type II,615361~Hypocalcemia, autosomal dominant 2,		SM00275:SM00275,	ADP-ribosylation,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,GTP-binding,Lipoprotein,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Palmitate,Proteomics identification,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein subunit alpha-11,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,
GNAQ	G protein subunit alpha q(GNAQ)	Homo sapiens		h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_calcineurinPathway:Effects of calcineurin in Keratinocyte Differentiation,h_ccr3Pathway:CCR3 signaling in Eosinophils,h_ccr5Pathway:Pertussis toxin-insensitive CCR5 Signaling in Macrophage,h_cxcr4Pathway:CXCR4 Signaling Pathway,h_gpcrPathway:Signaling Pathway from G-Protein Families,h_myosinPathway:PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase,h_par1pathway:Thrombin signaling and protease-activated receptors,h_pkcPathway:Activation of PKC through G protein coupled receptor,h_pyk2Pathway:Links between Pyk2 and Map Kinases,h_tubbyPathway:G-Protein Signaling Through Tubby Proteins,h_vipPathway:Neuropeptides VIP and PACAP inhibit the apoptosis of activated T cells,		GO:0001501~skeletal system development,GO:0001508~action potential,GO:0006469~negative regulation of protein kinase activity,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007202~activation of phospholipase C activity,GO:0007213~G-protein coupled acetylcholine receptor signaling pathway,GO:0007215~glutamate receptor signaling pathway,GO:0007507~heart development,GO:0007596~blood coagulation,GO:0007603~phototransduction, visible light,GO:0009649~entrainment of circadian clock,GO:0009791~post-embryonic development,GO:0016322~neuron remodeling,GO:0021884~forebrain neuron development,GO:0030168~platelet activation,GO:0035412~regulation of catenin import into nucleus,GO:0042711~maternal behavior,GO:0042733~embryonic digit morphogenesis,GO:0043547~positive regulation of GTPase activity,GO:0045634~regulation of melanocyte differentiation,GO:0048066~developmental pigmentation,GO:0050821~protein stabilization,GO:0060158~phospholipase C-activating dopamine receptor signaling pathway,	GO:0001750~photoreceptor outer segment,GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030425~dendrite,GO:0031965~nuclear membrane,GO:0044297~cell body,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019001~guanyl nucleotide binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0031826~type 2A serotonin receptor binding,GO:0046872~metal ion binding,	IPR000654:G-protein alpha subunit, group Q,IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04015:Rap1 signaling pathway,hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04270:Vascular smooth muscle contraction,hsa04540:Gap junction,hsa04611:Platelet activation,hsa04713:Circadian entrainment,hsa04720:Long-term potentiation,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04728:Dopaminergic synapse,hsa04730:Long-term depression,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04911:Insulin secretion,hsa04912:GnRH signaling pathway,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04918:Thyroid hormone synthesis,hsa04921:Oxytocin signaling pathway,hsa04922:Glucagon signaling pathway,hsa04924:Renin secretion,hsa04925:Aldosterone synthesis and secretion,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa05010:Alzheimer's disease,hsa05016:Huntington's disease,hsa05142:Chagas disease (American trypanosomiasis),hsa05143:African trypanosomiasis,hsa05146:Amoebiasis,hsa05200:Pathways in cancer,	163000~Capillary malformations, congenital, 1, somatic, mosaic,185300~Sturge-Weber syndrome, somatic, mosaic,		SM00275:SM00275,	ADP-ribosylation,Coiled coil,Complete proteome,Disease mutation,GTP-binding,Lipoprotein,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Nucleus,Palmitate,Polymorphism,Proteomics identification,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein G(q) subunit alpha,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,
GATA2	GATA binding protein 2(GATA2)	Homo sapiens			Transcription,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001655~urogenital system development,GO:0001709~cell fate determination,GO:0001764~neuron migration,GO:0001892~embryonic placenta development,GO:0006351~transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006909~phagocytosis,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007507~heart development,GO:0007596~blood coagulation,GO:0009887~organ morphogenesis,GO:0009888~tissue development,GO:0010725~regulation of primitive erythrocyte differentiation,GO:0021514~ventral spinal cord interneuron differentiation,GO:0021533~cell differentiation in hindbrain,GO:0021902~commitment of neuronal cell to specific neuron type in forebrain,GO:0021954~central nervous system neuron development,GO:0021983~pituitary gland development,GO:0030097~hemopoiesis,GO:0033993~response to lipid,GO:0035019~somatic stem cell population maintenance,GO:0035065~regulation of histone acetylation,GO:0035854~eosinophil fate commitment,GO:0042472~inner ear morphogenesis,GO:0043306~positive regulation of mast cell degranulation,GO:0045599~negative regulation of fat cell differentiation,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045650~negative regulation of macrophage differentiation,GO:0045654~positive regulation of megakaryocyte differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045746~negative regulation of Notch signaling pathway,GO:0045766~positive regulation of angiogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048469~cell maturation,GO:0048565~digestive tract development,GO:0048873~homeostasis of number of cells within a tissue,GO:0050766~positive regulation of phagocytosis,GO:0060100~positive regulation of phagocytosis, engulfment,GO:0060216~definitive hemopoiesis,GO:0060872~semicircular canal development,GO:0070345~negative regulation of fat cell proliferation,GO:0090102~cochlea development,GO:0097154~GABAergic neuron differentiation,GO:2000178~negative regulation of neural precursor cell proliferation,GO:2000977~regulation of forebrain neuron differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001158~enhancer sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0070742~C2H2 zinc finger domain binding,	IPR000679:Zinc finger, GATA-type,IPR013088:Zinc finger, NHR/GATA-type,IPR016374:Transcription factor, GATA-1/2/3,		601626~Leukemia, acute myeloid, susceptibility to,614038~Emberger syndrome,614172~Immunodeficiency 21,614286~Myelodysplastic syndrome, susceptibility to,	PIRSF003027:transcription factor, GATA-1/2/3 types,	SM00401:ZnF_GATA,	Activator,Alternative splicing,Complete proteome,Disease mutation,DNA-binding,Metal-binding,Methylation,Nucleus,Phagocytosis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Endothelial transcription factor GATA-2,sequence conflict,sequence variant,zinc finger region:GATA-type 1,zinc finger region:GATA-type 2,
GNAS	GNAS complex locus(GNAS)	Homo sapiens		h_agpcrPathway:Attenuation of GPCR Signaling,h_bArr-mapkPathway:Role of ï¿½-arrestins in the activation and targeting of MAP kinases,h_bArrestin-srcPathway:Roles of ï¿½-arrestin-dependent Recruitment of Src Kinases in GPCR Signaling,h_bArrestinPathway:ï¿½-arrestins in GPCR Desensitization,h_ccr3Pathway:CCR3 signaling in Eosinophils,h_cftrPathway:Cystic fibrosis transmembrane conductance regulator (CFTR) and beta 2 adrenergic receptor (b2AR) pathway,h_chrebpPathway:ChREBP regulation by carbohydrates and cAMP,h_crebPathway:Transcription factor CREB and its extracellular signals,h_cremPathway:Regulation of Spermatogenesis by CREM,h_cskPathway:Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_gcrpathway:Corticosteroids and cardioprotection,h_gpcrPathway:Signaling Pathway from G-Protein Families,h_gsPathway:Activation of cAMP-dependent protein kinase, PKA,h_mPRPathway:How Progesterone Initiates the Oocyte Maturation,h_plcePathway:Phospholipase C-epsilon pathway,h_raccPathway:Ion Channels and Their Functional Role in Vascular Endothelium,		GO:0001894~tissue homeostasis,GO:0001958~endochondral ossification,GO:0003091~renal water homeostasis,GO:0006112~energy reserve metabolic process,GO:0006306~DNA methylation,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007190~activation of adenylate cyclase activity,GO:0007191~adenylate cyclase-activating dopamine receptor signaling pathway,GO:0007565~female pregnancy,GO:0007606~sensory perception of chemical stimulus,GO:0007608~sensory perception of smell,GO:0009306~protein secretion,GO:0009966~regulation of signal transduction,GO:0030819~positive regulation of cAMP biosynthetic process,GO:0035116~embryonic hindlimb morphogenesis,GO:0035264~multicellular organism growth,GO:0040015~negative regulation of multicellular organism growth,GO:0040032~post-embryonic body morphogenesis,GO:0042493~response to drug,GO:0043547~positive regulation of GTPase activity,GO:0043950~positive regulation of cAMP-mediated signaling,GO:0045669~positive regulation of osteoblast differentiation,GO:0045672~positive regulation of osteoclast differentiation,GO:0046907~intracellular transport,GO:0048589~developmental growth,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0050796~regulation of insulin secretion,GO:0050890~cognition,GO:0051216~cartilage development,GO:0060348~bone development,GO:0060789~hair follicle placode formation,GO:0070527~platelet aggregation,GO:0071107~response to parathyroid hormone,GO:0071377~cellular response to glucagon stimulus,GO:0071380~cellular response to prostaglandin E stimulus,GO:0071514~genetic imprinting,GO:0071870~cellular response to catecholamine stimulus,GO:0071880~adenylate cyclase-activating adrenergic receptor signaling pathway,GO:2000828~regulation of parathyroid hormone secretion,	GO:0001726~ruffle,GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0030133~transport vesicle,GO:0030425~dendrite,GO:0031224~intrinsic component of membrane,GO:0032588~trans-Golgi network membrane,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005159~insulin-like growth factor receptor binding,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019001~guanyl nucleotide binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0031698~beta-2 adrenergic receptor binding,GO:0031748~D1 dopamine receptor binding,GO:0031852~mu-type opioid receptor binding,GO:0035255~ionotropic glutamate receptor binding,GO:0046872~metal ion binding,GO:0051430~corticotropin-releasing hormone receptor 1 binding,	IPR000367:G-protein alpha subunit, group S,IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR009434:Neuroendocrine-specific golgi P55,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04015:Rap1 signaling pathway,hsa04020:Calcium signaling pathway,hsa04024:cAMP signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04270:Vascular smooth muscle contraction,hsa04540:Gap junction,hsa04611:Platelet activation,hsa04713:Circadian entrainment,hsa04724:Glutamatergic synapse,hsa04726:Serotonergic synapse,hsa04728:Dopaminergic synapse,hsa04730:Long-term depression,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04911:Insulin secretion,hsa04912:GnRH signaling pathway,hsa04913:Ovarian steroidogenesis,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04918:Thyroid hormone synthesis,hsa04921:Oxytocin signaling pathway,hsa04922:Glucagon signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04924:Renin secretion,hsa04925:Aldosterone synthesis and secretion,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa04962:Vasopressin-regulated water reabsorption,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa04976:Bile secretion,hsa05030:Cocaine addiction,hsa05031:Amphetamine addiction,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05110:Vibrio cholerae infection,hsa05142:Chagas disease (American trypanosomiasis),hsa05146:Amoebiasis,hsa05200:Pathways in cancer,hsa05414:Dilated cardiomyopathy,	102200~Acromegaly, somatic,103580~Pseudohypoparathyroidism Ia,166350~Osseous heteroplasia, progressive,219080~ACTH-independent macronodular adrenal hyperplasia,603233~Pseudohypoparathyroidism Ib,612462~Pseudohypoparathyroidism Ic,612463~Pseudopseudohypoparathyroidism,McCune-Albright syndrome, somatic, mosaic 174800~McCune-Albright syndrome, somatic, mosaic 174800,		SM00275:SM00275,	3D-structure,ADP-ribosylation,Alternative splicing,Cell membrane,Cell projection,Cleavage on pair of basic residues,Coiled coil,Complete proteome,Cushing syndrome,Cytoplasmic vesicle,Direct protein sequencing,Disease mutation,Glycoprotein,GTP-binding,Isopeptide bond,Lipoprotein,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Obesity,Palmitate,Phosphoprotein,Polymorphism,Proteoglycan,Proteomics identification,Proto-oncogene,Reference proteome,Secreted,Signal,Transducer,Ubl conjugation,	chain:alpha subunit of GsGTP binding protein,chain:Guanine nucleotide-binding protein G(s) subunit alpha isoforms short,chain:Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas,chain:Neuroendocrine secretory protein 55,chain:Protein ALEX,compositionally biased region:Ala-rich,compositionally biased region:Glu-rich,compositionally biased region:Pro-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),lipid moiety-binding region:N-palmitoyl glycine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,peptide:GPIPIRRH peptide,peptide:LHAL tetrapeptide,sequence conflict,sequence variant,splice variant,
H3F3A	H3 histone family member 3A(H3F3A)	Homo sapiens				GO:0000183~chromatin silencing at rDNA,GO:0001649~osteoblast differentiation,GO:0006334~nucleosome assembly,GO:0006336~DNA replication-independent nucleosome assembly,GO:0006997~nucleus organization,GO:0007286~spermatid development,GO:0007338~single fertilization,GO:0007420~brain development,GO:0007566~embryo implantation,GO:0007596~blood coagulation,GO:0008283~cell proliferation,GO:0008584~male gonad development,GO:0009725~response to hormone,GO:0030307~positive regulation of cell growth,GO:0031047~gene silencing by RNA,GO:0031508~pericentric heterochromatin assembly,GO:0031509~telomeric heterochromatin assembly,GO:0032200~telomere organization,GO:0035264~multicellular organism growth,GO:0042692~muscle cell differentiation,GO:0044267~cellular protein metabolic process,GO:0045814~negative regulation of gene expression, epigenetic,GO:0045815~positive regulation of gene expression, epigenetic,GO:0048477~oogenesis,GO:0090230~regulation of centromere complex assembly,GO:1902340~negative regulation of chromosome condensation,	GO:0000228~nuclear chromosome,GO:0000784~nuclear chromosome, telomeric region,GO:0000786~nucleosome,GO:0000788~nuclear nucleosome,GO:0001740~Barr body,GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0031492~nucleosomal DNA binding,GO:0042393~histone binding,GO:0046982~protein heterodimerization activity,	IPR000164:Histone H3,IPR007125:Histone core,IPR009072:Histone-fold,	hsa05034:Alcoholism,hsa05202:Transcriptional misregulation in cancer,hsa05322:Systemic lupus erythematosus,			SM00428:H3,	3D-structure,Acetylation,Chromosome,Citrullination,Complete proteome,Direct protein sequencing,DNA-binding,Methylation,Nucleosome core,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Histone H3.3,modified residue,sequence conflict,
H3F3B	H3 histone family member 3B(H3F3B)	Homo sapiens				GO:0000183~chromatin silencing at rDNA,GO:0001649~osteoblast differentiation,GO:0006334~nucleosome assembly,GO:0006336~DNA replication-independent nucleosome assembly,GO:0006997~nucleus organization,GO:0007286~spermatid development,GO:0007338~single fertilization,GO:0007420~brain development,GO:0007566~embryo implantation,GO:0007596~blood coagulation,GO:0008283~cell proliferation,GO:0008584~male gonad development,GO:0009725~response to hormone,GO:0030307~positive regulation of cell growth,GO:0031047~gene silencing by RNA,GO:0031508~pericentric heterochromatin assembly,GO:0031509~telomeric heterochromatin assembly,GO:0032200~telomere organization,GO:0035264~multicellular organism growth,GO:0042692~muscle cell differentiation,GO:0044267~cellular protein metabolic process,GO:0045814~negative regulation of gene expression, epigenetic,GO:0045815~positive regulation of gene expression, epigenetic,GO:0048477~oogenesis,GO:0090230~regulation of centromere complex assembly,GO:1902340~negative regulation of chromosome condensation,	GO:0000228~nuclear chromosome,GO:0000784~nuclear chromosome, telomeric region,GO:0000786~nucleosome,GO:0000788~nuclear nucleosome,GO:0001740~Barr body,GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0031492~nucleosomal DNA binding,GO:0042393~histone binding,GO:0046982~protein heterodimerization activity,	IPR000164:Histone H3,IPR007125:Histone core,IPR009072:Histone-fold,	hsa05034:Alcoholism,hsa05202:Transcriptional misregulation in cancer,hsa05322:Systemic lupus erythematosus,			SM00428:H3,	3D-structure,Acetylation,Chromosome,Citrullination,Complete proteome,Direct protein sequencing,DNA-binding,Methylation,Nucleosome core,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Histone H3.3,modified residue,sequence conflict,
HNF1A	HNF1 homeobox A(HNF1A)	Homo sapiens		h_alkPathway:ALK in cardiac myocytes,h_ghPathway:Growth Hormone Signaling Pathway,h_hesPathway:Segmentation Clock,h_malPathway:Role of MAL in Rho-Mediated Activation of SRF,h_ps1Pathway:Presenilin action in Notch and Wnt signaling,h_wntPathway:WNT Signaling Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001824~blastocyst development,GO:0001889~liver development,GO:0001890~placenta development,GO:0006338~chromatin remodeling,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006633~fatty acid biosynthetic process,GO:0006699~bile acid biosynthetic process,GO:0006783~heme biosynthetic process,GO:0006979~response to oxidative stress,GO:0008203~cholesterol metabolic process,GO:0009749~response to glucose,GO:0015721~bile acid and bile salt transport,GO:0015908~fatty acid transport,GO:0016573~histone acetylation,GO:0030073~insulin secretion,GO:0030111~regulation of Wnt signaling pathway,GO:0030326~embryonic limb morphogenesis,GO:0031018~endocrine pancreas development,GO:0035565~regulation of pronephros size,GO:0035623~renal glucose absorption,GO:0042593~glucose homeostasis,GO:0043691~reverse cholesterol transport,GO:0045453~bone resorption,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046323~glucose import,GO:0048341~paraxial mesoderm formation,GO:0050796~regulation of insulin secretion,GO:0060261~positive regulation of transcription initiation from RNA polymerase II promoter,GO:0060395~SMAD protein signal transduction,	GO:0001750~photoreceptor outer segment,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0043234~protein complex,GO:0045120~pronucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,	IPR001356:Homeodomain,IPR006897:Hepatocyte nuclear factor 1, beta isoform, C-terminal,IPR006898:Hepatocyte nuclear factor 1, alpha isoform C-terminal,IPR006899:Hepatocyte nuclear factor 1, N-terminal,IPR009057:Homeodomain-like,IPR010982:Lambda repressor-like, DNA-binding domain,IPR023219:Hepatocyte nuclear factor 1, dimerisation domain,	hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04950:Maturity onset diabetes of the young,	125853~Diabetes mellitus, noninsulin-dependent, 2,142330~Hepatic adenoma, somatic,144700~Renal cell carcinoma,222100~Diabetes mellitus, insulin-dependent,600496~MODY, type III,612520~Diabetes mellitus, insulin-dependent, 20,		SM00389:HOX,	3D-structure,Activator,Alternative splicing,Complete proteome,Diabetes mellitus,Disease mutation,DNA-binding,Homeobox,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Hepatocyte nuclear factor 1-alpha,compositionally biased region:Asp/Glu-rich (acidic; potential involvement with transcription),DNA-binding region:Homeobox; HNF1-type,helix,modified residue,region of interest:Dimerization,sequence variant,short sequence motif:Nuclear localization signal,splice variant,turn,
HRAS	HRas proto-oncogene, GTPase(HRAS)	Homo sapiens	65.Integrin_affinity_modulation,	h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_bArrestin-srcPathway:Roles of ï¿½-arrestin-dependent Recruitment of Src Kinases in GPCR Signaling,h_bcrPathway:BCR Signaling Pathway,h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,h_cardiacEGFPathway:Role of EGF Receptor Transactivation by GPCRs in Cardiac Hypertrophy,h_ccr3Pathway:CCR3 signaling in Eosinophils,h_cdk5Pathway:Phosphorylation of MEK1 by cdk5/p35 down regulates the MAP kinase pathway,h_cdmacPathway:Cadmium induces DNA synthesis and proliferation in macrophages,h_crebPathway:Transcription factor CREB and its extracellular signals,h_cxcr4Pathway:CXCR4 Signaling Pathway,h_ecmPathway:Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia,h_egfPathway:EGF Signaling Pathway,h_epoPathway:EPO Signaling Pathway,h_erk5Pathway:Role of Erk5 in Neuronal Survival,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_etsPathway:METS affect on Macrophage Differentiation,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,h_ghPathway:Growth Hormone Signaling Pathway,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,h_gpcrPathway:Signaling Pathway from G-Protein Families,h_hbxPathway:Calcium Signaling by HBx of Hepatitis B virus,h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_igf1Pathway:IGF-1 Signaling Pathway,h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,h_il2Pathway:IL 2 signaling pathway,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il3Pathway:IL 3 signaling pathway,h_il6Pathway:IL 6 signaling pathway,h_insulinPathway:Insulin Signaling Pathway,h_integrinPathway:Integrin Signaling Pathway,h_keratinocytePathway:Keratinocyte Differentiation,h_longevityPathway:The IGF-1 Receptor and Longevity,h_malPathway:Role of MAL in Rho-Mediated Activation of SRF,h_mapkPathway:MAPKinase Signaling Pathway,h_mCalpainPathway:mCalpain and friends in Cell motility,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_mPRPathway:How Progesterone Initiates the Oocyte Maturation,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_ngfPathway:Nerve growth factor pathway (NGF),h_p38mapkPathway:p38 MAPK Signaling Pathway ,h_pdgfPathway:PDGF Signaling Pathway,h_pmlPathway:Regulation of transcriptional activity by PML,h_pyk2Pathway:Links between Pyk2 and Map Kinases,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_rasPathway:Ras Signaling Pathway,h_reckPathway:Inhibition of Matrix Metalloproteinases,h_sam68Pathway:Regulation of Splicing through Sam68,h_sppaPathway:Aspirin Blocks Signaling Pathway Involved in Platelet Activation,h_spryPathway:Sprouty regulation of tyrosine kinase signals,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,h_tpoPathway:TPO Signaling Pathway,h_trkaPathway:Trka Receptor Signaling Pathway,h_vegfPathway:VEGF, Hypoxia, and Angiogenesis,		GO:0000165~MAPK cascade,GO:0001934~positive regulation of protein phosphorylation,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0006897~endocytosis,GO:0006935~chemotaxis,GO:0007050~cell cycle arrest,GO:0007093~mitotic cell cycle checkpoint,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0007411~axon guidance,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009887~organ morphogenesis,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0030335~positive regulation of cell migration,GO:0032729~positive regulation of interferon-gamma production,GO:0034260~negative regulation of GTPase activity,GO:0035176~social behavior,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0038128~ERBB2 signaling pathway,GO:0042088~T-helper 1 type immune response,GO:0042832~defense response to protozoan,GO:0043406~positive regulation of MAP kinase activity,GO:0043410~positive regulation of MAPK cascade,GO:0043524~negative regulation of neuron apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0045740~positive regulation of DNA replication,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046330~positive regulation of JNK cascade,GO:0046579~positive regulation of Ras protein signal transduction,GO:0048013~ephrin receptor signaling pathway,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050852~T cell receptor signaling pathway,GO:0050900~leukocyte migration,GO:0051291~protein heterooligomerization,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0090303~positive regulation of wound healing,GO:0090398~cellular senescence,GO:0097193~intrinsic apoptotic signaling pathway,GO:1900029~positive regulation of ruffle assembly,GO:2000251~positive regulation of actin cytoskeleton reorganization,GO:2000630~positive regulation of miRNA metabolic process,	GO:0000139~Golgi membrane,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0008022~protein C-terminus binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR020849:Small GTPase superfamily, Ras type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04062:Chemokine signaling pathway,hsa04068:FoxO signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04144:Endocytosis,hsa04151:PI3K-Akt signaling pathway,hsa04360:Axon guidance,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa04540:Gap junction,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04912:GnRH signaling pathway,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04921:Oxytocin signaling pathway,hsa05034:Alcoholism,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05211:Renal cell carcinoma,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	109800~Bladder cancer, somatic,137550~Spitz nevus or nevus spilus, somatic,162900~Nevus sebaceous or woolly hair nevus, somatic,163200~Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic,188470~Thyroid carcinoma, follicular, somatic,218040~Congenital myopathy with excess of muscle spindles,218040~Costello syndrome,			3D-structure,Acetylation,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Golgi apparatus,GTP-binding,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Nucleus,Palmitate,Prenylation,Proto-oncogene,Reference proteome,S-nitrosylation,	chain:GTPase HRas,chain:GTPase HRas, N-terminally processed,helix,lipid moiety-binding region:S-farnesyl cysteine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,region of interest:Hypervariable region,sequence variant,short sequence motif:Effector region,strand,turn,
JAK3	Janus kinase 3(JAK3)	Homo sapiens	48.mice_minus_JAKs_and_STATs,	h_il22bpPathway:IL22 Soluble Receptor Signaling Pathway ,h_il2Pathway:IL 2 signaling pathway,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il4Pathway:IL 4 signaling pathway,h_il6Pathway:IL 6 signaling pathway,h_il7Pathway:IL-7 Signal Transduction,h_stat3Pathway:Stat3 Signaling Pathway,		GO:0000165~MAPK cascade,GO:0002250~adaptive immune response,GO:0002731~negative regulation of dendritic cell cytokine production,GO:0006468~protein phosphorylation,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007260~tyrosine phosphorylation of STAT protein,GO:0007262~STAT protein import into nucleus,GO:0016477~cell migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030183~B cell differentiation,GO:0032693~negative regulation of interleukin-10 production,GO:0032695~negative regulation of interleukin-12 production,GO:0035556~intracellular signal transduction,GO:0035771~interleukin-4-mediated signaling pathway,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0042102~positive regulation of T cell proliferation,GO:0043029~T cell homeostasis,GO:0043547~positive regulation of GTPase activity,GO:0045087~innate immune response,GO:0045221~negative regulation of FasL biosynthetic process,GO:0045626~negative regulation of T-helper 1 cell differentiation,GO:0050868~negative regulation of T cell activation,GO:0060397~JAK-STAT cascade involved in growth hormone signaling pathway,GO:0070232~regulation of T cell apoptotic process,GO:0070244~negative regulation of thymocyte apoptotic process,GO:0070669~response to interleukin-2,GO:0070670~response to interleukin-4,GO:0070672~response to interleukin-15,GO:0071104~response to interleukin-9,	GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,	GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019903~protein phosphatase binding,	IPR000299:FERM domain,IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011993:Pleckstrin homology-like domain,IPR016251:Tyrosine-protein kinase, non-receptor Jak/Tyk2,IPR017441:Protein kinase, ATP binding site,IPR019749:Band 4.1 domain,IPR020635:Tyrosine-protein kinase, catalytic domain,IPR020775:Tyrosine-protein kinase, non-receptor Jak3,	hsa04062:Chemokine signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04630:Jak-STAT signaling pathway,hsa05162:Measles,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05203:Viral carcinogenesis,	600802~SCID, autosomal recessive, T-negative/B-positive type,	PIRSF000636:tyrosine-protein kinase, Jak/Tyk2 type,	SM00219:TyrKc,SM00252:SH2,SM00295:B41,	3D-structure,Adaptive immunity,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Disease mutation,Immunity,Innate immunity,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,SCID,SH2 domain,Transferase,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Tyrosine-protein kinase JAK3,domain:FERM,domain:Protein kinase 1,domain:Protein kinase 2,domain:SH2; atypical,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,strand,turn,
JUN	Jun proto-oncogene, AP-1 transcription factor subunit(JUN)	Homo sapiens	114.Genomic_reformatting_Brain_Ischemia,3.T_cell_receptor,67.Ikaros_and_signaling_inhibitors,77.IkBa_Kinase_JNK_MEKK1,92.Ancient_Host_Defense_Pathways,	h_41BBPathway:The 4-1BB-dependent immune response,h_agrPathway:Agrin in Postsynaptic Differentiation,h_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2,h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_atmPathway:ATM Signaling Pathway,h_bcrPathway:BCR Signaling Pathway,h_cardiacEGFPathway:Role of EGF Receptor Transactivation by GPCRs in Cardiac Hypertrophy,h_ccr5Pathway:Pertussis toxin-insensitive CCR5 Signaling in Macrophage,h_cdmacPathway:Cadmium induces DNA synthesis and proliferation in macrophages,h_d4gdiPathway:D4-GDI Signaling Pathway,h_dreamPathway:Repression of Pain Sensation by the Transcriptional Regulator DREAM,h_egfPathway:EGF Signaling Pathway,h_epoPathway:EPO Signaling Pathway,h_etsPathway:METS affect on Macrophage Differentiation,h_fasPathway:FAS signaling pathway ( CD95 ),h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,h_gpcrPathway:Signaling Pathway from G-Protein Families,h_hifPathway:Hypoxia-Inducible Factor in the Cardiovascular System,h_igf1Pathway:IGF-1 Signaling Pathway,h_il12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development,h_il1rPathway:Signal transduction through IL1R,h_il2Pathway:IL 2 signaling pathway,h_il6Pathway:IL 6 signaling pathway,h_insulinPathway:Insulin Signaling Pathway,h_integrinPathway:Integrin Signaling Pathway,h_keratinocytePathway:Keratinocyte Differentiation,h_mapkPathway:MAPKinase Signaling Pathway,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_ngfPathway:Nerve growth factor pathway (NGF),h_pcafPathway:The information-processing pathway at the IFN-beta enhancer,h_pdgfPathway:PDGF Signaling Pathway,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_pyk2Pathway:Links between Pyk2 and Map Kinases,h_stressPathway:TNF/Stress Related Signaling,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tnfr1Pathway:TNFR1 Signaling Pathway,h_tollPathway:Toll-Like Receptor Pathway,h_tpoPathway:TPO Signaling Pathway,h_tsp1Pathway:TSP-1 Induced Apoptosis in Microvascular Endothelial Cell ,		GO:0001525~angiogenesis,GO:0001774~microglial cell activation,GO:0001836~release of cytochrome c from mitochondria,GO:0001889~liver development,GO:0001938~positive regulation of endothelial cell proliferation,GO:0003151~outflow tract morphogenesis,GO:0006366~transcription from RNA polymerase II promoter,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007184~SMAD protein import into nucleus,GO:0007265~Ras protein signal transduction,GO:0007568~aging,GO:0007612~learning,GO:0007623~circadian rhythm,GO:0008285~negative regulation of cell proliferation,GO:0009314~response to radiation,GO:0009612~response to mechanical stimulus,GO:0010634~positive regulation of epithelial cell migration,GO:0010941~regulation of cell death,GO:0030224~monocyte differentiation,GO:0031103~axon regeneration,GO:0031953~negative regulation of protein autophosphorylation,GO:0032496~response to lipopolysaccharide,GO:0032870~cellular response to hormone stimulus,GO:0034097~response to cytokine,GO:0035026~leading edge cell differentiation,GO:0035994~response to muscle stretch,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0043392~negative regulation of DNA binding,GO:0043524~negative regulation of neuron apoptotic process,GO:0043525~positive regulation of neuron apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0043922~negative regulation by host of viral transcription,GO:0043923~positive regulation by host of viral transcription,GO:0045597~positive regulation of cell differentiation,GO:0045657~positive regulation of monocyte differentiation,GO:0045740~positive regulation of DNA replication,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048146~positive regulation of fibroblast proliferation,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,GO:0051365~cellular response to potassium ion starvation,GO:0051591~response to cAMP,GO:0051726~regulation of cell cycle,GO:0051899~membrane depolarization,GO:0060395~SMAD protein signal transduction,GO:0061029~eyelid development in camera-type eye,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071277~cellular response to calcium ion,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1990441~negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,GO:2000144~positive regulation of DNA-templated transcription, initiation,	GO:0000228~nuclear chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005719~nuclear euchromatin,GO:0005829~cytosol,GO:0017053~transcriptional repressor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0001190~transcriptional activator activity, RNA polymerase II transcription factor binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003713~transcription coactivator activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019899~enzyme binding,GO:0035497~cAMP response element binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0044822~poly(A) RNA binding,GO:0046982~protein heterodimerization activity,GO:0070412~R-SMAD binding,GO:0071837~HMG box domain binding,	IPR002112:Transcription factor Jun,IPR004827:Basic-leucine zipper domain,IPR005643:Jun-like transcription factor,IPR008917:Eukaryotic transcription factor, Skn-1-like, DNA-binding,IPR015558:c-Jun Transcription Factor,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04024:cAMP signaling pathway,hsa04310:Wnt signaling pathway,hsa04380:Osteoclast differentiation,hsa04510:Focal adhesion,hsa04620:Toll-like receptor signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04668:TNF signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04912:GnRH signaling pathway,hsa04915:Estrogen signaling pathway,hsa04921:Oxytocin signaling pathway,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05030:Cocaine addiction,hsa05031:Amphetamine addiction,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05132:Salmonella infection,hsa05133:Pertussis,hsa05140:Leishmaniasis,hsa05142:Chagas disease (American trypanosomiasis),hsa05161:Hepatitis B,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05231:Choline metabolism in cancer,hsa05321:Inflammatory bowel disease (IBD),hsa05323:Rheumatoid arthritis,			SM00338:BRLZ,	3D-structure,Acetylation,Activator,Coiled coil,Complete proteome,Direct protein sequencing,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Transcription factor AP-1,DNA-binding region:Basic motif,domain:Leucine-zipper,helix,modified residue,sequence conflict,sequence variant,
KIT	KIT proto-oncogene receptor tyrosine kinase(KIT)	Homo sapiens		h_badPathway:Regulation of BAD phosphorylation,h_melanocytePathway:Melanocyte Development and Pigmentation Pathway,		GO:0000165~MAPK cascade,GO:0000187~activation of MAPK activity,GO:0001541~ovarian follicle development,GO:0002318~myeloid progenitor cell differentiation,GO:0002320~lymphoid progenitor cell differentiation,GO:0002327~immature B cell differentiation,GO:0002371~dendritic cell cytokine production,GO:0002551~mast cell chemotaxis,GO:0006687~glycosphingolipid metabolic process,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007283~spermatogenesis,GO:0007286~spermatid development,GO:0008284~positive regulation of cell proliferation,GO:0008354~germ cell migration,GO:0008360~regulation of cell shape,GO:0008542~visual learning,GO:0008584~male gonad development,GO:0010628~positive regulation of gene expression,GO:0010863~positive regulation of phospholipase C activity,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0019221~cytokine-mediated signaling pathway,GO:0019827~stem cell population maintenance,GO:0030032~lamellipodium assembly,GO:0030097~hemopoiesis,GO:0030217~T cell differentiation,GO:0030218~erythrocyte differentiation,GO:0030318~melanocyte differentiation,GO:0030335~positive regulation of cell migration,GO:0031274~positive regulation of pseudopodium assembly,GO:0031532~actin cytoskeleton reorganization,GO:0032762~mast cell cytokine production,GO:0035019~somatic stem cell population maintenance,GO:0035162~embryonic hemopoiesis,GO:0035234~ectopic germ cell programmed cell death,GO:0035556~intracellular signal transduction,GO:0035701~hematopoietic stem cell migration,GO:0035855~megakaryocyte development,GO:0038093~Fc receptor signaling pathway,GO:0038109~Kit signaling pathway,GO:0038162~erythropoietin-mediated signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042511~positive regulation of tyrosine phosphorylation of Stat1 protein,GO:0042517~positive regulation of tyrosine phosphorylation of Stat3 protein,GO:0042523~positive regulation of tyrosine phosphorylation of Stat5 protein,GO:0043069~negative regulation of programmed cell death,GO:0043303~mast cell degranulation,GO:0043406~positive regulation of MAP kinase activity,GO:0043410~positive regulation of MAPK cascade,GO:0043473~pigmentation,GO:0043547~positive regulation of GTPase activity,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0045747~positive regulation of Notch signaling pathway,GO:0046427~positive regulation of JAK-STAT cascade,GO:0046777~protein autophosphorylation,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048070~regulation of developmental pigmentation,GO:0048103~somatic stem cell division,GO:0048170~positive regulation of long-term neuronal synaptic plasticity,GO:0048565~digestive tract development,GO:0048863~stem cell differentiation,GO:0050673~epithelial cell proliferation,GO:0050910~detection of mechanical stimulus involved in sensory perception of sound,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0060326~cell chemotaxis,GO:0060374~mast cell differentiation,GO:0070662~mast cell proliferation,GO:0097067~cellular response to thyroid hormone stimulus,GO:0097324~melanocyte migration,GO:0097326~melanocyte adhesion,GO:1905065~positive regulation of vascular smooth muscle cell differentiation,	GO:0001669~acrosomal vesicle,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0009897~external side of plasma membrane,GO:0009898~cytoplasmic side of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0042629~mast cell granule,	GO:0002020~protease binding,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0004716~receptor signaling protein tyrosine kinase activity,GO:0005020~stem cell factor receptor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019955~cytokine binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001824:Tyrosine-protein kinase, receptor class III, conserved site,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,IPR016243:Tyrosine-protein kinase, CSF-1/PDGF receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,IPR027263:Mast/stem cell growth factor receptor,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04640:Hematopoietic cell lineage,hsa04916:Melanogenesis,hsa05200:Pathways in cancer,hsa05221:Acute myeloid leukemia,hsa05230:Central carbon metabolism in cancer,	154800~Mast cell disease,172800~Piebaldism,273300~Germ cell tumors,601626~Leukemia, acute myeloid,606764~Gastrointestinal stromal tumor, familial,	PIRSF000615:tyrosine-protein kinase, CSF-1/PDGF receptor type,PIRSF500951:mast/stem cell growth factor receptor [Parent=PIRSF000615],	SM00219:TyrKc,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Kinase,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proto-oncogene,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Mast/stem cell growth factor receptor,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,signal peptide,site:Interaction with APS,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
KRAS	KRAS proto-oncogene, GTPase(KRAS)	Homo sapiens	65.Integrin_affinity_modulation,	h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality,		GO:0000165~MAPK cascade,GO:0001889~liver development,GO:0001934~positive regulation of protein phosphorylation,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0007411~axon guidance,GO:0008284~positive regulation of cell proliferation,GO:0008542~visual learning,GO:0010628~positive regulation of gene expression,GO:0019221~cytokine-mediated signaling pathway,GO:0021897~forebrain astrocyte development,GO:0030036~actin cytoskeleton organization,GO:0031647~regulation of protein stability,GO:0032228~regulation of synaptic transmission, GABAergic,GO:0035022~positive regulation of Rac protein signal transduction,GO:0035176~social behavior,GO:0038002~endocrine signaling,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0038128~ERBB2 signaling pathway,GO:0043406~positive regulation of MAP kinase activity,GO:0043524~negative regulation of neuron apoptotic process,GO:0045596~negative regulation of cell differentiation,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0048873~homeostasis of number of cells within a tissue,GO:0050900~leukocyte migration,GO:0051000~positive regulation of nitric-oxide synthase activity,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051146~striated muscle cell differentiation,GO:0051384~response to glucocorticoid,GO:0051385~response to mineralocorticoid,GO:0060441~epithelial tube branching involved in lung morphogenesis,GO:2000774~positive regulation of cellular senescence,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0045121~membrane raft,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0019002~GMP binding,GO:0019003~GDP binding,GO:0030275~LRR domain binding,GO:0032403~protein complex binding,GO:0046872~metal ion binding,	IPR000608:Ubiquitin-conjugating enzyme, E2,IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR016135:Ubiquitin-conjugating enzyme/RWD-like,IPR020849:Small GTPase superfamily, Ras type,IPR023313:Ubiquitin-conjugating enzyme, active site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04062:Chemokine signaling pathway,hsa04068:FoxO signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04320:Dorso-ventral axis formation,hsa04360:Axon guidance,hsa04370:VEGF signaling pathway,hsa04540:Gap junction,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04912:GnRH signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04921:Oxytocin signaling pathway,hsa04960:Aldosterone-regulated sodium reabsorption,hsa05034:Alcoholism,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	109800~Bladder cancer, somatic,114480~Breast cancer, somatic,137215~Gastric cancer, somatic,163200~Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic,211980~Lung cancer, somatic,260350~Pancreatic carcinoma, somatic,601626~Leukemia, acute myeloid,609942~Noonan syndrome 3,614470~RAS-associated autoimmune leukoproliferative disorder,615278~Cardiofaciocutaneous syndrome 2,			3D-structure,Acetylation,Alternative splicing,ATP-binding,Cardiomyopathy,Cell membrane,Complete proteome,Cytoplasm,Deafness,Direct protein sequencing,Disease mutation,Ectodermal dysplasia,GTP-binding,Lipoprotein,Magnesium,Membrane,Mental retardation,Metal-binding,Methylation,Nucleotide-binding,Palmitate,Polymorphism,Prenylation,Proto-oncogene,Reference proteome,S-nitrosylation,Ubl conjugation pathway,	chain:GTPase KRas,chain:GTPase KRas, N-terminally processed,helix,lipid moiety-binding region:S-farnesyl cysteine; in isoform 2A,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,region of interest:Hypervariable region,sequence variant,short sequence motif:Effector region,splice variant,strand,turn,
KLF6	Kruppel like factor 6(KLF6)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0030183~B cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,		176807~Prostate cancer, somatic,613659~Gastric cancer, somatic,		SM00355:ZnF_C2H2,	Activator,Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Krueppel-like factor 6,sequence conflict,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
LRP1B	LDL receptor related protein 1B(LRP1B)	Homo sapiens				GO:0006898~receptor-mediated endocytosis,GO:0015031~protein transport,	GO:0016021~integral component of membrane,GO:0043235~receptor complex,	GO:0005509~calcium ion binding,	IPR000033:LDLR class B repeat,IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011042:Six-bladed beta-propeller, TolB-like,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,IPR026823:Complement Clr-like EGF domain,				SM00135:LY,SM00179:EGF_CA,SM00181:EGF,SM00192:LDLa,	Calcium,Complete proteome,Disulfide bond,EGF-like domain,Endocytosis,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Low-density lipoprotein receptor-related protein 1B,disulfide bond,domain:EGF-like 1,domain:EGF-like 10,domain:EGF-like 11,domain:EGF-like 12,domain:EGF-like 13,domain:EGF-like 14,domain:EGF-like 2; calcium-binding,domain:EGF-like 3,domain:EGF-like 4,domain:EGF-like 5,domain:EGF-like 6,domain:EGF-like 7,domain:EGF-like 8,domain:EGF-like 9,domain:LDL-receptor class A 1,domain:LDL-receptor class A 10,domain:LDL-receptor class A 11,domain:LDL-receptor class A 12,domain:LDL-receptor class A 13,domain:LDL-receptor class A 14,domain:LDL-receptor class A 15,domain:LDL-receptor class A 16,domain:LDL-receptor class A 17,domain:LDL-receptor class A 18,domain:LDL-receptor class A 19,domain:LDL-receptor class A 2,domain:LDL-receptor class A 20,domain:LDL-receptor class A 21,domain:LDL-receptor class A 22,domain:LDL-receptor class A 23,domain:LDL-receptor class A 24,domain:LDL-receptor class A 25,domain:LDL-receptor class A 26,domain:LDL-receptor class A 27,domain:LDL-receptor class A 28,domain:LDL-receptor class A 29,domain:LDL-receptor class A 3,domain:LDL-receptor class A 30,domain:LDL-receptor class A 31,domain:LDL-receptor class A 32,domain:LDL-receptor class A 4,domain:LDL-receptor class A 5,domain:LDL-receptor class A 6,domain:LDL-receptor class A 7,domain:LDL-receptor class A 8,domain:LDL-receptor class A 9,glycosylation site:N-linked (GlcNAc...),repeat:LDL-receptor class B 1,repeat:LDL-receptor class B 10,repeat:LDL-receptor class B 11,repeat:LDL-receptor class B 12,repeat:LDL-receptor class B 13,repeat:LDL-receptor class B 14,repeat:LDL-receptor class B 15,repeat:LDL-receptor class B 16,repeat:LDL-receptor class B 17,repeat:LDL-receptor class B 18,repeat:LDL-receptor class B 19,repeat:LDL-receptor class B 2,repeat:LDL-receptor class B 20,repeat:LDL-receptor class B 21,repeat:LDL-receptor class B 22,repeat:LDL-receptor class B 23,repeat:LDL-receptor class B 24,repeat:LDL-receptor class B 25,repeat:LDL-receptor class B 26,repeat:LDL-receptor class B 27,repeat:LDL-receptor class B 28,repeat:LDL-receptor class B 29,repeat:LDL-receptor class B 3,repeat:LDL-receptor class B 30,repeat:LDL-receptor class B 31,repeat:LDL-receptor class B 32,repeat:LDL-receptor class B 33,repeat:LDL-receptor class B 34,repeat:LDL-receptor class B 35,repeat:LDL-receptor class B 36,repeat:LDL-receptor class B 4,repeat:LDL-receptor class B 5,repeat:LDL-receptor class B 6,repeat:LDL-receptor class B 7,repeat:LDL-receptor class B 8,repeat:LDL-receptor class B 9,sequence conflict,sequence variant,short sequence motif:Endocytosis signal,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
MDM2	MDM2 proto-oncogene(MDM2)	Homo sapiens		h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,h_atmPathway:ATM Signaling Pathway,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_g2Pathway:Cell Cycle: G2/M Checkpoint,h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,h_p53Pathway:p53 Signaling Pathway,h_ranbp2Pathway:Sumoylation by RanBP2 Regulates Transcriptional Repression,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001568~blood vessel development,GO:0001974~blood vessel remodeling,GO:0002027~regulation of heart rate,GO:0003181~atrioventricular valve morphogenesis,GO:0003203~endocardial cushion morphogenesis,GO:0003281~ventricular septum development,GO:0003283~atrial septum development,GO:0006461~protein complex assembly,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007089~traversing start control point of mitotic cell cycle,GO:0008284~positive regulation of cell proliferation,GO:0009636~response to toxic substance,GO:0009743~response to carbohydrate,GO:0010039~response to iron ion,GO:0010628~positive regulation of gene expression,GO:0010955~negative regulation of protein processing,GO:0010977~negative regulation of neuron projection development,GO:0016032~viral process,GO:0016567~protein ubiquitination,GO:0016925~protein sumoylation,GO:0018205~peptidyl-lysine modification,GO:0031648~protein destabilization,GO:0032026~response to magnesium ion,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0034504~protein localization to nucleus,GO:0036369~transcription factor catabolic process,GO:0042176~regulation of protein catabolic process,GO:0042220~response to cocaine,GO:0042493~response to drug,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043278~response to morphine,GO:0043518~negative regulation of DNA damage response, signal transduction by p53 class mediator,GO:0045184~establishment of protein localization,GO:0045472~response to ether,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045931~positive regulation of mitotic cell cycle,GO:0046677~response to antibiotic,GO:0046827~positive regulation of protein export from nucleus,GO:0048545~response to steroid hormone,GO:0051865~protein autoubiquitination,GO:0060411~cardiac septum morphogenesis,GO:0070301~cellular response to hydrogen peroxide,GO:0071157~negative regulation of cell cycle arrest,GO:0071236~cellular response to antibiotic,GO:0071301~cellular response to vitamin B1,GO:0071312~cellular response to alkaloid,GO:0071363~cellular response to growth factor stimulus,GO:0071375~cellular response to peptide hormone stimulus,GO:0071391~cellular response to estrogen stimulus,GO:0071456~cellular response to hypoxia,GO:0071494~cellular response to UV-C,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1901797~negative regulation of signal transduction by p53 class mediator,GO:1904707~positive regulation of vascular smooth muscle cell proliferation,GO:1904754~positive regulation of vascular associated smooth muscle cell migration,GO:1990785~response to water-immersion restraint stress,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016604~nuclear body,GO:0030666~endocytic vesicle membrane,GO:0043234~protein complex,GO:0045202~synapse,	GO:0002039~p53 binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0019789~SUMO transferase activity,GO:0019899~enzyme binding,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0042975~peroxisome proliferator activated receptor binding,GO:0061630~ubiquitin protein ligase activity,GO:0097110~scaffold protein binding,	IPR001841:Zinc finger, RING-type,IPR001876:Zinc finger, RanBP2-type,IPR003121:SWIB/MDM2 domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR015459:Ubiquitin-protein ligase E3 MDM2,IPR016495:p53 negative regulator Mdm2/Mdm4,	hsa04068:FoxO signaling pathway,hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa04120:Ubiquitin mediated proteolysis,hsa04144:Endocytosis,hsa04151:PI3K-Akt signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,	614401~Accelerated tumor formation, susceptibility to,	PIRSF006748:p53 negative regulator Mdm2/Mdm4,PIRSF500700:p53 negative regulator Mdm2 [Parent=PIRSF006748],		3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Host-virus interaction,Ligase,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Proto-oncogene,Reference proteome,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase Mdm2,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Poly-Ser,domain:SWIB,helix,modified residue,mutagenesis site,region of interest:ARF-binding,region of interest:Interaction with MTBP,region of interest:Interaction with PYHIN1,region of interest:Interaction with USP7,region of interest:Region II,sequence conflict,short sequence motif:Nuclear export signal,short sequence motif:Nuclear localization signal,short sequence motif:Nucleolar localization signal,splice variant,strand,turn,zinc finger region:RanBP2-type,zinc finger region:RING-type,
MDM4	MDM4, p53 regulator(MDM4)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0016567~protein ubiquitination,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0042177~negative regulation of protein catabolic process,GO:0043066~negative regulation of apoptotic process,GO:0045023~G0 to G1 transition,GO:0050821~protein stabilization,GO:0071157~negative regulation of cell cycle arrest,GO:0071456~cellular response to hypoxia,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0019899~enzyme binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR001876:Zinc finger, RanBP2-type,IPR003121:SWIB/MDM2 domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR015458:MDM4,IPR016495:p53 negative regulator Mdm2/Mdm4,	hsa04115:p53 signaling pathway,hsa05206:MicroRNAs in cancer,		PIRSF006748:p53 negative regulator Mdm2/Mdm4,PIRSF500699:p53 negative regulator Mdm4 [Parent=PIRSF006748],		3D-structure,Alternative splicing,Complete proteome,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Zinc,Zinc-finger,	chain:Protein Mdm4,compositionally biased region:Asp/Glu-rich (acidic),domain:SWIB,helix,mutagenesis site,region of interest:Region II,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,strand,turn,zinc finger region:RanBP2-type,zinc finger region:RING-type,
MET	MET proto-oncogene, receptor tyrosine kinase(MET)	Homo sapiens		h_cblPathway:CBL mediated ligand-induced downregulation of EGF receptors,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,		GO:0001886~endothelial cell morphogenesis,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0008283~cell proliferation,GO:0010507~negative regulation of autophagy,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048012~hepatocyte growth factor receptor signaling pathway,GO:0048754~branching morphogenesis of an epithelial tube,GO:0050918~positive chemotaxis,GO:0071526~semaphorin-plexin signaling pathway,GO:1901299~negative regulation of hydrogen peroxide-mediated programmed cell death,GO:2001028~positive regulation of endothelial cell chemotaxis,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009925~basal plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005008~hepatocyte growth factor-activated receptor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0017154~semaphorin receptor activity,GO:0019903~protein phosphatase binding,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001627:Semaphorin/CD100 antigen,IPR002165:Plexin,IPR002909:Cell surface receptor IPT/TIG,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016201:Plexin-like fold,IPR016244:Tyrosine-protein kinase, HGF/MSP receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04360:Axon guidance,hsa04510:Focal adhesion,hsa04520:Adherens junction,hsa05100:Bacterial invasion of epithelial cells,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05144:Malaria,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05211:Renal cell carcinoma,hsa05218:Melanoma,hsa05230:Central carbon metabolism in cancer,	114550~Hepatocellular carcinoma, childhood type, somatic,605074~Renal cell carcinoma, papillary, 1, familial and somatic,616705~Deafness, autosomal recessive 97,	PIRSF000617:tyrosine-protein kinase, HGF/MSP receptor type,	SM00219:TyrKc,SM00423:PSI,SM00429:IPT,SM00630:Sema,	3D-structure,Alternative splicing,ATP-binding,Chromosomal rearrangement,Complete proteome,Deafness,Disease mutation,Disulfide bond,Glycoprotein,Kinase,Membrane,Non-syndromic deafness,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Receptor,Reference proteome,Repeat,Secreted,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Hepatocyte growth factor receptor,domain:IPT/TIG 1,domain:IPT/TIG 2,domain:IPT/TIG 3,domain:Protein kinase,domain:Sema,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Interaction with MUC20,region of interest:Interaction with RANBP9,sequence conflict,sequence variant,signal peptide,site:Breakpoint for translocation to form TPR- MET oncogene,site:Cleavage,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
MPL	MPL proto-oncogene, thrombopoietin receptor(MPL)	Homo sapiens		h_tpoPathway:TPO Signaling Pathway,		GO:0007166~cell surface receptor signaling pathway,GO:0008283~cell proliferation,GO:0038163~thrombopoietin-mediated signaling pathway,GO:0050671~positive regulation of lymphocyte proliferation,GO:0070527~platelet aggregation,GO:0071456~cellular response to hypoxia,	GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0043005~neuron projection,GO:0043025~neuronal cell body,	GO:0004888~transmembrane signaling receptor activity,GO:0004896~cytokine receptor activity,GO:0005515~protein binding,GO:0038164~thrombopoietin receptor activity,	IPR003528:Long hematopoietin receptor, single chain, conserved site,IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,IPR015152:Growth hormone/erythropoietin receptor, ligand binding,	hsa04060:Cytokine-cytokine receptor interaction,hsa04630:Jak-STAT signaling pathway,	254450~Myelofibrosis with myeloid metaplasia, somatic,601977~Thrombocythemia 2,604498~Thrombocytopenia, congenital amegakaryocytic,		SM00060:FN3,	Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Golgi apparatus,Isopeptide bond,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Thrombopoietin receptor,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Leu,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,short sequence motif:Box 1 motif,short sequence motif:WSXWS motif,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
MAX	MYC associated factor X(MAX)	Homo sapiens	61.Myc_network,	h_mapkPathway:MAPKinase Signaling Pathway,h_p38mapkPathway:p38 MAPK Signaling Pathway ,h_tertPathway:Overview of telomerase protein component gene hTert Transcriptional Regulation ,		GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0009267~cellular response to starvation,GO:0010629~negative regulation of gene expression,GO:0032868~response to insulin,GO:0048678~response to axon injury,GO:0051402~neuron apoptotic process,GO:0060041~retina development in camera-type eye,GO:0071375~cellular response to peptide hormone stimulus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016605~PML body,GO:0030425~dendrite,GO:0071339~MLL1 complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000983~transcription factor activity, RNA polymerase II core promoter sequence-specific,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0032403~protein complex binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,	hsa04010:MAPK signaling pathway,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05222:Small cell lung cancer,	171300~Pheochromocytoma, susceptibility to,		SM00353:HLH,	3D-structure,Acetylation,Activator,Alternative splicing,Cell projection,Coiled coil,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Protein max,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:Leucine-zipper,helix,modified residue,mutagenesis site,short sequence motif:Nuclear localization signal,splice variant,
NFKBIE	NFKB inhibitor epsilon(NFKBIE)	Homo sapiens				GO:0042942~D-serine transport,GO:0042994~cytoplasmic sequestering of transcription factor,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,	IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,	hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa05169:Epstein-Barr virus infection,			SM00248:ANK,	ANK repeat,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:NF-kappa-B inhibitor epsilon,modified residue,mutagenesis site,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,sequence conflict,sequence variant,
PHF6	PHD finger protein 6(PHF6)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0015631~tubulin binding,GO:0019899~enzyme binding,GO:0042393~histone binding,GO:0042826~histone deacetylase binding,GO:0043021~ribonucleoprotein complex binding,GO:0044822~poly(A) RNA binding,GO:0051219~phosphoprotein binding,GO:0097110~scaffold protein binding,	IPR001965:Zinc finger, PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,		301900~Borjeson-Forssman-Lehmann syndrome,		SM00249:PHD,	3D-structure,Acetylation,Alternative splicing,Centromere,Chromosome,Complete proteome,Disease mutation,DNA-binding,Epilepsy,Isopeptide bond,Kinetochore,Mental retardation,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:PHD finger protein 6,modified residue,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,short sequence motif:Nucleolar localization signal,splice variant,zinc finger region:PHD-type 1; degenerate,zinc finger region:PHD-type 2; degenerate,
PMS2	PMS1 homolog 2, mismatch repair system component(PMS2)	Homo sapiens				GO:0006298~mismatch repair,GO:0016446~somatic hypermutation of immunoglobulin genes,GO:0042493~response to drug,GO:0090305~nucleic acid phosphodiester bond hydrolysis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0015630~microtubule cytoskeleton,GO:0032300~mismatch repair complex,GO:0032389~MutLalpha complex,	GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0004519~endonuclease activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0030983~mismatched DNA binding,GO:0032138~single base insertion or deletion binding,GO:0032407~MutSalpha complex binding,	IPR002099:DNA mismatch repair protein,IPR003594:Histidine kinase-like ATPase, ATP-binding domain,IPR013507:DNA mismatch repair protein, C-terminal,IPR014721:Ribosomal protein S5 domain 2-type fold, subgroup,IPR014762:DNA mismatch repair, conserved site,IPR014790:MutL, C-terminal, dimerisation,IPR020568:Ribosomal protein S5 domain 2-type fold,	hsa03430:Mismatch repair,hsa03460:Fanconi anemia pathway,	276300~Mismatch repair cancer syndrome,614337~Colorectal cancer, hereditary nonpolyposis, type 4,		SM00853:SM00853,SM01340:SM01340,	3D-structure,Alternative splicing,Complete proteome,Disease mutation,DNA damage,DNA repair,Endonuclease,Hereditary nonpolyposis colorectal cancer,Hydrolase,Nuclease,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Tumor suppressor,	chain:Mismatch repair endonuclease PMS2,helix,modified residue,sequence variant,splice variant,strand,turn,
PRDM1	PR/SET domain 1(PRDM1)	Homo sapiens			General function prediction only,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001763~morphogenesis of a branching structure,GO:0001893~maternal placenta development,GO:0002250~adaptive immune response,GO:0003170~heart valve development,GO:0003281~ventricular septum development,GO:0006351~transcription, DNA-templated,GO:0007281~germ cell development,GO:0009791~post-embryonic development,GO:0010628~positive regulation of gene expression,GO:0030889~negative regulation of B cell proliferation,GO:0031665~negative regulation of lipopolysaccharide-mediated signaling pathway,GO:0032259~methylation,GO:0032823~regulation of natural killer cell differentiation,GO:0033082~regulation of extrathymic T cell differentiation,GO:0035904~aorta development,GO:0042462~eye photoreceptor cell development,GO:0045087~innate immune response,GO:0045165~cell fate commitment,GO:0045579~positive regulation of B cell differentiation,GO:0048844~artery morphogenesis,GO:0048869~cellular developmental process,GO:0051136~regulation of NK T cell differentiation,GO:0060576~intestinal epithelial cell development,GO:0060707~trophoblast giant cell differentiation,GO:0060976~coronary vasculature development,GO:1990654~sebum secreting cell proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008168~methyltransferase activity,GO:0042826~histone deacetylase binding,GO:0046872~metal ion binding,GO:1990841~promoter-specific chromatin binding,	IPR001214:SET domain,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,IPR016608:PR-domain zinc finger protein PRDM1,			PIRSF013212:PR-domain zinc finger protein PRDM1,	SM00317:SET,SM00355:ZnF_C2H2,	3D-structure,Adaptive immunity,Alternative splicing,Complete proteome,Cytoplasm,DNA-binding,Immunity,Innate immunity,Isopeptide bond,Metal-binding,Methyltransferase,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,S-adenosyl-L-methionine,Transcription,Transcription regulation,Transferase,Ubl conjugation,Zinc,Zinc-finger,	chain:PR domain zinc finger protein 1,domain:SET,helix,sequence variant,strand,turn,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,
RB1	RB transcriptional corepressor 1(RB1)	Homo sapiens	94.E2F_transcriptional_activity_cell_cycle,	h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,h_btg2Pathway:BTG family proteins and cell cycle regulation,h_cellcyclePathway:Cyclins and Cell Cycle Regulation,h_fasPathway:FAS signaling pathway ( CD95 ),h_fbw7Pathway:Cyclin E Destruction Pathway,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_hcmvPathway:Human Cytomegalovirus and Map Kinase Pathways,h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_p27Pathway:Regulation of p27 Phosphorylation during Cell Cycle Progression,h_p53Pathway:p53 Signaling Pathway,h_pmlPathway:Regulation of transcriptional activity by PML,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_rbPathway:RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage,h_skp2e2fPathway:E2F1 Destruction Pathway,h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality,h_tercPathway:Overview of telomerase RNA component gene hTerc Transcriptional Regulation,h_tidPathway:Chaperones modulate interferon Signaling Pathway,h_tnfr1Pathway:TNFR1 Signaling Pathway,		GO:0000075~cell cycle checkpoint,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001558~regulation of cell growth,GO:0001894~tissue homeostasis,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006469~negative regulation of protein kinase activity,GO:0006915~apoptotic process,GO:0007050~cell cycle arrest,GO:0007070~negative regulation of transcription from RNA polymerase II promoter during mitosis,GO:0007093~mitotic cell cycle checkpoint,GO:0007265~Ras protein signal transduction,GO:0007346~regulation of mitotic cell cycle,GO:0008285~negative regulation of cell proliferation,GO:0010629~negative regulation of gene expression,GO:0016032~viral process,GO:0016569~covalent chromatin modification,GO:0030521~androgen receptor signaling pathway,GO:0031134~sister chromatid biorientation,GO:0031175~neuron projection development,GO:0034088~maintenance of mitotic sister chromatid cohesion,GO:0034349~glial cell apoptotic process,GO:0035914~skeletal muscle cell differentiation,GO:0042551~neuron maturation,GO:0043353~enucleate erythrocyte differentiation,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043550~regulation of lipid kinase activity,GO:0045445~myoblast differentiation,GO:0045651~positive regulation of macrophage differentiation,GO:0045842~positive regulation of mitotic metaphase/anaphase transition,GO:0045879~negative regulation of smoothened signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048565~digestive tract development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051146~striated muscle cell differentiation,GO:0051301~cell division,GO:0051402~neuron apoptotic process,GO:0051726~regulation of cell cycle,GO:0071459~protein localization to chromosome, centromeric region,GO:0071466~cellular response to xenobiotic stimulus,GO:0071922~regulation of cohesin loading,GO:0071930~negative regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0090230~regulation of centromere complex assembly,GO:0097284~hepatocyte apoptotic process,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,GO:2000679~positive regulation of transcription regulatory region DNA binding,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005819~spindle,GO:0008024~cyclin/CDK positive transcription elongation factor complex,GO:0016514~SWI/SNF complex,GO:0016605~PML body,GO:0035189~Rb-E2F complex,	GO:0001047~core promoter binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019900~kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0050681~androgen receptor binding,GO:0051219~phosphoprotein binding,	IPR002719:Retinoblastoma-associated protein, B-box,IPR002720:Retinoblastoma-associated protein, A-box,IPR013763:Cyclin-like,IPR015030:Rb C-terminal,IPR024599:Domain of unknown function DUF3452, retinoblastoma-associated,	hsa04110:Cell cycle,hsa05161:Hepatitis B,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05212:Pancreatic cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,	109800~Bladder cancer, somatic,180200~Retinoblastoma,180200~Retinoblastoma, trilateral,182280~Small cell cancer of the lung, somatic,259500~Osteosarcoma, somatic,		SM00385:CYCLIN,SM01367:SM01367,SM01368:SM01368,SM01369:SM01369,	3D-structure,Acetylation,Cell cycle,Chromatin regulator,Complete proteome,Direct protein sequencing,Disease mutation,DNA-binding,Host-virus interaction,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Tumor suppressor,	chain:Retinoblastoma-associated protein,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Pro,helix,modified residue,mutagenesis site,region of interest:Domain A,region of interest:Domain B,region of interest:Domain C; mediates interaction with E4F1,region of interest:Interaction with LIMD1,region of interest:Pocket; binds T and E1A,region of interest:Spacer,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,strand,turn,
REL	REL proto-oncogene, NF-kB subunit(REL)	Homo sapiens	79.B_cell_Activation,			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006954~inflammatory response,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0010629~negative regulation of gene expression,GO:0032688~negative regulation of interferon-beta production,GO:0034097~response to cytokine,GO:0038061~NIK/NF-kappaB signaling,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045087~innate immune response,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:1901215~negative regulation of neuron death,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005829~cytosol,GO:0033256~I-kappaB/NF-kappaB complex,	GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001205~transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,	IPR000451:NF-kappa-B/Rel/Dorsal,IPR002909:Cell surface receptor IPT/TIG,IPR008967:p53-like transcription factor, DNA-binding,IPR011539:Rel homology domain,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,	hsa04014:Ras signaling pathway,hsa05202:Transcriptional misregulation in cancer,hsa05203:Viral carcinogenesis,			SM00429:IPT,	Acetylation,Activator,Alternative splicing,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,	chain:C-Rel proto-oncogene protein,modified residue,region of interest:RHD,short sequence motif:Nuclear localization signal,
RBM10	RNA binding motif protein 10(RBM10)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008285~negative regulation of cell proliferation,GO:0008380~RNA splicing,GO:0034393~positive regulation of smooth muscle cell apoptotic process,GO:0042981~regulation of apoptotic process,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:0070935~3'-UTR-mediated mRNA stabilization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0032403~protein complex binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR000467:G-patch domain,IPR000504:RNA recognition motif domain,IPR001876:Zinc finger, RanBP2-type,IPR007087:Zinc finger, C2H2,IPR012677:Nucleotide-binding, alpha-beta plait,		311900~TARP syndrome,		SM00360:RRM,SM00443:G_patch,SM00547:ZnF_RBZ,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Metal-binding,Methylation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,Zinc,Zinc-finger,	chain:RNA-binding protein 10,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Glu,compositionally biased region:Tyr-rich,domain:G-patch,domain:RRM 1,domain:RRM 2,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type; atypical,zinc finger region:RanBP2-type,
SBDS	SBDS ribosome assembly guanine nucleotide exchange factor(SBDS)	Homo sapiens			Translation, ribosomal structure and biogenesis,	GO:0001833~inner cell mass cell proliferation,GO:0006364~rRNA processing,GO:0007052~mitotic spindle organization,GO:0008283~cell proliferation,GO:0030282~bone mineralization,GO:0030595~leukocyte chemotaxis,GO:0042256~mature ribosome assembly,GO:0048539~bone marrow development,	GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0019843~rRNA binding,GO:0043022~ribosome binding,GO:0044822~poly(A) RNA binding,	IPR002140:Ribosome maturation protein SBDS,IPR018023:Ribosome maturation protein SBDS, conserved site,IPR018978:Ribosome maturation protein SBDS, C-terminal,IPR019783:Ribosome maturation protein SBDS, N-terminal,	hsa03008:Ribosome biogenesis in eukaryotes,	260400~Shwachman-Diamond syndrome,609135~Aplastic anemia, susceptibility to,			3D-structure,Acetylation,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Disease mutation,Nucleus,Proteomics identification,Reference proteome,Ribosome biogenesis,	chain:Ribosome maturation protein SBDS,modified residue,sequence conflict,sequence variant,
SETD2	SET domain containing 2(SETD2)	Homo sapiens				GO:0001525~angiogenesis,GO:0001763~morphogenesis of a branching structure,GO:0001843~neural tube closure,GO:0006298~mismatch repair,GO:0006355~regulation of transcription, DNA-templated,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0010793~regulation of mRNA export from nucleus,GO:0030900~forebrain development,GO:0034728~nucleosome organization,GO:0035441~cell migration involved in vasculogenesis,GO:0048332~mesoderm morphogenesis,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0048864~stem cell development,GO:0060039~pericardium development,GO:0060669~embryonic placenta morphogenesis,GO:0060977~coronary vasculature morphogenesis,GO:0097198~histone H3-K36 trimethylation,GO:0097676~histone H3-K36 dimethylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,	GO:0005515~protein binding,GO:0018024~histone-lysine N-methyltransferase activity,GO:0046975~histone methyltransferase activity (H3-K36 specific),	IPR001202:WW domain,IPR001214:SET domain,IPR003616:Post-SET domain,IPR006560:AWS,IPR009078:Ferritin-like superfamily,IPR013257:SRI, Set2 Rpb1 interacting,	hsa00310:Lysine degradation,			SM00317:SET,SM00456:WW,SM00508:PostSET,SM00570:AWS,	3D-structure,Activator,Alternative splicing,Autism spectrum disorder,Chromatin regulator,Chromosome,Coiled coil,Complete proteome,Isopeptide bond,Mental retardation,Methyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,Transcription,Transcription regulation,Transferase,Ubl conjugation,	chain:Histone-lysine N-methyltransferase SETD2,compositionally biased region:Arg-rich,compositionally biased region:Gln-rich,compositionally biased region:Pro-rich,domain:AWS,domain:Post-SET,domain:SET,domain:WW,helix,modified residue,mutagenesis site,region of interest:Interaction with POLR2A,region of interest:Low charge region,sequence conflict,sequence variant,splice variant,strand,turn,
SH2B3	SH2B adaptor protein 3(SH2B3)	Homo sapiens				GO:0007165~signal transduction,GO:0007596~blood coagulation,GO:0009967~positive regulation of signal transduction,GO:0030097~hemopoiesis,GO:0030154~cell differentiation,GO:0035162~embryonic hemopoiesis,GO:0035556~intracellular signal transduction,	GO:0005829~cytosol,	GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0035591~signaling adaptor activity,	IPR000980:SH2 domain,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR015012:Phenylalanine zipper,	hsa04722:Neurotrophin signaling pathway,	133100~Erythrocytosis, somatic,187950~Thrombocythemia, somatic,254450~Myelofibrosis, somatic,		SM00233:PH,SM00252:SH2,	Complete proteome,Diabetes mellitus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH2 domain,	chain:SH2B adapter protein 3,domain:PH,domain:SH2,sequence conflict,sequence variant,
SMAD2	SMAD family member 2(SMAD2)	Homo sapiens		h_tgfbPathway:TGF beta signaling pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001657~ureteric bud development,GO:0001701~in utero embryonic development,GO:0001706~endoderm formation,GO:0001707~mesoderm formation,GO:0006351~transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006468~protein phosphorylation,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007182~common-partner SMAD protein phosphorylation,GO:0007183~SMAD protein complex assembly,GO:0007352~zygotic specification of dorsal/ventral axis,GO:0007369~gastrulation,GO:0008285~negative regulation of cell proliferation,GO:0009749~response to glucose,GO:0009791~post-embryonic development,GO:0009880~embryonic pattern specification,GO:0009952~anterior/posterior pattern specification,GO:0010629~negative regulation of gene expression,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0023019~signal transduction involved in regulation of gene expression,GO:0030073~insulin secretion,GO:0030324~lung development,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030513~positive regulation of BMP signaling pathway,GO:0031016~pancreas development,GO:0031053~primary miRNA processing,GO:0032924~activin receptor signaling pathway,GO:0035019~somatic stem cell population maintenance,GO:0035265~organ growth,GO:0035556~intracellular signal transduction,GO:0038092~nodal signaling pathway,GO:0045165~cell fate commitment,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048340~paraxial mesoderm morphogenesis,GO:0048617~embryonic foregut morphogenesis,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0051098~regulation of binding,GO:0060021~palate development,GO:0060039~pericardium development,GO:0060395~SMAD protein signal transduction,GO:0070723~response to cholesterol,GO:1900224~positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0032444~activin responsive factor complex,GO:0071141~SMAD protein complex,GO:0071144~SMAD2-SMAD3 protein complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005160~transforming growth factor beta receptor binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019902~phosphatase binding,GO:0030618~transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,GO:0031625~ubiquitin protein ligase binding,GO:0033613~activating transcription factor binding,GO:0034713~type I transforming growth factor beta receptor binding,GO:0035326~enhancer binding,GO:0042803~protein homodimerization activity,GO:0046332~SMAD binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:0070410~co-SMAD binding,GO:0070411~I-SMAD binding,GO:0070412~R-SMAD binding,	IPR001132:SMAD domain, Dwarfin-type,IPR003619:MAD homology 1, Dwarfin-type,IPR008984:SMAD/FHA domain,IPR013019:MAD homology, MH1,IPR013790:Dwarfin,IPR017855:SMAD domain-like,	hsa04068:FoxO signaling pathway,hsa04110:Cell cycle,hsa04144:Endocytosis,hsa04350:TGF-beta signaling pathway,hsa04390:Hippo signaling pathway,hsa04520:Adherens junction,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa05142:Chagas disease (American trypanosomiasis),hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05212:Pancreatic cancer,hsa05321:Inflammatory bowel disease (IBD),			SM00523:DWA,SM00524:DWB,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Membrane,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,Ubl conjugation,Zinc,	chain:Mothers against decapentaplegic homolog 2,domain:MH1,domain:MH2,helix,modified residue,mutagenesis site,sequence variant,short sequence motif:PY-motif,splice variant,strand,
SMAD3	SMAD family member 3(SMAD3)	Homo sapiens		h_g1Pathway:Cell Cycle: G1/S Check Point ,h_nthiPathway:NFkB activation by Nontypeable Hemophilus influenzae,h_tgfbPathway:TGF beta signaling pathway,h_tob1Pathway:Role of Tob in T-cell activation,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001657~ureteric bud development,GO:0001666~response to hypoxia,GO:0001701~in utero embryonic development,GO:0001707~mesoderm formation,GO:0001756~somitogenesis,GO:0001889~liver development,GO:0001947~heart looping,GO:0002076~osteoblast development,GO:0002520~immune system development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006810~transport,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006955~immune response,GO:0007050~cell cycle arrest,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007183~SMAD protein complex assembly,GO:0007492~endoderm development,GO:0009880~embryonic pattern specification,GO:0010628~positive regulation of gene expression,GO:0010694~positive regulation of alkaline phosphatase activity,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0016202~regulation of striated muscle tissue development,GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0019049~evasion or tolerance of host defenses by virus,GO:0023019~signal transduction involved in regulation of gene expression,GO:0030308~negative regulation of cell growth,GO:0030335~positive regulation of cell migration,GO:0030501~positive regulation of bone mineralization,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030878~thyroid gland development,GO:0031053~primary miRNA processing,GO:0032332~positive regulation of chondrocyte differentiation,GO:0032731~positive regulation of interleukin-1 beta production,GO:0032909~regulation of transforming growth factor beta2 production,GO:0032916~positive regulation of transforming growth factor beta3 production,GO:0032924~activin receptor signaling pathway,GO:0033689~negative regulation of osteoblast proliferation,GO:0035413~positive regulation of catenin import into nucleus,GO:0038092~nodal signaling pathway,GO:0042060~wound healing,GO:0042110~T cell activation,GO:0042177~negative regulation of protein catabolic process,GO:0042993~positive regulation of transcription factor import into nucleus,GO:0043066~negative regulation of apoptotic process,GO:0045216~cell-cell junction organization,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045599~negative regulation of fat cell differentiation,GO:0045668~negative regulation of osteoblast differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045930~negative regulation of mitotic cell cycle,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048340~paraxial mesoderm morphogenesis,GO:0048589~developmental growth,GO:0048617~embryonic foregut morphogenesis,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0050678~regulation of epithelial cell proliferation,GO:0050728~negative regulation of inflammatory response,GO:0050776~regulation of immune response,GO:0050821~protein stabilization,GO:0050927~positive regulation of positive chemotaxis,GO:0051098~regulation of binding,GO:0051481~negative regulation of cytosolic calcium ion concentration,GO:0051496~positive regulation of stress fiber assembly,GO:0051894~positive regulation of focal adhesion assembly,GO:0060039~pericardium development,GO:0060070~canonical Wnt signaling pathway,GO:0060290~transdifferentiation,GO:0060395~SMAD protein signal transduction,GO:0061045~negative regulation of wound healing,GO:0070306~lens fiber cell differentiation,GO:0097191~extrinsic apoptotic signaling pathway,GO:0097296~activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,GO:1901203~positive regulation of extracellular matrix assembly,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,	GO:0000790~nuclear chromatin,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005637~nuclear inner membrane,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0043235~receptor complex,GO:0071141~SMAD protein complex,GO:0071144~SMAD2-SMAD3 protein complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000983~transcription factor activity, RNA polymerase II core promoter sequence-specific,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0000988~transcription factor activity, protein binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005160~transforming growth factor beta receptor binding,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0008013~beta-catenin binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0019901~protein kinase binding,GO:0019902~phosphatase binding,GO:0030618~transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,GO:0031490~chromatin DNA binding,GO:0031625~ubiquitin protein ligase binding,GO:0035326~enhancer binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043130~ubiquitin binding,GO:0043425~bHLH transcription factor binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,GO:0070410~co-SMAD binding,GO:0070412~R-SMAD binding,	IPR001132:SMAD domain, Dwarfin-type,IPR003619:MAD homology 1, Dwarfin-type,IPR008984:SMAD/FHA domain,IPR013019:MAD homology, MH1,IPR013790:Dwarfin,IPR017855:SMAD domain-like,	hsa04068:FoxO signaling pathway,hsa04110:Cell cycle,hsa04144:Endocytosis,hsa04350:TGF-beta signaling pathway,hsa04390:Hippo signaling pathway,hsa04520:Adherens junction,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa05142:Chagas disease (American trypanosomiasis),hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05212:Pancreatic cancer,hsa05321:Inflammatory bowel disease (IBD),	613795~Loeys-Dietz syndrome 3,		SM00523:DWA,SM00524:DWB,	3D-structure,Acetylation,ADP-ribosylation,Alternative splicing,Aortic aneurysm,Complete proteome,Cytoplasm,Disease mutation,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,Zinc,	chain:Mothers against decapentaplegic homolog 3,domain:MH1,domain:MH2,helix,modified residue,mutagenesis site,region of interest:Sufficient for interaction with XPO4,sequence conflict,sequence variant,strand,
SMAD4	SMAD family member 4(SMAD4)	Homo sapiens		h_alkPathway:ALK in cardiac myocytes,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_nthiPathway:NFkB activation by Nontypeable Hemophilus influenzae,h_tgfbPathway:TGF beta signaling pathway,h_tob1Pathway:Role of Tob in T-cell activation,h_wntPathway:WNT Signaling Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001541~ovarian follicle development,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001666~response to hypoxia,GO:0001701~in utero embryonic development,GO:0001702~gastrulation with mouth forming second,GO:0003148~outflow tract septum morphogenesis,GO:0003190~atrioventricular valve formation,GO:0003198~epithelial to mesenchymal transition involved in endocardial cushion formation,GO:0003220~left ventricular cardiac muscle tissue morphogenesis,GO:0003251~positive regulation of cell proliferation involved in heart valve morphogenesis,GO:0003279~cardiac septum development,GO:0003360~brainstem development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006879~cellular iron ion homeostasis,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007183~SMAD protein complex assembly,GO:0007283~spermatogenesis,GO:0007338~single fertilization,GO:0007411~axon guidance,GO:0007492~endoderm development,GO:0007498~mesoderm development,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0010614~negative regulation of cardiac muscle hypertrophy,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0014033~neural crest cell differentiation,GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0030308~negative regulation of cell growth,GO:0030509~BMP signaling pathway,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0030513~positive regulation of BMP signaling pathway,GO:0032525~somite rostral/caudal axis specification,GO:0032909~regulation of transforming growth factor beta2 production,GO:0033686~positive regulation of luteinizing hormone secretion,GO:0035019~somatic stem cell population maintenance,GO:0035556~intracellular signal transduction,GO:0036302~atrioventricular canal development,GO:0042118~endothelial cell activation,GO:0042733~embryonic digit morphogenesis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046881~positive regulation of follicle-stimulating hormone secretion,GO:0048589~developmental growth,GO:0048663~neuron fate commitment,GO:0048733~sebaceous gland development,GO:0048859~formation of anatomical boundary,GO:0051098~regulation of binding,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0051797~regulation of hair follicle development,GO:0060021~palate development,GO:0060065~uterus development,GO:0060391~positive regulation of SMAD protein import into nucleus,GO:0060395~SMAD protein signal transduction,GO:0060412~ventricular septum morphogenesis,GO:0060548~negative regulation of cell death,GO:0060956~endocardial cell differentiation,GO:0061040~female gonad morphogenesis,GO:0070102~interleukin-6-mediated signaling pathway,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:0071559~response to transforming growth factor beta,GO:0071773~cellular response to BMP stimulus,GO:0072133~metanephric mesenchyme morphogenesis,GO:0072134~nephrogenic mesenchyme morphogenesis,GO:0072520~seminiferous tubule development,GO:1901522~positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,GO:2000617~positive regulation of histone H3-K9 acetylation,	GO:0000790~nuclear chromatin,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0032444~activin responsive factor complex,GO:0071141~SMAD protein complex,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0000988~transcription factor activity, protein binding,GO:0001076~transcription factor activity, RNA polymerase II transcription factor binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0030616~transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:0070411~I-SMAD binding,GO:0070412~R-SMAD binding,	IPR001132:SMAD domain, Dwarfin-type,IPR003619:MAD homology 1, Dwarfin-type,IPR008984:SMAD/FHA domain,IPR013019:MAD homology, MH1,IPR013790:Dwarfin,IPR017855:SMAD domain-like,	hsa04068:FoxO signaling pathway,hsa04110:Cell cycle,hsa04310:Wnt signaling pathway,hsa04350:TGF-beta signaling pathway,hsa04390:Hippo signaling pathway,hsa04520:Adherens junction,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa05161:Hepatitis B,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05212:Pancreatic cancer,hsa05220:Chronic myeloid leukemia,	139210~Myhre syndrome,174900~Polyposis, juvenile intestinal,175050~Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,260350~Pancreatic cancer, somatic,		SM00523:DWA,SM00524:DWB,	3D-structure,Acetylation,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,Zinc,	chain:Mothers against decapentaplegic homolog 4,compositionally biased region:Poly-Ala,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:MH1,domain:MH2,helix,modified residue,mutagenesis site,region of interest:SAD,sequence variant,strand,turn,
SRC	SRC proto-oncogene, non-receptor tyrosine kinase(SRC)	Homo sapiens	85.Nuc_Rec-Coact_Complex,	h_achPathway:Role of nicotinic acetylcholine receptors in the regulation of apoptosis,h_agrPathway:Agrin in Postsynaptic Differentiation,h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_bArrestin-srcPathway:Roles of ï¿½-arrestin-dependent Recruitment of Src Kinases in GPCR Signaling,h_cblPathway:CBL mediated ligand-induced downregulation of EGF receptors,h_cell2cellPathway:Cell to Cell Adhesion Signaling,h_ecmPathway:Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia,h_edg1Pathway:Phospholipids as signalling intermediaries,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_gabaPathway:Gamma-aminobutyric Acid Receptor Life Cycle,h_hbxPathway:Calcium Signaling by HBx of Hepatitis B virus,h_integrinPathway:Integrin Signaling Pathway,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_mPRPathway:How Progesterone Initiates the Oocyte Maturation,h_pelp1Pathway:Pelp1 Modulation of Estrogen Receptor Activity,h_pyk2Pathway:Links between Pyk2 and Map Kinases,h_rhoPathway:Rho cell motility signaling pathway,h_sam68Pathway:Regulation of Splicing through Sam68,h_sppaPathway:Aspirin Blocks Signaling Pathway Involved in Platelet Activation,h_spryPathway:Sprouty regulation of tyrosine kinase signals,h_srcRPTPPathway:Activation of Src by Protein-tyrosine phosphatase alpha,h_uCalpainPathway:uCalpain and friends in Cell spread,		GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0007049~cell cycle,GO:0007165~signal transduction,GO:0007172~signal complex assembly,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007229~integrin-mediated signaling pathway,GO:0007417~central nervous system development,GO:0008283~cell proliferation,GO:0009612~response to mechanical stimulus,GO:0009615~response to virus,GO:0010447~response to acidic pH,GO:0010632~regulation of epithelial cell migration,GO:0010634~positive regulation of epithelial cell migration,GO:0010641~positive regulation of platelet-derived growth factor receptor signaling pathway,GO:0010907~positive regulation of glucose metabolic process,GO:0010954~positive regulation of protein processing,GO:0014911~positive regulation of smooth muscle cell migration,GO:0016337~single organismal cell-cell adhesion,GO:0018105~peptidyl-serine phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0022407~regulation of cell-cell adhesion,GO:0030168~platelet activation,GO:0030520~intracellular estrogen receptor signaling pathway,GO:0030900~forebrain development,GO:0031295~T cell costimulation,GO:0031648~protein destabilization,GO:0031667~response to nutrient levels,GO:0031954~positive regulation of protein autophosphorylation,GO:0032148~activation of protein kinase B activity,GO:0032211~negative regulation of telomere maintenance via telomerase,GO:0032463~negative regulation of protein homooligomerization,GO:0032869~cellular response to insulin stimulus,GO:0033146~regulation of intracellular estrogen receptor signaling pathway,GO:0033625~positive regulation of integrin activation,GO:0034332~adherens junction organization,GO:0034446~substrate adhesion-dependent cell spreading,GO:0034614~cellular response to reactive oxygen species,GO:0035556~intracellular signal transduction,GO:0036035~osteoclast development,GO:0036120~cellular response to platelet-derived growth factor stimulus,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0038128~ERBB2 signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043114~regulation of vascular permeability,GO:0043149~stress fiber assembly,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043393~regulation of protein binding,GO:0043406~positive regulation of MAP kinase activity,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0045056~transcytosis,GO:0045087~innate immune response,GO:0045124~regulation of bone resorption,GO:0045453~bone resorption,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046628~positive regulation of insulin receptor signaling pathway,GO:0046777~protein autophosphorylation,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048011~neurotrophin TRK receptor signaling pathway,GO:0048013~ephrin receptor signaling pathway,GO:0048477~oogenesis,GO:0050715~positive regulation of cytokine secretion,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050847~progesterone receptor signaling pathway,GO:0050900~leukocyte migration,GO:0051057~positive regulation of small GTPase mediated signal transduction,GO:0051385~response to mineralocorticoid,GO:0051602~response to electrical stimulus,GO:0051726~regulation of cell cycle,GO:0051895~negative regulation of focal adhesion assembly,GO:0051897~positive regulation of protein kinase B signaling,GO:0051902~negative regulation of mitochondrial depolarization,GO:0051974~negative regulation of telomerase activity,GO:0060065~uterus development,GO:0060444~branching involved in mammary gland duct morphogenesis,GO:0060491~regulation of cell projection assembly,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070555~response to interleukin-1,GO:0071222~cellular response to lipopolysaccharide,GO:0071375~cellular response to peptide hormone stimulus,GO:0071393~cellular response to progesterone stimulus,GO:0071398~cellular response to fatty acid,GO:0071456~cellular response to hypoxia,GO:0071498~cellular response to fluid shear stress,GO:0071801~regulation of podosome assembly,GO:0071803~positive regulation of podosome assembly,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:0086098~angiotensin-activated signaling pathway involved in heart process,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1900182~positive regulation of protein localization to nucleus,GO:2000394~positive regulation of lamellipodium morphogenesis,GO:2000573~positive regulation of DNA biosynthetic process,GO:2000641~regulation of early endosome to late endosome transport,GO:2000811~negative regulation of anoikis,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,GO:2001286~regulation of caveolin-mediated endocytosis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005764~lysosome,GO:0005770~late endosome,GO:0005829~cytosol,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0005913~cell-cell adherens junction,GO:0014069~postsynaptic density,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0032587~ruffle membrane,GO:0043005~neuron projection,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005070~SH3/SH2 adaptor activity,GO:0005080~protein kinase C binding,GO:0005102~receptor binding,GO:0005158~insulin receptor binding,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0016301~kinase activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0020037~heme binding,GO:0030331~estrogen receptor binding,GO:0042169~SH2 domain binding,GO:0044325~ion channel binding,GO:0046875~ephrin receptor binding,GO:0051219~phosphoprotein binding,GO:0051427~hormone receptor binding,GO:0070851~growth factor receptor binding,GO:0097110~scaffold protein binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001452:Src homology-3 domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04012:ErbB signaling pathway,hsa04015:Rap1 signaling pathway,hsa04062:Chemokine signaling pathway,hsa04144:Endocytosis,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa04520:Adherens junction,hsa04530:Tight junction,hsa04540:Gap junction,hsa04611:Platelet activation,hsa04727:GABAergic synapse,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04810:Regulation of actin cytoskeleton,hsa04912:GnRH signaling pathway,hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04921:Oxytocin signaling pathway,hsa05100:Bacterial invasion of epithelial cells,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05131:Shigellosis,hsa05152:Tuberculosis,hsa05161:Hepatitis B,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05219:Bladder cancer,	Colon cancer, advanced, somatic~Colon cancer, advanced, somatic,		SM00219:TyrKc,SM00252:SH2,SM00326:SH3,	3D-structure,Alternative splicing,ATP-binding,Cell adhesion,Cell cycle,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,Host-virus interaction,Immunity,Kinase,Lipoprotein,Membrane,Mitochondrion,Mitochondrion inner membrane,Myristate,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proto-oncogene,Reference proteome,SH2 domain,SH3 domain,Transferase,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Proto-oncogene tyrosine-protein kinase Src,domain:Protein kinase,domain:SH2,domain:SH3,helix,lipid moiety-binding region:N-myristoyl glycine,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,strand,turn,
SOX2	SRY-box 2(SOX2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001649~osteoblast differentiation,GO:0001654~eye development,GO:0001714~endodermal cell fate specification,GO:0006325~chromatin organization,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0007050~cell cycle arrest,GO:0009611~response to wounding,GO:0010468~regulation of gene expression,GO:0021781~glial cell fate commitment,GO:0021983~pituitary gland development,GO:0021984~adenohypophysis development,GO:0022409~positive regulation of cell-cell adhesion,GO:0030900~forebrain development,GO:0035019~somatic stem cell population maintenance,GO:0042246~tissue regeneration,GO:0043281~regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043410~positive regulation of MAPK cascade,GO:0045597~positive regulation of cell differentiation,GO:0045665~negative regulation of neuron differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048839~inner ear development,GO:0050680~negative regulation of epithelial cell proliferation,GO:0070848~response to growth factor,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0097150~neuronal stem cell population maintenance,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0035198~miRNA binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,	IPR009071:High mobility group (HMG) box domain,IPR022097:Transcription factor SOX,	hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,	206900~Microphthalmia, syndromic 3,206900~Optic nerve hypoplasia and abnormalities of the central nervous system,		SM00398:HMG,	3D-structure,Activator,Complete proteome,Developmental protein,Disease mutation,DNA-binding,Isopeptide bond,Microphthalmia,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Transcription factor SOX-2,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gly,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:HMG box,helix,
SUFU	SUFU negative regulator of hedgehog signaling(SUFU)	Homo sapiens		h_shhPathway:Sonic Hedgehog (Shh) Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001501~skeletal system development,GO:0001843~neural tube closure,GO:0001947~heart looping,GO:0003281~ventricular septum development,GO:0006355~regulation of transcription, DNA-templated,GO:0006508~proteolysis,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0021775~smoothened signaling pathway involved in ventral spinal cord interneuron specification,GO:0021776~smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,GO:0035904~aorta development,GO:0042992~negative regulation of transcription factor import into nucleus,GO:0042994~cytoplasmic sequestering of transcription factor,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043588~skin development,GO:0045668~negative regulation of osteoblast differentiation,GO:0045879~negative regulation of smoothened signaling pathway,GO:0060976~coronary vasculature development,GO:1901621~negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,GO:2000059~negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0072372~primary cilium,GO:0097542~ciliary tip,GO:0097546~ciliary base,	GO:0003714~transcription corepressor activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008134~transcription factor binding,GO:0019901~protein kinase binding,	IPR007768:Suppressor of fused-like,IPR016591:Suppressor of fused protein,IPR020941:Suppressor of fused domain,IPR024314:Suppressor of fused C-terminal,	hsa04340:Hedgehog signaling pathway,hsa05200:Pathways in cancer,hsa05217:Basal cell carcinoma,	109400~Basal cell nevus syndrome,155255~Medulloblastoma, desmoplastic,607174~Meningioma, familial, susceptibility to,	PIRSF011844:suppressor of fused protein,		3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Tumor suppressor,	chain:Suppressor of fused homolog,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,turn,
SMARCA4	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4(SMARCA4)	Homo sapiens		h_hSWI-SNFpathway:Chromatin Remodeling by hSWI/SNF ATP-dependent Complexes,h_vdrPathway:Control of Gene Expression by Vitamin D Receptor,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0003407~neural retina development,GO:0006337~nucleosome disassembly,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007070~negative regulation of transcription from RNA polymerase II promoter during mitosis,GO:0007399~nervous system development,GO:0016569~covalent chromatin modification,GO:0030177~positive regulation of Wnt signaling pathway,GO:0030308~negative regulation of cell growth,GO:0043044~ATP-dependent chromatin remodeling,GO:0043923~positive regulation by host of viral transcription,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0060766~negative regulation of androgen receptor signaling pathway,GO:1901838~positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,GO:1902661~positive regulation of glucose mediated signaling pathway,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1904837~beta-catenin-TCF complex assembly,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,	GO:0000790~nuclear chromatin,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016020~membrane,GO:0016514~SWI/SNF complex,GO:0043234~protein complex,GO:0071564~npBAF complex,GO:0071565~nBAF complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001105~RNA polymerase II transcription coactivator activity,GO:0001164~RNA polymerase I CORE element sequence-specific DNA binding,GO:0002039~p53 binding,GO:0003713~transcription coactivator activity,GO:0003714~transcription corepressor activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008094~DNA-dependent ATPase activity,GO:0008134~transcription factor binding,GO:0016887~ATPase activity,GO:0030957~Tat protein binding,GO:0031492~nucleosomal DNA binding,GO:0047485~protein N-terminus binding,GO:0050681~androgen receptor binding,GO:0070182~DNA polymerase binding,GO:0070577~lysine-acetylated histone binding,	IPR000330:SNF2-related,IPR001487:Bromodomain,IPR001650:Helicase, C-terminal,IPR006576:BRK domain,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014012:Helicase/SANT-associated, DNA binding,IPR014978:Glutamine-Leucine-Glutamine, QLQ,IPR018359:Bromodomain, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		613325~Rhabdoid tumor predisposition syndrome 2,614609~Mental retardation, autosomal dominant 16,		SM00297:BROMO,SM00487:DEXDc,SM00490:HELICc,SM00573:HSA,SM00592:BRK,SM00951:SM00951,SM01314:SM01314,	3D-structure,Acetylation,Activator,Alternative splicing,ATP-binding,Bromodomain,Chromatin regulator,Coiled coil,Complete proteome,Disease mutation,Helicase,Hydrolase,Mental retardation,Neurogenesis,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Transcription activator BRG1,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Lys,domain:Bromo,domain:Helicase ATP-binding,domain:Helicase C-terminal,domain:HSA,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Necessary for interaction with SS18L1/CREST,sequence conflict,sequence variant,short sequence motif:DEGH box,site:Required for binding to 'Lys-15'- acetylated histone 3,strand,turn,
SMARCB1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1(SMARCB1)	Homo sapiens		h_hSWI-SNFpathway:Chromatin Remodeling by hSWI/SNF ATP-dependent Complexes,		GO:0001835~blastocyst hatching,GO:0006281~DNA repair,GO:0006337~nucleosome disassembly,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007049~cell cycle,GO:0007399~nervous system development,GO:0008285~negative regulation of cell proliferation,GO:0015074~DNA integration,GO:0016569~covalent chromatin modification,GO:0030154~cell differentiation,GO:0039692~single stranded viral RNA replication via double stranded DNA intermediate,GO:0043044~ATP-dependent chromatin remodeling,GO:0043923~positive regulation by host of viral transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0090240~positive regulation of histone H4 acetylation,GO:1900110~negative regulation of histone H3-K9 dimethylation,GO:1900113~negative regulation of histone H3-K9 trimethylation,GO:1901838~positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,GO:1902661~positive regulation of glucose mediated signaling pathway,GO:2000617~positive regulation of histone H3-K9 acetylation,GO:2000618~regulation of histone H4-K16 acetylation,	GO:0000228~nuclear chromosome,GO:0000790~nuclear chromatin,GO:0001741~XY body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016514~SWI/SNF complex,GO:0043234~protein complex,GO:0071564~npBAF complex,GO:0071565~nBAF complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001164~RNA polymerase I CORE element sequence-specific DNA binding,GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0030957~Tat protein binding,GO:0031492~nucleosomal DNA binding,	IPR006939:SNF5/SMARCB1/INI1,IPR017393:SWI/SNF chromatin-remodeling complex, component hSNF5/Ini1,		162091~Schwannomatosis-1, susceptibility to,609322~Rhabdoid predisposition syndrome 1,609322~Rhabdoid tumors, somatic,614608~Mental retardation, autosomal dominant 15,	PIRSF038126:SWI/SNF chromatin-remodeling complex, component hSNF5/Ini1,		3D-structure,Activator,Alternative splicing,Cell cycle,Chromatin regulator,Complete proteome,Disease mutation,DNA-binding,Host-virus interaction,Mental retardation,Neurogenesis,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Tumor suppressor,	chain:SWI/SNF-related matrix-associated actin- dependent regulator of chromatin subfamily B member 1,modified residue,region of interest:2 X approximate tandem repeats,region of interest:DNA-binding,region of interest:HIV-1 integrase-binding,region of interest:Interaction with PPP1R15A,region of interest:MYC-binding,repeat:1,repeat:2,sequence conflict,splice variant,
SMARCD1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1(SMARCD1)	Homo sapiens		h_hSWI-SNFpathway:Chromatin Remodeling by hSWI/SNF ATP-dependent Complexes,h_vdrPathway:Control of Gene Expression by Vitamin D Receptor,	Chromatin structure and dynamics,	GO:0006337~nucleosome disassembly,GO:0006338~chromatin remodeling,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007399~nervous system development,GO:0016569~covalent chromatin modification,GO:0048096~chromatin-mediated maintenance of transcription,GO:0071398~cellular response to fatty acid,	GO:0016514~SWI/SNF complex,GO:0071564~npBAF complex,GO:0071565~nBAF complex,	GO:0003682~chromatin binding,GO:0003713~transcription coactivator activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0032947~protein complex scaffold,	IPR003121:SWIB/MDM2 domain,IPR019835:SWIB domain,				SM00151:SWIB,	Acetylation,Alternative splicing,Chromatin regulator,Coiled coil,Complete proteome,Methylation,Neurogenesis,Nucleus,Proteomics identification,Reference proteome,	chain:SWI/SNF-related matrix-associated actin- dependent regulator of chromatin subfamily D member 1,compositionally biased region:Poly-Lys,domain:SWIB,region of interest:Interaction with ESR1, NR1H4, NR3C1, PGR and SMARCA4,region of interest:Interaction with SMARCC1 and SMARCC2,region of interest:Necessary for GR/NR3C1-mediated remodeling and transcription from chromatin; required for GR/NR3C1 interaction with the BRG1/SMARCA4 complex in vivo,sequence conflict,splice variant,
TNFAIP3	TNF alpha induced protein 3(TNFAIP3)	Homo sapiens		h_cd40Pathway:CD40L Signaling Pathway,h_nfkbPathway:NF-kB Signaling Pathway,h_tnfr2Pathway:TNFR2 Signaling Pathway,		GO:0001922~B-1 B cell homeostasis,GO:0002237~response to molecule of bacterial origin,GO:0002634~regulation of germinal center formation,GO:0002677~negative regulation of chronic inflammatory response,GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0010803~regulation of tumor necrosis factor-mediated signaling pathway,GO:0016567~protein ubiquitination,GO:0016579~protein deubiquitination,GO:0031397~negative regulation of protein ubiquitination,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032480~negative regulation of type I interferon production,GO:0032495~response to muramyl dipeptide,GO:0032691~negative regulation of interleukin-1 beta production,GO:0032703~negative regulation of interleukin-2 production,GO:0032715~negative regulation of interleukin-6 production,GO:0032720~negative regulation of tumor necrosis factor production,GO:0034136~negative regulation of toll-like receptor 2 signaling pathway,GO:0034140~negative regulation of toll-like receptor 3 signaling pathway,GO:0034144~negative regulation of toll-like receptor 4 signaling pathway,GO:0034148~negative regulation of toll-like receptor 5 signaling pathway,GO:0035871~protein K11-linked deubiquitination,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045732~positive regulation of protein catabolic process,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045779~negative regulation of bone resorption,GO:0045824~negative regulation of innate immune response,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0050691~regulation of defense response to virus by host,GO:0050727~regulation of inflammatory response,GO:0050728~negative regulation of inflammatory response,GO:0050869~negative regulation of B cell activation,GO:0051259~protein oligomerization,GO:0061043~regulation of vascular wound healing,GO:0070301~cellular response to hydrogen peroxide,GO:0070423~nucleotide-binding oligomerization domain containing signaling pathway,GO:0070429~negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,GO:0070433~negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,GO:0070536~protein K63-linked deubiquitination,GO:0070936~protein K48-linked ubiquitination,GO:0071108~protein K48-linked deubiquitination,GO:0071222~cellular response to lipopolysaccharide,GO:0071947~protein deubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0072573~tolerance induction to lipopolysaccharide,GO:0072666~establishment of protein localization to vacuole,GO:0090291~negative regulation of osteoclast proliferation,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1903364~positive regulation of cellular protein catabolic process,GO:2000347~positive regulation of hepatocyte proliferation,GO:2000349~negative regulation of CD40 signaling pathway,GO:2000352~negative regulation of endothelial cell apoptotic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0002020~protease binding,GO:0003677~DNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0019900~kinase binding,GO:0042802~identical protein binding,GO:0043130~ubiquitin binding,GO:0043621~protein self-association,GO:0070530~K63-linked polyubiquitin binding,	IPR002653:Zinc finger, A20-type,IPR003323:Ovarian tumour, otubain,	hsa04064:NF-kappa B signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04668:TNF signaling pathway,hsa05162:Measles,hsa05169:Epstein-Barr virus infection,			SM00259:ZnF_A20,	3D-structure,Acetylation,Apoptosis,Complete proteome,Cytoplasm,Disease mutation,DNA-binding,Hydrolase,Inflammatory response,Ligase,Lysosome,Metal-binding,Multifunctional enzyme,Nucleus,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Repeat,Thiol protease,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Tumor necrosis factor, alpha-induced protein 3,domain:OTU,helix,modified residue,mutagenesis site,region of interest:2 X approximate repeats,region of interest:Interaction with NAF1,region of interest:TRAF-binding,repeat:1,repeat:2,sequence variant,strand,turn,zinc finger region:A20-type 1,zinc finger region:A20-type 2,zinc finger region:A20-type 3,zinc finger region:A20-type 4,zinc finger region:A20-type 5,zinc finger region:A20-type 6,zinc finger region:A20-type 7,
TRAF7	TNF receptor associated factor 7(TRAF7)	Homo sapiens				GO:0000185~activation of MAPKKK activity,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006915~apoptotic process,GO:0016567~protein ubiquitination,GO:0043410~positive regulation of MAPK cascade,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0000151~ubiquitin ligase complex,GO:0005886~plasma membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,GO:0043231~intracellular membrane-bounded organelle,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,	IPR001293:Zinc finger, TRAF-type,IPR001680:WD40 repeat,IPR001841:Zinc finger, RING-type,IPR008974:TRAF-like,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013323:SIAH-type domain,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017907:Zinc finger, RING-type, conserved site,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,IPR027370:RING-type zinc-finger, LisH dimerisation motif,				SM00184:RING,SM00320:WD40,	Alternative splicing,Apoptosis,Complete proteome,Cytoplasmic vesicle,Ligase,Metal-binding,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Ubl conjugation pathway,WD repeat,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase TRAF7,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,splice variant,zinc finger region:RING-type,zinc finger region:TRAF-type,
TNFRSF14	TNF receptor superfamily member 14(TNFRSF14)	Homo sapiens				GO:0002741~positive regulation of cytokine secretion involved in immune response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007166~cell surface receptor signaling pathway,GO:0007275~multicellular organism development,GO:0031295~T cell costimulation,GO:0032496~response to lipopolysaccharide,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptotic process,GO:0043410~positive regulation of MAPK cascade,GO:0046642~negative regulation of alpha-beta T cell proliferation,GO:0046718~viral entry into host cell,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,GO:0097190~apoptotic signaling pathway,GO:2000406~positive regulation of T cell migration,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,	GO:0001618~virus receptor activity,GO:0005031~tumor necrosis factor-activated receptor activity,GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,	IPR001368:TNFR/NGFR cysteine-rich region,IPR022332:Tumour necrosis factor receptor 14,	hsa04060:Cytokine-cytokine receptor interaction,hsa05168:Herpes simplex infection,			SM00208:TNFR,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Tumor necrosis factor receptor superfamily member 14,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,modified residue,repeat:TNFR-Cys 1,repeat:TNFR-Cys 2,repeat:TNFR-Cys 3,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
U2AF1	U2 small nuclear RNA auxiliary factor 1(U2AF1)	Homo sapiens		h_smPathway:Spliceosomal Assembly,		GO:0000398~mRNA splicing, via spliceosome,GO:0006369~termination of RNA polymerase II transcription,GO:0006397~mRNA processing,GO:0006405~RNA export from nucleus,GO:0006406~mRNA export from nucleus,GO:0008380~RNA splicing,GO:0031124~mRNA 3'-end processing,GO:1903146~regulation of mitophagy,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0015030~Cajal body,GO:0016607~nuclear speck,GO:0071013~catalytic step 2 spliceosome,GO:0089701~U2AF,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0030628~pre-mRNA 3'-splice site binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000504:RNA recognition motif domain,IPR000571:Zinc finger, CCCH-type,IPR003954:RNA recognition motif domain, eukaryote,IPR009145:U2 auxiliary factor small subunit,IPR012677:Nucleotide-binding, alpha-beta plait,	hsa03040:Spliceosome,hsa05131:Shigellosis,			SM00356:ZnF_C3H1,SM00360:RRM,SM00361:RRM_1,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Metal-binding,Methylation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Reference proteome,Repeat,RNA-binding,Spliceosome,Zinc,Zinc-finger,	chain:Splicing factor U2AF 35 kDa subunit,compositionally biased region:Arg/Gly/Ser-rich (RS domain),compositionally biased region:Poly-Gly,domain:RRM,helix,modified residue,mutagenesis site,strand,zinc finger region:C3H1-type 1,zinc finger region:C3H1-type 2,
WRN	Werner syndrome RecQ like helicase(WRN)	Homo sapiens				GO:0000722~telomere maintenance via recombination,GO:0000723~telomere maintenance,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0001302~replicative cell aging,GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006302~double-strand break repair,GO:0006310~DNA recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0006979~response to oxidative stress,GO:0007420~brain development,GO:0007568~aging,GO:0007569~cell aging,GO:0009267~cellular response to starvation,GO:0010225~response to UV-C,GO:0010259~multicellular organism aging,GO:0016925~protein sumoylation,GO:0031297~replication fork processing,GO:0032066~nucleolus to nucleoplasm transport,GO:0032508~DNA duplex unwinding,GO:0040009~regulation of growth rate,GO:0042981~regulation of apoptotic process,GO:0051345~positive regulation of hydrolase activity,GO:0071480~cellular response to gamma radiation,GO:0090305~nucleic acid phosphodiester bond hydrolysis,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0000784~nuclear chromosome, telomeric region,GO:0005622~intracellular,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0032389~MutLalpha complex,GO:0043005~neuron projection,	GO:0000287~magnesium ion binding,GO:0000403~Y-form DNA binding,GO:0000405~bubble DNA binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003682~chromatin binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004386~helicase activity,GO:0004527~exonuclease activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008408~3'-5' exonuclease activity,GO:0009378~four-way junction helicase activity,GO:0016887~ATPase activity,GO:0030145~manganese ion binding,GO:0032403~protein complex binding,GO:0042803~protein homodimerization activity,GO:0043138~3'-5' DNA helicase activity,GO:0043140~ATP-dependent 3'-5' DNA helicase activity,GO:0051880~G-quadruplex DNA binding,	IPR001650:Helicase, C-terminal,IPR002121:HRDC domain,IPR002562:3'-5' exonuclease domain,IPR004589:DNA helicase, ATP-dependent, RecQ type,IPR010997:HRDC-like,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR012337:Ribonuclease H-like domain,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR018982:RQC domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		277700~Werner syndrome,		SM00341:HRDC,SM00474:35EXOc,SM00487:DEXDc,SM00490:HELICc,SM00956:SM00956,	3D-structure,Acetylation,ATP-binding,Complete proteome,Direct protein sequencing,Disease mutation,DNA damage,DNA repair,DNA-binding,Exonuclease,Helicase,Hydrolase,Magnesium,Metal-binding,Multifunctional enzyme,Nuclease,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Zinc,	chain:Werner syndrome ATP-dependent helicase,compositionally biased region:Poly-Glu,domain:Helicase ATP-binding,domain:Helicase C-terminal,domain:HRDC,helix,modified residue,nucleotide phosphate-binding region:ATP,region of interest:2 X 27 AA tandem repeats of H-L-S-P-N-D- N-E-N-D-T-S-Y-V-I-E-S-D-E-D-L-E-M-E-M-L- K,region of interest:Interaction with WRNIP1,repeat:1,repeat:2,sequence variant,short sequence motif:DEAH box,strand,turn,
WAS	Wiskott-Aldrich syndrome(WAS)	Homo sapiens	82.TCR_and_Cap_or_SMAC,			GO:0002625~regulation of T cell antigen processing and presentation,GO:0006461~protein complex assembly,GO:0006952~defense response,GO:0006955~immune response,GO:0007015~actin filament organization,GO:0007596~blood coagulation,GO:0008154~actin polymerization or depolymerization,GO:0008544~epidermis development,GO:0016197~endosomal transport,GO:0030041~actin filament polymerization,GO:0030048~actin filament-based movement,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0042110~T cell activation,GO:0050790~regulation of catalytic activity,GO:0050852~T cell receptor signaling pathway,GO:2000146~negative regulation of cell motility,GO:2000601~positive regulation of Arp2/3 complex-mediated actin nucleation,	GO:0005829~cytosol,GO:0005911~cell-cell junction,GO:0012506~vesicle membrane,GO:0015629~actin cytoskeleton,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0017124~SH3 domain binding,GO:0019901~protein kinase binding,GO:0030695~GTPase regulator activity,GO:0042802~identical protein binding,GO:0043274~phospholipase binding,	IPR000095:PAK-box/P21-Rho-binding,IPR000697:EVH1,IPR003124:WH2 domain,IPR011026:Wiscott-Aldrich syndrome, C-terminal,IPR011993:Pleckstrin homology-like domain,	hsa04062:Chemokine signaling pathway,hsa04144:Endocytosis,hsa04520:Adherens junction,hsa04666:Fc gamma R-mediated phagocytosis,hsa04810:Regulation of actin cytoskeleton,hsa05100:Bacterial invasion of epithelial cells,hsa05130:Pathogenic Escherichia coli infection,hsa05131:Shigellosis,hsa05132:Salmonella infection,hsa05231:Choline metabolism in cancer,	300299~Neutropenia, severe congenital, X-linked,301000~Wiskott-Aldrich syndrome,313900~Thrombocytopenia, X-linked,313900~Thrombocytopenia, X-linked, intermittent,		SM00246:WH2,SM00285:PBD,SM00461:WH1,	3D-structure,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Disease mutation,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Wiskott-Aldrich syndrome protein,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Poly-Pro,domain:CRIB,domain:WH1,domain:WH2,helix,modified residue,repeat:GRSGPLPPXP motif 1,repeat:GRSGPLPPXP motif 2,sequence conflict,sequence variant,strand,turn,
XPA	XPA, DNA damage recognition and repair factor(XPA)	Homo sapiens				GO:0000715~nucleotide-excision repair, DNA damage recognition,GO:0000717~nucleotide-excision repair, DNA duplex unwinding,GO:0006281~DNA repair,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006284~base-excision repair,GO:0006289~nucleotide-excision repair,GO:0006293~nucleotide-excision repair, preincision complex stabilization,GO:0006294~nucleotide-excision repair, preincision complex assembly,GO:0006295~nucleotide-excision repair, DNA incision, 3'-to lesion,GO:0006296~nucleotide-excision repair, DNA incision, 5'-to lesion,GO:0006979~response to oxidative stress,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0009636~response to toxic substance,GO:0010996~response to auditory stimulus,GO:0033683~nucleotide-excision repair, DNA incision,GO:0035264~multicellular organism growth,GO:0070911~global genome nucleotide-excision repair,GO:0070914~UV-damage excision repair,GO:1901255~nucleotide-excision repair involved in interstrand cross-link repair,	GO:0000110~nucleotide-excision repair factor 1 complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005662~DNA replication factor A complex,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0045171~intercellular bridge,	GO:0003684~damaged DNA binding,GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,	IPR000465:XPA,IPR009061:DNA binding domain, putative,IPR022652:Zinc finger, XPA-type, conserved site,IPR022656:XPA C- terminal,IPR022658:XPA, conserved site,	hsa03420:Nucleotide excision repair,	278700~Xeroderma pigmentosum, group A,			3D-structure,Acetylation,Coiled coil,Complete proteome,Disease mutation,DNA damage,DNA repair,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Xeroderma pigmentosum,Zinc,Zinc-finger,	chain:DNA repair protein complementing XP-A cells,compositionally biased region:Poly-Glu,helix,modified residue,region of interest:Interaction with CEP164 and required for UV resistance,sequence variant,short sequence motif:Nuclear localization signal,strand,turn,
XPC	XPC complex subunit, DNA damage recognition and repair factor(XPC)	Homo sapiens				GO:0000715~nucleotide-excision repair, DNA damage recognition,GO:0000717~nucleotide-excision repair, DNA duplex unwinding,GO:0006281~DNA repair,GO:0006289~nucleotide-excision repair,GO:0006294~nucleotide-excision repair, preincision complex assembly,GO:0006298~mismatch repair,GO:0010224~response to UV-B,GO:0010996~response to auditory stimulus,GO:0016925~protein sumoylation,GO:0031573~intra-S DNA damage checkpoint,GO:0042493~response to drug,GO:0070911~global genome nucleotide-excision repair,GO:0070914~UV-damage excision repair,GO:1901990~regulation of mitotic cell cycle phase transition,	GO:0000111~nucleotide-excision repair factor 2 complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,GO:0071942~XPC complex,	GO:0000404~heteroduplex DNA loop binding,GO:0000405~bubble DNA binding,GO:0003684~damaged DNA binding,GO:0003697~single-stranded DNA binding,GO:0005515~protein binding,	IPR004583:DNA repair protein Rad4,IPR018026:DNA repair protein Rad4, subgroup,IPR018325:Rad4/PNGase transglutaminase-like fold,IPR018326:Rad4 beta-hairpin domain 1,IPR018327:Rad4 beta-hairpin domain 2,IPR018328:Rad4 beta-hairpin domain 3,	hsa03420:Nucleotide excision repair,	278720~Xeroderma pigmentosum, group C,		SM01030:SM01030,SM01031:SM01031,SM01032:SM01032,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,DNA damage,DNA repair,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Xeroderma pigmentosum,	chain:DNA repair protein complementing XP-C cells,compositionally biased region:Arg/Lys-rich (basic),compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Glu-rich (acidic),compositionally biased region:Lys-rich (basic),compositionally biased region:Poly-Glu,compositionally biased region:Poly-Ser,helix,modified residue,sequence variant,short sequence motif:Nuclear localization signal,
ACVR1	activin A receptor type 1(ACVR1)	Homo sapiens		h_alkPathway:ALK in cardiac myocytes,		GO:0000082~G1/S transition of mitotic cell cycle,GO:0001569~patterning of blood vessels,GO:0001701~in utero embryonic development,GO:0001702~gastrulation with mouth forming second,GO:0001707~mesoderm formation,GO:0001755~neural crest cell migration,GO:0002526~acute inflammatory response,GO:0003143~embryonic heart tube morphogenesis,GO:0003148~outflow tract septum morphogenesis,GO:0003181~atrioventricular valve morphogenesis,GO:0003183~mitral valve morphogenesis,GO:0003203~endocardial cushion morphogenesis,GO:0003274~endocardial cushion fusion,GO:0003289~atrial septum primum morphogenesis,GO:0006468~protein phosphorylation,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007281~germ cell development,GO:0007368~determination of left/right symmetry,GO:0007507~heart development,GO:0009968~negative regulation of signal transduction,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0023014~signal transduction by protein phosphorylation,GO:0030278~regulation of ossification,GO:0030335~positive regulation of cell migration,GO:0030501~positive regulation of bone mineralization,GO:0030509~BMP signaling pathway,GO:0032924~activin receptor signaling pathway,GO:0032926~negative regulation of activin receptor signaling pathway,GO:0045669~positive regulation of osteoblast differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051145~smooth muscle cell differentiation,GO:0060037~pharyngeal system development,GO:0060389~pathway-restricted SMAD protein phosphorylation,GO:0060412~ventricular septum morphogenesis,GO:0060923~cardiac muscle cell fate commitment,GO:0061312~BMP signaling pathway involved in heart development,GO:0061445~endocardial cushion cell fate commitment,GO:0071773~cellular response to BMP stimulus,GO:1905007~positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,GO:2000017~positive regulation of determination of dorsal identity,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0045177~apical part of cell,GO:0048179~activin receptor complex,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004675~transmembrane receptor protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0005025~transforming growth factor beta receptor activity, type I,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016361~activin receptor activity, type I,GO:0017046~peptide hormone binding,GO:0042803~protein homodimerization activity,GO:0046332~SMAD binding,GO:0046872~metal ion binding,GO:0048185~activin binding,GO:0050431~transforming growth factor beta binding,	IPR000333:Activin type II/Transforming growth factor-beta II receptor,IPR000472:TGF-beta receptor/activin receptor, type I/II,IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR003605:TGF beta receptor, GS motif,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04060:Cytokine-cytokine receptor interaction,hsa04350:TGF-beta signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,	135100~Fibrodysplasia ossificans progressiva,		SM00220:S_TKc,SM00467:GS,	3D-structure,ATP-binding,Complete proteome,Disease mutation,Glycoprotein,Kinase,Magnesium,Manganese,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Serine/threonine-protein kinase,Signal,Transferase,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:ATP,chain:Activin receptor type-1,domain:GS,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ACVR2A	activin A receptor type 2A(ACVR2A)	Homo sapiens				GO:0001702~gastrulation with mouth forming second,GO:0001934~positive regulation of protein phosphorylation,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007283~spermatogenesis,GO:0007368~determination of left/right symmetry,GO:0007498~mesoderm development,GO:0009952~anterior/posterior pattern specification,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0023014~signal transduction by protein phosphorylation,GO:0030501~positive regulation of bone mineralization,GO:0030509~BMP signaling pathway,GO:0030510~regulation of BMP signaling pathway,GO:0032924~activin receptor signaling pathway,GO:0032927~positive regulation of activin receptor signaling pathway,GO:0042713~sperm ejaculation,GO:0043084~penile erection,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048706~embryonic skeletal system development,GO:0050999~regulation of nitric-oxide synthase activity,GO:0060011~Sertoli cell proliferation,GO:0071773~cellular response to BMP stimulus,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0034673~inhibin-betaglycan-ActRII complex,GO:0043235~receptor complex,	GO:0004674~protein serine/threonine kinase activity,GO:0004675~transmembrane receptor protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0015026~coreceptor activity,GO:0017002~activin-activated receptor activity,GO:0019838~growth factor binding,GO:0030165~PDZ domain binding,GO:0034711~inhibin binding,GO:0043621~protein self-association,GO:0046872~metal ion binding,GO:0048185~activin binding,GO:0098821~BMP receptor activity,	IPR000333:Activin type II/Transforming growth factor-beta II receptor,IPR000472:TGF-beta receptor/activin receptor, type I/II,IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04350:TGF-beta signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,			SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Disulfide bond,Glycoprotein,Kinase,Magnesium,Manganese,Membrane,Metal-binding,Nucleotide-binding,Polymorphism,Receptor,Reference proteome,Serine/threonine-protein kinase,Signal,Transferase,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:ATP,chain:Activin receptor type-2A,disulfide bond,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ASXL1	additional sex combs like 1, transcriptional regulator(ASXL1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0003007~heart morphogenesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0032526~response to retinoic acid,GO:0035359~negative regulation of peroxisome proliferator activated receptor signaling pathway,GO:0035522~monoubiquitinated histone H2A deubiquitination,GO:0045599~negative regulation of fat cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048386~positive regulation of retinoic acid receptor signaling pathway,GO:0048387~negative regulation of retinoic acid receptor signaling pathway,GO:0060348~bone development,GO:0060430~lung saccule development,	GO:0000790~nuclear chromatin,GO:0035517~PR-DUB complex,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0042974~retinoic acid receptor binding,GO:0042975~peroxisome proliferator activated receptor binding,GO:0046872~metal ion binding,	IPR007759:DNA-directed RNA polymerase delta subunit,IPR024811:Polycomb protein ASX/ASX-like,IPR024815:ASX-like protein 1,IPR026905:Protein ASX-like, PHD domain,		605039~Bohring-Opitz syndrome,614286~Myelodysplastic syndrome, somatic,			Alternative splicing,Chromatin regulator,Complete proteome,Craniosynostosis,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Putative Polycomb group protein ASXL1,compositionally biased region:Gly-rich,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Ser,modified residue,sequence conflict,sequence variant,short sequence motif:LXXLL motif,short sequence motif:Nuclear localization signal 1,short sequence motif:Nuclear localization signal 2,splice variant,zinc finger region:PHD-type; atypical,
AR	androgen receptor(AR)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0003073~regulation of systemic arterial blood pressure,GO:0003382~epithelial cell morphogenesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006810~transport,GO:0007165~signal transduction,GO:0007267~cell-cell signaling,GO:0007283~spermatogenesis,GO:0007338~single fertilization,GO:0007548~sex differentiation,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0010628~positive regulation of gene expression,GO:0016049~cell growth,GO:0019102~male somatic sex determination,GO:0030521~androgen receptor signaling pathway,GO:0030522~intracellular receptor signaling pathway,GO:0030850~prostate gland development,GO:0033148~positive regulation of intracellular estrogen receptor signaling pathway,GO:0033327~Leydig cell differentiation,GO:0035264~multicellular organism growth,GO:0042327~positive regulation of phosphorylation,GO:0043410~positive regulation of MAPK cascade,GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway,GO:0045597~positive regulation of cell differentiation,GO:0045720~negative regulation of integrin biosynthetic process,GO:0045726~positive regulation of integrin biosynthetic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045945~positive regulation of transcription from RNA polymerase III promoter,GO:0048638~regulation of developmental growth,GO:0048645~organ formation,GO:0048808~male genitalia morphogenesis,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050790~regulation of catalytic activity,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051259~protein oligomerization,GO:0060520~activation of prostate induction by androgen receptor signaling pathway,GO:0060571~morphogenesis of an epithelial fold,GO:0060599~lateral sprouting involved in mammary gland duct morphogenesis,GO:0060736~prostate gland growth,GO:0060740~prostate gland epithelium morphogenesis,GO:0060742~epithelial cell differentiation involved in prostate gland development,GO:0060748~tertiary branching involved in mammary gland duct morphogenesis,GO:0060749~mammary gland alveolus development,GO:0072520~seminiferous tubule development,GO:0090003~regulation of establishment of protein localization to plasma membrane,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0043234~protein complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003707~steroid hormone receptor activity,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0004882~androgen receptor activity,GO:0005102~receptor binding,GO:0005496~steroid binding,GO:0005497~androgen binding,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0019899~enzyme binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046983~protein dimerization activity,GO:0051117~ATPase binding,GO:0070974~POU domain binding,	IPR000536:Nuclear hormone receptor, ligand-binding, core,IPR001103:Androgen receptor,IPR001628:Zinc finger, nuclear hormone receptor-type,IPR001723:Steroid hormone receptor,IPR013088:Zinc finger, NHR/GATA-type,	hsa04114:Oocyte meiosis,hsa05200:Pathways in cancer,hsa05215:Prostate cancer,	176807~Prostate cancer, susceptibility to,300068~Androgen insensitivity,300633~Hypospadias 1, X-linked,312300~Androgen insensitivity, partial, with or without breast cancer,313200~Spinal and bulbar muscular atrophy of Kennedy,		SM00399:ZnF_C4,SM00430:HOLI,	3D-structure,Activator,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,DNA-binding,Isopeptide bond,Lipid-binding,Lipoprotein,Membrane,Metal-binding,Neurodegeneration,Nucleus,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Pseudohermaphroditism,Receptor,Reference proteome,Steroid-binding,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,Triplet repeat expansion,Ubl conjugation,Zinc,Zinc-finger,	binding site:Androgen,chain:Androgen receptor,compositionally biased region:Gln-rich,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Pro,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:Nuclear receptor,helix,modified residue,mutagenesis site,region of interest:Interaction with HIPK3,region of interest:Interaction with MYST2,region of interest:Ligand-binding,region of interest:Modulating,sequence conflict,sequence variant,site:Interaction with coactivator FXXLF motif,site:Interaction with coactivator LXXL motif,splice variant,strand,zinc finger region:NR C4-type,
AXIN1	axin 1(AXIN1)	Homo sapiens		h_alkPathway:ALK in cardiac myocytes,H_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages,h_pitx2Pathway:Multi-step Regulation of Transcription by Pitx2,h_ps1Pathway:Presenilin action in Notch and Wnt signaling,h_wntPathway:WNT Signaling Pathway,		GO:0001743~optic placode formation,GO:0001934~positive regulation of protein phosphorylation,GO:0006915~apoptotic process,GO:0007165~signal transduction,GO:0007257~activation of JUN kinase activity,GO:0007368~determination of left/right symmetry,GO:0008219~cell death,GO:0009950~dorsal/ventral axis specification,GO:0010800~positive regulation of peptidyl-threonine phosphorylation,GO:0016055~Wnt signaling pathway,GO:0021797~forebrain anterior/posterior pattern specification,GO:0021881~Wnt-activated signaling pathway involved in forebrain neuron fate commitment,GO:0030178~negative regulation of Wnt signaling pathway,GO:0030910~olfactory placode formation,GO:0031122~cytoplasmic microtubule organization,GO:0031398~positive regulation of protein ubiquitination,GO:0032147~activation of protein kinase activity,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0034244~negative regulation of transcription elongation from RNA polymerase II promoter,GO:0035412~regulation of catenin import into nucleus,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043547~positive regulation of GTPase activity,GO:0043623~cellular protein complex assembly,GO:0045599~negative regulation of fat cell differentiation,GO:0045732~positive regulation of protein catabolic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046330~positive regulation of JNK cascade,GO:0048048~embryonic eye morphogenesis,GO:0048320~axial mesoderm formation,GO:0051443~positive regulation of ubiquitin-protein transferase activity,GO:0055001~muscle cell development,GO:0060070~canonical Wnt signaling pathway,GO:0060272~embryonic skeletal joint morphogenesis,GO:0060823~canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,GO:0071407~cellular response to organic cyclic compound,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090244~Wnt signaling pathway involved in somitogenesis,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1904885~beta-catenin destruction complex assembly,GO:1904886~beta-catenin destruction complex disassembly,GO:2000060~positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005881~cytoplasmic microtubule,GO:0005938~cell cortex,GO:0014069~postsynaptic density,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0016328~lateral plasma membrane,GO:0030877~beta-catenin destruction complex,GO:0031410~cytoplasmic vesicle,GO:0048471~perinuclear region of cytoplasm,GO:0071944~cell periphery,	GO:0004871~signal transducer activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0030159~receptor signaling complex scaffold activity,GO:0031625~ubiquitin protein ligase binding,GO:0032947~protein complex scaffold,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046332~SMAD binding,GO:0070016~armadillo repeat domain binding,GO:0070411~I-SMAD binding,	IPR001158:DIX domain,IPR014936:Axin beta-catenin binding,IPR016137:Regulator of G protein signalling superfamily,IPR024066:Regulator of G-protein signaling, domain 1,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05213:Endometrial cancer,hsa05217:Basal cell carcinoma,	114550~Hepatocellular carcinoma, somatic,607864~Caudal duplication anomaly,		SM00021:DAX,SM00315:RGS,	3D-structure,ADP-ribosylation,Alternative splicing,Apoptosis,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Developmental protein,Disease mutation,Isopeptide bond,Membrane,Nucleus,Phosphoprotein,Reference proteome,Tumor suppressor,Ubl conjugation,Wnt signaling pathway,	chain:Axin-1,domain:DIX,domain:RGS,helix,modified residue,region of interest:Interaction with beta-catenin,region of interest:Interaction with GSK3B,region of interest:Interaction with HIPK2,region of interest:Interaction with RNF111,region of interest:Interaction with TP53,sequence conflict,sequence variant,splice variant,turn,
AXIN2	axin 2(AXIN2)	Homo sapiens				GO:0001934~positive regulation of protein phosphorylation,GO:0001957~intramembranous ossification,GO:0003139~secondary heart field specification,GO:0003413~chondrocyte differentiation involved in endochondral bone morphogenesis,GO:0006355~regulation of transcription, DNA-templated,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009950~dorsal/ventral axis specification,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0010942~positive regulation of cell death,GO:0016055~Wnt signaling pathway,GO:0030282~bone mineralization,GO:0032423~regulation of mismatch repair,GO:0034613~cellular protein localization,GO:0035414~negative regulation of catenin import into nucleus,GO:0042476~odontogenesis,GO:0043547~positive regulation of GTPase activity,GO:0043570~maintenance of DNA repeat elements,GO:0045668~negative regulation of osteoblast differentiation,GO:0048255~mRNA stabilization,GO:0061181~regulation of chondrocyte development,GO:0070602~regulation of centromeric sister chromatid cohesion,GO:0071407~cellular response to organic cyclic compound,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090244~Wnt signaling pathway involved in somitogenesis,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1904837~beta-catenin-TCF complex assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005881~cytoplasmic microtubule,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0014069~postsynaptic density,GO:0015630~microtubule cytoskeleton,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030877~beta-catenin destruction complex,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0070016~armadillo repeat domain binding,GO:0070411~I-SMAD binding,	IPR001158:DIX domain,IPR014936:Axin beta-catenin binding,IPR016137:Regulator of G protein signalling superfamily,IPR024066:Regulator of G-protein signaling, domain 1,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05213:Endometrial cancer,hsa05217:Basal cell carcinoma,	114500~Colorectal cancer, somatic,608615~Oligodontia-colorectal cancer syndrome,		SM00021:DAX,SM00315:RGS,	ADP-ribosylation,Coiled coil,Complete proteome,Cytoplasm,Developmental protein,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Wnt signaling pathway,	chain:Axin-2,compositionally biased region:Poly-His,domain:DIX,domain:RGS,modified residue,region of interest:Interaction with beta-catenin,region of interest:Interaction with GSK3B,sequence conflict,sequence variant,
B2M	beta-2-microglobulin(B2M)	Homo sapiens		h_ctlPathway:CTL mediated immune response against target cells ,h_mhcPathway:Antigen Processing and Presentation,h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity,		GO:0001895~retina homeostasis,GO:0001916~positive regulation of T cell mediated cytotoxicity,GO:0002474~antigen processing and presentation of peptide antigen via MHC class I,GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0002480~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,GO:0002481~antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,GO:0002726~positive regulation of T cell cytokine production,GO:0003254~regulation of membrane depolarization,GO:0006955~immune response,GO:0010977~negative regulation of neuron projection development,GO:0019731~antibacterial humoral response,GO:0019885~antigen processing and presentation of endogenous peptide antigen via MHC class I,GO:0032092~positive regulation of protein binding,GO:0033077~T cell differentiation in thymus,GO:0042026~protein refolding,GO:0042493~response to drug,GO:0044267~cellular protein metabolic process,GO:0045087~innate immune response,GO:0046686~response to cadmium ion,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0050690~regulation of defense response to virus by virus,GO:0050776~regulation of immune response,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,GO:0055072~iron ion homeostasis,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0071222~cellular response to lipopolysaccharide,GO:0071281~cellular response to iron ion,GO:1900121~negative regulation of receptor binding,GO:1900122~positive regulation of receptor binding,GO:1903991~positive regulation of ferrous iron import into cell,GO:1904434~positive regulation of ferrous iron binding,GO:1904437~positive regulation of transferrin receptor binding,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005788~endoplasmic reticulum lumen,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0009897~external side of plasma membrane,GO:0012507~ER to Golgi transport vesicle membrane,GO:0016020~membrane,GO:0030670~phagocytic vesicle membrane,GO:0031901~early endosome membrane,GO:0031905~early endosome lumen,GO:0042612~MHC class I protein complex,GO:0070062~extracellular exosome,GO:1990712~HFE-transferrin receptor complex,	GO:0001948~glycoprotein binding,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003597:Immunoglobulin C1-set,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,IPR015370:Domain of unknown function DUF1968,IPR015707:Beta-2-Microglobulin,	hsa04612:Antigen processing and presentation,	105200~Amyloidosis, familial visceral,241600~Immunodeficiency 43,		SM00406:IGv,SM00407:IGc1,SM00409:IG,	3D-structure,Amyloid,Amyloidosis,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycation,Glycoprotein,Immunity,Immunoglobulin domain,MHC I,Proteomics identification,Pyrrolidone carboxylic acid,Reference proteome,Secreted,Signal,	chain:Beta-2-microglobulin,chain:Beta-2-microglobulin form pI 5.3,disulfide bond,domain:Ig-like C1-type,glycosylation site:N-linked (Glc) (glycation); in hemodialysis-associated amyloidosis,glycosylation site:N-linked (Glc) (glycation); in vitro,modified residue,mutagenesis site,sequence conflict,sequence variant,signal peptide,strand,
CDH1	cadherin 1(CDH1)	Homo sapiens		h_ctbp1Pathway:SUMOylation as a mechanism to modulate CtBP-dependent gene responses,h_mta3Pathway:Downregulated of MTA-3 in ER-negative Breast Tumors,h_tgfbPathway:TGF beta signaling pathway,		GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007416~synapse assembly,GO:0009636~response to toxic substance,GO:0010033~response to organic substance,GO:0016337~single organismal cell-cell adhesion,GO:0021983~pituitary gland development,GO:0022408~negative regulation of cell-cell adhesion,GO:0022617~extracellular matrix disassembly,GO:0030198~extracellular matrix organization,GO:0031175~neuron projection development,GO:0034332~adherens junction organization,GO:0042493~response to drug,GO:0042993~positive regulation of transcription factor import into nucleus,GO:0045893~positive regulation of transcription, DNA-templated,GO:0071285~cellular response to lithium ion,GO:0071681~cellular response to indole-3-methanol,GO:0072659~protein localization to plasma membrane,GO:0090002~establishment of protein localization to plasma membrane,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0009898~cytoplasmic side of plasma membrane,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016235~aggresome,GO:0016328~lateral plasma membrane,GO:0016342~catenin complex,GO:0016600~flotillin complex,GO:0030027~lamellipodium,GO:0030054~cell junction,GO:0030864~cortical actin cytoskeleton,GO:0043296~apical junction complex,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0001948~glycoprotein binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0030506~ankyrin binding,GO:0032794~GTPase activating protein binding,GO:0045295~gamma-catenin binding,GO:0050839~cell adhesion molecule binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000233:Cadherin, cytoplasmic domain,IPR002126:Cadherin,IPR014868:Cadherin prodomain,IPR015919:Cadherin-like,IPR020894:Cadherin conserved site,IPR027397:Catenin binding domain,	hsa04015:Rap1 signaling pathway,hsa04390:Hippo signaling pathway,hsa04514:Cell adhesion molecules (CAMs),hsa04520:Adherens junction,hsa05100:Bacterial invasion of epithelial cells,hsa05130:Pathogenic Escherichia coli infection,hsa05200:Pathways in cancer,hsa05213:Endometrial cancer,hsa05216:Thyroid cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,	114480~Breast cancer, lobular,137215~Gastric cancer, familial diffuse, with or without cleft lip and/or palate,167000~Ovarian carcinoma, somatic,176807~Prostate cancer, susceptibility to,608089~Endometrial carcinoma, somatic,		SM00112:CA,SM01055:SM01055,	3D-structure,Alternative splicing,Calcium,Cell adhesion,Cell junction,Cell membrane,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Endosome,Glycoprotein,Golgi apparatus,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Cadherin-1,chain:E-Cad/CTF1,chain:E-Cad/CTF2,chain:E-Cad/CTF3,compositionally biased region:Ser-rich,disulfide bond,domain:Cadherin 1,domain:Cadherin 2,domain:Cadherin 3,domain:Cadherin 4,domain:Cadherin 5,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,region of interest:Required for binding alpha, beta and gamma catenins,region of interest:Required for binding CTNND1 and PSEN1,sequence conflict,sequence variant,signal peptide,site:Cleavage; by a metalloproteinase,site:Cleavage; by caspase-3,site:Cleavage; by gamma-secretase/PS1,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
CACNA1D	calcium voltage-gated channel subunit alpha1 D(CACNA1D)	Homo sapiens				GO:0006816~calcium ion transport,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007605~sensory perception of sound,GO:0050796~regulation of insulin secretion,GO:0051928~positive regulation of calcium ion transport,GO:0060372~regulation of atrial cardiac muscle cell membrane repolarization,GO:0061337~cardiac conduction,GO:0070509~calcium ion import,GO:0070588~calcium ion transmembrane transport,GO:0086002~cardiac muscle cell action potential involved in contraction,GO:0086012~membrane depolarization during cardiac muscle cell action potential,GO:0086046~membrane depolarization during SA node cell action potential,GO:0086091~regulation of heart rate by cardiac conduction,GO:1901016~regulation of potassium ion transmembrane transporter activity,GO:1901379~regulation of potassium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0005891~voltage-gated calcium channel complex,GO:0030018~Z disc,GO:1990454~L-type voltage-gated calcium channel complex,	GO:0005245~voltage-gated calcium channel activity,GO:0008331~high voltage-gated calcium channel activity,GO:0030506~ankyrin binding,GO:0046872~metal ion binding,GO:0051393~alpha-actinin binding,GO:0086007~voltage-gated calcium channel activity involved in cardiac muscle cell action potential,GO:0086059~voltage-gated calcium channel activity involved SA node cell action potential,	IPR002077:Voltage-dependent calcium channel, alpha-1 subunit,IPR005446:Voltage-dependent calcium channel, L-type, alpha-1 subunit,IPR005452:Voltage-dependent calcium channel, L-type, alpha-1D subunit,IPR005821:Ion transport domain,IPR014873:Voltage-dependent calcium channel, alpha-1 subunit, IQ domain,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,	hsa04010:MAPK signaling pathway,hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04270:Vascular smooth muscle contraction,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa04911:Insulin secretion,hsa04912:GnRH signaling pathway,hsa04921:Oxytocin signaling pathway,hsa04924:Renin secretion,hsa04925:Aldosterone synthesis and secretion,hsa04930:Type II diabetes mellitus,hsa04973:Carbohydrate digestion and absorption,hsa05010:Alzheimer's disease,hsa05031:Amphetamine addiction,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,	614896~Sinoatrial node dysfunction and deafness,615474~Primary aldosteronism, seizures, and neurologic abnormalities,		SM01062:SM01062,	3D-structure,Alternative splicing,Calcium,Calcium channel,Calcium transport,Coiled coil,Complete proteome,Deafness,Disease mutation,Disulfide bond,Epilepsy,Glycoprotein,Ion channel,Ion transport,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Transport,Triplet repeat expansion,Voltage-gated channel,	chain:Voltage-dependent L-type calcium channel subunit alpha-1D,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Met,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:Binding to the beta subunit,region of interest:Dihydropyridine binding,region of interest:Phenylalkylamine binding,repeat:I,repeat:II,repeat:III,repeat:IV,sequence conflict,sequence variant,site:Calcium ion selectivity and permeability,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CALR	calreticulin(CALR)	Homo sapiens		h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002474~antigen processing and presentation of peptide antigen via MHC class I,GO:0002502~peptide antigen assembly with MHC class I protein complex,GO:0006355~regulation of transcription, DNA-templated,GO:0006457~protein folding,GO:0006611~protein export from nucleus,GO:0006874~cellular calcium ion homeostasis,GO:0006898~receptor-mediated endocytosis,GO:0007050~cell cycle arrest,GO:0007283~spermatogenesis,GO:0008284~positive regulation of cell proliferation,GO:0010628~positive regulation of gene expression,GO:0017148~negative regulation of translation,GO:0022417~protein maturation by protein folding,GO:0030866~cortical actin cytoskeleton organization,GO:0032355~response to estradiol,GO:0033144~negative regulation of intracellular steroid hormone receptor signaling pathway,GO:0033574~response to testosterone,GO:0034504~protein localization to nucleus,GO:0034975~protein folding in endoplasmic reticulum,GO:0036500~ATF6-mediated unfolded protein response,GO:0040020~regulation of meiotic nuclear division,GO:0042493~response to drug,GO:0042921~glucocorticoid receptor signaling pathway,GO:0042981~regulation of apoptotic process,GO:0045665~negative regulation of neuron differentiation,GO:0045740~positive regulation of DNA replication,GO:0045787~positive regulation of cell cycle,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048387~negative regulation of retinoic acid receptor signaling pathway,GO:0050766~positive regulation of phagocytosis,GO:0050821~protein stabilization,GO:0051208~sequestering of calcium ion,GO:0055007~cardiac muscle cell differentiation,GO:0061077~chaperone-mediated protein folding,GO:0071285~cellular response to lithium ion,GO:0071310~cellular response to organic substance,GO:0090398~cellular senescence,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,GO:1901224~positive regulation of NIK/NF-kappaB signaling,GO:2000510~positive regulation of dendritic cell chemotaxis,	GO:0001669~acrosomal vesicle,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0005790~smooth endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005844~polysome,GO:0005925~focal adhesion,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016529~sarcoplasmic reticulum,GO:0031012~extracellular matrix,GO:0033018~sarcoplasmic reticulum lumen,GO:0042824~MHC class I peptide loading complex,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0071556~integral component of lumenal side of endoplasmic reticulum membrane,GO:0071682~endocytic vesicle lumen,	GO:0001849~complement component C1q binding,GO:0001948~glycoprotein binding,GO:0003677~DNA binding,GO:0003729~mRNA binding,GO:0005178~integrin binding,GO:0005506~iron ion binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0030246~carbohydrate binding,GO:0031625~ubiquitin protein ligase binding,GO:0042277~peptide binding,GO:0042562~hormone binding,GO:0044183~protein binding involved in protein folding,GO:0044822~poly(A) RNA binding,GO:0050681~androgen receptor binding,GO:0051082~unfolded protein binding,GO:0051087~chaperone binding,	IPR001580:Calreticulin/calnexin,IPR009033:Calreticulin/calnexin, P domain,IPR009169:Calreticulin,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR018124:Calreticulin/calnexin, conserved site,	hsa04141:Protein processing in endoplasmic reticulum,hsa04145:Phagosome,hsa04612:Antigen processing and presentation,hsa05142:Chagas disease (American trypanosomiasis),hsa05166:HTLV-I infection,	187950~Thrombocythemia, somatic,254450~Myelofibrosis, somatic,	PIRSF002356:calreticulin,		3D-structure,Acetylation,Calcium,Chaperone,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,Endoplasmic reticulum,Extracellular matrix,Glycoprotein,Lectin,Metal-binding,Proteomics identification,Reference proteome,Repeat,Sarcoplasmic reticulum,Secreted,Signal,Zinc,	chain:Calreticulin,compositionally biased region:Asp/Glu/Lys-rich,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:3 X approximate repeats,region of interest:4 X approximate repeats,region of interest:C-domain,region of interest:N-domain,region of interest:P-domain,repeat:1-1,repeat:1-2,repeat:1-3,repeat:1-4,repeat:2-1,repeat:2-2,repeat:2-3,sequence conflict,short sequence motif:Prevents secretion from ER,signal peptide,
CASP8	caspase 8(CASP8)	Homo sapiens	150.caspase_and_NFKB_activation,39.Deg_of_Chromosomal_DNA,40.Deg_of_Chrom_DNA_TNF-ind_apoptosis,44.Sig_Trans_TNFR1-DR3-DR4_DR5,46.P13K_PTEN,72.IAP_interaction_with_cell_death_pathways,86.Apoptosis_Nematode&_Vert,	h_caspasePathway:Caspase Cascade in Apoptosis,h_ceramidePathway:Ceramide Signaling Pathway,h_d4gdiPathway:D4-GDI Signaling Pathway,h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_fasPathway:FAS signaling pathway ( CD95 ),h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,h_soddPathway:SODD/TNFR1 Signaling Pathway,h_tnfr1Pathway:TNFR1 Signaling Pathway,		GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006921~cellular component disassembly involved in execution phase of apoptosis,GO:0007166~cell surface receptor signaling pathway,GO:0009409~response to cold,GO:0010803~regulation of tumor necrosis factor-mediated signaling pathway,GO:0010939~regulation of necrotic cell death,GO:0030101~natural killer cell activation,GO:0030225~macrophage differentiation,GO:0032025~response to cobalt ion,GO:0032355~response to estradiol,GO:0032496~response to lipopolysaccharide,GO:0034612~response to tumor necrosis factor,GO:0035666~TRIF-dependent toll-like receptor signaling pathway,GO:0036462~TRAIL-activated apoptotic signaling pathway,GO:0039650~suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,GO:0042110~T cell activation,GO:0042113~B cell activation,GO:0042981~regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045471~response to ethanol,GO:0045651~positive regulation of macrophage differentiation,GO:0045862~positive regulation of proteolysis,GO:0046677~response to antibiotic,GO:0051291~protein heterooligomerization,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0060715~syncytiotrophoblast cell differentiation involved in labyrinthine layer development,GO:0070423~nucleotide-binding oligomerization domain containing signaling pathway,GO:0071260~cellular response to mechanical stimulus,GO:0071407~cellular response to organic cyclic compound,GO:0071550~death-inducing signaling complex assembly,GO:0097190~apoptotic signaling pathway,GO:0097191~extrinsic apoptotic signaling pathway,GO:0097194~execution phase of apoptosis,GO:0097202~activation of cysteine-type endopeptidase activity,GO:0097296~activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:1902041~regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0031264~death-inducing signaling complex,GO:0031265~CD95 death-inducing signaling complex,GO:0043005~neuron projection,GO:0044297~cell body,GO:0045121~membrane raft,GO:0097342~ripoptosome,	GO:0004197~cysteine-type endopeptidase activity,GO:0005123~death receptor binding,GO:0005164~tumor necrosis factor receptor binding,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0031625~ubiquitin protein ligase binding,GO:0032403~protein complex binding,GO:0035877~death effector domain binding,GO:0042802~identical protein binding,GO:0097110~scaffold protein binding,GO:0097153~cysteine-type endopeptidase activity involved in apoptotic process,GO:0097199~cysteine-type endopeptidase activity involved in apoptotic signaling pathway,	IPR001309:Peptidase C14, ICE, catalytic subunit p20,IPR001875:Death effector domain,IPR002138:Peptidase C14, caspase non-catalytic subunit p10,IPR011029:Death-like domain,IPR015917:Peptidase C14, caspase precursor p45, core,IPR016129:Peptidase C14, ICE, catalytic subunit p20, active site,	hsa04115:p53 signaling pathway,hsa04210:Apoptosis,hsa04620:Toll-like receptor signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04622:RIG-I-like receptor signaling pathway,hsa04668:TNF signaling pathway,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05016:Huntington's disease,hsa05134:Legionellosis,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05161:Hepatitis B,hsa05168:Herpes simplex infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05416:Viral myocarditis,	114480~Breast cancer, protection against,114550~Hepatocellular carcinoma, somatic,211980~Lung cancer, protection against,607271~Autoimmune lymphoproliferative syndrome, type IIB,		SM00031:DED,SM00115:CASc,	3D-structure,Acetylation,Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Host-virus interaction,Hydrolase,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Repeat,Thiol protease,Zymogen,	chain:Caspase-8 subunit p10,chain:Caspase-8 subunit p18,domain:DED 1,domain:DED 2,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,turn,
CARD11	caspase recruitment domain family member 11(CARD11)	Homo sapiens			Cell division and chromosome partitioning,	GO:0001819~positive regulation of cytokine production,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0007165~signal transduction,GO:0030890~positive regulation of B cell proliferation,GO:0031295~T cell costimulation,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0042102~positive regulation of T cell proliferation,GO:0042981~regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045061~thymic T cell selection,GO:0045086~positive regulation of interleukin-2 biosynthetic process,GO:0045577~regulation of B cell differentiation,GO:0045580~regulation of T cell differentiation,GO:0046037~GMP metabolic process,GO:0046710~GDP metabolic process,GO:0050776~regulation of immune response,GO:0050852~T cell receptor signaling pathway,GO:0051092~positive regulation of NF-kappaB transcription factor activity,	GO:0001772~immunological synapse,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0042101~T cell receptor complex,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0004385~guanylate kinase activity,GO:0005515~protein binding,GO:0050700~CARD domain binding,	IPR001315:Caspase Recruitment,IPR001478:PDZ domain,IPR011029:Death-like domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04064:NF-kappa B signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,	615206~Immunodeficiency 11,616452~B-cell expansion with NFKB and T-cell anergy,			3D-structure,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Caspase recruitment domain-containing protein 11,domain:CARD,domain:Guanylate kinase-like,domain:PDZ,modified residue,sequence conflict,sequence variant,
CDC73	cell division cycle 73(CDC73)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001711~endodermal cell fate commitment,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006378~mRNA polyadenylation,GO:0007049~cell cycle,GO:0008285~negative regulation of cell proliferation,GO:0010390~histone monoubiquitination,GO:0016055~Wnt signaling pathway,GO:0016570~histone modification,GO:0019827~stem cell population maintenance,GO:0030177~positive regulation of Wnt signaling pathway,GO:0031442~positive regulation of mRNA 3'-end processing,GO:0031648~protein destabilization,GO:0032968~positive regulation of transcription elongation from RNA polymerase II promoter,GO:0033523~histone H2B ubiquitination,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048147~negative regulation of fibroblast proliferation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051301~cell division,GO:0071222~cellular response to lipopolysaccharide,GO:1904837~beta-catenin-TCF complex assembly,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016593~Cdc73/Paf1 complex,	GO:0000993~RNA polymerase II core binding,GO:0005515~protein binding,	IPR007852:RNA polymerase II accessory factor, Cdc73,		145000~Hyperparathyroidism, familial primary,145001~Hyperparathyroidism-jaw tumor syndrome,145001~Parathyroid adenoma with cystic changes,608266~Parathyroid carcinoma,			Acetylation,Cell cycle,Cell division,Complete proteome,Direct protein sequencing,Disease mutation,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Tumor suppressor,Ubl conjugation,Wnt signaling pathway,	chain:Parafibromin,compositionally biased region:Poly-Ile,modified residue,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,
CHEK2	checkpoint kinase 2(CHEK2)	Homo sapiens		h_atmPathway:ATM Signaling Pathway,h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_g2Pathway:Cell Cycle: G2/M Checkpoint,h_plk3Pathway:Regulation of cell cycle progression by Plk3,		GO:0000077~DNA damage checkpoint,GO:0000086~G2/M transition of mitotic cell cycle,GO:0001302~replicative cell aging,GO:0001934~positive regulation of protein phosphorylation,GO:0006302~double-strand break repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0006974~cellular response to DNA damage stimulus,GO:0006975~DNA damage induced protein phosphorylation,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0010332~response to gamma radiation,GO:0018105~peptidyl-serine phosphorylation,GO:0035690~cellular response to drug,GO:0042176~regulation of protein catabolic process,GO:0042770~signal transduction in response to DNA damage,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0044257~cellular protein catabolic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046777~protein autophosphorylation,GO:0050821~protein stabilization,GO:0051301~cell division,GO:0071157~negative regulation of cell cycle arrest,GO:0071480~cellular response to gamma radiation,GO:0072428~signal transduction involved in intra-S DNA damage checkpoint,GO:0090307~mitotic spindle assembly,GO:0090399~replicative senescence,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1903926~cellular response to bisphenol A,GO:2000002~negative regulation of DNA damage checkpoint,GO:2000210~positive regulation of anoikis,	GO:0000781~chromosome, telomeric region,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0016605~PML body,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019901~protein kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,	IPR000253:Forkhead-associated (FHA) domain,IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR008984:SMAD/FHA domain,IPR011009:Protein kinase-like domain,IPR020636:Calcium/calmodulin-dependent/calcium-dependent protein kinase,	hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa05166:HTLV-I infection,	114480~Breast cancer, susceptibility to,176807~Prostate cancer, familial, susceptibility to,259500~Osteosarcoma, somatic,609265~Li-Fraumeni syndrome,Breast and colorectal cancer, susceptibility to~Breast and colorectal cancer, susceptibility to,		SM00220:S_TKc,SM00240:FHA,	3D-structure,Alternative splicing,Apoptosis,ATP-binding,Cell cycle,Cell division,Complete proteome,Disease mutation,DNA damage,DNA repair,Kinase,Li-Fraumeni syndrome,Magnesium,Metal-binding,Mitosis,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transcription,Transcription regulation,Transferase,Tumor suppressor,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase Chk2,domain:FHA,domain:Protein kinase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,strand,turn,
CHD4	chromodomain helicase DNA binding protein 4(CHD4)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006325~chromatin organization,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0016575~histone deacetylation,GO:0032508~DNA duplex unwinding,GO:0043044~ATP-dependent chromatin remodeling,GO:0051225~spindle assembly,GO:0072553~terminal button organization,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0016020~membrane,GO:0016581~NuRD complex,GO:0032993~protein-DNA complex,GO:0043234~protein complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0003677~DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0008026~ATP-dependent helicase activity,GO:0008270~zinc ion binding,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0031492~nucleosomal DNA binding,	IPR000330:SNF2-related,IPR000953:Chromo domain/shadow,IPR001650:Helicase, C-terminal,IPR001965:Zinc finger, PHD-type,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR009462:Domain of unknown function DUF1086,IPR009463:Domain of unknown function DUF1087,IPR011011:Zinc finger, FYVE/PHD-type,IPR012957:CHD, C-terminal 2,IPR012958:CHD, N-terminal,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR016197:Chromo domain-like,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,IPR023780:Chromo domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa05203:Viral carcinogenesis,			SM00249:PHD,SM00298:CHROMO,SM00487:DEXDc,SM00490:HELICc,SM01146:SM01146,SM01147:SM01147,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Chromatin regulator,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,DNA-binding,Helicase,Hydrolase,Isopeptide bond,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Chromodomain-helicase-DNA-binding protein 4,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Asp,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Pro,domain:Chromo 1,domain:Chromo 2,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAH box,splice variant,strand,turn,zinc finger region:PHD-type 1,zinc finger region:PHD-type 2,
CSF3R	colony stimulating factor 3 receptor(CSF3R)	Homo sapiens				GO:0006952~defense response,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0019221~cytokine-mediated signaling pathway,GO:0030593~neutrophil chemotaxis,GO:0045637~regulation of myeloid cell differentiation,GO:0097186~amelogenesis,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004872~receptor activity,GO:0004896~cytokine receptor activity,GO:0005515~protein binding,GO:0051916~granulocyte colony-stimulating factor binding,	IPR003529:Long hematopoietin receptor, Gp130 family 2, conserved site,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR010457:Immunoglobulin C2-set-like, ligand-binding,IPR013783:Immunoglobulin-like fold,	hsa04060:Cytokine-cytokine receptor interaction,hsa04151:PI3K-Akt signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04640:Hematopoietic cell lineage,hsa05200:Pathways in cancer,	162830~Neutrophilia, hereditary,		SM00060:FN3,	3D-structure,Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Granulocyte colony-stimulating factor receptor,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Ig-like C2-type,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,short sequence motif:Box 1 motif,short sequence motif:WSXWS motif,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
CCNE1	cyclin E1(CCNE1)	Homo sapiens		h_cellcyclePathway:Cyclins and Cell Cycle Regulation,h_fbw7Pathway:Cyclin E Destruction Pathway,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_mcmPathway:CDK Regulation of DNA Replication,h_p27Pathway:Regulation of p27 Phosphorylation during Cell Cycle Progression,h_p53Pathway:p53 Signaling Pathway,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_skp2e2fPathway:E2F1 Destruction Pathway,	Cell division and chromosome partitioning,	GO:0000082~G1/S transition of mitotic cell cycle,GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0006270~DNA replication initiation,GO:0006468~protein phosphorylation,GO:0016055~Wnt signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0045859~regulation of protein kinase activity,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051301~cell division,GO:0051726~regulation of cell cycle,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0097134~cyclin E1-CDK2 complex,	GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0016301~kinase activity,GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,GO:0019901~protein kinase binding,GO:0050681~androgen receptor binding,	IPR004367:Cyclin, C-terminal domain,IPR006671:Cyclin, N-terminal,IPR013763:Cyclin-like,	hsa04110:Cell cycle,hsa04114:Oocyte meiosis,hsa04115:p53 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa05161:Hepatitis B,hsa05162:Measles,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05206:MicroRNAs in cancer,hsa05215:Prostate cancer,hsa05222:Small cell lung cancer,			SM00385:CYCLIN,SM01332:SM01332,	3D-structure,Alternative splicing,Cell cycle,Cell division,Complete proteome,Cyclin,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,	chain:G1/S-specific cyclin-E1,helix,modified residue,sequence conflict,splice variant,strand,turn,
CDK12	cyclin dependent kinase 12(CDK12)	Homo sapiens				GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0043405~regulation of MAP kinase activity,GO:0043484~regulation of RNA splicing,GO:0046777~protein autophosphorylation,GO:0051726~regulation of cell cycle,GO:0070816~phosphorylation of RNA polymerase II C-terminal domain,	GO:0002944~cyclin K-CDK12 complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016607~nuclear speck,GO:0019908~nuclear cyclin-dependent protein kinase holoenzyme complex,	GO:0004672~protein kinase activity,GO:0004693~cyclin-dependent protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008353~RNA polymerase II carboxy-terminal domain kinase activity,GO:0030332~cyclin binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Chromosomal rearrangement,Complete proteome,Kinase,mRNA processing,mRNA splicing,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Cell division protein kinase 12,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Pro,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
CDK4	cyclin dependent kinase 4(CDK4)	Homo sapiens	26.cyclin-CDK_complexes,4.cyclins_&_p27_cell_cycle,83.Growth_factors_Survival_factors_Mitogens,94.E2F_transcriptional_activity_cell_cycle,	h_cellcyclePathway:Cyclins and Cell Cycle Regulation,h_EfpPathway:Estrogen-responsive protein Efp controls cell cycle and breast tumors growth,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_p53Pathway:p53 Signaling Pathway,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_rbPathway:RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage,		GO:0000082~G1/S transition of mitotic cell cycle,GO:0002088~lens development in camera-type eye,GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0007623~circadian rhythm,GO:0008284~positive regulation of cell proliferation,GO:0009636~response to toxic substance,GO:0010288~response to lead ion,GO:0010468~regulation of gene expression,GO:0010971~positive regulation of G2/M transition of mitotic cell cycle,GO:0031100~organ regeneration,GO:0033574~response to testosterone,GO:0042493~response to drug,GO:0043065~positive regulation of apoptotic process,GO:0045727~positive regulation of translation,GO:0045787~positive regulation of cell cycle,GO:0045793~positive regulation of cell size,GO:0045859~regulation of protein kinase activity,GO:0048146~positive regulation of fibroblast proliferation,GO:0051301~cell division,GO:0055093~response to hyperoxia,GO:0071157~negative regulation of cell cycle arrest,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0005923~bicellular tight junction,GO:0031965~nuclear membrane,GO:0048471~perinuclear region of cytoplasm,GO:0097129~cyclin D2-CDK4 complex,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004693~cyclin-dependent protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,GO:0030332~cyclin binding,GO:0032403~protein complex binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04530:Tight junction,hsa04660:T cell receptor signaling pathway,hsa05161:Hepatitis B,hsa05162:Measles,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05212:Pancreatic cancer,hsa05214:Glioma,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,	609048~Melanoma, cutaneous malignant, 3,		SM00220:S_TKc,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Cell cycle,Cell division,Complete proteome,Cyclin,Cytoplasm,Disease mutation,Kinase,Membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Cell division protein kinase 4,compositionally biased region:Poly-Gly,domain:Protein kinase,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,strand,turn,
CDKN1B	cyclin dependent kinase inhibitor 1B(CDKN1B)	Homo sapiens	1.RBphosphoE2F,26.cyclin-CDK_complexes,4.cyclins_&_p27_cell_cycle,62.G1-phase_progression_by_Myc,84.Ubiquitination_Pathways_Cell_Cycle,	h_cellcyclePathway:Cyclins and Cell Cycle Regulation,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_mcmPathway:CDK Regulation of DNA Replication,h_p27Pathway:Regulation of p27 Phosphorylation during Cell Cycle Progression,h_ptenPathway:PTEN dependent cell cycle arrest and apoptosis,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,		GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0001666~response to hypoxia,GO:0006813~potassium ion transport,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007050~cell cycle arrest,GO:0007219~Notch signaling pathway,GO:0007605~sensory perception of sound,GO:0008219~cell death,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009749~response to glucose,GO:0010942~positive regulation of cell death,GO:0030308~negative regulation of cell growth,GO:0031116~positive regulation of microtubule polymerization,GO:0032355~response to estradiol,GO:0033673~negative regulation of kinase activity,GO:0042127~regulation of cell proliferation,GO:0042326~negative regulation of phosphorylation,GO:0042493~response to drug,GO:0043066~negative regulation of apoptotic process,GO:0043200~response to amino acid,GO:0043434~response to peptide hormone,GO:0045732~positive regulation of protein catabolic process,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045787~positive regulation of cell cycle,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045930~negative regulation of mitotic cell cycle,GO:0046686~response to cadmium ion,GO:0048102~autophagic cell death,GO:0048839~inner ear development,GO:0051271~negative regulation of cellular component movement,GO:0060770~negative regulation of epithelial cell proliferation involved in prostate gland development,GO:0071236~cellular response to antibiotic,GO:0071285~cellular response to lithium ion,GO:0071407~cellular response to organic cyclic compound,GO:0071850~mitotic cell cycle arrest,GO:1904706~negative regulation of vascular smooth muscle cell proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005829~cytosol,GO:0031464~Cul4A-RING E3 ubiquitin ligase complex,GO:0043234~protein complex,	GO:0004861~cyclin-dependent protein serine/threonine kinase inhibitor activity,GO:0005072~transforming growth factor beta receptor, cytoplasmic mediator activity,GO:0005515~protein binding,GO:0008656~cysteine-type endopeptidase activator activity involved in apoptotic process,GO:0016301~kinase activity,GO:0019903~protein phosphatase binding,GO:0030544~Hsp70 protein binding,GO:0032403~protein complex binding,GO:0051087~chaperone binding,	IPR003175:Cyclin-dependent kinase inhibitor,	hsa04012:ErbB signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04110:Cell cycle,hsa04151:PI3K-Akt signaling pathway,hsa05161:Hepatitis B,hsa05162:Measles,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05203:Viral carcinogenesis,hsa05206:MicroRNAs in cancer,hsa05215:Prostate cancer,hsa05220:Chronic myeloid leukemia,hsa05222:Small cell lung cancer,	610755~Multiple endocrine neoplasia, type IV,			3D-structure,Cell cycle,Complete proteome,Cyclin,Cytoplasm,Direct protein sequencing,Endosome,Kinase,Nucleus,Phosphoprotein,Polymorphism,Protein kinase inhibitor,Proteomics identification,Reference proteome,Transferase,Tumor suppressor,Ubl conjugation,	chain:Cyclin-dependent kinase inhibitor 1B,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,strand,turn,
CDKN2A	cyclin dependent kinase inhibitor 2A(CDKN2A)	Homo sapiens	1.RBphosphoE2F,26.cyclin-CDK_complexes,94.E2F_transcriptional_activity_cell_cycle,	h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,h_cellcyclePathway:Cyclins and Cell Cycle Regulation,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_g1Pathway:Cell Cycle: G1/S Check Point ,		GO:0000082~G1/S transition of mitotic cell cycle,GO:0000209~protein polyubiquitination,GO:0000422~mitophagy,GO:0001953~negative regulation of cell-matrix adhesion,GO:0006351~transcription, DNA-templated,GO:0006364~rRNA processing,GO:0006469~negative regulation of protein kinase activity,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007050~cell cycle arrest,GO:0007265~Ras protein signal transduction,GO:0008285~negative regulation of cell proliferation,GO:0008637~apoptotic mitochondrial changes,GO:0010389~regulation of G2/M transition of mitotic cell cycle,GO:0016925~protein sumoylation,GO:0030308~negative regulation of cell growth,GO:0030889~negative regulation of B cell proliferation,GO:0031647~regulation of protein stability,GO:0031648~protein destabilization,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0033088~negative regulation of immature T cell proliferation in thymus,GO:0033235~positive regulation of protein sumoylation,GO:0034393~positive regulation of smooth muscle cell apoptotic process,GO:0035986~senescence-associated heterochromatin focus assembly,GO:0042326~negative regulation of phosphorylation,GO:0043065~positive regulation of apoptotic process,GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046825~regulation of protein export from nucleus,GO:0048103~somatic stem cell division,GO:0050821~protein stabilization,GO:0051444~negative regulation of ubiquitin-protein transferase activity,GO:0051882~mitochondrial depolarization,GO:0070534~protein K63-linked ubiquitination,GO:0071158~positive regulation of cell cycle arrest,GO:0090398~cellular senescence,GO:0090399~replicative senescence,GO:1900182~positive regulation of protein localization to nucleus,GO:1901798~positive regulation of signal transduction by p53 class mediator,GO:1902510~regulation of apoptotic DNA fragmentation,GO:1903051~negative regulation of proteolysis involved in cellular protein catabolic process,GO:1903214~regulation of protein targeting to mitochondrion,GO:2000059~negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:2000111~positive regulation of macrophage apoptotic process,GO:2000774~positive regulation of cellular senescence,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0035985~senescence-associated heterochromatin focus,GO:0043234~protein complex,	GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0004861~cyclin-dependent protein serine/threonine kinase inhibitor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0016301~kinase activity,GO:0019789~SUMO transferase activity,GO:0019901~protein kinase binding,GO:0044822~poly(A) RNA binding,GO:0051059~NF-kappaB binding,GO:0055105~ubiquitin-protein transferase inhibitor activity,GO:0097371~MDM2/MDM4 family protein binding,	IPR010868:Cyclin-dependent kinase inhibitor 2A,IPR020683:Ankyrin repeat-containing domain,	hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05206:MicroRNAs in cancer,hsa05212:Pancreatic cancer,hsa05214:Glioma,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05223:Non-small cell lung cancer,	155601~Melanoma, cutaneous malignant, 2,155755~Melanoma and neural system tumor syndrome,606719~Pancreatic cancer/melanoma syndrome,Orolaryngeal cancer, multiple,~Orolaryngeal cancer, multiple,,			3D-structure,Acetylation,Alternative splicing,ANK repeat,Apoptosis,Cell cycle,Complete proteome,Cyclin,Cytoplasm,Disease mutation,DNA-binding,Kinase,Li-Fraumeni syndrome,Mitochondrion,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,rRNA processing,Transcription,Transcription regulation,Transferase,Tumor suppressor,Ubl conjugation,Ubl conjugation pathway,	chain:Cyclin-dependent kinase inhibitor 2A, isoform 4,chain:Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3,helix,modified residue,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,sequence conflict,sequence variant,splice variant,strand,turn,
CDKN2C	cyclin dependent kinase inhibitor 2C(CDKN2C)	Homo sapiens	1.RBphosphoE2F,26.cyclin-CDK_complexes,	h_cellcyclePathway:Cyclins and Cell Cycle Regulation,		GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0007050~cell cycle arrest,GO:0008285~negative regulation of cell proliferation,GO:0030308~negative regulation of cell growth,GO:0042326~negative regulation of phosphorylation,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0048709~oligodendrocyte differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004861~cyclin-dependent protein serine/threonine kinase inhibitor activity,GO:0005515~protein binding,GO:0016301~kinase activity,GO:0019901~protein kinase binding,	IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,	hsa04110:Cell cycle,hsa05166:HTLV-I infection,hsa05202:Transcriptional misregulation in cancer,			SM00248:ANK,	3D-structure,ANK repeat,Cell cycle,Complete proteome,Cyclin,Kinase,Polymorphism,Reference proteome,Repeat,Transferase,	chain:Cyclin-dependent kinase 4 inhibitor C,helix,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,sequence variant,
DICER1	dicer 1, ribonuclease III(DICER1)	Homo sapiens		h_dicerPathway:Dicer Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006309~apoptotic DNA fragmentation,GO:0006396~RNA processing,GO:0010626~negative regulation of Schwann cell proliferation,GO:0014040~positive regulation of Schwann cell differentiation,GO:0021675~nerve development,GO:0030422~production of siRNA involved in RNA interference,GO:0030423~targeting of mRNA for destruction involved in RNA interference,GO:0031047~gene silencing by RNA,GO:0031054~pre-miRNA processing,GO:0031643~positive regulation of myelination,GO:0032290~peripheral nervous system myelin formation,GO:0033168~conversion of ds siRNA to ss siRNA involved in RNA interference,GO:0035087~siRNA loading onto RISC involved in RNA interference,GO:0035196~production of miRNAs involved in gene silencing by miRNA,GO:0035280~miRNA loading onto RISC involved in gene silencing by miRNA,GO:0036404~conversion of ds siRNA to ss siRNA,GO:0048812~neuron projection morphogenesis,GO:0090502~RNA phosphodiester bond hydrolysis, endonucleolytic,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005829~cytosol,GO:0016442~RISC complex,GO:0030424~axon,GO:0030425~dendrite,GO:0030426~growth cone,GO:0033167~ARC complex,GO:0070578~RISC-loading complex,	GO:0003725~double-stranded RNA binding,GO:0004386~helicase activity,GO:0004521~endoribonuclease activity,GO:0004525~ribonuclease III activity,GO:0004530~deoxyribonuclease I activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019904~protein domain specific binding,GO:0035197~siRNA binding,GO:0046872~metal ion binding,GO:0070883~pre-miRNA binding,	IPR000999:Ribonuclease III domain,IPR001650:Helicase, C-terminal,IPR003100:Argonaute/Dicer protein, PAZ,IPR005034:Dicer double-stranded RNA-binding fold,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014720:Double-stranded RNA-binding-like domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa05206:MicroRNAs in cancer,	138800~Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors,180295~Rhabdomyosarcoma, embryonal, 2,601200~Pleuropulmonary blastoma,		SM00358:DSRM,SM00487:DEXDc,SM00490:HELICc,SM00535:RIBOc,SM00949:SM00949,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Disease mutation,Endonuclease,Helicase,Hydrolase,Magnesium,Manganese,Metal-binding,Nuclease,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,RNA-mediated gene silencing,	chain:Endoribonuclease Dicer,domain:Dicer dsRNA-binding fold,domain:DRBM,domain:Helicase ATP-binding,domain:Helicase C-terminal,domain:PAZ,domain:RNase III 1,domain:RNase III 2,helix,metal ion-binding site:Magnesium or manganese 1,metal ion-binding site:Magnesium or manganese 2,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Required for interaction with PRKRA and TARBP2,sequence conflict,short sequence motif:DECH box,site:Important for activity,turn,
DDR2	discoidin domain receptor tyrosine kinase 2(DDR2)	Homo sapiens				GO:0001503~ossification,GO:0003416~endochondral bone growth,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0010715~regulation of extracellular matrix disassembly,GO:0010763~positive regulation of fibroblast migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0030500~regulation of bone mineralization,GO:0031214~biomineral tissue development,GO:0035988~chondrocyte proliferation,GO:0038063~collagen-activated tyrosine kinase receptor signaling pathway,GO:0045669~positive regulation of osteoblast differentiation,GO:0045860~positive regulation of protein kinase activity,GO:0046777~protein autophosphorylation,GO:0048146~positive regulation of fibroblast proliferation,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0090091~positive regulation of extracellular matrix disassembly,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0016324~apical plasma membrane,GO:0070062~extracellular exosome,	GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0005524~ATP binding,GO:0038062~protein tyrosine kinase collagen receptor activity,	IPR000421:Coagulation factor 5/8 C-terminal type domain,IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR002011:Tyrosine-protein kinase, receptor class II, conserved site,IPR008266:Tyrosine-protein kinase, active site,IPR008979:Galactose-binding domain-like,IPR011009:Protein kinase-like domain,IPR020635:Tyrosine-protein kinase, catalytic domain,		271665~Spondylometaepiphyseal dysplasia, short limb-hand type,		SM00219:TyrKc,SM00231:FA58C,	3D-structure,ATP-binding,Cell membrane,Complete proteome,Disease mutation,Disulfide bond,Dwarfism,Glycoprotein,Kinase,Membrane,Nucleotide-binding,Osteogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Discoidin domain-containing receptor 2,disulfide bond,domain:F5/8 type C,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
DROSHA	drosha ribonuclease III(DROSHA)	Homo sapiens				GO:0010586~miRNA metabolic process,GO:0010628~positive regulation of gene expression,GO:0016075~rRNA catabolic process,GO:0030422~production of siRNA involved in RNA interference,GO:0031047~gene silencing by RNA,GO:0031053~primary miRNA processing,GO:0031054~pre-miRNA processing,GO:0042254~ribosome biogenesis,GO:0045589~regulation of regulatory T cell differentiation,GO:0050727~regulation of inflammatory response,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,GO:0090502~RNA phosphodiester bond hydrolysis, endonucleolytic,GO:2000628~regulation of miRNA metabolic process,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0070877~microprocessor complex,	GO:0001530~lipopolysaccharide binding,GO:0003725~double-stranded RNA binding,GO:0004525~ribonuclease III activity,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0070878~primary miRNA binding,	IPR000999:Ribonuclease III domain,IPR011907:Ribonuclease III,IPR014720:Double-stranded RNA-binding-like domain,	hsa03008:Ribosome biogenesis in eukaryotes,hsa05205:Proteoglycans in cancer,			SM00358:DSRM,SM00535:RIBOc,	3D-structure,Alternative splicing,Complete proteome,Endonuclease,Hydrolase,Magnesium,Manganese,Metal-binding,Nuclease,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ribosome biogenesis,RNA-binding,RNA-mediated gene silencing,	chain:Ribonuclease 3,compositionally biased region:Arg-rich,compositionally biased region:Pro-rich,domain:DRBM,domain:RNase III 1,domain:RNase III 2,metal ion-binding site:Magnesium or manganese,modified residue,mutagenesis site,region of interest:Necessary for interaction with DGCR8 and pri-miRNA processing activity,sequence conflict,sequence variant,site:Important for activity,splice variant,
DNM2	dynamin 2(DNM2)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0000266~mitochondrial fission,GO:0002031~G-protein coupled receptor internalization,GO:0003281~ventricular septum development,GO:0003374~dynamin polymerization involved in mitochondrial fission,GO:0006355~regulation of transcription, DNA-templated,GO:0006893~Golgi to plasma membrane transport,GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0006909~phagocytosis,GO:0007165~signal transduction,GO:0007283~spermatogenesis,GO:0009416~response to light stimulus,GO:0010592~positive regulation of lamellipodium assembly,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030516~regulation of axon extension,GO:0031623~receptor internalization,GO:0033572~transferrin transport,GO:0035020~regulation of Rac protein signal transduction,GO:0035904~aorta development,GO:0042220~response to cocaine,GO:0043065~positive regulation of apoptotic process,GO:0044351~macropinocytosis,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048489~synaptic vesicle transport,GO:0048812~neuron projection morphogenesis,GO:0050766~positive regulation of phagocytosis,GO:0050999~regulation of nitric-oxide synthase activity,GO:0060271~cilium morphogenesis,GO:0060976~coronary vasculature development,GO:0061025~membrane fusion,GO:0071245~cellular response to carbon monoxide,GO:0071481~cellular response to X-ray,GO:0071732~cellular response to nitric oxide,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,GO:1903351~cellular response to dopamine,GO:1903358~regulation of Golgi organization,GO:1903408~positive regulation of sodium:potassium-exchanging ATPase activity,GO:1903526~negative regulation of membrane tubulation,	GO:0000139~Golgi membrane,GO:0001891~phagocytic cup,GO:0001917~photoreceptor inner segment,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0005905~clathrin-coated pit,GO:0005925~focal adhesion,GO:0014069~postsynaptic density,GO:0030027~lamellipodium,GO:0030426~growth cone,GO:0030496~midbody,GO:0030666~endocytic vesicle membrane,GO:0030670~phagocytic vesicle membrane,GO:0031966~mitochondrial membrane,GO:0032587~ruffle membrane,GO:0043234~protein complex,GO:0045211~postsynaptic membrane,GO:0045334~clathrin-coated endocytic vesicle,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0008017~microtubule binding,GO:0017124~SH3 domain binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0031749~D2 dopamine receptor binding,GO:0032403~protein complex binding,GO:0036312~phosphatidylinositol 3-kinase regulatory subunit binding,GO:0050699~WW domain binding,GO:0050998~nitric-oxide synthase binding,	IPR000375:Dynamin central domain,IPR001401:Dynamin, GTPase domain,IPR001849:Pleckstrin homology domain,IPR003130:Dynamin GTPase effector,IPR011993:Pleckstrin homology-like domain,IPR019762:Dynamin, GTPase region, conserved site,IPR020850:GTPase effector domain, GED,IPR022812:Dynamin,IPR027188:Dynamin-2,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04144:Endocytosis,hsa04721:Synaptic vesicle cycle,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa05100:Bacterial invasion of epithelial cells,	160150~Myopathy, centronuclear,606482~Charcot-Marie-Tooth disease, axonal, type 2M,606482~Charcot-Marie-Tooth disease, dominant intermediate B,615368~Lethal congenital contracture syndrome 5,		SM00053:DYNc,SM00233:PH,SM00302:GED,	3D-structure,Acetylation,Alternative splicing,Cell junction,Cell membrane,Cell projection,Charcot-Marie-Tooth disease,Coated pit,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Disease mutation,Endocytosis,GTP-binding,Hydrolase,Membrane,Microtubule,Motor protein,Neurodegeneration,Neuropathy,Nucleotide-binding,Phagocytosis,Phosphoprotein,Polymorphism,Postsynaptic cell membrane,Proteomics identification,Reference proteome,Synapse,	chain:Dynamin-2,compositionally biased region:Pro-rich,domain:GED,domain:PH,helix,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,splice variant,strand,
EGFR	epidermal growth factor receptor(EGFR)	Homo sapiens		h_agrPathway:Agrin in Postsynaptic Differentiation,h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_cardiacEGFPathway:Role of EGF Receptor Transactivation by GPCRs in Cardiac Hypertrophy,h_cblPathway:CBL mediated ligand-induced downregulation of EGF receptors,h_eea1Pathway:The role of FYVE-finger proteins in vesicle transport,h_egfPathway:EGF Signaling Pathway,h_egfr_smrtePathway:Map Kinase Inactivation of SMRT Corepressor,h_ErbB3Pathway:Neuroregulin receptor degredation protein-1 Controls ErbB3 receptor recycling,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_keratinocytePathway:Keratinocyte Differentiation,h_mCalpainPathway:mCalpain and friends in Cell motility,h_spryPathway:Sprouty regulation of tyrosine kinase signals,h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality,h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,		GO:0000165~MAPK cascade,GO:0000186~activation of MAPKK activity,GO:0001503~ossification,GO:0001892~embryonic placenta development,GO:0001934~positive regulation of protein phosphorylation,GO:0001942~hair follicle development,GO:0006412~translation,GO:0006898~receptor-mediated endocytosis,GO:0006950~response to stress,GO:0006970~response to osmotic stress,GO:0006979~response to oxidative stress,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007202~activation of phospholipase C activity,GO:0007435~salivary gland morphogenesis,GO:0007494~midgut development,GO:0007611~learning or memory,GO:0007623~circadian rhythm,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0010960~magnesium ion homeostasis,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0016101~diterpenoid metabolic process,GO:0016337~single organismal cell-cell adhesion,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0021795~cerebral cortex cell migration,GO:0030307~positive regulation of cell growth,GO:0030324~lung development,GO:0030335~positive regulation of cell migration,GO:0031659~positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,GO:0032930~positive regulation of superoxide anion generation,GO:0033590~response to cobalamin,GO:0033594~response to hydroxyisoflavone,GO:0035413~positive regulation of catenin import into nucleus,GO:0035690~cellular response to drug,GO:0038128~ERBB2 signaling pathway,GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway,GO:0042060~wound healing,GO:0042177~negative regulation of protein catabolic process,GO:0042327~positive regulation of phosphorylation,GO:0042698~ovulation cycle,GO:0042743~hydrogen peroxide metabolic process,GO:0043006~activation of phospholipase A2 activity by calcium-mediated signaling,GO:0043066~negative regulation of apoptotic process,GO:0043406~positive regulation of MAP kinase activity,GO:0043547~positive regulation of GTPase activity,GO:0043586~tongue development,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045739~positive regulation of DNA repair,GO:0045740~positive regulation of DNA replication,GO:0045780~positive regulation of bone resorption,GO:0045907~positive regulation of vasoconstriction,GO:0045909~positive regulation of vasodilation,GO:0045930~negative regulation of mitotic cell cycle,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046777~protein autophosphorylation,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048143~astrocyte activation,GO:0048146~positive regulation of fibroblast proliferation,GO:0048546~digestive tract morphogenesis,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048812~neuron projection morphogenesis,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050729~positive regulation of inflammatory response,GO:0050730~regulation of peptidyl-tyrosine phosphorylation,GO:0050999~regulation of nitric-oxide synthase activity,GO:0051205~protein insertion into membrane,GO:0051592~response to calcium ion,GO:0051897~positive regulation of protein kinase B signaling,GO:0051968~positive regulation of synaptic transmission, glutamatergic,GO:0060571~morphogenesis of an epithelial fold,GO:0061029~eyelid development in camera-type eye,GO:0070141~response to UV-A,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071230~cellular response to amino acid stimulus,GO:0071260~cellular response to mechanical stimulus,GO:0071364~cellular response to epidermal growth factor stimulus,GO:0071392~cellular response to estradiol stimulus,GO:0071549~cellular response to dexamethasone stimulus,GO:0097421~liver regeneration,GO:1902722~positive regulation of prolactin secretion,GO:1903800~positive regulation of production of miRNAs involved in gene silencing by miRNA,GO:1905208~negative regulation of cardiocyte differentiation,GO:2000145~regulation of cell motility,	GO:0000139~Golgi membrane,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0030122~AP-2 adaptor complex,GO:0030139~endocytic vesicle,GO:0031901~early endosome membrane,GO:0031965~nuclear membrane,GO:0043235~receptor complex,GO:0045121~membrane raft,GO:0045202~synapse,GO:0048471~perinuclear region of cytoplasm,GO:0070435~Shc-EGFR complex,GO:0097489~multivesicular body, internal vesicle lumen,	GO:0001948~glycoprotein binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0004672~protein kinase activity,GO:0004709~MAP kinase kinase kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0004716~receptor signaling protein tyrosine kinase activity,GO:0004888~transmembrane signaling receptor activity,GO:0005006~epidermal growth factor-activated receptor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0030235~nitric-oxide synthase regulator activity,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,GO:0046982~protein heterodimerization activity,GO:0048408~epidermal growth factor binding,GO:0051015~actin filament binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000494:EGF receptor, L domain,IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR006211:Furin-like cysteine-rich domain,IPR006212:Furin-like repeat,IPR008266:Tyrosine-protein kinase, active site,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011009:Protein kinase-like domain,IPR016245:Tyrosine protein kinase, EGF/ERB/XmrK receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04020:Calcium signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04144:Endocytosis,hsa04151:PI3K-Akt signaling pathway,hsa04320:Dorso-ventral axis formation,hsa04510:Focal adhesion,hsa04520:Adherens junction,hsa04540:Gap junction,hsa04810:Regulation of actin cytoskeleton,hsa04912:GnRH signaling pathway,hsa04915:Estrogen signaling pathway,hsa04921:Oxytocin signaling pathway,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05160:Hepatitis C,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	211980~Adenocarcinoma of lung, response to tyrosine kinase inhibitor in,211980~Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in,211980~Nonsmall cell lung cancer, susceptibility to,616069~Inflammatory skin and bowel disease, neonatal, 2,	PIRSF000619:tyrosine-protein kinase, EGF receptor type,	SM00219:TyrKc,SM00261:FU,	3D-structure,Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Developmental protein,Direct protein sequencing,Disease mutation,Disulfide bond,Endoplasmic reticulum,Endosome,Glycoprotein,Golgi apparatus,Isopeptide bond,Kinase,Membrane,Methylation,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Receptor,Reference proteome,Repeat,Secreted,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Epidermal growth factor receptor,compositionally biased region:Ser-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),disulfide bond,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),glycosylation site:N-linked (GlcNAc...) (complex); atypical; partial,glycosylation site:N-linked (GlcNAc...); partial,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,repeat:Approximate,sequence conflict,sequence variant,signal peptide,site:Important for interaction with PIK3C2B,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ERBB3	erb-b2 receptor tyrosine kinase 3(ERBB3)	Homo sapiens		h_ErbB3Pathway:Neuroregulin receptor degredation protein-1 Controls ErbB3 receptor recycling,h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,		GO:0000165~MAPK cascade,GO:0003197~endocardial cushion development,GO:0007162~negative regulation of cell adhesion,GO:0007165~signal transduction,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007422~peripheral nervous system development,GO:0007507~heart development,GO:0009968~negative regulation of signal transduction,GO:0010628~positive regulation of gene expression,GO:0014037~Schwann cell differentiation,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0021545~cranial nerve development,GO:0038128~ERBB2 signaling pathway,GO:0042060~wound healing,GO:0042127~regulation of cell proliferation,GO:0043524~negative regulation of neuron apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0051048~negative regulation of secretion,GO:0051402~neuron apoptotic process,GO:0055025~positive regulation of cardiac muscle tissue development,GO:0061098~positive regulation of protein tyrosine kinase activity,GO:0070886~positive regulation of calcineurin-NFAT signaling cascade,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:2000145~regulation of cell motility,	GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0016328~lateral plasma membrane,GO:0043235~receptor complex,	GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0004716~receptor signaling protein tyrosine kinase activity,GO:0004888~transmembrane signaling receptor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019838~growth factor binding,GO:0030296~protein tyrosine kinase activator activity,GO:0038132~neuregulin binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,GO:0046982~protein heterodimerization activity,	IPR000494:EGF receptor, L domain,IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR006211:Furin-like cysteine-rich domain,IPR006212:Furin-like repeat,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011009:Protein kinase-like domain,IPR016245:Tyrosine protein kinase, EGF/ERB/XmrK receptor,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04012:ErbB signaling pathway,hsa04020:Calcium signaling pathway,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,	607598~Lethal congenital contractural syndrome 2,	PIRSF000619:tyrosine-protein kinase, EGF receptor type,	SM00219:TyrKc,SM00261:FU,	3D-structure,Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Secreted,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Receptor tyrosine-protein kinase erbB-3,disulfide bond,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ETNK1	ethanolamine kinase 1(ETNK1)	Homo sapiens				GO:0006646~phosphatidylethanolamine biosynthetic process,GO:0016310~phosphorylation,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004305~ethanolamine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR011009:Protein kinase-like domain,	hsa00564:Glycerophospholipid metabolism,hsa01100:Metabolic pathways,				Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Kinase,Lipid biosynthesis,Lipid metabolism,Membrane,Nucleotide-binding,Phospholipid biosynthesis,Phospholipid metabolism,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Ethanolamine kinase 1,compositionally biased region:Poly-Val,modified residue,sequence conflict,
EXT2	exostosin glycosyltransferase 2(EXT2)	Homo sapiens				GO:0001503~ossification,GO:0001707~mesoderm formation,GO:0006024~glycosaminoglycan biosynthetic process,GO:0006486~protein glycosylation,GO:0007165~signal transduction,GO:0015012~heparan sulfate proteoglycan biosynthetic process,GO:0015014~heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,GO:0030154~cell differentiation,GO:0033692~cellular polysaccharide biosynthetic process,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043541~UDP-N-acetylglucosamine transferase complex,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008375~acetylglucosaminyltransferase activity,GO:0015020~glucuronosyltransferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0042328~heparan sulfate N-acetylglucosaminyltransferase activity,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:0050508~glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,GO:0050509~N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,	IPR004263:Exostosin-like,IPR015338:EXTL2, alpha-1,4-N-acetylhexosaminyltransferase,	hsa00534:Glycosaminoglycan biosynthesis - heparan sulfate / heparin,hsa01100:Metabolic pathways,	133701~Exostoses, multiple, type 2,616682~Seizures, scoliosis, and macrocephaly syndrome,			Alternative splicing,Complete proteome,Disease mutation,Disulfide bond,Endoplasmic reticulum,Epilepsy,Glycoprotein,Glycosyltransferase,Golgi apparatus,Hereditary multiple exostoses,Manganese,Membrane,Mental retardation,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,Tumor suppressor,	chain:Exostosin-2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
XPO1	exportin 1(XPO1)	Homo sapiens		h_cremPathway:Regulation of Spermatogenesis by CREM,h_ptc1Pathway:Sonic Hedgehog (SHH) Receptor Ptc1 Regulates cell cycle,	Nuclear structure / Intracellular trafficking and secretion,	GO:0000055~ribosomal large subunit export from nucleus,GO:0000056~ribosomal small subunit export from nucleus,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006611~protein export from nucleus,GO:0006886~intracellular protein transport,GO:0007062~sister chromatid cohesion,GO:0010824~regulation of centrosome duplication,GO:0016032~viral process,GO:0034504~protein localization to nucleus,GO:0042176~regulation of protein catabolic process,GO:0042493~response to drug,GO:0043488~regulation of mRNA stability,GO:0046825~regulation of protein export from nucleus,GO:0051028~mRNA transport,GO:0075733~intracellular transport of virus,	GO:0000776~kinetochore,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005642~annulate lamellae,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0015030~Cajal body,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0031965~nuclear membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0003723~RNA binding,GO:0005049~nuclear export signal receptor activity,GO:0005215~transporter activity,GO:0005487~nucleocytoplasmic transporter activity,GO:0005515~protein binding,GO:0008536~Ran GTPase binding,GO:0019904~protein domain specific binding,	IPR001494:Importin-beta, N-terminal,IPR011989:Armadillo-like helical,IPR013598:Exportin-1/Importin-beta-like,IPR014877:CRM1 C-terminal domain,IPR016024:Armadillo-type fold,	hsa03008:Ribosome biogenesis in eukaryotes,hsa03013:RNA transport,hsa05164:Influenza A,hsa05166:HTLV-I infection,			SM00913:SM00913,SM01102:SM01102,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Host-virus interaction,mRNA transport,Nucleus,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Repeat,RNA-binding,Transport,	chain:Exportin-1,domain:Importin N-terminal,helix,modified residue,mutagenesis site,region of interest:Interaction with HIV-1 Rev,region of interest:Interaction with Ran and nuclear export complex formation,region of interest:Interaction with RANBP3,region of interest:Necessary for HTLV-1 Rex multimerization,region of interest:Necessary for HTLV-1 Rex-mediated mRNA export,repeat:HEAT 1,repeat:HEAT 10,repeat:HEAT 2,repeat:HEAT 3,repeat:HEAT 4,repeat:HEAT 5,repeat:HEAT 6,repeat:HEAT 7,repeat:HEAT 8,repeat:HEAT 9,sequence conflict,strand,turn,
FAM46C	family with sequence similarity 46 member C(FAM46C)	Homo sapiens						GO:0005515~protein binding,	IPR012937:Domain of unknown function DUF1693,				SM01153:SM01153,	Complete proteome,Polymorphism,Reference proteome,	chain:Protein FAM46C,sequence conflict,sequence variant,
FUBP1	far upstream element binding protein 1(FUBP1)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0010628~positive regulation of gene expression,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003697~single-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR015096:Domain of unknown function DUF1897,				SM00322:KH,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,DNA-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,	chain:Far upstream element-binding protein 1,compositionally biased region:Gly-rich,compositionally biased region:Pro-rich,domain:KH 1,domain:KH 2,domain:KH 3,domain:KH 4,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
FGFR4	fibroblast growth factor receptor 4(FGFR4)	Homo sapiens				GO:0000165~MAPK cascade,GO:0008284~positive regulation of cell proliferation,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0010628~positive regulation of gene expression,GO:0010715~regulation of extracellular matrix disassembly,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0016477~cell migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0019216~regulation of lipid metabolic process,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0042593~glucose homeostasis,GO:0043085~positive regulation of catalytic activity,GO:0043547~positive regulation of GTPase activity,GO:0045862~positive regulation of proteolysis,GO:0046777~protein autophosphorylation,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0055062~phosphate ion homeostasis,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070857~regulation of bile acid biosynthetic process,GO:1903412~response to bile acid,GO:2000188~regulation of cholesterol homeostasis,GO:2000573~positive regulation of DNA biosynthetic process,	GO:0005576~extracellular region,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0016021~integral component of membrane,GO:0030133~transport vesicle,	GO:0004713~protein tyrosine kinase activity,GO:0005007~fibroblast growth factor-activated receptor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008201~heparin binding,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0017134~fibroblast growth factor binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,IPR016248:Tyrosine-protein kinase, fibroblast growth factor receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04144:Endocytosis,hsa04151:PI3K-Akt signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04810:Regulation of actin cytoskeleton,	Cancer progression/metastasis~Cancer progression/metastasis,	PIRSF000628:fibroblast growth factor receptor,	SM00219:TyrKc,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Disulfide bond,Endoplasmic reticulum,Endosome,Glycoprotein,Immunoglobulin domain,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Fibroblast growth factor receptor 4,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
FLT3	fms related tyrosine kinase 3(FLT3)	Homo sapiens		h_erythPathway:Erythrocyte Differentiation Pathway,		GO:0001776~leukocyte homeostasis,GO:0002318~myeloid progenitor cell differentiation,GO:0002328~pro-B cell differentiation,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0010243~response to organonitrogen compound,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0019221~cytokine-mediated signaling pathway,GO:0030097~hemopoiesis,GO:0030154~cell differentiation,GO:0030183~B cell differentiation,GO:0031100~organ regeneration,GO:0035726~common myeloid progenitor cell proliferation,GO:0038084~vascular endothelial growth factor signaling pathway,GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein,GO:0042981~regulation of apoptotic process,GO:0043406~positive regulation of MAP kinase activity,GO:0043410~positive regulation of MAPK cascade,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0046651~lymphocyte proliferation,GO:0046777~protein autophosphorylation,GO:0071345~cellular response to cytokine stimulus,GO:0071385~cellular response to glucocorticoid stimulus,GO:0097028~dendritic cell differentiation,	GO:0005634~nucleus,GO:0005788~endoplasmic reticulum lumen,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0043234~protein complex,	GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0004896~cytokine receptor activity,GO:0005021~vascular endothelial growth factor-activated receptor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0032403~protein complex binding,GO:0035259~glucocorticoid receptor binding,GO:0042803~protein homodimerization activity,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001824:Tyrosine-protein kinase, receptor class III, conserved site,IPR007110:Immunoglobulin-like domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04640:Hematopoietic cell lineage,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05221:Acute myeloid leukemia,hsa05230:Central carbon metabolism in cancer,	601626~Leukemia, acute myeloid, reduced survival in, somatic,601626~Leukemia, acute myeloid, somatic,613065~Leukemia, acute lymphoblastic, somatic,		SM00219:TyrKc,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Disease mutation,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Immunoglobulin domain,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Receptor,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:FL cytokine receptor,domain:Ig-like C2-type,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
FLT4	fms related tyrosine kinase 4(FLT4)	Homo sapiens		h_no1Pathway:Actions of Nitric Oxide in the Heart,h_vegfPathway:VEGF, Hypoxia, and Angiogenesis,		GO:0001934~positive regulation of protein phosphorylation,GO:0001938~positive regulation of endothelial cell proliferation,GO:0001944~vasculature development,GO:0001945~lymph vessel development,GO:0001946~lymphangiogenesis,GO:0002040~sprouting angiogenesis,GO:0003016~respiratory system process,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0010595~positive regulation of endothelial cell migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0035924~cellular response to vascular endothelial growth factor stimulus,GO:0038084~vascular endothelial growth factor signaling pathway,GO:0043066~negative regulation of apoptotic process,GO:0043410~positive regulation of MAPK cascade,GO:0046330~positive regulation of JNK cascade,GO:0046777~protein autophosphorylation,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048286~lung alveolus development,GO:0048514~blood vessel morphogenesis,GO:0060312~regulation of blood vessel remodeling,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0090037~positive regulation of protein kinase C signaling,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0043235~receptor complex,	GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005021~vascular endothelial growth factor-activated receptor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019838~growth factor binding,GO:0019903~protein phosphatase binding,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001824:Tyrosine-protein kinase, receptor class III, conserved site,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR008266:Tyrosine-protein kinase, active site,IPR009137:Tyrosine-protein kinase, vascular endothelial growth factor receptor 3 (VEGFR3), N-terminal,IPR011009:Protein kinase-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,	153100~Lymphedema, hereditary, IA,602089~Hemangioma, capillary infantile, somatic,		SM00219:TyrKc,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Angiogenesis,ATP-binding,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Kinase,Membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Vascular endothelial growth factor receptor 3,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,domain:Ig-like C2-type 7,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
FLCN	folliculin(FLCN)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0001932~regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0007043~cell-cell junction assembly,GO:0010508~positive regulation of autophagy,GO:0010629~negative regulation of gene expression,GO:0010823~negative regulation of mitochondrion organization,GO:0030097~hemopoiesis,GO:0030308~negative regulation of cell growth,GO:0030336~negative regulation of cell migration,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0031929~TOR signaling,GO:0032006~regulation of TOR signaling,GO:0032007~negative regulation of TOR signaling,GO:0032008~positive regulation of TOR signaling,GO:0032465~regulation of cytokinesis,GO:0035024~negative regulation of Rho protein signal transduction,GO:0035065~regulation of histone acetylation,GO:0043065~positive regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0045785~positive regulation of cell adhesion,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051898~negative regulation of protein kinase B signaling,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:1900181~negative regulation of protein localization to nucleus,GO:1901723~negative regulation of cell proliferation involved in kidney development,GO:1901856~negative regulation of cellular respiration,GO:1901859~negative regulation of mitochondrial DNA metabolic process,GO:1901862~negative regulation of muscle tissue development,GO:1901874~negative regulation of post-translational protein modification,GO:2000506~negative regulation of energy homeostasis,GO:2000973~regulation of pro-B cell differentiation,GO:2001170~negative regulation of ATP biosynthetic process,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005886~plasma membrane,GO:0005929~cilium,GO:0030496~midbody,GO:0044291~cell-cell contact zone,GO:0072372~primary cilium,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0032403~protein complex binding,	IPR021713:Folliculin,	hsa05211:Renal cell carcinoma,	114500~Colorectal cancer, somatic,135150~Birt-Hogg-Dube syndrome,144700~Renal carcinoma, chromophobe, somatic,173600~Pneumothorax, primary spontaneous,			3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Tumor suppressor,	chain:Folliculin,modified residue,sequence variant,splice variant,
FOXA1	forkhead box A1(FOXA1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006338~chromatin remodeling,GO:0006366~transcription from RNA polymerase II promoter,GO:0007219~Notch signaling pathway,GO:0010719~negative regulation of epithelial to mesenchymal transition,GO:0016569~covalent chromatin modification,GO:0021904~dorsal/ventral neural tube patterning,GO:0032355~response to estradiol,GO:0033148~positive regulation of intracellular estrogen receptor signaling pathway,GO:0042445~hormone metabolic process,GO:0042593~glucose homeostasis,GO:0045666~positive regulation of neuron differentiation,GO:0045880~positive regulation of smoothened signaling pathway,GO:0045931~positive regulation of mitotic cell cycle,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048665~neuron fate specification,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0060441~epithelial tube branching involved in lung morphogenesis,GO:0060487~lung epithelial cell differentiation,GO:0060528~secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,GO:0060738~epithelial-mesenchymal signaling involved in prostate gland development,GO:0060740~prostate gland epithelium morphogenesis,GO:0060741~prostate gland stromal morphogenesis,GO:0060743~epithelial cell maturation involved in prostate gland development,GO:0061144~alveolar secondary septum development,GO:0071542~dopaminergic neuron differentiation,GO:1902691~respiratory basal cell differentiation,GO:2000049~positive regulation of cell-cell adhesion mediated by cadherin,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005902~microvillus,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008134~transcription factor binding,GO:0019904~protein domain specific binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,	IPR001766:Transcription factor, fork head,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013638:Fork-head N-terminal,IPR018122:Transcription factor, fork head, conserved site,IPR018533:Forkhead box protein, C-terminal,				SM00339:FH,	Activator,Alternative splicing,Chromatin regulator,Complete proteome,Developmental protein,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Hepatocyte nuclear factor 3-alpha,DNA-binding region:Fork-head,modified residue,sequence variant,
FH	fumarate hydratase(FH)	Homo sapiens				GO:0006099~tricarboxylic acid cycle,GO:0006106~fumarate metabolic process,GO:0006108~malate metabolic process,GO:0048873~homeostasis of number of cells within a tissue,GO:0051262~protein tetramerization,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0045239~tricarboxylic acid cycle enzyme complex,GO:0070062~extracellular exosome,	GO:0003824~catalytic activity,GO:0004333~fumarate hydratase activity,GO:0005515~protein binding,GO:0016829~lyase activity,	IPR000362:Fumarate lyase,IPR005677:Fumarate hydratase, class II,IPR008948:L-Aspartase-like,IPR018951:Fumarase C, C-terminal,IPR020557:Fumarate lyase, conserved site,IPR022761:Fumarate lyase, N-terminal,IPR024083:Fumarase/histidase, N-terminal,	hsa00020:Citrate cycle (TCA cycle),hsa00620:Pyruvate metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa05200:Pathways in cancer,hsa05211:Renal cell carcinoma,	150800~Leiomyomatosis and renal cell cancer,606812~Fumarase deficiency,			3D-structure,Acetylation,Alternative initiation,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Lyase,Mitochondrion,Phosphoprotein,Reference proteome,Transit peptide,Tricarboxylic acid cycle,Tumor suppressor,	binding site:Substrate,chain:Fumarate hydratase, mitochondrial,helix,modified residue,region of interest:B site,region of interest:Substrate binding,sequence variant,splice variant,strand,transit peptide:Mitochondrion,turn,
GRIN2A	glutamate ionotropic receptor NMDA type subunit 2A(GRIN2A)	Homo sapiens		h_nos1Pathway:Nitric Oxide Signaling Pathway,		GO:0000165~MAPK cascade,GO:0001964~startle response,GO:0001975~response to amphetamine,GO:0006810~transport,GO:0007215~glutamate receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0007611~learning or memory,GO:0007613~memory,GO:0008104~protein localization,GO:0008542~visual learning,GO:0009611~response to wounding,GO:0019233~sensory perception of pain,GO:0022008~neurogenesis,GO:0030431~sleep,GO:0033058~directional locomotion,GO:0035235~ionotropic glutamate receptor signaling pathway,GO:0042177~negative regulation of protein catabolic process,GO:0042417~dopamine metabolic process,GO:0042428~serotonin metabolic process,GO:0042493~response to drug,GO:0043065~positive regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0045471~response to ethanol,GO:0051930~regulation of sensory perception of pain,GO:0060079~excitatory postsynaptic potential,GO:0060291~long-term synaptic potentiation,GO:0070588~calcium ion transmembrane transport,GO:1900273~positive regulation of long-term synaptic potentiation,	GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0008021~synaptic vesicle,GO:0009986~cell surface,GO:0014069~postsynaptic density,GO:0016021~integral component of membrane,GO:0017146~NMDA selective glutamate receptor complex,GO:0030054~cell junction,GO:0042734~presynaptic membrane,GO:0043005~neuron projection,GO:0045211~postsynaptic membrane,	GO:0004970~ionotropic glutamate receptor activity,GO:0004972~NMDA glutamate receptor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005234~extracellular-glutamate-gated ion channel activity,GO:0005262~calcium channel activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001320:Ionotropic glutamate receptor,IPR001508:NMDA receptor,IPR001828:Extracellular ligand-binding receptor,IPR018884:Glutamate [NMDA] receptor, epsilon subunit, C-terminal,IPR019594:Glutamate receptor, L-glutamate/glycine-binding,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04020:Calcium signaling pathway,hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04713:Circadian entrainment,hsa04720:Long-term potentiation,hsa04724:Glutamatergic synapse,hsa04728:Dopaminergic synapse,hsa05010:Alzheimer's disease,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05030:Cocaine addiction,hsa05031:Amphetamine addiction,hsa05033:Nicotine addiction,hsa05034:Alcoholism,hsa05322:Systemic lupus erythematosus,	245570~Epilepsy, focal, with speech disorder and with or without mental retardation,		SM00079:PBPe,SM00918:SM00918,	3D-structure,Alternative splicing,Calcium,Cell junction,Cell membrane,Chromosomal rearrangement,Complete proteome,Disease mutation,Disulfide bond,Epilepsy,Glycoprotein,Ion channel,Ion transport,Ligand-gated ion channel,Magnesium,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Postsynaptic cell membrane,Proteomics identification,Receptor,Reference proteome,Signal,Synapse,Transmembrane,Transmembrane helix,Transport,Zinc,	binding site:Glutamate,binding site:Glutamate; via amide nitrogen,chain:Glutamate [NMDA] receptor subunit epsilon-1,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:Glutamate binding,sequence variant,short sequence motif:PDZ-binding,signal peptide,site:Functional determinant of NMDA receptors,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
HIST1H3B	histone cluster 1 H3 family member b(HIST1H3B)	Homo sapiens				GO:0000183~chromatin silencing at rDNA,GO:0006334~nucleosome assembly,GO:0006335~DNA replication-dependent nucleosome assembly,GO:0007596~blood coagulation,GO:0031047~gene silencing by RNA,GO:0032200~telomere organization,GO:0044267~cellular protein metabolic process,GO:0045814~negative regulation of gene expression, epigenetic,GO:0045815~positive regulation of gene expression, epigenetic,GO:0051290~protein heterotetramerization,GO:0060968~regulation of gene silencing,GO:0098609~cell-cell adhesion,	GO:0000228~nuclear chromosome,GO:0000784~nuclear chromosome, telomeric region,GO:0000786~nucleosome,GO:0000788~nuclear nucleosome,GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0031492~nucleosomal DNA binding,GO:0042393~histone binding,GO:0046982~protein heterodimerization activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000164:Histone H3,IPR007125:Histone core,IPR009072:Histone-fold,	hsa05034:Alcoholism,hsa05202:Transcriptional misregulation in cancer,hsa05322:Systemic lupus erythematosus,			SM00428:H3,	3D-structure,Acetylation,Chromosome,Citrullination,Complete proteome,Direct protein sequencing,DNA-binding,Methylation,Nucleosome core,Nucleus,Phosphoprotein,Reference proteome,Ubl conjugation,	chain:Histone H2A type 1-D,chain:Histone H3.1,chain:Histone H3.2,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),helix,modified residue,mutagenesis site,sequence conflict,sequence variant,strand,
HIF1A	hypoxia inducible factor 1 alpha subunit(HIF1A)	Homo sapiens		h_eponfkbPathway:Erythropoietin mediated neuroprotection through NF-kB,h_hifPathway:Hypoxia-Inducible Factor in the Cardiovascular System,h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,h_vegfPathway:VEGF, Hypoxia, and Angiogenesis,		GO:0001525~angiogenesis,GO:0001666~response to hypoxia,GO:0001755~neural crest cell migration,GO:0001837~epithelial to mesenchymal transition,GO:0001892~embryonic placenta development,GO:0001922~B-1 B cell homeostasis,GO:0001938~positive regulation of endothelial cell proliferation,GO:0001947~heart looping,GO:0002052~positive regulation of neuroblast proliferation,GO:0002248~connective tissue replacement involved in inflammatory response wound healing,GO:0003151~outflow tract morphogenesis,GO:0003208~cardiac ventricle morphogenesis,GO:0006089~lactate metabolic process,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006879~cellular iron ion homeostasis,GO:0007165~signal transduction,GO:0007595~lactation,GO:0008542~visual learning,GO:0010468~regulation of gene expression,GO:0010573~vascular endothelial growth factor production,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0010628~positive regulation of gene expression,GO:0010634~positive regulation of epithelial cell migration,GO:0010870~positive regulation of receptor biosynthetic process,GO:0014850~response to muscle activity,GO:0016239~positive regulation of macroautophagy,GO:0019896~axonal transport of mitochondrion,GO:0021502~neural fold elevation formation,GO:0021987~cerebral cortex development,GO:0030502~negative regulation of bone mineralization,GO:0030949~positive regulation of vascular endothelial growth factor receptor signaling pathway,GO:0032007~negative regulation of TOR signaling,GO:0032364~oxygen homeostasis,GO:0032722~positive regulation of chemokine production,GO:0032909~regulation of transforming growth factor beta2 production,GO:0032963~collagen metabolic process,GO:0035162~embryonic hemopoiesis,GO:0035774~positive regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0042541~hemoglobin biosynthetic process,GO:0042593~glucose homeostasis,GO:0042789~mRNA transcription from RNA polymerase II promoter,GO:0043619~regulation of transcription from RNA polymerase II promoter in response to oxidative stress,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045766~positive regulation of angiogenesis,GO:0045821~positive regulation of glycolytic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045926~negative regulation of growth,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046716~muscle cell cellular homeostasis,GO:0046886~positive regulation of hormone biosynthetic process,GO:0048546~digestive tract morphogenesis,GO:0051000~positive regulation of nitric-oxide synthase activity,GO:0051216~cartilage development,GO:0051541~elastin metabolic process,GO:0060574~intestinal epithelial cell maturation,GO:0061030~epithelial cell differentiation involved in mammary gland alveolus development,GO:0061072~iris morphogenesis,GO:0061298~retina vasculature development in camera-type eye,GO:0061418~regulation of transcription from RNA polymerase II promoter in response to hypoxia,GO:0061419~positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,GO:0070101~positive regulation of chemokine-mediated signaling pathway,GO:0070244~negative regulation of thymocyte apoptotic process,GO:0071347~cellular response to interleukin-1,GO:0071456~cellular response to hypoxia,GO:0071542~dopaminergic neuron differentiation,GO:0097411~hypoxia-inducible factor-1alpha signaling pathway,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1903377~negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,GO:1903599~positive regulation of mitophagy,GO:1903715~regulation of aerobic respiration,GO:2000378~negative regulation of reactive oxygen species metabolic process,GO:2001054~negative regulation of mesenchymal cell apoptotic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016607~nuclear speck,GO:0031514~motile cilium,GO:0090575~RNA polymerase II transcription factor complex,GO:1904115~axon cytoplasm,	GO:0000989~transcription factor activity, transcription factor binding,GO:0001076~transcription factor activity, RNA polymerase II transcription factor binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0035035~histone acetyltransferase binding,GO:0035257~nuclear hormone receptor binding,GO:0042826~histone deacetylase binding,GO:0043565~sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,GO:0051879~Hsp90 protein binding,	IPR000014:PAS domain,IPR001321:Hypoxia-inducible factor-1 alpha,IPR001610:PAC motif,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR013655:PAS fold-3,IPR013767:PAS fold,IPR014887:HIF-1 alpha, transactivation domain, C-terminal,IPR021537:Hypoxia-inducible factor, alpha subunit,	hsa04066:HIF-1 signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05211:Renal cell carcinoma,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,			SM00086:PAC,SM00091:PAS,SM00353:HLH,	3D-structure,Acetylation,Activator,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Hydroxylation,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,S-nitrosylation,Transcription,Transcription regulation,Ubl conjugation,	chain:Hypoxia-inducible factor 1-alpha,compositionally biased region:Poly-Thr,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:PAC,domain:PAS 1,domain:PAS 2,helix,modified residue,mutagenesis site,region of interest:C-terminal VHL recognition site,region of interest:CTAD,region of interest:ID,region of interest:Interaction with TSGA10,region of interest:N-terminal VHL recognition site,region of interest:NTAD,region of interest:ODD,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,turn,
IKBKB	inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta(IKBKB)	Homo sapiens		h_41BBPathway:The 4-1BB-dependent immune response,h_aktPathway:AKT Signaling Pathway,h_cd40Pathway:CD40L Signaling Pathway,h_il1rPathway:Signal transduction through IL1R,h_keratinocytePathway:Keratinocyte Differentiation,h_mapkPathway:MAPKinase Signaling Pathway,h_nfkbPathway:NF-kB Signaling Pathway,h_nthiPathway:NFkB activation by Nontypeable Hemophilus influenzae,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_relaPathway:Acetylation and Deacetylation of RelA in The Nucleus,h_stressPathway:TNF/Stress Related Signaling,h_tidPathway:Chaperones modulate interferon Signaling Pathway,h_tnfr2Pathway:TNFR2 Signaling Pathway,h_tollPathway:Toll-Like Receptor Pathway,		GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0006468~protein phosphorylation,GO:0006954~inflammatory response,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0007252~I-kappaB phosphorylation,GO:0009615~response to virus,GO:0010803~regulation of tumor necrosis factor-mediated signaling pathway,GO:0030866~cortical actin cytoskeleton organization,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0035509~negative regulation of myosin-light-chain-phosphatase activity,GO:0035666~TRIF-dependent toll-like receptor signaling pathway,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0042325~regulation of phosphorylation,GO:0042501~serine phosphorylation of STAT protein,GO:0043066~negative regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045087~innate immune response,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050852~T cell receptor signaling pathway,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051403~stress-activated MAPK cascade,GO:0070423~nucleotide-binding oligomerization domain containing signaling pathway,GO:0070498~interleukin-1-mediated signaling pathway,GO:0071356~cellular response to tumor necrosis factor,GO:0090002~establishment of protein localization to plasma membrane,GO:1903140~regulation of establishment of endothelial barrier,GO:1903347~negative regulation of bicellular tight junction assembly,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0008385~IkappaB kinase complex,GO:0009898~cytoplasmic side of plasma membrane,GO:0035631~CD40 receptor complex,GO:0045121~membrane raft,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008384~IkappaB kinase activity,GO:0019901~protein kinase binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0097110~scaffold protein binding,	IPR000626:Ubiquitin,IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR022007:I-kappa-kinase-beta NEMO binding domain,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04064:NF-kappa B signaling pathway,hsa04068:FoxO signaling pathway,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04210:Apoptosis,hsa04380:Osteoclast differentiation,hsa04620:Toll-like receptor signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04622:RIG-I-like receptor signaling pathway,hsa04623:Cytosolic DNA-sensing pathway,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04668:TNF signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04910:Insulin signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04930:Type II diabetes mellitus,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05131:Shigellosis,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05206:MicroRNAs in cancer,hsa05212:Pancreatic cancer,hsa05215:Prostate cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,	615592~Immunodeficiency 15,		SM00220:S_TKc,SM01239:SM01239,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Direct protein sequencing,Hydroxylation,Isopeptide bond,Kinase,Membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,S-nitrosylation,SCID,Serine/threonine-protein kinase,Transferase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Inhibitor of nuclear factor kappa-B kinase subunit beta,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:Leucine-zipper,domain:Protein kinase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:NEMO-binding,sequence conflict,sequence variant,
IL6ST	interleukin 6 signal transducer(IL6ST)	Homo sapiens	11.IL-6_gp130-Jak-STAT,12.IL-6_type_cytok-signal-transduct,	h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_il6Pathway:IL 6 signaling pathway,		GO:0002675~positive regulation of acute inflammatory response,GO:0002821~positive regulation of adaptive immune response,GO:0005977~glycogen metabolic process,GO:0008284~positive regulation of cell proliferation,GO:0008593~regulation of Notch signaling pathway,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0010613~positive regulation of cardiac muscle hypertrophy,GO:0016032~viral process,GO:0019221~cytokine-mediated signaling pathway,GO:0034097~response to cytokine,GO:0038154~interleukin-11-mediated signaling pathway,GO:0038165~oncostatin-M-mediated signaling pathway,GO:0042102~positive regulation of T cell proliferation,GO:0042511~positive regulation of tyrosine phosphorylation of Stat1 protein,GO:0042517~positive regulation of tyrosine phosphorylation of Stat3 protein,GO:0043066~negative regulation of apoptotic process,GO:0045669~positive regulation of osteoblast differentiation,GO:0048711~positive regulation of astrocyte differentiation,GO:0048861~leukemia inhibitory factor signaling pathway,GO:0070102~interleukin-6-mediated signaling pathway,GO:0070104~negative regulation of interleukin-6-mediated signaling pathway,GO:0070106~interleukin-27-mediated signaling pathway,GO:0070120~ciliary neurotrophic factor-mediated signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005896~interleukin-6 receptor complex,GO:0005900~oncostatin-M receptor complex,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0070062~extracellular exosome,GO:0070110~ciliary neurotrophic factor receptor complex,	GO:0004896~cytokine receptor activity,GO:0004897~ciliary neurotrophic factor receptor activity,GO:0004915~interleukin-6 receptor activity,GO:0004921~interleukin-11 receptor activity,GO:0004923~leukemia inhibitory factor receptor activity,GO:0004924~oncostatin-M receptor activity,GO:0005127~ciliary neurotrophic factor receptor binding,GO:0005138~interleukin-6 receptor binding,GO:0005515~protein binding,GO:0019838~growth factor binding,GO:0019970~interleukin-11 binding,GO:0019981~interleukin-6 binding,GO:0042803~protein homodimerization activity,GO:0045509~interleukin-27 receptor activity,	IPR003529:Long hematopoietin receptor, Gp130 family 2, conserved site,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR010457:Immunoglobulin C2-set-like, ligand-binding,IPR013783:Immunoglobulin-like fold,IPR015321:Interleukin-6 receptor alpha chain, binding,	hsa04060:Cytokine-cytokine receptor interaction,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04630:Jak-STAT signaling pathway,hsa05203:Viral carcinogenesis,			SM00060:FN3,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Host-virus interaction,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-6 receptor subunit beta,compositionally biased region:Ser-rich,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Ig-like C2-type,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,sequence variant,short sequence motif:Box 1 motif,short sequence motif:WSXWS motif,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
IL7R	interleukin 7 receptor(IL7R)	Homo sapiens	78.B_Cell_Development,	h_il7Pathway:IL-7 Signal Transduction,		GO:0000018~regulation of DNA recombination,GO:0000902~cell morphogenesis,GO:0001915~negative regulation of T cell mediated cytotoxicity,GO:0002377~immunoglobulin production,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0008361~regulation of cell size,GO:0010628~positive regulation of gene expression,GO:0016049~cell growth,GO:0030217~T cell differentiation,GO:0033089~positive regulation of T cell differentiation in thymus,GO:0038111~interleukin-7-mediated signaling pathway,GO:0042100~B cell proliferation,GO:0048535~lymph node development,GO:0048872~homeostasis of number of cells,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0003823~antigen binding,GO:0004896~cytokine receptor activity,GO:0004917~interleukin-7 receptor activity,GO:0005515~protein binding,	IPR003531:Short hematopoietin receptor, family 1, conserved site,IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,	hsa04060:Cytokine-cytokine receptor interaction,hsa04068:FoxO signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04640:Hematopoietic cell lineage,hsa05340:Primary immunodeficiency,	608971~Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type,			3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,SCID,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-7 receptor subunit alpha,compositionally biased region:Ser/Thr-rich,domain:Fibronectin type-III,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,sequence variant,short sequence motif:Box 1 motif,short sequence motif:WSXWS motif,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
IDH1	isocitrate dehydrogenase (NADP(+)) 1, cytosolic(IDH1)	Homo sapiens				GO:0006097~glyoxylate cycle,GO:0006099~tricarboxylic acid cycle,GO:0006102~isocitrate metabolic process,GO:0006103~2-oxoglutarate metabolic process,GO:0006740~NADPH regeneration,GO:0006749~glutathione metabolic process,GO:0006979~response to oxidative stress,GO:0008585~female gonad development,GO:0048545~response to steroid hormone,GO:0060696~regulation of phospholipid catabolic process,GO:0071071~regulation of phospholipid biosynthetic process,GO:0098609~cell-cell adhesion,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005777~peroxisome,GO:0005782~peroxisomal matrix,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0070062~extracellular exosome,	GO:0000287~magnesium ion binding,GO:0004450~isocitrate dehydrogenase (NADP+) activity,GO:0005102~receptor binding,GO:0042803~protein homodimerization activity,GO:0050661~NADP binding,GO:0051287~NAD binding,GO:0051990~(R)-2-hydroxyglutarate dehydrogenase activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR004790:Isocitrate dehydrogenase NADP-dependent,IPR019818:Isocitrate/isopropylmalate dehydrogenase, conserved site,IPR024084:Isopropylmalate dehydrogenase-like domain,	hsa00020:Citrate cycle (TCA cycle),hsa00480:Glutathione metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa01210:2-Oxocarboxylic acid metabolism,hsa01230:Biosynthesis of amino acids,hsa04146:Peroxisome,	137800~Glioma, susceptibility to, somatic,	PIRSF000108:isocitrate dehydrogenase (NADP),	SM01329:SM01329,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Glyoxylate bypass,Magnesium,Manganese,Metal-binding,NADP,Oxidoreductase,Peroxisome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Tricarboxylic acid cycle,	binding site:NADP,binding site:NADP; via amide nitrogen and carbonyl oxygen,binding site:Substrate,chain:Isocitrate dehydrogenase [NADP] cytoplasmic,helix,metal ion-binding site:Magnesium or manganese,modified residue,nucleotide phosphate-binding region:NADP,region of interest:Substrate binding,sequence conflict,sequence variant,site:Critical for catalysis,strand,turn,
IDH2	isocitrate dehydrogenase (NADP(+)) 2, mitochondrial(IDH2)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006097~glyoxylate cycle,GO:0006099~tricarboxylic acid cycle,GO:0006102~isocitrate metabolic process,GO:0006103~2-oxoglutarate metabolic process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005777~peroxisome,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0000287~magnesium ion binding,GO:0004450~isocitrate dehydrogenase (NADP+) activity,GO:0051287~NAD binding,	IPR004790:Isocitrate dehydrogenase NADP-dependent,IPR019818:Isocitrate/isopropylmalate dehydrogenase, conserved site,IPR024084:Isopropylmalate dehydrogenase-like domain,	hsa00020:Citrate cycle (TCA cycle),hsa00480:Glutathione metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa01210:2-Oxocarboxylic acid metabolism,hsa01230:Biosynthesis of amino acids,hsa04146:Peroxisome,	613657~D-2-hydroxyglutaric aciduria 2,	PIRSF000108:isocitrate dehydrogenase (NADP),	SM01329:SM01329,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Disease mutation,Glyoxylate bypass,Magnesium,Manganese,Metal-binding,Mitochondrion,NADP,Oxidoreductase,Proteomics identification,Reference proteome,Transit peptide,Tricarboxylic acid cycle,	binding site:NADP,binding site:NADP; via amide nitrogen and carbonyl oxygen,binding site:Substrate,chain:Isocitrate dehydrogenase [NADP], mitochondrial,metal ion-binding site:Magnesium or manganese,modified residue,nucleotide phosphate-binding region:NADP,region of interest:Substrate binding,sequence conflict,site:Critical for catalysis,transit peptide:Mitochondrion,
KEAP1	kelch like ECH associated protein 1(KEAP1)	Homo sapiens		h_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2,		GO:0001701~in utero embryonic development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0010499~proteasomal ubiquitin-independent protein catabolic process,GO:0016567~protein ubiquitination,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0042994~cytoplasmic sequestering of transcription factor,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045604~regulation of epidermal cell differentiation,GO:0071353~cellular response to interleukin-4,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005884~actin filament,GO:0030496~midbody,GO:0031463~Cul3-RING ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,	IPR000210:BTB/POZ-like,IPR006652:Kelch repeat type 1,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,IPR015915:Kelch-type beta propeller,IPR015916:Galactose oxidase, beta-propeller,IPR017096:Kelch-like protein, gigaxonin,	hsa04120:Ubiquitin mediated proteolysis,		PIRSF037037:kelch-like protein, gigaxonin type,	SM00225:BTB,SM00612:Kelch,SM00875:SM00875,	3D-structure,Complete proteome,Cytoplasm,Kelch repeat,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Ubl conjugation pathway,	chain:Kelch-like ECH-associated protein 1,domain:BACK,domain:BTB,modified residue,mutagenesis site,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,repeat:Kelch 5,repeat:Kelch 6,sequence variant,short sequence motif:Nuclear export signal,strand,turn,
KDR	kinase insert domain receptor(KDR)	Homo sapiens		h_no1Pathway:Actions of Nitric Oxide in the Heart,h_vegfPathway:VEGF, Hypoxia, and Angiogenesis,		GO:0001525~angiogenesis,GO:0001570~vasculogenesis,GO:0001934~positive regulation of protein phosphorylation,GO:0001938~positive regulation of endothelial cell proliferation,GO:0002042~cell migration involved in sprouting angiogenesis,GO:0003158~endothelium development,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0008360~regulation of cell shape,GO:0010595~positive regulation of endothelial cell migration,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0016032~viral process,GO:0016239~positive regulation of macroautophagy,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0023014~signal transduction by protein phosphorylation,GO:0030198~extracellular matrix organization,GO:0030335~positive regulation of cell migration,GO:0035162~embryonic hemopoiesis,GO:0035584~calcium-mediated signaling using intracellular calcium source,GO:0035924~cellular response to vascular endothelial growth factor stimulus,GO:0038033~positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0043066~negative regulation of apoptotic process,GO:0043410~positive regulation of MAPK cascade,GO:0045766~positive regulation of angiogenesis,GO:0046777~protein autophosphorylation,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0050927~positive regulation of positive chemotaxis,GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process,GO:0051894~positive regulation of focal adhesion assembly,GO:0051901~positive regulation of mitochondrial depolarization,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0090141~positive regulation of mitochondrial fission,GO:2000352~negative regulation of endothelial cell apoptotic process,GO:2001214~positive regulation of vasculogenesis,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005768~endosome,GO:0005769~early endosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030054~cell junction,GO:0045121~membrane raft,GO:0097443~sorting endosome,	GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0004716~receptor signaling protein tyrosine kinase activity,GO:0005021~vascular endothelial growth factor-activated receptor activity,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019838~growth factor binding,GO:0038085~vascular endothelial growth factor binding,GO:0051879~Hsp90 protein binding,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001824:Tyrosine-protein kinase, receptor class III, conserved site,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR008266:Tyrosine-protein kinase, active site,IPR009136:Tyrosine-protein kinase, vascular endothelial growth factor receptor 2 (VEGFR2),IPR011009:Protein kinase-like domain,IPR013098:Immunoglobulin I-set,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa05205:Proteoglycans in cancer,	602089~Hemangioma, capillary infantile, somatic,602089~Hemangioma, capillary infantile, susceptibility to,		SM00219:TyrKc,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Angiogenesis,ATP-binding,Cell junction,Cell membrane,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Developmental protein,Differentiation,Disulfide bond,Endoplasmic reticulum,Endosome,Glycoprotein,Host-virus interaction,Immunoglobulin domain,Kinase,Membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Secreted,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Vascular endothelial growth factor receptor 2,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,domain:Ig-like C2-type 7,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,site:Interaction with SHB,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
LZTR1	leucine zipper like transcription regulator 1(LZTR1)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0009653~anatomical structure morphogenesis,	GO:0005794~Golgi apparatus,	GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR000210:BTB/POZ-like,IPR006652:Kelch repeat type 1,IPR011333:BTB/POZ fold,IPR011498:Kelch repeat type 2,IPR015915:Kelch-type beta propeller,		615670~Schwannomatosis-2, susceptibility to,616564~Noonan syndrome 10,		SM00225:BTB,SM00612:Kelch,	Acetylation,Complete proteome,Disease mutation,Kelch repeat,Proteomics identification,Reference proteome,Repeat,	chain:Leucine-zipper-like transcriptional regulator 1,domain:BTB 1,domain:BTB 2,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,repeat:Kelch 5,repeat:Kelch 6,sequence conflict,
KDM5C	lysine demethylase 5C(KDM5C)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0034720~histone H3-K4 demethylation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0032452~histone demethylase activity,GO:0032453~histone demethylase activity (H3-K4 specific),	IPR001606:ARID/BRIGHT DNA-binding domain,IPR001965:Zinc finger, PHD-type,IPR003347:JmjC domain,IPR003349:Transcription factor jumonji, JmjN,IPR004198:Zinc finger, C5HC2-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013637:Lysine-specific demethylase-like domain,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,		300534~Mental retardation, X-linked, syndromic, Claes-Jensen type,		SM00249:PHD,SM00501:BRIGHT,SM00545:JmjN,SM00558:JmjC,	3D-structure,Alternative splicing,Biological rhythms,Chromatin regulator,Complete proteome,Dioxygenase,Disease mutation,Iron,Mental retardation,Metal-binding,Nucleus,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Lysine-specific demethylase 5C,domain:ARID,domain:JmjC,domain:JmjN,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,turn,zinc finger region:PHD-type 1,zinc finger region:PHD-type 2,
KMT2C	lysine methyltransferase 2C(KMT2C)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0051568~histone H3-K4 methylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0035097~histone methyltransferase complex,GO:0044666~MLL3/4 complex,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008168~methyltransferase activity,GO:0008270~zinc ion binding,GO:0016746~transferase activity, transferring acyl groups,GO:0018024~histone-lysine N-methyltransferase activity,GO:0042800~histone methyltransferase activity (H3-K4 specific),GO:0044822~poly(A) RNA binding,	IPR000637:HMG-I/HMG-Y, DNA-binding, conserved site,IPR001214:SET domain,IPR001594:Zinc finger, DHHC-type, palmitoyltransferase,IPR001841:Zinc finger, RING-type,IPR001965:Zinc finger, PHD-type,IPR003616:Post-SET domain,IPR003888:FY-rich, N-terminal,IPR003889:FY-rich, C-terminal,IPR009071:High mobility group (HMG) box domain,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019787:Zinc finger, PHD-finger,	hsa00310:Lysine degradation,			SM00184:RING,SM00249:PHD,SM00317:SET,SM00398:HMG,SM00508:PostSET,SM00541:FYRN,SM00542:FYRC,	3D-structure,Acetylation,Activator,Acyltransferase,Alternative splicing,Chromatin regulator,Coiled coil,Complete proteome,DNA-binding,Lipoprotein,Metal-binding,Methylation,Methyltransferase,Nucleus,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,S-adenosyl-L-methionine,Transcription,Transcription regulation,Transferase,Zinc,Zinc-finger,	binding site:S-adenosyl-L-methionine,chain:Histone-lysine N-methyltransferase MLL3,compositionally biased region:Asp-rich,compositionally biased region:Gln-rich,compositionally biased region:Pro-rich,DNA-binding region:A.T hook,domain:Post-SET,domain:SET,helix,metal ion-binding site:Zinc,modified residue,region of interest:S-adenosyl-L-methionine binding,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:DHHC-type,zinc finger region:PHD-type 1,zinc finger region:PHD-type 2,zinc finger region:PHD-type 3,zinc finger region:PHD-type 4,zinc finger region:PHD-type 5,zinc finger region:PHD-type 6,zinc finger region:RING-type,
MTOR	mechanistic target of rapamycin(MTOR)	Homo sapiens	104.Insulin_signaling,105.Signaling_glucose_uptake,106.Glycogen_synthase-synthesis,107.mRNA_translation-protein_synthesis,108.Regulating_glucose_transport,	h_bcellsurvivalPathway:B Cell Survival Pathway,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,h_igf1mtorPathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway,h_mtorPathway:mTOR Signaling Pathway,h_stat3Pathway:Stat3 Signaling Pathway,		GO:0001933~negative regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0001938~positive regulation of endothelial cell proliferation,GO:0003007~heart morphogenesis,GO:0003179~heart valve morphogenesis,GO:0005979~regulation of glycogen biosynthetic process,GO:0006112~energy reserve metabolic process,GO:0006207~'de novo' pyrimidine nucleobase biosynthetic process,GO:0006281~DNA repair,GO:0006468~protein phosphorylation,GO:0006914~autophagy,GO:0006950~response to stress,GO:0007050~cell cycle arrest,GO:0007165~signal transduction,GO:0007281~germ cell development,GO:0007420~brain development,GO:0007569~cell aging,GO:0007584~response to nutrient,GO:0007616~long-term memory,GO:0008542~visual learning,GO:0009791~post-embryonic development,GO:0010507~negative regulation of autophagy,GO:0010592~positive regulation of lamellipodium assembly,GO:0010628~positive regulation of gene expression,GO:0010831~positive regulation of myotube differentiation,GO:0014042~positive regulation of neuron maturation,GO:0014736~negative regulation of muscle atrophy,GO:0016049~cell growth,GO:0016236~macroautophagy,GO:0016242~negative regulation of macroautophagy,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0021510~spinal cord development,GO:0030163~protein catabolic process,GO:0030838~positive regulation of actin filament polymerization,GO:0031295~T cell costimulation,GO:0031397~negative regulation of protein ubiquitination,GO:0031529~ruffle organization,GO:0031641~regulation of myelination,GO:0031669~cellular response to nutrient levels,GO:0031929~TOR signaling,GO:0031998~regulation of fatty acid beta-oxidation,GO:0032095~regulation of response to food,GO:0032868~response to insulin,GO:0032956~regulation of actin cytoskeleton organization,GO:0035176~social behavior,GO:0035264~multicellular organism growth,GO:0040007~growth,GO:0042060~wound healing,GO:0042220~response to cocaine,GO:0043087~regulation of GTPase activity,GO:0043200~response to amino acid,GO:0043278~response to morphine,GO:0043610~regulation of carbohydrate utilization,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045670~regulation of osteoclast differentiation,GO:0045727~positive regulation of translation,GO:0045792~negative regulation of cell size,GO:0045859~regulation of protein kinase activity,GO:0045945~positive regulation of transcription from RNA polymerase III promoter,GO:0046777~protein autophosphorylation,GO:0046889~positive regulation of lipid biosynthetic process,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048255~mRNA stabilization,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048714~positive regulation of oligodendrocyte differentiation,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050882~voluntary musculoskeletal movement,GO:0051496~positive regulation of stress fiber assembly,GO:0051534~negative regulation of NFAT protein import into nucleus,GO:0051897~positive regulation of protein kinase B signaling,GO:0055013~cardiac muscle cell development,GO:0060048~cardiac muscle contraction,GO:0060135~maternal process involved in female pregnancy,GO:0060252~positive regulation of glial cell proliferation,GO:0060999~positive regulation of dendritic spine development,GO:0061051~positive regulation of cell growth involved in cardiac muscle cell development,GO:0071456~cellular response to hypoxia,GO:0090335~regulation of brown fat cell differentiation,GO:0090559~regulation of membrane permeability,GO:1900034~regulation of cellular response to heat,GO:1901216~positive regulation of neuron death,GO:1901838~positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,GO:1904000~positive regulation of eating behavior,GO:1904056~positive regulation of cholangiocyte proliferation,GO:1904058~positive regulation of sensory perception of pain,GO:1904193~negative regulation of cholangiocyte apoptotic process,GO:1904197~positive regulation of granulosa cell proliferation,GO:1904206~positive regulation of skeletal muscle hypertrophy,GO:1904213~negative regulation of iodide transmembrane transport,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005741~mitochondrial outer membrane,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0005942~phosphatidylinositol 3-kinase complex,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0016605~PML body,GO:0030425~dendrite,GO:0031931~TORC1 complex,GO:0031932~TORC2 complex,GO:0043025~neuronal cell body,	GO:0001030~RNA polymerase III type 1 promoter DNA binding,GO:0001031~RNA polymerase III type 2 promoter DNA binding,GO:0001032~RNA polymerase III type 3 promoter DNA binding,GO:0001156~TFIIIC-class transcription factor binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,GO:0043022~ribosome binding,GO:0044877~macromolecular complex binding,GO:0051219~phosphoprotein binding,	IPR000403:Phosphatidylinositol 3-/4-kinase, catalytic domain,IPR003151:PIK-related kinase, FAT,IPR003152:PIK-related kinase, FATC,IPR009076:Rapamycin-binding domain,IPR011009:Protein kinase-like domain,IPR011989:Armadillo-like helical,IPR011990:Tetratricopeptide-like helical,IPR014009:PIK-related kinase,IPR016024:Armadillo-type fold,IPR018936:Phosphatidylinositol 3/4-kinase, conserved site,IPR024585:Domain of unknown function DUF3385,  target of rapamycin protein,IPR026683:Serine/threonine-protein kinase TOR/Smg1,	hsa04012:ErbB signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04910:Insulin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04930:Type II diabetes mellitus,hsa04931:Insulin resistance,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05221:Acute myeloid leukemia,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	616638~Smith-Kingsmore syndrome,		SM00146:PI3Kc,SM01343:SM01343,SM01346:SM01346,	3D-structure,Acetylation,ATP-binding,Complete proteome,Cytoplasm,Disease mutation,Endoplasmic reticulum,Epilepsy,Golgi apparatus,Kinase,Lysosome,Membrane,Mental retardation,Microsome,Mitochondrion,Mitochondrion outer membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Serine/threonine-protein kinase,TPR repeat,Transferase,	chain:Serine/threonine-protein kinase mTOR,domain:FAT,domain:FATC,domain:PI3K/PI4K,helix,modified residue,repeat:HEAT 1,repeat:HEAT 2,repeat:HEAT 3,repeat:HEAT 4,repeat:HEAT 5,repeat:HEAT 6,repeat:HEAT 7,sequence conflict,sequence variant,
MED12	mediator complex subunit 12(MED12)	Homo sapiens				GO:0001843~neural tube closure,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0007492~endoderm development,GO:0007507~heart development,GO:0014003~oligodendrocyte development,GO:0014044~Schwann cell development,GO:0016567~protein ubiquitination,GO:0019827~stem cell population maintenance,GO:0021510~spinal cord development,GO:0030178~negative regulation of Wnt signaling pathway,GO:0030518~intracellular steroid hormone receptor signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0036342~post-anal tail morphogenesis,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048702~embryonic neurocranium morphogenesis,GO:0060070~canonical Wnt signaling pathway,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0090245~axis elongation involved in somitogenesis,GO:1990403~embryonic brain development,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005813~centrosome,GO:0016020~membrane,GO:0016592~mediator complex,	GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001104~RNA polymerase II transcription cofactor activity,GO:0001105~RNA polymerase II transcription coactivator activity,GO:0003682~chromatin binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0004872~receptor activity,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008022~protein C-terminus binding,GO:0019904~protein domain specific binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0042809~vitamin D receptor binding,GO:0046966~thyroid hormone receptor binding,GO:0061630~ubiquitin protein ligase activity,	IPR019035:Mediator complex, subunit Med12,IPR021989:Mediator complex, subunit Med12, catenin-binding,IPR021990:Mediator complex, subunit Med12, LCEWAV-domain,	hsa04919:Thyroid hormone signaling pathway,	300895~Ohdo syndrome, X-linked,305450~Opitz-Kaveggia syndrome,309520~Lujan-Fryns syndrome,		SM01281:SM01281,	Acetylation,Activator,Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,Mental retardation,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Mediator of RNA polymerase II transcription subunit 12,compositionally biased region:Gln-rich,compositionally biased region:Pro-rich,modified residue,region of interest:Interaction with CTNNB1 and GLI3,sequence conflict,sequence variant,splice variant,
MITF	melanogenesis associated transcription factor(MITF)	Homo sapiens	53.Early-response_Tr_Fac_mast_cells,	h_melanocytePathway:Melanocyte Development and Pigmentation Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0007275~multicellular organism development,GO:0010628~positive regulation of gene expression,GO:0016925~protein sumoylation,GO:0030318~melanocyte differentiation,GO:0042981~regulation of apoptotic process,GO:0045670~regulation of osteoclast differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0097531~mast cell migration,GO:2000144~positive regulation of DNA-templated transcription, initiation,GO:2001141~regulation of RNA biosynthetic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0043234~protein complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046983~protein dimerization activity,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR021802:Basic helix-loop-helix leucine zipper transcrition factor MiT/TFE,	hsa04380:Osteoclast differentiation,hsa04916:Melanogenesis,hsa05200:Pathways in cancer,hsa05218:Melanoma,	103470~Waardenburg syndrome/ocular albinism, digenic,103500~Tietz albinism-deafness syndrome,193510~Waardenburg syndrome, type 2A,614456~Melanoma, cutaneous malignant, susceptibility to, 8,		SM00353:HLH,	3D-structure,Activator,Albinism,Alternative splicing,Coiled coil,Complete proteome,Deafness,Developmental protein,Disease mutation,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,Waardenburg syndrome,	chain:Microphthalmia-associated transcription factor,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:Leucine-zipper,modified residue,mutagenesis site,region of interest:DNA binding regulation,region of interest:Transactivation,sequence variant,splice variant,
MEN1	menin 1(MEN1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000165~MAPK cascade,GO:0000278~mitotic cell cycle,GO:0001933~negative regulation of protein phosphorylation,GO:0002076~osteoblast development,GO:0003309~type B pancreatic cell differentiation,GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0007420~brain development,GO:0008285~negative regulation of cell proliferation,GO:0009411~response to UV,GO:0010332~response to gamma radiation,GO:0010812~negative regulation of cell-substrate adhesion,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0032092~positive regulation of protein binding,GO:0032925~regulation of activin receptor signaling pathway,GO:0034968~histone lysine methylation,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045668~negative regulation of osteoblast differentiation,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045786~negative regulation of cell cycle,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046329~negative regulation of JNK cascade,GO:0046697~decidualization,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051974~negative regulation of telomerase activity,GO:0061469~regulation of type B pancreatic cell proliferation,GO:0071333~cellular response to glucose stimulus,GO:0071375~cellular response to peptide hormone stimulus,GO:0071559~response to transforming growth factor beta,GO:1902807~negative regulation of cell cycle G1/S phase transition,GO:1904837~beta-catenin-TCF complex assembly,	GO:0000784~nuclear chromosome, telomeric region,GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016363~nuclear matrix,GO:0032154~cleavage furrow,GO:0035097~histone methyltransferase complex,GO:0043234~protein complex,	GO:0000400~four-way junction DNA binding,GO:0000403~Y-form DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0005515~protein binding,GO:0018024~histone-lysine N-methyltransferase activity,GO:0030674~protein binding, bridging,GO:0044212~transcription regulatory region DNA binding,GO:0047485~protein N-terminus binding,GO:0070412~R-SMAD binding,	IPR007747:Menin,	hsa05202:Transcriptional misregulation in cancer,	131100~Multiple endocrine neoplasia 1,Adrenal adenoma, somatic~Adrenal adenoma, somatic,Angiofibroma, somatic~Angiofibroma, somatic,Carcinoid tumor of lung~Carcinoid tumor of lung,Lipoma, somatic~Lipoma, somatic,Parathyroid adenoma, somatic~Parathyroid adenoma, somatic,			3D-structure,Alternative splicing,Chromatin regulator,Complete proteome,Disease mutation,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Menin,modified residue,region of interest:Interaction with FANCD2,sequence variant,splice variant,
MAPK1	mitogen-activated protein kinase 1(MAPK1)	Homo sapiens	100.MAPK_signaling_cascades,104.Insulin_signaling,105.Signaling_glucose_uptake,106.Glycogen_synthase-synthesis,107.mRNA_translation-protein_synthesis,2.Cytokine_Receptors,37.Akt-PKB_Effector_of_P13K_in_Vivo,54.T-cell_anergy,63.LAT_couples_T-cell_receptor,65.Integrin_affinity_modulation,67.Ikaros_and_signaling_inhibitors,68.Mitogen_signaling_in_growth_control,82.TCR_and_Cap_or_SMAC,87.Activation_ERK-MAPK_Synaptic_Act,	h_agrPathway:Agrin in Postsynaptic Differentiation,h_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2,h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_badPathway:Regulation of BAD phosphorylation,h_bArr-mapkPathway:Role of ï¿½-arrestins in the activation and targeting of MAP kinases,h_bArrestin-srcPathway:Roles of ï¿½-arrestin-dependent Recruitment of Src Kinases in GPCR Signaling,h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,h_ccr3Pathway:CCR3 signaling in Eosinophils,h_cdk5Pathway:Phosphorylation of MEK1 by cdk5/p35 down regulates the MAP kinase pathway,h_cdmacPathway:Cadmium induces DNA synthesis and proliferation in macrophages,h_ceramidePathway:Ceramide Signaling Pathway,h_crebPathway:Transcription factor CREB and its extracellular signals,h_cxcr4Pathway:CXCR4 Signaling Pathway,h_ecmPathway:Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia,h_edg1Pathway:Phospholipids as signalling intermediaries,h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,h_erk5Pathway:Role of Erk5 in Neuronal Survival,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,h_ghPathway:Growth Hormone Signaling Pathway,h_hcmvPathway:Human Cytomegalovirus and Map Kinase Pathways,h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_integrinPathway:Integrin Signaling Pathway,h_keratinocytePathway:Keratinocyte Differentiation,h_malPathway:Role of MAL in Rho-Mediated Activation of SRF,h_mapkPathway:MAPKinase Signaling Pathway,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_mPRPathway:How Progesterone Initiates the Oocyte Maturation,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_pelp1Pathway:Pelp1 Modulation of Estrogen Receptor Activity,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_ptenPathway:PTEN dependent cell cycle arrest and apoptosis,h_pyk2Pathway:Links between Pyk2 and Map Kinases,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_sam68Pathway:Regulation of Splicing through Sam68,h_sppaPathway:Aspirin Blocks Signaling Pathway Involved in Platelet Activation,h_spryPathway:Sprouty regulation of tyrosine kinase signals,h_stat3Pathway:Stat3 Signaling Pathway,h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,		GO:0000165~MAPK cascade,GO:0000187~activation of MAPK activity,GO:0000189~MAPK import into nucleus,GO:0006351~transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0006935~chemotaxis,GO:0006950~response to stress,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007165~signal transduction,GO:0007268~chemical synaptic transmission,GO:0007411~axon guidance,GO:0008284~positive regulation of cell proliferation,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0009636~response to toxic substance,GO:0010800~positive regulation of peptidyl-threonine phosphorylation,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0016032~viral process,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0019233~sensory perception of pain,GO:0019858~cytosine metabolic process,GO:0030168~platelet activation,GO:0030278~regulation of ossification,GO:0030335~positive regulation of cell migration,GO:0030878~thyroid gland development,GO:0031647~regulation of protein stability,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0032872~regulation of stress-activated MAPK cascade,GO:0033598~mammary gland epithelial cell proliferation,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0038127~ERBB signaling pathway,GO:0042473~outer ear morphogenesis,GO:0043330~response to exogenous dsRNA,GO:0043627~response to estrogen,GO:0045596~negative regulation of cell differentiation,GO:0045727~positive regulation of translation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048538~thymus development,GO:0050852~T cell receptor signaling pathway,GO:0050853~B cell receptor signaling pathway,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,GO:0051493~regulation of cytoskeleton organization,GO:0051973~positive regulation of telomerase activity,GO:0060020~Bergmann glial cell differentiation,GO:0060291~long-term synaptic potentiation,GO:0060324~face development,GO:0060397~JAK-STAT cascade involved in growth hormone signaling pathway,GO:0060425~lung morphogenesis,GO:0060440~trachea formation,GO:0060716~labyrinthine layer blood vessel development,GO:0061308~cardiac neural crest cell development involved in heart development,GO:0070371~ERK1 and ERK2 cascade,GO:0070849~response to epidermal growth factor,GO:0072584~caveolin-mediated endocytosis,GO:0090170~regulation of Golgi inheritance,GO:0097011~cellular response to granulocyte macrophage colony-stimulating factor stimulus,GO:1900034~regulation of cellular response to heat,GO:1904355~positive regulation of telomere capping,GO:2000641~regulation of early endosome to late endosome transport,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005794~Golgi apparatus,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005901~caveola,GO:0005925~focal adhesion,GO:0015630~microtubule cytoskeleton,GO:0030424~axon,GO:0031143~pseudopodium,GO:0032839~dendrite cytoplasm,GO:0043204~perikaryon,GO:0043234~protein complex,GO:0070062~extracellular exosome,GO:0072686~mitotic spindle,	GO:0001784~phosphotyrosine binding,GO:0003677~DNA binding,GO:0004674~protein serine/threonine kinase activity,GO:0004707~MAP kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0008353~RNA polymerase II carboxy-terminal domain kinase activity,GO:0016301~kinase activity,GO:0019902~phosphatase binding,GO:0031435~mitogen-activated protein kinase kinase kinase binding,GO:0042802~identical protein binding,	IPR000719:Protein kinase, catalytic domain,IPR003527:Mitogen-activated protein (MAP) kinase, conserved site,IPR008271:Serine/threonine-protein kinase, active site,IPR008349:Mitogen-activated protein (MAP) kinase, ERK1/2,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04114:Oocyte meiosis,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04270:Vascular smooth muscle contraction,hsa04320:Dorso-ventral axis formation,hsa04350:TGF-beta signaling pathway,hsa04360:Axon guidance,hsa04370:VEGF signaling pathway,hsa04380:Osteoclast differentiation,hsa04510:Focal adhesion,hsa04520:Adherens junction,hsa04540:Gap junction,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04611:Platelet activation,hsa04620:Toll-like receptor signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04668:TNF signaling pathway,hsa04713:Circadian entrainment,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04912:GnRH signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04921:Oxytocin signaling pathway,hsa04930:Type II diabetes mellitus,hsa04960:Aldosterone-regulated sodium reabsorption,hsa05010:Alzheimer's disease,hsa05020:Prion diseases,hsa05034:Alcoholism,hsa05131:Shigellosis,hsa05132:Salmonella infection,hsa05133:Pertussis,hsa05140:Leishmaniasis,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05164:Influenza A,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,			SM00220:S_TKc,	3D-structure,Acetylation,Alternative splicing,Apoptosis,ATP-binding,Cell cycle,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,DNA-binding,Host-virus interaction,Kinase,Magnesium,Nucleotide-binding,Nucleus,Phosphoprotein,Reference proteome,Repressor,Serine/threonine-protein kinase,Transcription,Transcription regulation,Transferase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Mitogen-activated protein kinase 1,compositionally biased region:Poly-Ala,domain:Protein kinase,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:TXY,strand,turn,
MAP2K1	mitogen-activated protein kinase kinase 1(MAP2K1)	Homo sapiens	100.MAPK_signaling_cascades,67.Ikaros_and_signaling_inhibitors,	h_AnthraxPathway:Anthrax Toxin Mechanism of Action,h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_bArr-mapkPathway:Role of ï¿½-arrestins in the activation and targeting of MAP kinases,h_bArrestin-srcPathway:Roles of ï¿½-arrestin-dependent Recruitment of Src Kinases in GPCR Signaling,h_bcrPathway:BCR Signaling Pathway,h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,h_ccr3Pathway:CCR3 signaling in Eosinophils,h_cdk5Pathway:Phosphorylation of MEK1 by cdk5/p35 down regulates the MAP kinase pathway,h_cdmacPathway:Cadmium induces DNA synthesis and proliferation in macrophages,h_ceramidePathway:Ceramide Signaling Pathway,h_cxcr4Pathway:CXCR4 Signaling Pathway,h_ecmPathway:Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia,h_egfPathway:EGF Signaling Pathway,h_egfr_smrtePathway:Map Kinase Inactivation of SMRT Corepressor,h_epoPathway:EPO Signaling Pathway,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,h_ghPathway:Growth Hormone Signaling Pathway,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,h_gpcrPathway:Signaling Pathway from G-Protein Families,h_hcmvPathway:Human Cytomegalovirus and Map Kinase Pathways,h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_igf1Pathway:IGF-1 Signaling Pathway,h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,h_il2Pathway:IL 2 signaling pathway,h_il3Pathway:IL 3 signaling pathway,h_il6Pathway:IL 6 signaling pathway,h_insulinPathway:Insulin Signaling Pathway,h_integrinPathway:Integrin Signaling Pathway,h_keratinocytePathway:Keratinocyte Differentiation,h_malPathway:Role of MAL in Rho-Mediated Activation of SRF,h_mapkPathway:MAPKinase Signaling Pathway,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_ngfPathway:Nerve growth factor pathway (NGF),h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity,h_pdgfPathway:PDGF Signaling Pathway,h_pyk2Pathway:Links between Pyk2 and Map Kinases,h_rasPathway:Ras Signaling Pathway,h_sppaPathway:Aspirin Blocks Signaling Pathway Involved in Platelet Activation,h_spryPathway:Sprouty regulation of tyrosine kinase signals,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tgfbPathway:TGF beta signaling pathway,h_tpoPathway:TPO Signaling Pathway,		GO:0000165~MAPK cascade,GO:0000187~activation of MAPK activity,GO:0006928~movement of cell or subcellular component,GO:0006935~chemotaxis,GO:0007050~cell cycle arrest,GO:0007165~signal transduction,GO:0007507~heart development,GO:0008285~negative regulation of cell proliferation,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0021697~cerebellar cortex formation,GO:0030182~neuron differentiation,GO:0030216~keratinocyte differentiation,GO:0030878~thyroid gland development,GO:0032872~regulation of stress-activated MAPK cascade,GO:0035897~proteolysis in other organism,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048538~thymus development,GO:0048679~regulation of axon regeneration,GO:0048870~cell motility,GO:0050772~positive regulation of axonogenesis,GO:0060020~Bergmann glial cell differentiation,GO:0060324~face development,GO:0060440~trachea formation,GO:0060502~epithelial cell proliferation involved in lung morphogenesis,GO:0060674~placenta blood vessel development,GO:0060711~labyrinthine layer development,GO:0070371~ERK1 and ERK2 cascade,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:0090170~regulation of Golgi inheritance,GO:0090398~cellular senescence,GO:1903800~positive regulation of production of miRNAs involved in gene silencing by miRNA,GO:2000641~regulation of early endosome to late endosome transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005815~microtubule organizing center,GO:0005816~spindle pole body,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0070062~extracellular exosome,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0004708~MAP kinase kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004728~receptor signaling protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0019901~protein kinase binding,GO:0043539~protein serine/threonine kinase activator activity,GO:0047485~protein N-terminus binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04114:Oocyte meiosis,hsa04151:PI3K-Akt signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04320:Dorso-ventral axis formation,hsa04370:VEGF signaling pathway,hsa04380:Osteoclast differentiation,hsa04510:Focal adhesion,hsa04540:Gap junction,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04620:Toll-like receptor signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04668:TNF signaling pathway,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04912:GnRH signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04921:Oxytocin signaling pathway,hsa05020:Prion diseases,hsa05034:Alcoholism,hsa05161:Hepatitis B,hsa05164:Influenza A,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	615279~Cardiofaciocutaneous syndrome 3,		SM00220:S_TKc,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Cardiomyopathy,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Disease mutation,Ectodermal dysplasia,Kinase,Membrane,Mental retardation,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Dual specificity mitogen-activated protein kinase kinase 1,compositionally biased region:Pro-rich,domain:Protein kinase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,site:Cleavage; by anthrax lethal factor,strand,turn,
MAP2K2	mitogen-activated protein kinase kinase 2(MAP2K2)	Homo sapiens	100.MAPK_signaling_cascades,	h_AnthraxPathway:Anthrax Toxin Mechanism of Action,h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_bArr-mapkPathway:Role of ï¿½-arrestins in the activation and targeting of MAP kinases,h_bArrestin-srcPathway:Roles of ï¿½-arrestin-dependent Recruitment of Src Kinases in GPCR Signaling,h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,h_cdk5Pathway:Phosphorylation of MEK1 by cdk5/p35 down regulates the MAP kinase pathway,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,h_hcmvPathway:Human Cytomegalovirus and Map Kinase Pathways,h_integrinPathway:Integrin Signaling Pathway,h_malPathway:Role of MAL in Rho-Mediated Activation of SRF,h_mapkPathway:MAPKinase Signaling Pathway,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_pyk2Pathway:Links between Pyk2 and Map Kinases,		GO:0000165~MAPK cascade,GO:0000187~activation of MAPK activity,GO:0010629~negative regulation of gene expression,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0032872~regulation of stress-activated MAPK cascade,GO:0035897~proteolysis in other organism,GO:0036289~peptidyl-serine autophosphorylation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0070371~ERK1 and ERK2 cascade,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:0090170~regulation of Golgi inheritance,GO:1903800~positive regulation of production of miRNAs involved in gene silencing by miRNA,GO:2000641~regulation of early endosome to late endosome transport,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005778~peroxisomal membrane,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005874~microtubule,GO:0005911~cell-cell junction,GO:0005925~focal adhesion,GO:0009898~cytoplasmic side of plasma membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0004708~MAP kinase kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0030165~PDZ domain binding,GO:0043539~protein serine/threonine kinase activator activity,GO:0046872~metal ion binding,GO:0097110~scaffold protein binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04370:VEGF signaling pathway,hsa04540:Gap junction,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04620:Toll-like receptor signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04912:GnRH signaling pathway,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04921:Oxytocin signaling pathway,hsa05020:Prion diseases,hsa05161:Hepatitis B,hsa05164:Influenza A,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05211:Renal cell carcinoma,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	615280~Cardiofaciocutaneous syndrome 4,		SM00220:S_TKc,	3D-structure,Acetylation,ATP-binding,Cardiomyopathy,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Ectodermal dysplasia,Kinase,Magnesium,Membrane,Mental retardation,Metal-binding,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Dual specificity mitogen-activated protein kinase kinase 2,compositionally biased region:Pro-rich,domain:Protein kinase,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,site:Cleavage; by anthrax lethal factor,strand,turn,
MLH1	mutL homolog 1(MLH1)	Homo sapiens				GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0000712~resolution of meiotic recombination intermediates,GO:0006298~mismatch repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0007060~male meiosis chromosome segregation,GO:0007129~synapsis,GO:0007283~spermatogenesis,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0016321~female meiosis chromosome segregation,GO:0016446~somatic hypermutation of immunoglobulin genes,GO:0043060~meiotic metaphase I plate congression,GO:0045141~meiotic telomere clustering,GO:0045190~isotype switching,GO:0045950~negative regulation of mitotic recombination,GO:0048477~oogenesis,GO:0051257~meiotic spindle midzone assembly,	GO:0000795~synaptonemal complex,GO:0001673~male germ cell nucleus,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005712~chiasma,GO:0016020~membrane,GO:0032389~MutLalpha complex,	GO:0003682~chromatin binding,GO:0003697~single-stranded DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0030983~mismatched DNA binding,GO:0032137~guanine/thymine mispair binding,GO:0032407~MutSalpha complex binding,	IPR002099:DNA mismatch repair protein,IPR003594:Histidine kinase-like ATPase, ATP-binding domain,IPR013507:DNA mismatch repair protein, C-terminal,IPR014721:Ribosomal protein S5 domain 2-type fold, subgroup,IPR014762:DNA mismatch repair, conserved site,IPR020568:Ribosomal protein S5 domain 2-type fold,	hsa03430:Mismatch repair,hsa03460:Fanconi anemia pathway,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05213:Endometrial cancer,	158320~Muir-Torre syndrome,276300~Mismatch repair cancer syndrome,609310~Colorectal cancer, hereditary nonpolyposis, type 2,		SM01340:SM01340,	3D-structure,Acetylation,Alternative splicing,Cell cycle,Complete proteome,Disease mutation,DNA damage,DNA repair,Hereditary nonpolyposis colorectal cancer,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Tumor suppressor,	chain:DNA mismatch repair protein Mlh1,modified residue,region of interest:Interaction with EXO1,sequence conflict,sequence variant,
MSH2	mutS homolog 2(MSH2)	Homo sapiens			DNA replication, recombination, and repair,	GO:0000710~meiotic mismatch repair,GO:0001701~in utero embryonic development,GO:0006119~oxidative phosphorylation,GO:0006281~DNA repair,GO:0006298~mismatch repair,GO:0006301~postreplication repair,GO:0006302~double-strand break repair,GO:0006311~meiotic gene conversion,GO:0007050~cell cycle arrest,GO:0007131~reciprocal meiotic recombination,GO:0007281~germ cell development,GO:0008340~determination of adult lifespan,GO:0008584~male gonad development,GO:0010165~response to X-ray,GO:0010224~response to UV-B,GO:0016446~somatic hypermutation of immunoglobulin genes,GO:0016447~somatic recombination of immunoglobulin gene segments,GO:0019724~B cell mediated immunity,GO:0030183~B cell differentiation,GO:0031573~intra-S DNA damage checkpoint,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0043524~negative regulation of neuron apoptotic process,GO:0043570~maintenance of DNA repeat elements,GO:0045128~negative regulation of reciprocal meiotic recombination,GO:0045190~isotype switching,GO:0045910~negative regulation of DNA recombination,GO:0051096~positive regulation of helicase activity,	GO:0000784~nuclear chromosome, telomeric region,GO:0005654~nucleoplasm,GO:0016020~membrane,GO:0032300~mismatch repair complex,GO:0032301~MutSalpha complex,GO:0032302~MutSbeta complex,	GO:0000287~magnesium ion binding,GO:0000400~four-way junction DNA binding,GO:0000403~Y-form DNA binding,GO:0000404~heteroduplex DNA loop binding,GO:0000406~double-strand/single-strand DNA junction binding,GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0016887~ATPase activity,GO:0019237~centromeric DNA binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0030983~mismatched DNA binding,GO:0032137~guanine/thymine mispair binding,GO:0032139~dinucleotide insertion or deletion binding,GO:0032142~single guanine insertion binding,GO:0032143~single thymine insertion binding,GO:0032181~dinucleotide repeat insertion binding,GO:0032357~oxidized purine DNA binding,GO:0032405~MutLalpha complex binding,GO:0042803~protein homodimerization activity,GO:0043531~ADP binding,	IPR000432:DNA mismatch repair protein MutS, C-terminal,IPR007695:DNA mismatch repair protein MutS-like, N-terminal,IPR007696:DNA mismatch repair protein MutS, core,IPR007860:DNA mismatch repair protein MutS, connector domain,IPR007861:DNA mismatch repair protein MutS, clamp,IPR011184:DNA mismatch repair protein, MSH2,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03430:Mismatch repair,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,	120435~Colorectal cancer, hereditary nonpolyposis, type 1,158320~Muir-Torre syndrome,276300~Mismatch repair cancer syndrome,	PIRSF005813:DNA mismatch repair protein, eukaryotic MSH2 type,	SM00533:MUTSd,SM00534:MUTSac,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Disease mutation,DNA damage,DNA repair,DNA-binding,Hereditary nonpolyposis colorectal cancer,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Tumor suppressor,	chain:DNA mismatch repair protein Msh2,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Interaction with EXO1,sequence variant,strand,turn,
MSH6	mutS homolog 6(MSH6)	Homo sapiens			DNA replication, recombination, and repair,	GO:0000710~meiotic mismatch repair,GO:0006281~DNA repair,GO:0006298~mismatch repair,GO:0007131~reciprocal meiotic recombination,GO:0008340~determination of adult lifespan,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0009411~response to UV,GO:0016032~viral process,GO:0016446~somatic hypermutation of immunoglobulin genes,GO:0016447~somatic recombination of immunoglobulin gene segments,GO:0043570~maintenance of DNA repeat elements,GO:0045190~isotype switching,GO:0045830~positive regulation of isotype switching,GO:0045910~negative regulation of DNA recombination,GO:0051096~positive regulation of helicase activity,GO:0097193~intrinsic apoptotic signaling pathway,	GO:0000228~nuclear chromosome,GO:0000790~nuclear chromatin,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0032301~MutSalpha complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0000287~magnesium ion binding,GO:0000400~four-way junction DNA binding,GO:0003682~chromatin binding,GO:0003684~damaged DNA binding,GO:0003690~double-stranded DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0030983~mismatched DNA binding,GO:0032137~guanine/thymine mispair binding,GO:0032142~single guanine insertion binding,GO:0032143~single thymine insertion binding,GO:0032357~oxidized purine DNA binding,GO:0032405~MutLalpha complex binding,GO:0035064~methylated histone binding,GO:0042803~protein homodimerization activity,GO:0043531~ADP binding,	IPR000313:PWWP,IPR000432:DNA mismatch repair protein MutS, C-terminal,IPR007695:DNA mismatch repair protein MutS-like, N-terminal,IPR007696:DNA mismatch repair protein MutS, core,IPR007860:DNA mismatch repair protein MutS, connector domain,IPR007861:DNA mismatch repair protein MutS, clamp,IPR016151:DNA mismatch repair protein MutS, N-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03430:Mismatch repair,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,	276300~Mismatch repair cancer syndrome,608089~Endometrial cancer, familial,614350~Colorectal cancer, hereditary nonpolyposis, type 5,		SM00293:PWWP,SM00533:MUTSd,SM00534:MUTSac,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Chromosome,Complete proteome,Direct protein sequencing,Disease mutation,DNA damage,DNA repair,DNA-binding,Hereditary nonpolyposis colorectal cancer,Host-virus interaction,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:DNA mismatch repair protein Msh6,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Glu,domain:PWWP,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,strand,turn,
MUTYH	mutY DNA glycosylase(MUTYH)	Homo sapiens			DNA replication, recombination, and repair,	GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006298~mismatch repair,GO:0045007~depurination,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,	GO:0003677~DNA binding,GO:0003824~catalytic activity,GO:0005515~protein binding,GO:0016787~hydrolase activity,GO:0019104~DNA N-glycosylase activity,GO:0032405~MutLalpha complex binding,GO:0032406~MutLbeta complex binding,GO:0032407~MutSalpha complex binding,GO:0032408~MutSbeta complex binding,GO:0046872~metal ion binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR000086:NUDIX hydrolase domain,IPR000445:Helix-hairpin-helix motif,IPR003265:HhH-GPD domain,IPR003651:Endonuclease III-like, iron-sulphur cluster loop motif,IPR004035:Endonuclease III, iron-sulphur binding site,IPR004036:Endonuclease III, conserved site-2,IPR011257:DNA glycosylase,IPR015797:NUDIX hydrolase domain-like,IPR023170:Helix-turn-helix, base-excision DNA repair, C-terminal,	hsa03410:Base excision repair,	132600~Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas,608456~Adenomas, multiple colorectal,613659~Gastric cancer, somatic,		SM00478:ENDO3c,SM00525:FES,	3D-structure,4Fe-4S,Alternative splicing,Complete proteome,Disease mutation,DNA damage,DNA repair,Glycosidase,Hydrolase,Iron,Iron-sulfur,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Tumor suppressor,	chain:A/G-specific adenine DNA glycosylase,domain:Nudix hydrolase,helix,metal ion-binding site:Iron-sulfur (4Fe-4S),sequence variant,splice variant,strand,
MYD88	myeloid differentiation primary response 88(MYD88)	Homo sapiens	92.Ancient_Host_Defense_Pathways,	H_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages,h_il1rPathway:Signal transduction through IL1R,h_nfkbPathway:NF-kB Signaling Pathway,h_nthiPathway:NFkB activation by Nontypeable Hemophilus influenzae,h_tollPathway:Toll-Like Receptor Pathway,		GO:0002224~toll-like receptor signaling pathway,GO:0002238~response to molecule of fungal origin,GO:0002755~MyD88-dependent toll-like receptor signaling pathway,GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007254~JNK cascade,GO:0008063~Toll signaling pathway,GO:0009615~response to virus,GO:0009682~induced systemic resistance,GO:0016064~immunoglobulin mediated immune response,GO:0019221~cytokine-mediated signaling pathway,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032481~positive regulation of type I interferon production,GO:0032494~response to peptidoglycan,GO:0032740~positive regulation of interleukin-17 production,GO:0032747~positive regulation of interleukin-23 production,GO:0032755~positive regulation of interleukin-6 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0034162~toll-like receptor 9 signaling pathway,GO:0043066~negative regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0044130~negative regulation of growth of symbiont in host,GO:0045080~positive regulation of chemokine biosynthetic process,GO:0045087~innate immune response,GO:0045351~type I interferon biosynthetic process,GO:0046330~positive regulation of JNK cascade,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0050671~positive regulation of lymphocyte proliferation,GO:0050727~regulation of inflammatory response,GO:0050830~defense response to Gram-positive bacterium,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0070555~response to interleukin-1,GO:0070935~3'-UTR-mediated mRNA stabilization,GO:0071260~cellular response to mechanical stimulus,GO:0090557~establishment of endothelial intestinal barrier,GO:1902622~regulation of neutrophil migration,GO:2000338~regulation of chemokine (C-X-C motif) ligand 1 production,GO:2000341~regulation of chemokine (C-X-C motif) ligand 2 production,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0014069~postsynaptic density,GO:0043234~protein complex,	GO:0005123~death receptor binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0043621~protein self-association,GO:0070976~TIR domain binding,	IPR000157:Toll/interleukin-1 receptor homology (TIR) domain,IPR000488:Death domain,IPR011029:Death-like domain,IPR017281:Myeloid differentiation primary response protein MyD88,	hsa04064:NF-kappa B signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa05132:Salmonella infection,hsa05133:Pertussis,hsa05134:Legionellosis,hsa05140:Leishmaniasis,hsa05142:Chagas disease (American trypanosomiasis),hsa05143:African trypanosomiasis,hsa05144:Malaria,hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05168:Herpes simplex infection,	153600~Macroglobulinemia, Waldenstrom, somatic,612260~Pyogenic bacterial infections, recurrent, due to MYD88 deficiency,	PIRSF037756:myeloid differentiation primary response protein MyD88 ,	SM00005:DEATH,SM00255:TIR,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Immunity,Inflammatory response,Innate immunity,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Myeloid differentiation primary response protein MyD88,domain:Death,domain:TIR,helix,sequence conflict,sequence variant,strand,turn,
MYOD1	myogenic differentiation 1(MYOD1)	Homo sapiens		h_hdacPathway:Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK),h_mitrPathway:Signal Dependent Regulation of Myogenesis by Corepressor MITR,		GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006468~protein phosphorylation,GO:0007517~muscle organ development,GO:0007518~myoblast fate determination,GO:0007519~skeletal muscle tissue development,GO:0007520~myoblast fusion,GO:0009267~cellular response to starvation,GO:0014904~myotube cell development,GO:0014908~myotube differentiation involved in skeletal muscle regeneration,GO:0035914~skeletal muscle cell differentiation,GO:0042693~muscle cell fate commitment,GO:0043415~positive regulation of skeletal muscle tissue regeneration,GO:0043484~regulation of RNA splicing,GO:0043503~skeletal muscle fiber adaptation,GO:0043966~histone H3 acetylation,GO:0043967~histone H4 acetylation,GO:0045663~positive regulation of myoblast differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048741~skeletal muscle fiber development,GO:0048743~positive regulation of skeletal muscle fiber development,GO:0051149~positive regulation of muscle cell differentiation,GO:0071385~cellular response to glucocorticoid stimulus,GO:0071392~cellular response to estradiol stimulus,GO:0071453~cellular response to oxygen levels,GO:1901741~positive regulation of myoblast fusion,GO:2000818~negative regulation of myoblast proliferation,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0030016~myofibril,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003682~chromatin binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0031490~chromatin DNA binding,GO:0031625~ubiquitin protein ligase binding,GO:0035257~nuclear hormone receptor binding,GO:0046982~protein heterodimerization activity,GO:0070888~E-box binding,	IPR002546:Myogenic basic muscle-specific protein,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR022032:Myogenic determination factor 5,				SM00353:HLH,SM00520:BASIC,	Acetylation,Activator,Complete proteome,Developmental protein,Differentiation,DNA-binding,Methylation,Myogenesis,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Myoblast determination protein 1,cross-link:Peptide (Met-Gly) (interchain with G-Cter in ubiquitin),DNA-binding region:Basic motif,domain:Helix-loop-helix motif,sequence conflict,sequence variant,
NRAS	neuroblastoma RAS viral oncogene homolog(NRAS)	Homo sapiens	65.Integrin_affinity_modulation,			GO:0000165~MAPK cascade,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0007411~axon guidance,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0038128~ERBB2 signaling pathway,GO:0050900~leukocyte migration,GO:0072600~establishment of protein localization to Golgi,	GO:0000139~Golgi membrane,GO:0005622~intracellular,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0005525~GTP binding,GO:0032403~protein complex binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR020849:Small GTPase superfamily, Ras type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04062:Chemokine signaling pathway,hsa04068:FoxO signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04360:Axon guidance,hsa04370:VEGF signaling pathway,hsa04540:Gap junction,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04912:GnRH signaling pathway,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04921:Oxytocin signaling pathway,hsa05034:Alcoholism,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05211:Renal cell carcinoma,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	114500~Colorectal cancer, somatic,137550~Melanocytic nevus syndrome, congenital, somatic,162900~Epidermal nevus, somatic,163200~Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic,188470~Thyroid carcinoma, follicular, somatic,249400~Neurocutaneous melanosis, somatic,613224~Noonan syndrome 6,614470~RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic,			3D-structure,Acetylation,Cell membrane,Complete proteome,Disease mutation,Golgi apparatus,GTP-binding,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Palmitate,Prenylation,Proto-oncogene,Reference proteome,	chain:GTPase NRas,helix,lipid moiety-binding region:S-farnesyl cysteine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,region of interest:Hypervariable region,sequence variant,short sequence motif:Effector region,strand,turn,
NF2	neurofibromin 2(NF2)	Homo sapiens				GO:0001707~mesoderm formation,GO:0001953~negative regulation of cell-matrix adhesion,GO:0006469~negative regulation of protein kinase activity,GO:0007398~ectoderm development,GO:0008156~negative regulation of DNA replication,GO:0008285~negative regulation of cell proliferation,GO:0014010~Schwann cell proliferation,GO:0014013~regulation of gliogenesis,GO:0021766~hippocampus development,GO:0022408~negative regulation of cell-cell adhesion,GO:0030036~actin cytoskeleton organization,GO:0030336~negative regulation of cell migration,GO:0031647~regulation of protein stability,GO:0035330~regulation of hippo signaling,GO:0042475~odontogenesis of dentin-containing tooth,GO:0042518~negative regulation of tyrosine phosphorylation of Stat3 protein,GO:0042524~negative regulation of tyrosine phosphorylation of Stat5 protein,GO:0043409~negative regulation of MAPK cascade,GO:0045216~cell-cell junction organization,GO:0045597~positive regulation of cell differentiation,GO:0046426~negative regulation of JAK-STAT cascade,GO:0051496~positive regulation of stress fiber assembly,GO:0070306~lens fiber cell differentiation,GO:0072091~regulation of stem cell proliferation,GO:1900180~regulation of protein localization to nucleus,GO:2000177~regulation of neural precursor cell proliferation,	GO:0001726~ruffle,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0016020~membrane,GO:0019898~extrinsic component of membrane,GO:0030027~lamellipodium,GO:0030175~filopodium,GO:0030864~cortical actin cytoskeleton,GO:0031527~filopodium membrane,GO:0032154~cleavage furrow,GO:0032587~ruffle membrane,GO:0043005~neuron projection,GO:0044297~cell body,GO:0045177~apical part of cell,GO:0048471~perinuclear region of cytoplasm,	GO:0003779~actin binding,GO:0005515~protein binding,	IPR000299:FERM domain,IPR000798:Ezrin/radixin/moesin like,IPR008954:Moesin,IPR011174:Ezrin/radixin/moesin,IPR011259:Ezrin/radixin/moesin, C-terminal,IPR011993:Pleckstrin homology-like domain,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR018979:FERM, N-terminal,IPR018980:FERM, C-terminal PH-like domain,IPR019747:FERM conserved site,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,	hsa04390:Hippo signaling pathway,	101000~Neurofibromatosis, type 2,162091~Schwannomatosis,607174~Meningioma, NF2-related, somatic,	PIRSF002305:ezrin/radixin/moesin,	SM00295:B41,SM01196:SM01196,	3D-structure,Alternative splicing,Cell membrane,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Deafness,Disease mutation,Membrane,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Tumor suppressor,Ubl conjugation,	chain:Merlin,compositionally biased region:Glu-rich,domain:FERM,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,turn,
NBN	nibrin(NBN)	Homo sapiens		h_atmPathway:ATM Signaling Pathway,h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,		GO:0000077~DNA damage checkpoint,GO:0000723~telomere maintenance,GO:0000724~double-strand break repair via homologous recombination,GO:0000729~DNA double-strand break processing,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0001832~blastocyst growth,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0007050~cell cycle arrest,GO:0007093~mitotic cell cycle checkpoint,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0008283~cell proliferation,GO:0030174~regulation of DNA-dependent DNA replication initiation,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0031860~telomeric 3' overhang formation,GO:0031954~positive regulation of protein autophosphorylation,GO:0032206~positive regulation of telomere maintenance,GO:0032508~DNA duplex unwinding,GO:0033674~positive regulation of kinase activity,GO:0045190~isotype switching,GO:0050885~neuromuscular process controlling balance,GO:0051321~meiotic cell cycle,GO:0097193~intrinsic apoptotic signaling pathway,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1904354~negative regulation of telomere capping,	GO:0000781~chromosome, telomeric region,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0016605~PML body,GO:0030870~Mre11 complex,GO:0035861~site of double-strand break,GO:0042405~nuclear inclusion body,	GO:0003684~damaged DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0047485~protein N-terminus binding,	IPR000253:Forkhead-associated (FHA) domain,IPR001357:BRCT domain,IPR008984:SMAD/FHA domain,IPR013908:DNA repair Nbs1, C-terminal,IPR016592:Nibrin,	hsa03440:Homologous recombination,	251260~Nijmegen breakage syndrome,609135~Aplastic anemia,613065~Leukemia, acute lymphoblastic,	PIRSF011869:nibrin, animal type,	SM00240:FHA,SM01348:SM01348,	Cell cycle,Chromosome,Complete proteome,Direct protein sequencing,Disease mutation,DNA damage,DNA repair,Meiosis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Telomere,	chain:Nibrin,compositionally biased region:Poly-Gln,domain:BRCT,domain:FHA,modified residue,mutagenesis site,sequence conflict,sequence variant,short sequence motif:EEXXXDDL motif,short sequence motif:Nuclear localization signal,
NCOR1	nuclear receptor corepressor 1(NCOR1)	Homo sapiens		h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_vdrPathway:Control of Gene Expression by Vitamin D Receptor,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007623~circadian rhythm,GO:0016569~covalent chromatin modification,GO:0044255~cellular lipid metabolic process,GO:0046329~negative regulation of JNK cascade,GO:0051225~spindle assembly,GO:0072362~regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,GO:0072368~regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,GO:1903799~negative regulation of production of miRNAs involved in gene silencing by miRNA,GO:2000191~regulation of fatty acid transport,	GO:0000118~histone deacetylase complex,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005876~spindle microtubule,GO:0016020~membrane,GO:0016580~Sin3 complex,GO:0017053~transcriptional repressor complex,	GO:0001102~RNA polymerase II activating transcription factor binding,GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0016922~ligand-dependent nuclear receptor binding,GO:0035257~nuclear hormone receptor binding,GO:0042826~histone deacetylase binding,GO:0044212~transcription regulatory region DNA binding,GO:0046966~thyroid hormone receptor binding,	IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR017884:SANT domain,	hsa04919:Thyroid hormone signaling pathway,hsa05202:Transcriptional misregulation in cancer,			SM00717:SANT,	3D-structure,Acetylation,Alternative splicing,Chromatin regulator,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:Nuclear receptor corepressor 1,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,domain:SANT 1,domain:SANT 2,helix,modified residue,region of interest:ID1,region of interest:ID2,region of interest:Interaction with C1D,region of interest:Interaction with ETO,region of interest:Interaction with SIN3A/B,region of interest:Interaction with ZBTB33 and HEXIM1,sequence conflict,short sequence motif:CORNR box 1,short sequence motif:CORNR box 2,short sequence motif:CORNR box 3,splice variant,
NCOR2	nuclear receptor corepressor 2(NCOR2)	Homo sapiens		h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor,h_egfr_smrtePathway:Map Kinase Inactivation of SMRT Corepressor,h_etsPathway:METS affect on Macrophage Differentiation,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_rarrxrPathway:Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0007595~lactation,GO:0010243~response to organonitrogen compound,GO:0032355~response to estradiol,GO:0044255~cellular lipid metabolic process,GO:0044849~estrous cycle,GO:0072365~regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,GO:1903799~negative regulation of production of miRNAs involved in gene silencing by miRNA,	GO:0000118~histone deacetylase complex,GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016020~membrane,GO:0016363~nuclear matrix,GO:0016604~nuclear body,GO:0017053~transcriptional repressor complex,	GO:0001012~RNA polymerase II regulatory region DNA binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003714~transcription corepressor activity,GO:0005112~Notch binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0016922~ligand-dependent nuclear receptor binding,GO:0042826~histone deacetylase binding,GO:0047485~protein N-terminus binding,	IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR017884:SANT domain,	hsa04330:Notch signaling pathway,hsa05169:Epstein-Barr virus infection,			SM00717:SANT,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,	chain:Nuclear receptor corepressor 2,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Pro,compositionally biased region:Pro-rich,domain:SANT 1,domain:SANT 2,helix,modified residue,region of interest:Interaction with SIN3A/B,sequence conflict,sequence variant,short sequence motif:CORNR box of ID1,short sequence motif:CORNR box of ID2,splice variant,strand,turn,
PHOX2B	paired like homeobox 2b(PHOX2B)	Homo sapiens				GO:0001764~neuron migration,GO:0002087~regulation of respiratory gaseous exchange by neurological system process,GO:0003357~noradrenergic neuron differentiation,GO:0003358~noradrenergic neuron development,GO:0003360~brainstem development,GO:0006366~transcription from RNA polymerase II promoter,GO:0008285~negative regulation of cell proliferation,GO:0010001~glial cell differentiation,GO:0010468~regulation of gene expression,GO:0010971~positive regulation of G2/M transition of mitotic cell cycle,GO:0021533~cell differentiation in hindbrain,GO:0021723~medullary reticular formation development,GO:0021934~hindbrain tangential cell migration,GO:0035914~skeletal muscle cell differentiation,GO:0045665~negative regulation of neuron differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048483~autonomic nervous system development,GO:0048484~enteric nervous system development,GO:0048485~sympathetic nervous system development,GO:0048486~parasympathetic nervous system development,GO:0048839~inner ear development,GO:0048894~efferent axon development in a lateral line nerve,GO:0060541~respiratory system development,GO:0061452~retrotrapezoid nucleus neuron differentiation,GO:0061549~sympathetic ganglion development,GO:0071157~negative regulation of cell cycle arrest,GO:0071542~dopaminergic neuron differentiation,GO:0071773~cellular response to BMP stimulus,GO:1901166~neural crest cell migration involved in autonomic nervous system development,	GO:0000790~nuclear chromatin,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,	IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,		209880~Central hypoventilation syndrome, congenital, with or without Hirschsprung disease,613013~Neuroblastoma with Hirschsprung disease,613013~Neuroblastoma, susceptibility to, 2,		SM00389:HOX,	Activator,Complete proteome,Developmental protein,Disease mutation,DNA-binding,Homeobox,Nucleus,Reference proteome,Transcription,Transcription regulation,Triplet repeat expansion,	chain:Paired mesoderm homeobox protein 2B,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gly,DNA-binding region:Homeobox,sequence conflict,sequence variant,
PALB2	partner and localizer of BRCA2(PALB2)	Homo sapiens				GO:0000724~double-strand break repair via homologous recombination,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0001756~somitogenesis,GO:0001833~inner cell mass cell proliferation,GO:0007498~mesoderm development,GO:0009887~organ morphogenesis,GO:0031052~chromosome breakage,GO:0035264~multicellular organism growth,GO:0036342~post-anal tail morphogenesis,GO:0043066~negative regulation of apoptotic process,GO:0048568~embryonic organ development,	GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,	hsa03460:Fanconi anemia pathway,	114480~Breast cancer, susceptibility to,610832~Fanconi anemia, complementation group N,613348~Pancreatic cancer, susceptibility to, 3,			3D-structure,Coiled coil,Complete proteome,DNA damage,DNA recombination,DNA repair,DNA-binding,Fanconi anemia,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Tumor suppressor,WD repeat,	chain:Partner and localizer of BRCA2,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,sequence variant,
PTCH1	patched 1(PTCH1)	Homo sapiens		h_ptc1Pathway:Sonic Hedgehog (SHH) Receptor Ptc1 Regulates cell cycle,h_shhPathway:Sonic Hedgehog (Shh) Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001701~in utero embryonic development,GO:0001709~cell fate determination,GO:0001843~neural tube closure,GO:0003007~heart morphogenesis,GO:0007224~smoothened signaling pathway,GO:0007346~regulation of mitotic cell cycle,GO:0007420~brain development,GO:0008589~regulation of smoothened signaling pathway,GO:0009612~response to mechanical stimulus,GO:0009887~organ morphogenesis,GO:0009953~dorsal/ventral pattern formation,GO:0009957~epidermal cell fate specification,GO:0010157~response to chlorate,GO:0010875~positive regulation of cholesterol efflux,GO:0016485~protein processing,GO:0021522~spinal cord motor neuron differentiation,GO:0021532~neural tube patterning,GO:0021997~neural plate axis specification,GO:0030326~embryonic limb morphogenesis,GO:0032355~response to estradiol,GO:0032526~response to retinoic acid,GO:0032880~regulation of protein localization,GO:0035108~limb morphogenesis,GO:0035137~hindlimb morphogenesis,GO:0040015~negative regulation of multicellular organism growth,GO:0042493~response to drug,GO:0042593~glucose homeostasis,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043616~keratinocyte proliferation,GO:0045606~positive regulation of epidermal cell differentiation,GO:0045668~negative regulation of osteoblast differentiation,GO:0045879~negative regulation of smoothened signaling pathway,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048568~embryonic organ development,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051782~negative regulation of cell division,GO:0060037~pharyngeal system development,GO:0060603~mammary gland duct morphogenesis,GO:0060644~mammary gland epithelial cell differentiation,GO:0060831~smoothened signaling pathway involved in dorsal/ventral neural tube patterning,GO:0061005~cell differentiation involved in kidney development,GO:0061053~somite development,GO:0071397~cellular response to cholesterol,GO:0072001~renal system development,GO:0072203~cell proliferation involved in metanephros development,GO:0072661~protein targeting to plasma membrane,	GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0014069~postsynaptic density,GO:0016021~integral component of membrane,GO:0030496~midbody,GO:0030666~endocytic vesicle membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0044294~dendritic growth cone,GO:0044295~axonal growth cone,GO:0048471~perinuclear region of cytoplasm,GO:0060170~ciliary membrane,GO:0072372~primary cilium,	GO:0005113~patched binding,GO:0005119~smoothened binding,GO:0005515~protein binding,GO:0008158~hedgehog receptor activity,GO:0008201~heparin binding,GO:0015485~cholesterol binding,GO:0030332~cyclin binding,GO:0032403~protein complex binding,GO:0097108~hedgehog family protein binding,	IPR000731:Sterol-sensing domain,IPR003392:Patched,IPR004766:Transmembrane receptor, patched,	hsa04024:cAMP signaling pathway,hsa04340:Hedgehog signaling pathway,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05217:Basal cell carcinoma,	109400~Basal cell nevus syndrome,605462~Basal cell carcinoma, somatic,610828~Holoprosencephaly-7,			Alternative splicing,Complete proteome,Disease mutation,Glycoprotein,Holoprosencephaly,Isopeptide bond,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transmembrane,Transmembrane helix,Tumor suppressor,Ubl conjugation,	chain:Protein patched homolog 1,compositionally biased region:Gly-rich,domain:SSD,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
PRF1	perforin 1(PRF1)	Homo sapiens		h_caspasePathway:Caspase Cascade in Apoptosis,h_ctlPathway:CTL mediated immune response against target cells ,h_d4gdiPathway:D4-GDI Signaling Pathway,h_setPathway:Granzyme A mediated Apoptosis Pathway,		GO:0001771~immunological synapse formation,GO:0002357~defense response to tumor cell,GO:0002418~immune response to tumor cell,GO:0006915~apoptotic process,GO:0006968~cellular defense response,GO:0019835~cytolysis,GO:0051260~protein homooligomerization,GO:0051607~defense response to virus,GO:0055085~transmembrane transport,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031904~endosome lumen,GO:0044194~cytolytic granule,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0022829~wide pore channel activity,	IPR000008:C2 calcium-dependent membrane targeting,IPR020863:Membrane attack complex component/perforin domain, conserved site,IPR020864:Membrane attack complex component/perforin (MACPF) domain,	hsa04650:Natural killer cell mediated cytotoxicity,hsa04940:Type I diabetes mellitus,hsa05320:Autoimmune thyroid disease,hsa05330:Allograft rejection,hsa05332:Graft-versus-host disease,hsa05416:Viral myocarditis,	603553~Hemophagocytic lymphohistiocytosis, familial, 2,605027~Lymphoma, non-Hodgkin,609135~Aplastic anemia,		SM00239:C2,SM00457:MACPF,	Calcium,Cell membrane,Complete proteome,Cytolysis,Disease mutation,Disulfide bond,EGF-like domain,Endosome,Familial hemophagocytic lymphohistiocytosis,Glycoprotein,Membrane,Metal-binding,Polymorphism,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane beta strand,	chain:Perforin-1,disulfide bond,domain:C2,domain:EGF-like,domain:MACPF,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,site:Important for oligomerization,transmembrane region,
PTEN	phosphatase and tensin homolog(PTEN)	Homo sapiens		h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,h_igf1mtorPathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_mtorPathway:mTOR Signaling Pathway,h_ptenPathway:PTEN dependent cell cycle arrest and apoptosis,		GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0001525~angiogenesis,GO:0001933~negative regulation of protein phosphorylation,GO:0002902~regulation of B cell apoptotic process,GO:0006470~protein dephosphorylation,GO:0006661~phosphatidylinositol biosynthetic process,GO:0006915~apoptotic process,GO:0007270~neuron-neuron synaptic transmission,GO:0007416~synapse assembly,GO:0007417~central nervous system development,GO:0007507~heart development,GO:0007568~aging,GO:0007584~response to nutrient,GO:0007611~learning or memory,GO:0007613~memory,GO:0007626~locomotory behavior,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009749~response to glucose,GO:0010043~response to zinc ion,GO:0010975~regulation of neuron projection development,GO:0014067~negative regulation of phosphatidylinositol 3-kinase signaling,GO:0016477~cell migration,GO:0021542~dentate gyrus development,GO:0021955~central nervous system neuron axonogenesis,GO:0030336~negative regulation of cell migration,GO:0030534~adult behavior,GO:0031642~negative regulation of myelination,GO:0031647~regulation of protein stability,GO:0031658~negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,GO:0032228~regulation of synaptic transmission, GABAergic,GO:0032286~central nervous system myelin maintenance,GO:0032355~response to estradiol,GO:0032535~regulation of cellular component size,GO:0033032~regulation of myeloid cell apoptotic process,GO:0033198~response to ATP,GO:0033555~multicellular organismal response to stress,GO:0035176~social behavior,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0042493~response to drug,GO:0042711~maternal behavior,GO:0043066~negative regulation of apoptotic process,GO:0043491~protein kinase B signaling,GO:0043542~endothelial cell migration,GO:0043647~inositol phosphate metabolic process,GO:0045471~response to ethanol,GO:0045475~locomotor rhythm,GO:0045792~negative regulation of cell size,GO:0046621~negative regulation of organ growth,GO:0046685~response to arsenic-containing substance,GO:0046855~inositol phosphate dephosphorylation,GO:0046856~phosphatidylinositol dephosphorylation,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048681~negative regulation of axon regeneration,GO:0048738~cardiac muscle tissue development,GO:0048853~forebrain morphogenesis,GO:0048854~brain morphogenesis,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050765~negative regulation of phagocytosis,GO:0050771~negative regulation of axonogenesis,GO:0050821~protein stabilization,GO:0050852~T cell receptor signaling pathway,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051726~regulation of cell cycle,GO:0051895~negative regulation of focal adhesion assembly,GO:0051898~negative regulation of protein kinase B signaling,GO:0060024~rhythmic synaptic transmission,GO:0060044~negative regulation of cardiac muscle cell proliferation,GO:0060070~canonical Wnt signaling pathway,GO:0060074~synapse maturation,GO:0060134~prepulse inhibition,GO:0060179~male mating behavior,GO:0060291~long-term synaptic potentiation,GO:0060292~long term synaptic depression,GO:0060736~prostate gland growth,GO:0060997~dendritic spine morphogenesis,GO:0061002~negative regulation of dendritic spine morphogenesis,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071456~cellular response to hypoxia,GO:0090071~negative regulation of ribosome biogenesis,GO:0090344~negative regulation of cell aging,GO:0090394~negative regulation of excitatory postsynaptic potential,GO:0097105~presynaptic membrane assembly,GO:0097107~postsynaptic density assembly,GO:1903984~positive regulation of TRAIL-activated apoptotic signaling pathway,GO:1904668~positive regulation of ubiquitin protein ligase activity,GO:2000060~positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,GO:2000463~positive regulation of excitatory postsynaptic potential,GO:2000808~negative regulation of synaptic vesicle clustering,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009898~cytoplasmic side of plasma membrane,GO:0016324~apical plasma membrane,GO:0016605~PML body,GO:0035749~myelin sheath adaxonal region,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043197~dendritic spine,GO:0043220~Schmidt-Lanterman incisure,GO:0045211~postsynaptic membrane,	GO:0000287~magnesium ion binding,GO:0004438~phosphatidylinositol-3-phosphatase activity,GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0005161~platelet-derived growth factor receptor binding,GO:0005515~protein binding,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0008289~lipid binding,GO:0010997~anaphase-promoting complex binding,GO:0016314~phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0030165~PDZ domain binding,GO:0042802~identical protein binding,GO:0051717~inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,GO:0051800~phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,	IPR000008:C2 calcium-dependent membrane targeting,IPR000340:Dual specificity phosphatase, catalytic domain,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR014020:Tensin phosphatase, C2 domain,IPR016130:Protein-tyrosine phosphatase, active site,IPR017361:Bifunctional phosphatidylinositol trisphosphate phosphatase/dual specificity phosphatase PTEN,	hsa00562:Inositol phosphate metabolism,hsa04068:FoxO signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04071:Sphingolipid signaling pathway,hsa04115:p53 signaling pathway,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04931:Insulin resistance,hsa05161:Hepatitis B,hsa05200:Pathways in cancer,hsa05206:MicroRNAs in cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05222:Small cell lung cancer,hsa05230:Central carbon metabolism in cancer,	153480~Bannayan-Riley-Ruvalcaba syndrome,155600~Malignant melanoma, somatic,158350~Cowden syndrome 1,158350~Lhermitte-Duclos syndrome,176807~Prostate cancer, somatic,275355~Squamous cell carcinoma, head and neck, somatic,276950~VATER association with macrocephaly and ventriculomegaly,605309~Macrocephaly/autism syndrome,607174~Meningioma,608089~Endometrial carcinoma, somatic,613028~Glioma susceptibility 2,PTEN hamartoma tumor syndrome~PTEN hamartoma tumor syndrome,	PIRSF038025:bifunctional phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase/dual-specificity protein phosphatase PTEN ,	SM00404:PTPc_motif,SM01326:SM01326,	3D-structure,Acetylation,Alternative initiation,Alternative splicing,Apoptosis,Autism spectrum disorder,Complete proteome,Cytoplasm,Disease mutation,Hydrolase,Isopeptide bond,Lipid metabolism,Lipid-binding,Neurogenesis,Nucleus,Phosphoprotein,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,Secreted,Tumor suppressor,Ubl conjugation,	active site:Phosphocysteine intermediate,chain:Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN,domain:C2 tensin-type,domain:Phosphatase tensin-type,helix,modified residue,mutagenesis site,region of interest:PDZ domain-binding,sequence variant,strand,turn,
PREX2	phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2(PREX2)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0008344~adult locomotory behavior,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0035023~regulation of Rho protein signal transduction,GO:0035556~intracellular signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0048813~dendrite morphogenesis,	GO:0005622~intracellular,GO:0005886~plasma membrane,	GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,GO:0030676~Rac guanyl-nucleotide exchange factor activity,	IPR000219:Dbl homology (DH) domain,IPR000591:DEP domain,IPR001331:Guanine-nucleotide dissociation stimulator, CDC24, conserved site,IPR001478:PDZ domain,IPR001849:Pleckstrin homology domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR011993:Pleckstrin homology-like domain,				SM00049:DEP,SM00228:PDZ,SM00233:PH,SM00325:RhoGEF,	Alternative splicing,Complete proteome,Guanine-nucleotide releasing factor,Polymorphism,Reference proteome,Repeat,	chain:Phosphatidylinositol 3,4,5-trisphosphate- dependent Rac exchanger 2 protein,domain:DEP 1,domain:DEP 2,domain:DH,domain:PDZ 1,domain:PDZ 2,domain:PH,sequence conflict,sequence variant,splice variant,
PIK3CA	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha(PIK3CA)	Homo sapiens		h_achPathway:Role of nicotinic acetylcholine receptors in the regulation of apoptosis,h_aktPathway:AKT Signaling Pathway,h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,h_badPathway:Regulation of BAD phosphorylation,h_bcellsurvivalPathway:B Cell Survival Pathway,h_cdc42racPathway:Role of PI3K subunit p85 in regulation of Actin Organization and Cell Migration,h_crebPathway:Transcription factor CREB and its extracellular signals,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation,h_cxcr4Pathway:CXCR4 Signaling Pathway,h_ecmPathway:Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia,h_edg1Pathway:Phospholipids as signalling intermediaries,h_egfPathway:EGF Signaling Pathway,h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,h_erk5Pathway:Role of Erk5 in Neuronal Survival,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_gcrpathway:Corticosteroids and cardioprotection,h_ghPathway:Growth Hormone Signaling Pathway,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,H_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages,h_hcmvPathway:Human Cytomegalovirus and Map Kinase Pathways,h_hdacPathway:Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK),h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_igf1mtorPathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway,h_igf1Pathway:IGF-1 Signaling Pathway,h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il7Pathway:IL-7 Signal Transduction,h_insulinPathway:Insulin Signaling Pathway,h_longevityPathway:The IGF-1 Receptor and Longevity,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_mtorPathway:mTOR Signaling Pathway,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_ngfPathway:Nerve growth factor pathway (NGF),h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity,h_par1pathway:Thrombin signaling and protease-activated receptors,h_pdgfPathway:PDGF Signaling Pathway,h_plcPathway:Phospholipase C Signaling Pathway,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_ptenPathway:PTEN dependent cell cycle arrest and apoptosis,h_rac1Pathway:Rac 1 cell motility signaling pathway,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_rasPathway:Ras Signaling Pathway,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,h_tpoPathway:TPO Signaling Pathway,h_trkaPathway:Trka Receptor Signaling Pathway,h_vegfPathway:VEGF, Hypoxia, and Angiogenesis,		GO:0001525~angiogenesis,GO:0001889~liver development,GO:0001944~vasculature development,GO:0006006~glucose metabolic process,GO:0006468~protein phosphorylation,GO:0006661~phosphatidylinositol biosynthetic process,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0010468~regulation of gene expression,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0016310~phosphorylation,GO:0030168~platelet activation,GO:0031295~T cell costimulation,GO:0032147~activation of protein kinase activity,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0038028~insulin receptor signaling pathway via phosphatidylinositol 3-kinase,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0038128~ERBB2 signaling pathway,GO:0040014~regulation of multicellular organism growth,GO:0043457~regulation of cellular respiration,GO:0043491~protein kinase B signaling,GO:0043524~negative regulation of neuron apoptotic process,GO:0043542~endothelial cell migration,GO:0044029~hypomethylation of CpG island,GO:0046854~phosphatidylinositol phosphorylation,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048015~phosphatidylinositol-mediated signaling,GO:0050852~T cell receptor signaling pathway,GO:0050900~leukocyte migration,GO:0060048~cardiac muscle contraction,GO:0060612~adipose tissue development,GO:0071333~cellular response to glucose stimulus,GO:0097009~energy homeostasis,GO:2000270~negative regulation of fibroblast apoptotic process,GO:2000653~regulation of genetic imprinting,GO:2000811~negative regulation of anoikis,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005942~phosphatidylinositol 3-kinase complex,GO:0005943~phosphatidylinositol 3-kinase complex, class IA,GO:0030027~lamellipodium,	GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0030295~protein kinase activator activity,GO:0035004~phosphatidylinositol 3-kinase activity,GO:0035005~1-phosphatidylinositol-4-phosphate 3-kinase activity,GO:0043560~insulin receptor substrate binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,	IPR000008:C2 calcium-dependent membrane targeting,IPR000341:Phosphatidylinositol 3-kinase Ras-binding (PI3K RBD) domain,IPR000403:Phosphatidylinositol 3-/4-kinase, catalytic domain,IPR001263:Phosphoinositide 3-kinase, accessory (PIK) domain,IPR002420:Phosphatidylinositol 3-kinase C2 (PI3K C2) domain,IPR003113:Phosphatidylinositol 3-kinase adaptor-binding (PI3K ABD) domain,IPR011009:Protein kinase-like domain,IPR015433:Phosphatidylinositol Kinase,IPR016024:Armadillo-type fold,IPR018936:Phosphatidylinositol 3/4-kinase, conserved site,	hsa00562:Inositol phosphate metabolism,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04071:Sphingolipid signaling pathway,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04210:Apoptosis,hsa04370:VEGF signaling pathway,hsa04380:Osteoclast differentiation,hsa04510:Focal adhesion,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04611:Platelet activation,hsa04620:Toll-like receptor signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04668:TNF signaling pathway,hsa04670:Leukocyte transendothelial migration,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04930:Type II diabetes mellitus,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa04960:Aldosterone-regulated sodium reabsorption,hsa04973:Carbohydrate digestion and absorption,hsa05100:Bacterial invasion of epithelial cells,hsa05142:Chagas disease (American trypanosomiasis),hsa05146:Amoebiasis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	114480~Breast cancer, somatic,114500~Colorectal cancer, somatic,114550~Hepatocellular carcinoma, somatic,162900~Nevus, epidermal, somatic,167000~Ovarian cancer, somatic,182000~Keratosis, seborrheic, somatic,211980~Nonsmall cell lung cancer, somatic,602501~Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic,612918~CLOVE syndrome, somatic,613659~Gastric cancer, somatic,615108~Cowden syndrome 5,		SM00142:PI3K_C2,SM00143:PI3K_p85B,SM00144:PI3K_rbd,SM00145:PI3Ka,SM00146:PI3Kc,	3D-structure,Angiogenesis,ATP-binding,Complete proteome,Disease mutation,Kinase,Nucleotide-binding,Phagocytosis,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Serine/threonine-protein kinase,Transferase,	chain:Phosphatidylinositol-4,5-bisphosphate 3- kinase catalytic subunit alpha isoform,domain:C2,domain:PI3K/PI4K,helix,sequence conflict,sequence variant,strand,turn,
PIK3R1	phosphoinositide-3-kinase regulatory subunit 1(PIK3R1)	Homo sapiens	104.Insulin_signaling,105.Signaling_glucose_uptake,106.Glycogen_synthase-synthesis,107.mRNA_translation-protein_synthesis,2.Cytokine_Receptors,37.Akt-PKB_Effector_of_P13K_in_Vivo,63.LAT_couples_T-cell_receptor,	h_achPathway:Role of nicotinic acetylcholine receptors in the regulation of apoptosis,h_aktPathway:AKT Signaling Pathway,h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,h_badPathway:Regulation of BAD phosphorylation,h_bcellsurvivalPathway:B Cell Survival Pathway,h_cdc42racPathway:Role of PI3K subunit p85 in regulation of Actin Organization and Cell Migration,h_crebPathway:Transcription factor CREB and its extracellular signals,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation,h_cxcr4Pathway:CXCR4 Signaling Pathway,h_ecmPathway:Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia,h_edg1Pathway:Phospholipids as signalling intermediaries,h_egfPathway:EGF Signaling Pathway,h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,h_erk5Pathway:Role of Erk5 in Neuronal Survival,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_gcrpathway:Corticosteroids and cardioprotection,h_ghPathway:Growth Hormone Signaling Pathway,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,H_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages,h_hcmvPathway:Human Cytomegalovirus and Map Kinase Pathways,h_hdacPathway:Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK),h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_igf1mtorPathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway,h_igf1Pathway:IGF-1 Signaling Pathway,h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il7Pathway:IL-7 Signal Transduction,h_insulinPathway:Insulin Signaling Pathway,h_longevityPathway:The IGF-1 Receptor and Longevity,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_mtorPathway:mTOR Signaling Pathway,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_ngfPathway:Nerve growth factor pathway (NGF),h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity,h_par1pathway:Thrombin signaling and protease-activated receptors,h_pdgfPathway:PDGF Signaling Pathway,h_plcPathway:Phospholipase C Signaling Pathway,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_ptenPathway:PTEN dependent cell cycle arrest and apoptosis,h_rac1Pathway:Rac 1 cell motility signaling pathway,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_rasPathway:Ras Signaling Pathway,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,h_tpoPathway:TPO Signaling Pathway,h_trkaPathway:Trka Receptor Signaling Pathway,h_vegfPathway:VEGF, Hypoxia, and Angiogenesis,	Cell division and chromosome partitioning,	GO:0001678~cellular glucose homeostasis,GO:0001953~negative regulation of cell-matrix adhesion,GO:0006468~protein phosphorylation,GO:0006661~phosphatidylinositol biosynthetic process,GO:0007165~signal transduction,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0008286~insulin receptor signaling pathway,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0016032~viral process,GO:0030168~platelet activation,GO:0030183~B cell differentiation,GO:0030335~positive regulation of cell migration,GO:0031295~T cell costimulation,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032869~cellular response to insulin stimulus,GO:0033120~positive regulation of RNA splicing,GO:0034644~cellular response to UV,GO:0034976~response to endoplasmic reticulum stress,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0038128~ERBB2 signaling pathway,GO:0042993~positive regulation of transcription factor import into nucleus,GO:0043066~negative regulation of apoptotic process,GO:0043551~regulation of phosphatidylinositol 3-kinase activity,GO:0045671~negative regulation of osteoclast differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046326~positive regulation of glucose import,GO:0046854~phosphatidylinositol phosphorylation,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048015~phosphatidylinositol-mediated signaling,GO:0050821~protein stabilization,GO:0050852~T cell receptor signaling pathway,GO:0050900~leukocyte migration,GO:0051492~regulation of stress fiber assembly,GO:0051531~NFAT protein import into nucleus,GO:0060396~growth hormone receptor signaling pathway,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,GO:1900103~positive regulation of endoplasmic reticulum unfolded protein response,GO:2001275~positive regulation of glucose import in response to insulin stimulus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005801~cis-Golgi network,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005942~phosphatidylinositol 3-kinase complex,GO:0005943~phosphatidylinositol 3-kinase complex, class IA,GO:0016020~membrane,GO:1990578~perinuclear endoplasmic reticulum membrane,	GO:0005068~transmembrane receptor protein tyrosine kinase adaptor activity,GO:0005158~insulin receptor binding,GO:0005159~insulin-like growth factor receptor binding,GO:0005168~neurotrophin TRKA receptor binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0016301~kinase activity,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0019903~protein phosphatase binding,GO:0035014~phosphatidylinositol 3-kinase regulator activity,GO:0036312~phosphatidylinositol 3-kinase regulatory subunit binding,GO:0043125~ErbB-3 class receptor binding,GO:0043548~phosphatidylinositol 3-kinase binding,GO:0043559~insulin binding,GO:0043560~insulin receptor substrate binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,GO:0046935~1-phosphatidylinositol-3-kinase regulator activity,GO:0046982~protein heterodimerization activity,	IPR000198:Rho GTPase-activating protein domain,IPR000980:SH2 domain,IPR001452:Src homology-3 domain,IPR001720:PI3 kinase, P85 regulatory subunit,IPR008936:Rho GTPase activation protein,	hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04071:Sphingolipid signaling pathway,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04210:Apoptosis,hsa04370:VEGF signaling pathway,hsa04380:Osteoclast differentiation,hsa04510:Focal adhesion,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04611:Platelet activation,hsa04620:Toll-like receptor signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04668:TNF signaling pathway,hsa04670:Leukocyte transendothelial migration,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04930:Type II diabetes mellitus,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa04960:Aldosterone-regulated sodium reabsorption,hsa04973:Carbohydrate digestion and absorption,hsa05100:Bacterial invasion of epithelial cells,hsa05142:Chagas disease (American trypanosomiasis),hsa05146:Amoebiasis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	269880~SHORT syndrome,615214~Agammaglobulinemia 7, autosomal recessive,616005~Immunodeficiency 36,		SM00252:SH2,SM00324:RhoGAP,SM00326:SH3,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Disease mutation,Dwarfism,Host-virus interaction,Kinase,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,SH2 domain,SH3 domain,Stress response,Transferase,Transport,Ubl conjugation,	chain:Phosphatidylinositol 3-kinase regulatory subunit alpha,domain:Rho-GAP,domain:SH2 1,domain:SH2 2,domain:SH3,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
PBRM1	polybromo 1(PBRM1)	Homo sapiens			Chromatin structure and dynamics / Transcription,	GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007067~mitotic nuclear division,GO:0008285~negative regulation of cell proliferation,GO:0016569~covalent chromatin modification,	GO:0000228~nuclear chromosome,GO:0005654~nucleoplasm,GO:0090544~BAF-type complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,	IPR001025:Bromo adjacent homology (BAH) domain,IPR001487:Bromodomain,IPR009071:High mobility group (HMG) box domain,IPR018359:Bromodomain, conserved site,				SM00297:BROMO,SM00398:HMG,SM00439:BAH,	3D-structure,Acetylation,Alternative splicing,Bromodomain,Chromatin regulator,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Tumor suppressor,Ubl conjugation,	chain:Protein polybromo-1,compositionally biased region:Poly-Asp,compositionally biased region:Pro-rich,DNA-binding region:HMG box,domain:BAH 1,domain:BAH 2,domain:Bromo 1,domain:Bromo 2,domain:Bromo 3,domain:Bromo 4,domain:Bromo 5,domain:Bromo 6,helix,modified residue,sequence conflict,splice variant,turn,
KCNJ5	potassium voltage-gated channel subfamily J member 5(KCNJ5)	Homo sapiens				GO:0006813~potassium ion transport,GO:0010107~potassium ion import,GO:0034765~regulation of ion transmembrane transport,GO:0086091~regulation of heart rate by cardiac conduction,GO:0098914~membrane repolarization during atrial cardiac muscle cell action potential,GO:0098915~membrane repolarization during ventricular cardiac muscle cell action potential,GO:0099625~ventricular cardiac muscle cell membrane repolarization,GO:1990573~potassium ion import across plasma membrane,	GO:0005886~plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0030315~T-tubule,	GO:0005242~inward rectifier potassium channel activity,GO:0005515~protein binding,GO:0015467~G-protein activated inward rectifier potassium channel activity,GO:0086089~voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,GO:1902282~voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,	IPR003277:Potassium channel, inwardly rectifying, Kir3.4,IPR013518:Potassium channel, inwardly rectifying, Kir, cytoplasmic,IPR014756:Immunoglobulin E-set,IPR016449:Potassium channel, inwardly rectifying, Kir,	hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04726:Serotonergic synapse,hsa04728:Dopaminergic synapse,hsa04915:Estrogen signaling pathway,hsa04921:Oxytocin signaling pathway,hsa05032:Morphine addiction,	613485~Long QT syndrome 13,613677~Hyperaldosteronism, familial, type III,	PIRSF005465:G protein-activated inward rectifier potassium channel,		Complete proteome,Disease mutation,Ion channel,Ion transport,Long QT syndrome,Membrane,Phosphoprotein,Polymorphism,Potassium,Potassium transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:G protein-activated inward rectifier potassium channel 4,region of interest:H5 (pore-forming helix),sequence conflict,short sequence motif:Selectivity filter,site:Role in the control of polyamine-mediated channel gating and in the blocking by intracellular magnesium,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
POT1	protection of telomeres 1(POT1)	Homo sapiens				GO:0000723~telomere maintenance,GO:0007004~telomere maintenance via telomerase,GO:0016233~telomere capping,GO:0032202~telomere assembly,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0032508~DNA duplex unwinding,GO:0051096~positive regulation of helicase activity,GO:0051973~positive regulation of telomerase activity,GO:0051974~negative regulation of telomerase activity,GO:0060383~positive regulation of DNA strand elongation,GO:0070200~establishment of protein localization to telomere,	GO:0000781~chromosome, telomeric region,GO:0000783~nuclear telomere cap complex,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0070187~telosome,	GO:0005515~protein binding,GO:0010521~telomerase inhibitor activity,GO:0017151~DEAD/H-box RNA helicase binding,GO:0042162~telomeric DNA binding,GO:0043047~single-stranded telomeric DNA binding,GO:0098505~G-rich strand telomeric DNA binding,	IPR011564:Telomere end binding protein,IPR012340:Nucleic acid-binding, OB-fold,		615848~Melanoma, cutaneous malignant, susceptibility to, 10,616568~Glioma susceptibility 9,		SM00976:SM00976,	3D-structure,Alternative splicing,Chromosome,Complete proteome,Disease mutation,DNA-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Telomere,	chain:Protection of telomeres protein 1,helix,region of interest:DNA binding,sequence conflict,sequence variant,site:DNA binding,splice variant,strand,
PRKACA	protein kinase cAMP-activated catalytic subunit alpha(PRKACA)	Homo sapiens		h_gsPathway:Activation of cAMP-dependent protein kinase, PKA,		GO:0000086~G2/M transition of mitotic cell cycle,GO:0001707~mesoderm formation,GO:0001843~neural tube closure,GO:0002027~regulation of heart rate,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0003091~renal water homeostasis,GO:0006397~mRNA processing,GO:0006468~protein phosphorylation,GO:0007596~blood coagulation,GO:0010881~regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0034199~activation of protein kinase A activity,GO:0035584~calcium-mediated signaling using intracellular calcium source,GO:0042157~lipoprotein metabolic process,GO:0043393~regulation of protein binding,GO:0045667~regulation of osteoblast differentiation,GO:0046777~protein autophosphorylation,GO:0046827~positive regulation of protein export from nucleus,GO:0048240~sperm capacitation,GO:0050804~modulation of synaptic transmission,GO:0051480~regulation of cytosolic calcium ion concentration,GO:0055117~regulation of cardiac muscle contraction,GO:0060314~regulation of ryanodine-sensitive calcium-release channel activity,GO:0061136~regulation of proteasomal protein catabolic process,GO:0070613~regulation of protein processing,GO:0071158~positive regulation of cell cycle arrest,GO:0071333~cellular response to glucose stimulus,GO:0071374~cellular response to parathyroid hormone stimulus,GO:0071377~cellular response to glucagon stimulus,GO:0071872~cellular response to epinephrine stimulus,GO:0086064~cell communication by electrical coupling involved in cardiac conduction,GO:1901621~negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,GO:1903779~regulation of cardiac conduction,GO:2000810~regulation of bicellular tight junction assembly,	GO:0001669~acrosomal vesicle,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005952~cAMP-dependent protein kinase complex,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0031514~motile cilium,GO:0031588~nucleotide-activated protein kinase complex,GO:0031594~neuromuscular junction,GO:0034704~calcium channel complex,GO:0044853~plasma membrane raft,GO:0070062~extracellular exosome,GO:0097225~sperm midpiece,GO:0097546~ciliary base,	GO:0004674~protein serine/threonine kinase activity,GO:0004691~cAMP-dependent protein kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019901~protein kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0034237~protein kinase A regulatory subunit binding,	IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04020:Calcium signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04114:Oocyte meiosis,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04270:Vascular smooth muscle contraction,hsa04310:Wnt signaling pathway,hsa04340:Hedgehog signaling pathway,hsa04540:Gap junction,hsa04611:Platelet activation,hsa04713:Circadian entrainment,hsa04720:Long-term potentiation,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa04740:Olfactory transduction,hsa04742:Taste transduction,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04910:Insulin signaling pathway,hsa04911:Insulin secretion,hsa04912:GnRH signaling pathway,hsa04913:Ovarian steroidogenesis,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04918:Thyroid hormone synthesis,hsa04919:Thyroid hormone signaling pathway,hsa04921:Oxytocin signaling pathway,hsa04922:Glucagon signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04924:Renin secretion,hsa04925:Aldosterone synthesis and secretion,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa04962:Vasopressin-regulated water reabsorption,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04976:Bile secretion,hsa05012:Parkinson's disease,hsa05020:Prion diseases,hsa05030:Cocaine addiction,hsa05031:Amphetamine addiction,hsa05032:Morphine addiction,hsa05110:Vibrio cholerae infection,hsa05146:Amoebiasis,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05414:Dilated cardiomyopathy,	615830~Cushing syndrome, ACTH-independent adrenal, somatic,		SM00133:S_TK_X,SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,cAMP,Cell membrane,Cell projection,Cilium,Complete proteome,Cushing syndrome,Cytoplasm,Disease mutation,Flagellum,Kinase,Lipoprotein,Membrane,Mitochondrion,Myristate,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:cAMP-dependent protein kinase catalytic subunit alpha,domain:AGC-kinase C-terminal,domain:Protein kinase,helix,lipid moiety-binding region:N-myristoyl glycine,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,strand,turn,
PPP2R1A	protein phosphatase 2 scaffold subunit Aalpha(PPP2R1A)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000188~inactivation of MAPK activity,GO:0006275~regulation of DNA replication,GO:0006355~regulation of transcription, DNA-templated,GO:0006461~protein complex assembly,GO:0006470~protein dephosphorylation,GO:0006672~ceramide metabolic process,GO:0006915~apoptotic process,GO:0007059~chromosome segregation,GO:0007084~mitotic nuclear envelope reassembly,GO:0007143~female meiotic division,GO:0008380~RNA splicing,GO:0010033~response to organic substance,GO:0019932~second-messenger-mediated signaling,GO:0030111~regulation of Wnt signaling pathway,GO:0030155~regulation of cell adhesion,GO:0030308~negative regulation of cell growth,GO:0040008~regulation of growth,GO:0042518~negative regulation of tyrosine phosphorylation of Stat3 protein,GO:0045595~regulation of cell differentiation,GO:0051232~meiotic spindle elongation,GO:0051306~mitotic sister chromatid separation,GO:0051754~meiotic sister chromatid cohesion, centromeric,GO:0070262~peptidyl-serine dephosphorylation,GO:1903538~regulation of meiotic cell cycle process involved in oocyte maturation,GO:2001241~positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0000159~protein phosphatase type 2A complex,GO:0000775~chromosome, centromeric region,GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0015630~microtubule cytoskeleton,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0003823~antigen binding,GO:0004722~protein serine/threonine phosphatase activity,GO:0005515~protein binding,GO:0008601~protein phosphatase type 2A regulator activity,GO:0019888~protein phosphatase regulator activity,GO:0046982~protein heterodimerization activity,	IPR000357:HEAT,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR021133:HEAT, type 2,	hsa03015:mRNA surveillance pathway,hsa04071:Sphingolipid signaling pathway,hsa04114:Oocyte meiosis,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04350:TGF-beta signaling pathway,hsa04390:Hippo signaling pathway,hsa04530:Tight junction,hsa04728:Dopaminergic synapse,hsa04730:Long-term depression,hsa05142:Chagas disease (American trypanosomiasis),hsa05160:Hepatitis C,	616362~Mental retardation, autosomal dominant 36,			3D-structure,Acetylation,Centromere,Chromosome,Chromosome partition,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Mental retardation,Proteomics identification,Reference proteome,Repeat,	chain:Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,helix,modified residue,region of interest:Polyoma small and medium T antigens Binding,region of interest:PP2A subunit B binding,region of interest:PP2A subunit C binding,region of interest:SV40 small T antigen binding,repeat:HEAT 1,repeat:HEAT 10,repeat:HEAT 11,repeat:HEAT 12,repeat:HEAT 13,repeat:HEAT 14,repeat:HEAT 15,repeat:HEAT 2,repeat:HEAT 3,repeat:HEAT 4,repeat:HEAT 5,repeat:HEAT 6,repeat:HEAT 7,repeat:HEAT 8,repeat:HEAT 9,sequence conflict,sequence variant,turn,
PPP6C	protein phosphatase 6 catalytic subunit(PPP6C)	Homo sapiens				GO:0000082~G1/S transition of mitotic cell cycle,GO:0006470~protein dephosphorylation,GO:0048208~COPII vesicle coating,	GO:0000139~Golgi membrane,GO:0005829~cytosol,	GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR004843:Metallophosphoesterase domain,IPR006186:Serine/threonine-specific protein phosphatase/bis(5-nucleosyl)-tetraphosphatase,				SM00156:PP2Ac,	Acetylation,Alternative splicing,Cell cycle,Complete proteome,Cytoplasm,Direct protein sequencing,Hydrolase,Manganese,Metal-binding,Protein phosphatase,Proteomics identification,Reference proteome,	active site:Proton donor,chain:Serine/threonine-protein phosphatase 6 catalytic subunit,metal ion-binding site:Iron,metal ion-binding site:Manganese,sequence conflict,splice variant,
PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D(PPM1D)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0006470~protein dephosphorylation,GO:0008285~negative regulation of cell proliferation,GO:0009267~cellular response to starvation,GO:0009314~response to radiation,GO:0009617~response to bacterium,GO:0035970~peptidyl-threonine dephosphorylation,	GO:0005634~nucleus,	GO:0004722~protein serine/threonine phosphatase activity,GO:0005515~protein binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0051019~mitogen-activated protein kinase binding,	IPR000222:Protein phosphatase 2C, manganese/magnesium aspartate binding site,IPR001932:Protein phosphatase 2C (PP2C)-like,IPR015655:Protein phosphatase 2C,	hsa04115:p53 signaling pathway,	114480~Breast cancer,		SM00332:PP2Cc,	Alternative splicing,Cell cycle,Complete proteome,Hydrolase,Magnesium,Manganese,Metal-binding,Phosphoprotein,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,	chain:Protein phosphatase 1D,domain:PP2C-like,metal ion-binding site:Manganese 1,metal ion-binding site:Manganese 1; via carbonyl oxygen,metal ion-binding site:Manganese 2,modified residue,mutagenesis site,region of interest:Interaction with CHEK1,
PTPN11	protein tyrosine phosphatase, non-receptor type 11(PTPN11)	Homo sapiens	104.Insulin_signaling,12.IL-6_type_cytok-signal-transduct,	h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation,h_igf1Pathway:IGF-1 Signaling Pathway,h_il6Pathway:IL 6 signaling pathway,h_insulinPathway:Insulin Signaling Pathway,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,		GO:0000077~DNA damage checkpoint,GO:0000187~activation of MAPK activity,GO:0006641~triglyceride metabolic process,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007229~integrin-mediated signaling pathway,GO:0007409~axonogenesis,GO:0007420~brain development,GO:0007507~heart development,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0009755~hormone-mediated signaling pathway,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0021697~cerebellar cortex formation,GO:0030168~platelet activation,GO:0030220~platelet formation,GO:0031295~T cell costimulation,GO:0032528~microvillus organization,GO:0033277~abortive mitotic cell cycle,GO:0033628~regulation of cell adhesion mediated by integrin,GO:0033629~negative regulation of cell adhesion mediated by integrin,GO:0035264~multicellular organism growth,GO:0035265~organ growth,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0035855~megakaryocyte development,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0036302~atrioventricular canal development,GO:0038127~ERBB signaling pathway,GO:0040014~regulation of multicellular organism growth,GO:0042445~hormone metabolic process,GO:0042593~glucose homeostasis,GO:0043254~regulation of protein complex assembly,GO:0045931~positive regulation of mitotic cell cycle,GO:0046676~negative regulation of insulin secretion,GO:0046825~regulation of protein export from nucleus,GO:0046854~phosphatidylinositol phosphorylation,GO:0046887~positive regulation of hormone secretion,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0048011~neurotrophin TRK receptor signaling pathway,GO:0048013~ephrin receptor signaling pathway,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048609~multicellular organismal reproductive process,GO:0048806~genitalia development,GO:0048839~inner ear development,GO:0048873~homeostasis of number of cells within a tissue,GO:0050900~leukocyte migration,GO:0051463~negative regulation of cortisol secretion,GO:0060020~Bergmann glial cell differentiation,GO:0060125~negative regulation of growth hormone secretion,GO:0060325~face morphogenesis,GO:0060338~regulation of type I interferon-mediated signaling pathway,GO:0061582~intestinal epithelial cell migration,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:2001275~positive regulation of glucose import in response to insulin stimulus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0043234~protein complex,	GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0004726~non-membrane spanning protein tyrosine phosphatase activity,GO:0005070~SH3/SH2 adaptor activity,GO:0005158~insulin receptor binding,GO:0005515~protein binding,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0019904~protein domain specific binding,GO:0030971~receptor tyrosine kinase binding,GO:0031748~D1 dopamine receptor binding,GO:0043274~phospholipase binding,GO:0043560~insulin receptor substrate binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,GO:0050839~cell adhesion molecule binding,GO:0051428~peptide hormone receptor binding,	IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR000980:SH2 domain,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR012152:Protein-tyrosine phosphatase, non-receptor type-6, -11,IPR016130:Protein-tyrosine phosphatase, active site,	hsa04014:Ras signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04670:Leukocyte transendothelial migration,hsa04722:Neurotrophin signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04931:Insulin resistance,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05168:Herpes simplex infection,hsa05205:Proteoglycans in cancer,hsa05211:Renal cell carcinoma,hsa05220:Chronic myeloid leukemia,	151100~LEOPARD syndrome 1,156250~Metachondromatosis,163950~Noonan syndrome 1,607785~Leukemia, juvenile myelomonocytic, somatic,	PIRSF000929:non-receptor tyrosine-protein phosphatase, 6/11 types,	SM00194:PTPc,SM00252:SH2,SM00404:PTPc_motif,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Deafness,Disease mutation,Hydrolase,Nucleus,Phosphoprotein,Protein phosphatase,Proteomics identification,Reference proteome,Repeat,SH2 domain,	active site:Phosphocysteine intermediate,chain:Tyrosine-protein phosphatase non-receptor type 11,domain:SH2 1,domain:SH2 2,domain:Tyrosine-protein phosphatase,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,turn,
PTPN13	protein tyrosine phosphatase, non-receptor type 13(PTPN13)	Homo sapiens		h_fasPathway:FAS signaling pathway ( CD95 ),		GO:0006470~protein dephosphorylation,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0070830~bicellular tight junction assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0030027~lamellipodium,GO:0043005~neuron projection,GO:0044297~cell body,GO:0070062~extracellular exosome,	GO:0004725~protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0036312~phosphatidylinositol 3-kinase regulatory subunit binding,	IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type,IPR000299:FERM domain,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR001478:PDZ domain,IPR003100:Argonaute/Dicer protein, PAZ,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR011019:KIND,IPR011993:Pleckstrin homology-like domain,IPR012153:Protein-tyrosine phosphatase, non-receptor type-13,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR018979:FERM, N-terminal,IPR018980:FERM, C-terminal PH-like domain,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,			PIRSF000933:non-receptor tyrosine-protein phosphatase, type 13,	SM00194:PTPc,SM00228:PDZ,SM00295:B41,SM00404:PTPc_motif,SM00750:KIND,SM01196:SM01196,	3D-structure,Alternative splicing,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Hydrolase,Nucleus,Phosphoprotein,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,Repeat,	active site:Phosphocysteine intermediate,chain:Tyrosine-protein phosphatase non-receptor type 13,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Ser,domain:FERM,domain:KIND,domain:PDZ 1,domain:PDZ 2,domain:PDZ 3,domain:PDZ 4,domain:PDZ 5,domain:Tyrosine-protein phosphatase,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
PTPRB	protein tyrosine phosphatase, receptor type B(PTPRB)	Homo sapiens		h_spryPathway:Sprouty regulation of tyrosine kinase signals,		GO:0001525~angiogenesis,GO:0006470~protein dephosphorylation,GO:0006796~phosphate-containing compound metabolic process,GO:0016311~dephosphorylation,GO:0035335~peptidyl-tyrosine dephosphorylation,	GO:0005887~integral component of plasma membrane,GO:0043235~receptor complex,	GO:0004725~protein tyrosine phosphatase activity,GO:0005001~transmembrane receptor protein tyrosine phosphatase activity,GO:0005515~protein binding,	IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR000772:Ricin B lectin domain,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,IPR016130:Protein-tyrosine phosphatase, active site,	hsa04520:Adherens junction,			SM00060:FN3,SM00194:PTPc,SM00404:PTPc_motif,	3D-structure,Alternative splicing,Angiogenesis,Complete proteome,Glycoprotein,Hydrolase,Membrane,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	active site:Phosphocysteine intermediate,binding site:Substrate,chain:Receptor-type tyrosine-protein phosphatase beta,domain:Fibronectin type-III 1,domain:Fibronectin type-III 10,domain:Fibronectin type-III 11,domain:Fibronectin type-III 12,domain:Fibronectin type-III 13,domain:Fibronectin type-III 14,domain:Fibronectin type-III 15,domain:Fibronectin type-III 16,domain:Fibronectin type-III 17,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Fibronectin type-III 6,domain:Fibronectin type-III 7,domain:Fibronectin type-III 8,domain:Fibronectin type-III 9,domain:Tyrosine-protein phosphatase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
PTPRC	protein tyrosine phosphatase, receptor type C(PTPRC)	Homo sapiens		h_blymphocytePathway:B Lymphocyte Cell Surface Molecules,h_cskPathway:Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor,h_tcraPathway:Lck and Fyn tyrosine kinases in initiation of TCR Activation,h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules,h_thelperPathway:T Helper Cell Surface Molecules,		GO:0001915~negative regulation of T cell mediated cytotoxicity,GO:0001960~negative regulation of cytokine-mediated signaling pathway,GO:0002244~hematopoietic progenitor cell differentiation,GO:0002378~immunoglobulin biosynthetic process,GO:0006469~negative regulation of protein kinase activity,GO:0006470~protein dephosphorylation,GO:0006933~negative regulation of cell adhesion involved in substrate-bound cell migration,GO:0007166~cell surface receptor signaling pathway,GO:0010332~response to gamma radiation,GO:0016311~dephosphorylation,GO:0030217~T cell differentiation,GO:0030890~positive regulation of B cell proliferation,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0042100~B cell proliferation,GO:0042102~positive regulation of T cell proliferation,GO:0044770~cell cycle phase transition,GO:0045860~positive regulation of protein kinase activity,GO:0048539~bone marrow development,GO:0048864~stem cell development,GO:0050852~T cell receptor signaling pathway,GO:0050853~B cell receptor signaling pathway,GO:0050857~positive regulation of antigen receptor-mediated signaling pathway,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051607~defense response to virus,GO:0051726~regulation of cell cycle,GO:2000473~positive regulation of hematopoietic stem cell migration,GO:2000648~positive regulation of stem cell proliferation,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0004725~protein tyrosine phosphatase activity,GO:0005001~transmembrane receptor protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0019901~protein kinase binding,	IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,IPR016130:Protein-tyrosine phosphatase, active site,IPR016335:Leukocyte common antigen,IPR024739:Protein tyrosine phosphatase, receptor type, N-terminal,	hsa04514:Cell adhesion molecules (CAMs),hsa04660:T cell receptor signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa05340:Primary immunodeficiency,	608971~Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive,609532~Hepatitic C virus, susceptibility to,	PIRSF002004:leukocyte common antigen,	SM00060:FN3,SM00194:PTPc,SM00404:PTPc_motif,	3D-structure,Alternative splicing,Complete proteome,Disease mutation,Glycoprotein,Hydrolase,Membrane,Phosphoprotein,Polymorphism,Protein phosphatase,Proteomics identification,Receptor,Reference proteome,Repeat,SCID,Signal,Transmembrane,Transmembrane helix,	active site:Phosphocysteine intermediate,chain:Leukocyte common antigen,chain:T200 leukocyte common antigen,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Tyrosine-protein phosphatase 1,domain:Tyrosine-protein phosphatase 2,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
PTPRT	protein tyrosine phosphatase, receptor type T(PTPRT)	Homo sapiens				GO:0006470~protein dephosphorylation,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007165~signal transduction,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0035335~peptidyl-tyrosine dephosphorylation,	GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004725~protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0016790~thiolester hydrolase activity,GO:0045294~alpha-catenin binding,GO:0045295~gamma-catenin binding,GO:0045296~cadherin binding,GO:0070097~delta-catenin binding,	IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR000998:MAM domain,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR013783:Immunoglobulin-like fold,IPR016130:Protein-tyrosine phosphatase, active site,				SM00060:FN3,SM00137:MAM,SM00194:PTPc,SM00404:PTPc_motif,	3D-structure,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Protein phosphatase,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	active site:Phosphocysteine intermediate,chain:Receptor-type tyrosine-protein phosphatase T,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Ig-like C2-type,domain:MAM,domain:Tyrosine-protein phosphatase 1,domain:Tyrosine-protein phosphatase 2,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
RAC1	ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)(RAC1)	Homo sapiens	102.Cholesterol_Stress_Response,	h_actinYPathway:Y branching of actin filaments,h_agrPathway:Agrin in Postsynaptic Differentiation,h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_bcrPathway:BCR Signaling Pathway,h_cdc42racPathway:Role of PI3K subunit p85 in regulation of Actin Organization and Cell Migration,h_crebPathway:Transcription factor CREB and its extracellular signals,h_edg1Pathway:Phospholipids as signalling intermediaries,h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,h_malPathway:Role of MAL in Rho-Mediated Activation of SRF,h_mapkPathway:MAPKinase Signaling Pathway,h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity,h_p38mapkPathway:p38 MAPK Signaling Pathway ,h_ptdinsPathway:Phosphoinositides and their downstream targets.,h_pyk2Pathway:Links between Pyk2 and Map Kinases,h_rac1Pathway:Rac 1 cell motility signaling pathway,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_rasPathway:Ras Signaling Pathway,h_salmonellaPathway:How does salmonella hijack a cell,h_tcrPathway:T Cell Receptor Signaling Pathway,h_uCalpainPathway:uCalpain and friends in Cell spread,		GO:0001934~positive regulation of protein phosphorylation,GO:0002093~auditory receptor cell morphogenesis,GO:0002551~mast cell chemotaxis,GO:0003382~epithelial cell morphogenesis,GO:0006928~movement of cell or subcellular component,GO:0006954~inflammatory response,GO:0006972~hyperosmotic response,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007264~small GTPase mediated signal transduction,GO:0007411~axon guidance,GO:0007596~blood coagulation,GO:0008283~cell proliferation,GO:0008361~regulation of cell size,GO:0009611~response to wounding,GO:0009653~anatomical structure morphogenesis,GO:0010310~regulation of hydrogen peroxide metabolic process,GO:0010592~positive regulation of lamellipodium assembly,GO:0010762~regulation of fibroblast migration,GO:0010811~positive regulation of cell-substrate adhesion,GO:0014041~regulation of neuron maturation,GO:0021799~cerebral cortex radially oriented cell migration,GO:0021831~embryonic olfactory bulb interneuron precursor migration,GO:0021894~cerebral cortex GABAergic interneuron development,GO:0022604~regulation of cell morphogenesis,GO:0030032~lamellipodium assembly,GO:0030036~actin cytoskeleton organization,GO:0030041~actin filament polymerization,GO:0030168~platelet activation,GO:0030334~regulation of cell migration,GO:0030838~positive regulation of actin filament polymerization,GO:0031295~T cell costimulation,GO:0031529~ruffle organization,GO:0032707~negative regulation of interleukin-23 production,GO:0034446~substrate adhesion-dependent cell spreading,GO:0035025~positive regulation of Rho protein signal transduction,GO:0035556~intracellular signal transduction,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0043065~positive regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0043652~engulfment of apoptotic cell,GO:0045216~cell-cell junction organization,GO:0045453~bone resorption,GO:0045740~positive regulation of DNA replication,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048013~ephrin receptor signaling pathway,GO:0048168~regulation of neuronal synaptic plasticity,GO:0048261~negative regulation of receptor-mediated endocytosis,GO:0048532~anatomical structure arrangement,GO:0048813~dendrite morphogenesis,GO:0048870~cell motility,GO:0048873~homeostasis of number of cells within a tissue,GO:0050690~regulation of defense response to virus by virus,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051496~positive regulation of stress fiber assembly,GO:0051668~localization within membrane,GO:0051894~positive regulation of focal adhesion assembly,GO:0051932~synaptic transmission, GABAergic,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0060263~regulation of respiratory burst,GO:0060999~positive regulation of dendritic spine development,GO:0071260~cellular response to mechanical stimulus,GO:0071526~semaphorin-plexin signaling pathway,GO:0072659~protein localization to plasma membrane,GO:0090023~positive regulation of neutrophil chemotaxis,GO:0090103~cochlea morphogenesis,GO:0097178~ruffle assembly,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,GO:1904948~midbrain dopaminergic neuron differentiation,	GO:0000139~Golgi membrane,GO:0000242~pericentriolar material,GO:0001891~phagocytic cup,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0019897~extrinsic component of plasma membrane,GO:0030027~lamellipodium,GO:0031012~extracellular matrix,GO:0031901~early endosome membrane,GO:0032587~ruffle membrane,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0042470~melanosome,GO:0060091~kinocilium,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0017137~Rab GTPase binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0030742~GTP-dependent protein binding,GO:0031996~thioesterase binding,GO:0042826~histone deacetylase binding,GO:0051022~Rho GDP-dissociation inhibitor binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04145:Phagosome,hsa04151:PI3K-Akt signaling pathway,hsa04310:Wnt signaling pathway,hsa04360:Axon guidance,hsa04370:VEGF signaling pathway,hsa04380:Osteoclast differentiation,hsa04510:Focal adhesion,hsa04520:Adherens junction,hsa04620:Toll-like receptor signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04670:Leukocyte transendothelial migration,hsa04722:Neurotrophin signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa04972:Pancreatic secretion,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05100:Bacterial invasion of epithelial cells,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05131:Shigellosis,hsa05132:Salmonella infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05231:Choline metabolism in cancer,hsa05416:Viral myocarditis,				3D-structure,ADP-ribosylation,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Glycoprotein,GTP-binding,Isopeptide bond,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Phosphoprotein,Polymorphism,Prenylation,Reference proteome,Ubl conjugation,	chain:Ras-related C3 botulinum toxin substrate 1,helix,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,sequence conflict,sequence variant,short sequence motif:Effector region,splice variant,strand,turn,
RPL10	ribosomal protein L10(RPL10)	Homo sapiens				GO:0000027~ribosomal large subunit assembly,GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0006364~rRNA processing,GO:0006412~translation,GO:0006413~translational initiation,GO:0006614~SRP-dependent cotranslational protein targeting to membrane,GO:0019083~viral transcription,	GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005840~ribosome,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,	GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR001197:Ribosomal protein L10e,IPR016180:Ribosomal protein L10e/L16,IPR018255:Ribosomal protein L10e, conserved site,	hsa03010:Ribosome,	300847~Autism, susceptibility to, X-linked 5,	PIRSF005590:ribosomal protein L10a/L10e types,		3D-structure,Autism,Autism spectrum disorder,Citrullination,Complete proteome,Direct protein sequencing,Disease mutation,Isopeptide bond,Polymorphism,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,Ubl conjugation,	chain:60S ribosomal protein L10,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),helix,modified residue,sequence conflict,sequence variant,strand,turn,
RPL5	ribosomal protein L5(RPL5)	Homo sapiens				GO:0000027~ribosomal large subunit assembly,GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0006364~rRNA processing,GO:0006412~translation,GO:0006413~translational initiation,GO:0006614~SRP-dependent cotranslational protein targeting to membrane,GO:0019083~viral transcription,GO:0042273~ribosomal large subunit biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0008097~5S rRNA binding,GO:0044822~poly(A) RNA binding,	IPR005485:Ribosomal protein L5 eukaryotic/L18 archaeal,IPR025607:Ribosomal protein L5 eukaryotic/L18 archaeal, C-terminal,	hsa03010:Ribosome,	612561~Diamond-Blackfan anemia 6,			3D-structure,Acetylation,Complete proteome,Cytoplasm,Diamond-Blackfan anemia,Direct protein sequencing,Disease mutation,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,RNA-binding,rRNA-binding,Ubl conjugation,	chain:60S ribosomal protein L5,modified residue,sequence conflict,sequence variant,
RNF43	ring finger protein 43(RNF43)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0016055~Wnt signaling pathway,GO:0016567~protein ubiquitination,GO:0030178~negative regulation of Wnt signaling pathway,GO:0038018~Wnt receptor catabolic process,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0072089~stem cell proliferation,	GO:0005635~nuclear envelope,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004842~ubiquitin-protein transferase activity,GO:0005109~frizzled binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00184:RING,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Ligase,Membrane,Metal-binding,Nucleus,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,Ubl conjugation,Ubl conjugation pathway,Wnt signaling pathway,Zinc,Zinc-finger,	chain:RING finger protein 43,compositionally biased region:His-rich,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,zinc finger region:RING-type; atypical,
SFRP4	secreted frizzled related protein 4(SFRP4)	Homo sapiens				GO:0002092~positive regulation of receptor internalization,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007275~multicellular organism development,GO:0008285~negative regulation of cell proliferation,GO:0009725~response to hormone,GO:0010628~positive regulation of gene expression,GO:0030154~cell differentiation,GO:0030178~negative regulation of Wnt signaling pathway,GO:0035567~non-canonical Wnt signaling pathway,GO:0043065~positive regulation of apoptotic process,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045606~positive regulation of epidermal cell differentiation,GO:0055062~phosphate ion homeostasis,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1902174~positive regulation of keratinocyte apoptotic process,GO:2000119~negative regulation of sodium-dependent phosphate transport,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,GO:0017147~Wnt-protein binding,GO:0042813~Wnt-activated receptor activity,	IPR001134:Netrin domain,IPR008993:Tissue inhibitor of metalloproteinases-like, OB-fold,IPR015526:Frizzled/secreted frizzled-related protein,IPR018933:Netrin module, non-TIMP type,IPR020067:Frizzled domain,IPR026560:Secreted frizzled-related protein 4,	hsa04310:Wnt signaling pathway,			SM00063:FRI,SM00643:C345C,	Complete proteome,Developmental protein,Differentiation,Disulfide bond,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,Wnt signaling pathway,	chain:Secreted frizzled-related protein 4,disulfide bond,domain:FZ,domain:NTR,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
SRSF2	serine and arginine rich splicing factor 2(SRSF2)	Homo sapiens		h_smPathway:Spliceosomal Assembly,		GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0000398~mRNA splicing, via spliceosome,GO:0006369~termination of RNA polymerase II transcription,GO:0006397~mRNA processing,GO:0006405~RNA export from nucleus,GO:0006406~mRNA export from nucleus,GO:0007067~mitotic nuclear division,GO:0008380~RNA splicing,GO:0031124~mRNA 3'-end processing,GO:0033197~response to vitamin E,GO:1903507~negative regulation of nucleic acid-templated transcription,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0016605~PML body,GO:0016607~nuclear speck,GO:0035061~interchromatin granule,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003714~transcription corepressor activity,GO:0005080~protein kinase C binding,GO:0005515~protein binding,GO:0036002~pre-mRNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR003954:RNA recognition motif domain, eukaryote,IPR012677:Nucleotide-binding, alpha-beta plait,	hsa03040:Spliceosome,hsa05168:Herpes simplex infection,			SM00360:RRM,SM00361:RRM_1,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,	chain:Splicing factor, arginine/serine-rich 2,compositionally biased region:Arg/Ser-rich (RS domain),compositionally biased region:Gly-rich (hinge region),domain:RRM,modified residue,sequence conflict,
STK11	serine/threonine kinase 11(STK11)	Homo sapiens				GO:0001558~regulation of cell growth,GO:0001894~tissue homeostasis,GO:0001944~vasculature development,GO:0006468~protein phosphorylation,GO:0006914~autophagy,GO:0006974~cellular response to DNA damage stimulus,GO:0007050~cell cycle arrest,GO:0007283~spermatogenesis,GO:0007286~spermatid development,GO:0007409~axonogenesis,GO:0008285~negative regulation of cell proliferation,GO:0010212~response to ionizing radiation,GO:0010508~positive regulation of autophagy,GO:0030010~establishment of cell polarity,GO:0030111~regulation of Wnt signaling pathway,GO:0030308~negative regulation of cell growth,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0032147~activation of protein kinase activity,GO:0036399~TCR signalosome assembly,GO:0042593~glucose homeostasis,GO:0043276~anoikis,GO:0045059~positive thymic T cell selection,GO:0046777~protein autophosphorylation,GO:0048814~regulation of dendrite morphogenesis,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050772~positive regulation of axonogenesis,GO:0050852~T cell receptor signaling pathway,GO:0051055~negative regulation of lipid biosynthetic process,GO:0051645~Golgi localization,GO:0051896~regulation of protein kinase B signaling,GO:0060070~canonical Wnt signaling pathway,GO:0060770~negative regulation of epithelial cell proliferation involved in prostate gland development,GO:0071493~cellular response to UV-B,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,GO:0097484~dendrite extension,GO:1900182~positive regulation of protein localization to nucleus,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1904262~negative regulation of TORC1 signaling,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0016020~membrane,GO:0036398~TCR signalosome,GO:0070062~extracellular exosome,	GO:0000287~magnesium ion binding,GO:0002039~p53 binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0030275~LRR domain binding,GO:0030295~protein kinase activator activity,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020636:Calcium/calmodulin-dependent/calcium-dependent protein kinase,	hsa04068:FoxO signaling pathway,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04920:Adipocytokine signaling pathway,	175200~Peutz-Jeghers syndrome,260350~Pancreatic cancer,273300~Testicular tumor, somatic,Melanoma, malignant, somatic~Melanoma, malignant, somatic,		SM00220:S_TKc,	3D-structure,Acetylation,Alternative splicing,Apoptosis,ATP-binding,Autophagy,Cell cycle,Complete proteome,Cytoplasm,Differentiation,Disease mutation,DNA damage,Kinase,Lipoprotein,Magnesium,Manganese,Membrane,Metal-binding,Methylation,Mitochondrion,Nucleotide-binding,Nucleus,Palmitate,Phosphoprotein,Polymorphism,Prenylation,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Spermatogenesis,Transferase,Tumor suppressor,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase 11,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,
STAT3	signal transducer and activator of transcription 3(STAT3)	Homo sapiens	11.IL-6_gp130-Jak-STAT,12.IL-6_type_cytok-signal-transduct,48.mice_minus_JAKs_and_STATs,	h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,h_egfPathway:EGF Signaling Pathway,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_il10Pathway:IL-10 Anti-inflammatory Signaling Pathway,h_il22bpPathway:IL22 Soluble Receptor Signaling Pathway ,h_il6Pathway:IL 6 signaling pathway,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_pdgfPathway:PDGF Signaling Pathway,h_stat3Pathway:Stat3 Signaling Pathway,h_tpoPathway:TPO Signaling Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001659~temperature homeostasis,GO:0001754~eye photoreceptor cell differentiation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006606~protein import into nucleus,GO:0006928~movement of cell or subcellular component,GO:0006953~acute-phase response,GO:0007165~signal transduction,GO:0007259~JAK-STAT cascade,GO:0007399~nervous system development,GO:0007568~aging,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0010628~positive regulation of gene expression,GO:0010730~negative regulation of hydrogen peroxide biosynthetic process,GO:0016032~viral process,GO:0016310~phosphorylation,GO:0019221~cytokine-mediated signaling pathway,GO:0019953~sexual reproduction,GO:0030522~intracellular receptor signaling pathway,GO:0032355~response to estradiol,GO:0032870~cellular response to hormone stimulus,GO:0033210~leptin-mediated signaling pathway,GO:0035019~somatic stem cell population maintenance,GO:0035278~miRNA mediated inhibition of translation,GO:0040014~regulation of multicellular organism growth,GO:0042493~response to drug,GO:0042517~positive regulation of tyrosine phosphorylation of Stat3 protein,GO:0042593~glucose homeostasis,GO:0042755~eating behavior,GO:0042789~mRNA transcription from RNA polymerase II promoter,GO:0043066~negative regulation of apoptotic process,GO:0044320~cellular response to leptin stimulus,GO:0044321~response to leptin,GO:0045471~response to ethanol,GO:0045747~positive regulation of Notch signaling pathway,GO:0045820~negative regulation of glycolytic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046902~regulation of mitochondrial membrane permeability,GO:0048708~astrocyte differentiation,GO:0051726~regulation of cell cycle,GO:0060019~radial glial cell differentiation,GO:0060259~regulation of feeding behavior,GO:0060396~growth hormone receptor signaling pathway,GO:0060397~JAK-STAT cascade involved in growth hormone signaling pathway,GO:0070102~interleukin-6-mediated signaling pathway,GO:0071407~cellular response to organic cyclic compound,GO:0097009~energy homeostasis,GO:1901215~negative regulation of neuron death,GO:1902728~positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1904685~positive regulation of metalloendopeptidase activity,GO:2000637~positive regulation of gene silencing by miRNA,GO:2000737~negative regulation of stem cell differentiation,GO:2001171~positive regulation of ATP biosynthetic process,GO:2001223~negative regulation of neuron migration,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005743~mitochondrial inner membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004871~signal transducer activity,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0031490~chromatin DNA binding,GO:0031730~CCR5 chemokine receptor binding,GO:0035259~glucocorticoid receptor binding,GO:0042802~identical protein binding,GO:0044212~transcription regulatory region DNA binding,GO:0046983~protein dimerization activity,	IPR000980:SH2 domain,IPR001217:STAT transcription factor, core,IPR008967:p53-like transcription factor, DNA-binding,IPR011992:EF-hand-like domain,IPR012345:STAT transcription factor, DNA-binding, subdomain,IPR013799:STAT transcription factor, protein interaction,IPR013800:STAT transcription factor, all-alpha,IPR013801:STAT transcription factor, DNA-binding,IPR015988:STAT transcription factor, coiled coil,	hsa04062:Chemokine signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04630:Jak-STAT signaling pathway,hsa04917:Prolactin signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04931:Insulin resistance,hsa05145:Toxoplasmosis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05212:Pancreatic cancer,hsa05221:Acute myeloid leukemia,hsa05321:Inflammatory bowel disease (IBD),	147060~Hyper-IgE recurrent infection syndrome,615952~Autoimmune disease, multisystem, infantile-onset,		SM00964:SM00964,	3D-structure,Acetylation,Activator,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Diabetes mellitus,Disease mutation,DNA-binding,Dwarfism,Host-virus interaction,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH2 domain,Transcription,Transcription regulation,	chain:Signal transducer and activator of transcription 3,domain:SH2,modified residue,sequence conflict,sequence variant,short sequence motif:Essential for nuclear import,splice variant,
SMO	smoothened, frizzled class receptor(SMO)	Homo sapiens		h_shhPathway:Sonic Hedgehog (Shh) Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001570~vasculogenesis,GO:0001649~osteoblast differentiation,GO:0001701~in utero embryonic development,GO:0001708~cell fate specification,GO:0001755~neural crest cell migration,GO:0001947~heart looping,GO:0002052~positive regulation of neuroblast proliferation,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0003140~determination of left/right asymmetry in lateral mesoderm,GO:0003323~type B pancreatic cell development,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007224~smoothened signaling pathway,GO:0007228~positive regulation of hh target transcription factor activity,GO:0007371~ventral midline determination,GO:0007494~midgut development,GO:0009952~anterior/posterior pattern specification,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0021542~dentate gyrus development,GO:0021696~cerebellar cortex morphogenesis,GO:0021794~thalamus development,GO:0021904~dorsal/ventral neural tube patterning,GO:0021910~smoothened signaling pathway involved in ventral spinal cord patterning,GO:0021938~smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,GO:0021953~central nervous system neuron differentiation,GO:0021987~cerebral cortex development,GO:0030857~negative regulation of epithelial cell differentiation,GO:0031069~hair follicle morphogenesis,GO:0034504~protein localization to nucleus,GO:0035264~multicellular organism growth,GO:0035567~non-canonical Wnt signaling pathway,GO:0040018~positive regulation of multicellular organism growth,GO:0042307~positive regulation of protein import into nucleus,GO:0042475~odontogenesis of dentin-containing tooth,GO:0043066~negative regulation of apoptotic process,GO:0043392~negative regulation of DNA binding,GO:0045880~positive regulation of smoothened signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046622~positive regulation of organ growth,GO:0048143~astrocyte activation,GO:0048741~skeletal muscle fiber development,GO:0048853~forebrain morphogenesis,GO:0048873~homeostasis of number of cells within a tissue,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050821~protein stabilization,GO:0051451~myoblast migration,GO:0051799~negative regulation of hair follicle development,GO:0060070~canonical Wnt signaling pathway,GO:0060248~detection of cell density by contact stimulus involved in contact inhibition,GO:0060413~atrial septum morphogenesis,GO:0060644~mammary gland epithelial cell differentiation,GO:0060684~epithelial-mesenchymal cell signaling,GO:0061053~somite development,GO:0061113~pancreas morphogenesis,GO:0070986~left/right axis specification,GO:0071397~cellular response to cholesterol,GO:0072001~renal system development,GO:0072285~mesenchymal to epithelial transition involved in metanephric renal vesicle formation,GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis,GO:2000036~regulation of stem cell population maintenance,GO:2000826~regulation of heart morphogenesis,	GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0005929~cilium,GO:0016021~integral component of membrane,GO:0030666~endocytic vesicle membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0060170~ciliary membrane,GO:0070062~extracellular exosome,GO:0072372~primary cilium,GO:0097542~ciliary tip,	GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0005113~patched binding,GO:0005515~protein binding,GO:0008144~drug binding,GO:0017147~Wnt-protein binding,GO:0042813~Wnt-activated receptor activity,	IPR000539:Frizzled protein,IPR015526:Frizzled/secreted frizzled-related protein,IPR017981:GPCR, family 2-like,IPR020067:Frizzled domain,IPR026544:Smoothened,	hsa04340:Hedgehog signaling pathway,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05217:Basal cell carcinoma,	Basal cell carcinoma, somatic~Basal cell carcinoma, somatic,		SM00063:FRI,SM01330:SM01330,	3D-structure,Cell projection,Complete proteome,Developmental protein,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Smoothened homolog,disulfide bond,domain:FZ,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SALL4	spalt like transcription factor 4(SALL4)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001833~inner cell mass cell proliferation,GO:0001843~neural tube closure,GO:0003281~ventricular septum development,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0030326~embryonic limb morphogenesis,GO:0035019~somatic stem cell population maintenance,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0043231~intracellular membrane-bounded organelle,GO:0043234~protein complex,	GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,		147750~IVIC syndrome,607323~Duane-radial ray syndrome,		SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Oncogene,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Sal-like protein 4,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,
SPOP	speckle type BTB/POZ protein(SPOP)	Homo sapiens				GO:0030162~regulation of proteolysis,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0019005~SCF ubiquitin ligase complex,GO:0031463~Cul3-RING ubiquitin ligase complex,	GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,	IPR000210:BTB/POZ-like,IPR002083:MATH,IPR008974:TRAF-like,IPR011333:BTB/POZ fold,				SM00061:MATH,SM00225:BTB,	3D-structure,Complete proteome,Nucleus,Proteomics identification,Reference proteome,Ubl conjugation pathway,	chain:Speckle-type POZ protein,domain:BTB,domain:MATH,helix,region of interest:Homodimerization,region of interest:Required for nuclear localization,sequence conflict,strand,turn,
SPEN	spen family transcriptional repressor(SPEN)	Homo sapiens		h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000398~mRNA splicing, via spliceosome,GO:0006351~transcription, DNA-templated,GO:0007219~Notch signaling pathway,GO:0016032~viral process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0050769~positive regulation of neurogenesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0017053~transcriptional repressor complex,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001191~transcriptional repressor activity, RNA polymerase II transcription factor binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR010912:Spen paralogue/orthologue C-terminal, metazoa,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012921:Spen paralogue and orthologue SPOC, C-terminal,IPR016194:SPOC like C-terminal domain,				SM00360:RRM,	3D-structure,Activator,Coiled coil,Complete proteome,DNA-binding,Host-virus interaction,Methylation,Notch signaling pathway,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,RNA-binding,Transcription,Transcription regulation,	chain:Msx2-interacting protein,compositionally biased region:Arg-rich,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,compositionally biased region:Tyr-rich,domain:RID,domain:RRM 1,domain:RRM 2,domain:RRM 3,domain:RRM 4,domain:SPOC,helix,modified residue,region of interest:Interaction with MSX2,region of interest:Interaction with RBPSUH,sequence conflict,sequence variant,strand,turn,
SF3B1	splicing factor 3b subunit 1(SF3B1)	Homo sapiens			RNA processing and modification,	GO:0000245~spliceosomal complex assembly,GO:0000375~RNA splicing, via transesterification reactions,GO:0000398~mRNA splicing, via spliceosome,GO:0045815~positive regulation of gene expression, epigenetic,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005686~U2 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0016607~nuclear speck,GO:0034693~U11/U12 snRNP,GO:0071004~U2-type prespliceosome,GO:0071013~catalytic step 2 spliceosome,	GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR011989:Armadillo-like helical,IPR015016:Splicing factor 3B subunit 1,IPR016024:Armadillo-type fold,	hsa03040:Spliceosome,	614286~Myelodysplastic syndrome, somatic,			3D-structure,Acetylation,Alternative splicing,Citrullination,Coiled coil,Complete proteome,Isopeptide bond,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Spliceosome,Ubl conjugation,	chain:Splicing factor 3B subunit 1,helix,modified residue,mutagenesis site,region of interest:Interaction with PPP1R8,region of interest:Interaction with SF3B14,repeat:HEAT 1,repeat:HEAT 10,repeat:HEAT 11,repeat:HEAT 2,repeat:HEAT 3,repeat:HEAT 4,repeat:HEAT 5,repeat:HEAT 6,repeat:HEAT 7,repeat:HEAT 8,repeat:HEAT 9,sequence conflict,strand,
STAG2	stromal antigen 2(STAG2)	Homo sapiens			Cell division and chromosome partitioning,	GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0016925~protein sumoylation,GO:0032876~negative regulation of DNA endoreduplication,GO:0051301~cell division,GO:0051321~meiotic cell cycle,	GO:0000775~chromosome, centromeric region,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0045111~intermediate filament cytoskeleton,	GO:0005515~protein binding,	IPR013721:STAG,IPR016024:Armadillo-type fold,IPR020839:Stromalin conservative domain,	hsa04110:Cell cycle,				3D-structure,Acetylation,Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Chromosome partition,Coiled coil,Complete proteome,Meiosis,Mitosis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Cohesin subunit SA-2,compositionally biased region:Poly-Ser,domain:SCD,modified residue,sequence conflict,sequence variant,
SDHAF2	succinate dehydrogenase complex assembly factor 2(SDHAF2)	Homo sapiens				GO:0006121~mitochondrial electron transport, succinate to ubiquinone,GO:0006470~protein dephosphorylation,GO:0010719~negative regulation of epithelial to mesenchymal transition,GO:0018293~protein-FAD linkage,GO:0090090~negative regulation of canonical Wnt signaling pathway,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0005515~protein binding,	IPR005631:Protein of unknown function DUF339,		601650~Paragangliomas 2,			Chaperone,Complete proteome,Disease mutation,Mitochondrion,Reference proteome,Signal,Transit peptide,	chain:Succinate dehydrogenase assembly factor 2, mitochondrial,sequence variant,transit peptide:Mitochondrion,
SDHA	succinate dehydrogenase complex flavoprotein subunit A(SDHA)	Homo sapiens		h_etcPathway:Electron Transport Reaction in Mitochondria,		GO:0006099~tricarboxylic acid cycle,GO:0006105~succinate metabolic process,GO:0006121~mitochondrial electron transport, succinate to ubiquinone,GO:0007399~nervous system development,GO:0009061~anaerobic respiration,GO:0022900~electron transport chain,GO:0022904~respiratory electron transport chain,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005749~mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),GO:0016020~membrane,GO:0043209~myelin sheath,	GO:0000104~succinate dehydrogenase activity,GO:0005515~protein binding,GO:0008177~succinate dehydrogenase (ubiquinone) activity,GO:0009055~electron carrier activity,GO:0016491~oxidoreductase activity,GO:0050660~flavin adenine dinucleotide binding,	IPR003952:Fumarate reductase/succinate dehydrogenase, FAD-binding site,IPR003953:FAD binding domain,IPR011281:Succinate dehydrogenase, flavoprotein subunit,IPR014006:Succinate dehydrogenase/fumarate reductase, flavoprotein subunit,IPR015939:Fumarate reductase/succinate dehydrogenase flavoprotein-like, C-terminal,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,IPR027477:Succinate dehydrogenase/fumarate reductase flavoprotein, catalytic domain,	hsa00020:Citrate cycle (TCA cycle),hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	252011~Mitochondrial respiratory chain complex II deficiency,256000~Leigh syndrome,613642~Cardiomyopathy, dilated, 1GG,614165~Paragangliomas 5,	PIRSF000171:succinate dehydrogenase, flavoprotein subunit (SDHA/APRA/LASPO),		Acetylation,Alternative splicing,Cardiomyopathy,Complete proteome,Direct protein sequencing,Disease mutation,Electron transport,FAD,Flavoprotein,Leigh syndrome,Membrane,Mitochondrion,Mitochondrion inner membrane,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transit peptide,Transport,Tricarboxylic acid cycle,Tumor suppressor,	active site:Proton acceptor,binding site:Substrate,chain:Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial,modified residue,nucleotide phosphate-binding region:FAD,sequence conflict,sequence variant,transit peptide:Mitochondrion,
SDHB	succinate dehydrogenase complex iron sulfur subunit B(SDHB)	Homo sapiens		h_etcPathway:Electron Transport Reaction in Mitochondria,		GO:0006099~tricarboxylic acid cycle,GO:0006105~succinate metabolic process,GO:0009060~aerobic respiration,GO:0022904~respiratory electron transport chain,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005749~mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),GO:0005886~plasma membrane,GO:0031966~mitochondrial membrane,GO:0045273~respiratory chain complex II,GO:0070062~extracellular exosome,	GO:0000104~succinate dehydrogenase activity,GO:0005515~protein binding,GO:0008177~succinate dehydrogenase (ubiquinone) activity,GO:0009055~electron carrier activity,GO:0016491~oxidoreductase activity,GO:0046872~metal ion binding,GO:0048039~ubiquinone binding,GO:0051537~2 iron, 2 sulfur cluster binding,GO:0051538~3 iron, 4 sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR001041:2Fe-2S ferredoxin-type domain,IPR004489:Succinate dehydrogenase/fumarate reductase iron-sulphur protein,IPR006058:2Fe-2S ferredoxin, iron-sulphur binding site,IPR009051:Alpha-helical ferredoxin,IPR012675:Beta-grasp domain,IPR017896:4Fe-4S ferredoxin-type, iron-sulpur binding domain,IPR017900:4Fe-4S ferredoxin, iron-sulphur binding, conserved site,IPR025192:Succinate dehydogenase/fumarate reductase N-terminal,	hsa00020:Citrate cycle (TCA cycle),hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	115310~Paragangliomas 4,171300~Pheochromocytoma,606764~Gastrointestinal stromal tumor,606864~Paraganglioma and gastric stromal sarcoma,612359~Cowden syndrome 2,			2Fe-2S,3Fe-4S,4Fe-4S,Acetylation,Complete proteome,Disease mutation,Electron transport,Iron,Iron-sulfur,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,Transport,Tricarboxylic acid cycle,	binding site:Ubiquinone; shared with DHSD,chain:Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial,domain:2Fe-2S ferredoxin-type,domain:4Fe-4S ferredoxin-type,metal ion-binding site:Iron-sulfur 1 (2Fe-2S),metal ion-binding site:Iron-sulfur 2 (4Fe-4S),metal ion-binding site:Iron-sulfur 3 (3Fe-4S),sequence conflict,sequence variant,transit peptide:Mitochondrion,
SDHC	succinate dehydrogenase complex subunit C(SDHC)	Homo sapiens		h_etcPathway:Electron Transport Reaction in Mitochondria,		GO:0006099~tricarboxylic acid cycle,GO:0006121~mitochondrial electron transport, succinate to ubiquinone,GO:0009060~aerobic respiration,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005749~mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0045273~respiratory chain complex II,GO:0045281~succinate dehydrogenase complex,	GO:0000104~succinate dehydrogenase activity,GO:0009055~electron carrier activity,GO:0020037~heme binding,GO:0046872~metal ion binding,	IPR000701:Succinate dehydrogenase/Fumarate reductase, transmembrane subunit,IPR014314:Succinate dehydrogenase, cytochrome b556 subunit,IPR018495:Succinate dehydrogenase, cytochrome b subunit, conserved site,	hsa00020:Citrate cycle (TCA cycle),hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	605373~Paragangliomas 3,606764~Gastrointestinal stromal tumor,606864~Paraganglioma and gastric stromal sarcoma,			Alternative splicing,Complete proteome,Electron transport,Heme,Iron,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,Proteomics identification,Reference proteome,Transit peptide,Transmembrane,Transmembrane helix,Transport,Tricarboxylic acid cycle,	chain:Succinate dehydrogenase cytochrome b560 subunit, mitochondrial,metal ion-binding site:Iron (heme axial ligand),transit peptide:Mitochondrion,transmembrane region,
SDHD	succinate dehydrogenase complex subunit D(SDHD)	Homo sapiens		h_etcPathway:Electron Transport Reaction in Mitochondria,		GO:0006099~tricarboxylic acid cycle,GO:0006121~mitochondrial electron transport, succinate to ubiquinone,	GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0005749~mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),GO:0016021~integral component of membrane,	GO:0000104~succinate dehydrogenase activity,GO:0008177~succinate dehydrogenase (ubiquinone) activity,GO:0009055~electron carrier activity,GO:0020037~heme binding,GO:0046872~metal ion binding,GO:0048039~ubiquinone binding,	IPR007992:Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, CybS,	hsa00020:Citrate cycle (TCA cycle),hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,	114900~Carcinoid tumors, intestinal,168000~Paragangliomas 1, with or without deafness,171300~Pheochromocytoma,252011~Mitochondrial complex II deficiency,606864~Paraganglioma and gastric stromal sarcoma,615106~Cowden syndrome 3,Merkel cell carcinoma, somatic~Merkel cell carcinoma, somatic,			Alternative splicing,Complete proteome,Disease mutation,Electron transport,Heme,Iron,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Reference proteome,Signal,Transit peptide,Transmembrane,Transmembrane helix,Transport,Tricarboxylic acid cycle,	binding site:Ubiquinone; shared with IP/sdhb,chain:Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial,metal ion-binding site:Iron (heme axial ligand); shared with SDHC,sequence conflict,sequence variant,topological domain:Mitochondrial intermembrane,topological domain:Mitochondrial matrix,transit peptide:Mitochondrion,transmembrane region,
SOCS1	suppressor of cytokine signaling 1(SOCS1)	Homo sapiens	12.IL-6_type_cytok-signal-transduct,	h_ghPathway:Growth Hormone Signaling Pathway,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,		GO:0001932~regulation of protein phosphorylation,GO:0006469~negative regulation of protein kinase activity,GO:0007259~JAK-STAT cascade,GO:0010534~regulation of activation of JAK2 kinase activity,GO:0016567~protein ubiquitination,GO:0019221~cytokine-mediated signaling pathway,GO:0040008~regulation of growth,GO:0042510~regulation of tyrosine phosphorylation of Stat1 protein,GO:0042512~negative regulation of tyrosine phosphorylation of Stat1 protein,GO:0042518~negative regulation of tyrosine phosphorylation of Stat3 protein,GO:0045444~fat cell differentiation,GO:0046426~negative regulation of JAK-STAT cascade,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0050707~regulation of cytokine secretion,GO:0060334~regulation of interferon-gamma-mediated signaling pathway,GO:0071230~cellular response to amino acid stimulus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,	GO:0004860~protein kinase inhibitor activity,GO:0005159~insulin-like growth factor receptor binding,GO:0005515~protein binding,GO:0019210~kinase inhibitor activity,GO:0019901~protein kinase binding,	IPR000980:SH2 domain,IPR001496:SOCS protein, C-terminal,	hsa04120:Ubiquitin mediated proteolysis,hsa04380:Osteoclast differentiation,hsa04630:Jak-STAT signaling pathway,hsa04910:Insulin signaling pathway,hsa04917:Prolactin signaling pathway,hsa04930:Type II diabetes mellitus,hsa05145:Toxoplasmosis,hsa05206:MicroRNAs in cancer,			SM00252:SH2,SM00253:SOCS,SM00969:SM00969,	Complete proteome,Cytoplasmic vesicle,Growth regulation,Nucleus,Polymorphism,Reference proteome,SH2 domain,Signal transduction inhibitor,Ubl conjugation pathway,	chain:Suppressor of cytokine signaling 1,compositionally biased region:Poly-Ser,domain:SH2,domain:SOCS box,region of interest:Extended SH2 subdomain (ESS),region of interest:Interaction with Elongin BC complex,region of interest:Kinase inhibitory region (KIR),sequence conflict,sequence variant,
TET2	tet methylcytosine dioxygenase 2(TET2)	Homo sapiens				GO:0001822~kidney development,GO:0002318~myeloid progenitor cell differentiation,GO:0006211~5-methylcytosine catabolic process,GO:0006493~protein O-linked glycosylation,GO:0007049~cell cycle,GO:0009791~post-embryonic development,GO:0014070~response to organic cyclic compound,GO:0019511~peptidyl-proline hydroxylation,GO:0019857~5-methylcytosine metabolic process,GO:0019858~cytosine metabolic process,GO:0020027~hemoglobin metabolic process,GO:0030099~myeloid cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048536~spleen development,GO:0061484~hematopoietic stem cell homeostasis,GO:0070989~oxidative demethylation,GO:0072576~liver morphogenesis,GO:0080111~DNA demethylation,GO:0080182~histone H3-K4 trimethylation,	GO:0005634~nucleus,	GO:0000907~sulfonate dioxygenase activity,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008198~ferrous iron binding,GO:0008270~zinc ion binding,GO:0018602~2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity,GO:0019798~procollagen-proline dioxygenase activity,GO:0034792~hypophosphite dioxygenase activity,GO:0043734~DNA-N1-methyladenine dioxygenase activity,GO:0052634~C-19 gibberellin 2-beta-dioxygenase activity,GO:0052635~C-20 gibberellin 2-beta-dioxygenase activity,GO:0070579~methylcytosine dioxygenase activity,	IPR024779:2OGFeDO domain, nucleic acid-modifying type,		614286~Myelodysplastic syndrome, somatic,		SM01333:SM01333,	3D-structure,Alternative splicing,Cell cycle,Chromatin regulator,Complete proteome,Dioxygenase,DNA-binding,Glycoprotein,Iron,Metal-binding,Methylation,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Tumor suppressor,Zinc,	binding site:2-oxoglutarate,chain:Probable methylcytosine dioxygenase TET2,compositionally biased region:Gln-rich,compositionally biased region:Pro-rich,metal ion-binding site:Iron; catalytic,modified residue,sequence conflict,sequence variant,splice variant,
TSHR	thyroid stimulating hormone receptor(TSHR)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007190~activation of adenylate cyclase activity,GO:0007267~cell-cell signaling,GO:0007399~nervous system development,GO:0008284~positive regulation of cell proliferation,GO:0008344~adult locomotory behavior,GO:0009755~hormone-mediated signaling pathway,GO:0030183~B cell differentiation,GO:0038194~thyroid-stimulating hormone signaling pathway,GO:0040012~regulation of locomotion,GO:0040018~positive regulation of multicellular organism growth,GO:0060122~inner ear receptor stereocilium organization,GO:0071542~dopaminergic neuron differentiation,GO:0090103~cochlea morphogenesis,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0043235~receptor complex,	GO:0004996~thyroid-stimulating hormone receptor activity,GO:0005515~protein binding,GO:0008528~G-protein coupled peptide receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR002131:Glycoprotein hormone receptor,IPR002274:Thyrotropin receptor,IPR017452:GPCR, rhodopsin-like, 7TM,IPR026906:Leucine rich repeat 5,	hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04918:Thyroid hormone synthesis,hsa04923:Regulation of lipolysis in adipocytes,hsa05320:Autoimmune thyroid disease,	603373~Hyperthyroidism, familial gestational,609152~Hyperthyroidism, nonautoimmune,Hypothyroidism, congenital, nongoitrous, 1 275200~Hypothyroidism, congenital, nongoitrous, 1 275200,Thyroid adenoma, hyperfunctioning, somatic~Thyroid adenoma, hyperfunctioning, somatic,Thyroid carcinoma with thyrotoxicosis~Thyroid carcinoma with thyrotoxicosis,			3D-structure,Alternative splicing,Cell membrane,Complete proteome,Congenital hypothyroidism,Direct protein sequencing,Disease mutation,Disulfide bond,G-protein coupled receptor,Glycoprotein,Leucine-rich repeat,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Thyrotropin receptor,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,sequence conflict,sequence variant,short sequence motif:PDZ-binding,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
TRRAP	transformation/transcription domain associated protein(TRRAP)	Homo sapiens		h_pitx2Pathway:Multi-step Regulation of Transcription by Pitx2,		GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016310~phosphorylation,GO:0016573~histone acetylation,GO:0016578~histone deubiquitination,GO:0043967~histone H4 acetylation,GO:0043968~histone H2A acetylation,GO:1904837~beta-catenin-TCF complex assembly,	GO:0000123~histone acetyltransferase complex,GO:0000125~PCAF complex,GO:0000812~Swr1 complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0030914~STAGA complex,GO:0033276~transcription factor TFTC complex,GO:0035267~NuA4 histone acetyltransferase complex,	GO:0003712~transcription cofactor activity,GO:0005515~protein binding,GO:0016301~kinase activity,	IPR000403:Phosphatidylinositol 3-/4-kinase, catalytic domain,IPR003151:PIK-related kinase, FAT,IPR003152:PIK-related kinase, FATC,IPR011009:Protein kinase-like domain,IPR011989:Armadillo-like helical,IPR011990:Tetratricopeptide-like helical,IPR014009:PIK-related kinase,IPR016024:Armadillo-type fold,	hsa05166:HTLV-I infection,			SM00146:PI3Kc,SM01343:SM01343,	Acetylation,Activator,Alternative splicing,Chromatin regulator,Coiled coil,Complete proteome,Direct protein sequencing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Transformation/transcription domain- associated protein,compositionally biased region:Pro-rich,domain:FAT,domain:FATC,domain:PI3K/PI4K,modified residue,region of interest:Interaction with TP53,sequence conflict,sequence variant,short sequence motif:Bipartite nuclear localization signal,splice variant,
TGFBR2	transforming growth factor beta receptor 2(TGFBR2)	Homo sapiens		h_alkPathway:ALK in cardiac myocytes,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_nthiPathway:NFkB activation by Nontypeable Hemophilus influenzae,h_tgfbPathway:TGF beta signaling pathway,h_tob1Pathway:Role of Tob in T-cell activation,		GO:0001568~blood vessel development,GO:0001569~patterning of blood vessels,GO:0001570~vasculogenesis,GO:0001666~response to hypoxia,GO:0001701~in utero embryonic development,GO:0001947~heart looping,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0002088~lens development in camera-type eye,GO:0002651~positive regulation of tolerance induction to self antigen,GO:0002663~positive regulation of B cell tolerance induction,GO:0002666~positive regulation of T cell tolerance induction,GO:0003148~outflow tract septum morphogenesis,GO:0003149~membranous septum morphogenesis,GO:0003151~outflow tract morphogenesis,GO:0003181~atrioventricular valve morphogenesis,GO:0003186~tricuspid valve morphogenesis,GO:0003214~cardiac left ventricle morphogenesis,GO:0003274~endocardial cushion fusion,GO:0003430~growth plate cartilage chondrocyte growth,GO:0006468~protein phosphorylation,GO:0006898~receptor-mediated endocytosis,GO:0006915~apoptotic process,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007182~common-partner SMAD protein phosphorylation,GO:0007219~Notch signaling pathway,GO:0007224~smoothened signaling pathway,GO:0007369~gastrulation,GO:0007420~brain development,GO:0007507~heart development,GO:0007566~embryo implantation,GO:0007568~aging,GO:0007584~response to nutrient,GO:0008284~positive regulation of cell proliferation,GO:0009612~response to mechanical stimulus,GO:0009749~response to glucose,GO:0010468~regulation of gene expression,GO:0010634~positive regulation of epithelial cell migration,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0023014~signal transduction by protein phosphorylation,GO:0030154~cell differentiation,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0031100~organ regeneration,GO:0032147~activation of protein kinase activity,GO:0035162~embryonic hemopoiesis,GO:0040008~regulation of growth,GO:0042060~wound healing,GO:0042127~regulation of cell proliferation,GO:0042493~response to drug,GO:0043011~myeloid dendritic cell differentiation,GO:0043415~positive regulation of skeletal muscle tissue regeneration,GO:0043627~response to estrogen,GO:0045766~positive regulation of angiogenesis,GO:0048545~response to steroid hormone,GO:0048565~digestive tract development,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0051138~positive regulation of NK T cell differentiation,GO:0060021~palate development,GO:0060044~negative regulation of cardiac muscle cell proliferation,GO:0060389~pathway-restricted SMAD protein phosphorylation,GO:0060412~ventricular septum morphogenesis,GO:0060434~bronchus morphogenesis,GO:0060440~trachea formation,GO:0060443~mammary gland morphogenesis,GO:0060463~lung lobe morphogenesis,GO:0070723~response to cholesterol,GO:1905007~positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,GO:1990086~lens fiber cell apoptotic process,GO:2000379~positive regulation of reactive oxygen species metabolic process,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005901~caveola,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0043235~receptor complex,GO:0045121~membrane raft,GO:0070022~transforming growth factor beta receptor homodimeric complex,	GO:0004675~transmembrane receptor protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0005024~transforming growth factor beta-activated receptor activity,GO:0005026~transforming growth factor beta receptor activity, type II,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005539~glycosaminoglycan binding,GO:0031435~mitogen-activated protein kinase kinase kinase binding,GO:0034713~type I transforming growth factor beta receptor binding,GO:0034714~type III transforming growth factor beta receptor binding,GO:0046332~SMAD binding,GO:0046872~metal ion binding,GO:0050431~transforming growth factor beta binding,	IPR000333:Activin type II/Transforming growth factor-beta II receptor,IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR015013:Transforming growth factor beta receptor 2 ectodomain,IPR017194:Transforming growth factor-beta receptor, type II,IPR017441:Protein kinase, ATP binding site,	hsa04010:MAPK signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,hsa04068:FoxO signaling pathway,hsa04144:Endocytosis,hsa04350:TGF-beta signaling pathway,hsa04380:Osteoclast differentiation,hsa04390:Hippo signaling pathway,hsa04520:Adherens junction,hsa05142:Chagas disease (American trypanosomiasis),hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05210:Colorectal cancer,hsa05212:Pancreatic cancer,hsa05220:Chronic myeloid leukemia,	133239~Esophageal cancer, somatic,610168~Loeys-Dietz syndrome 2,614331~Colorectal cancer, hereditary nonpolyposis, type 6,	PIRSF037393:transforming growth factor-beta receptor, type II,	SM00220:S_TKc,	3D-structure,Alternative splicing,Aortic aneurysm,Apoptosis,ATP-binding,Cell membrane,Complete proteome,Differentiation,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Growth regulation,Hereditary nonpolyposis colorectal cancer,Kinase,Magnesium,Manganese,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Serine/threonine-protein kinase,Signal,Transferase,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:ATP,chain:TGF-beta receptor type-2,disulfide bond,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
TMEM127	transmembrane protein 127(TMEM127)	Homo sapiens				GO:0007032~endosome organization,GO:0008285~negative regulation of cell proliferation,GO:0032007~negative regulation of TOR signaling,	GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0017137~Rab GTPase binding,			171300~Pheochromocytoma, susceptibility to,			Acetylation,Cell membrane,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Tumor suppressor,	chain:Transmembrane protein 127,modified residue,transmembrane region,
TSC1	tuberous sclerosis 1(TSC1)	Homo sapiens		h_mtorPathway:mTOR Signaling Pathway,		GO:0001822~kidney development,GO:0001843~neural tube closure,GO:0001952~regulation of cell-matrix adhesion,GO:0002250~adaptive immune response,GO:0006407~rRNA export from nucleus,GO:0006417~regulation of translation,GO:0006813~potassium ion transport,GO:0007050~cell cycle arrest,GO:0007160~cell-matrix adhesion,GO:0008285~negative regulation of cell proliferation,GO:0008344~adult locomotory behavior,GO:0016242~negative regulation of macroautophagy,GO:0017148~negative regulation of translation,GO:0021766~hippocampus development,GO:0021987~cerebral cortex development,GO:0030030~cell projection organization,GO:0032007~negative regulation of TOR signaling,GO:0032868~response to insulin,GO:0042552~myelination,GO:0043379~memory T cell differentiation,GO:0043666~regulation of phosphoprotein phosphatase activity,GO:0045792~negative regulation of cell size,GO:0045859~regulation of protein kinase activity,GO:0046323~glucose import,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0050808~synapse organization,GO:0050821~protein stabilization,GO:0051291~protein heterooligomerization,GO:0051492~regulation of stress fiber assembly,GO:0051726~regulation of cell cycle,GO:0051893~regulation of focal adhesion assembly,GO:0051894~positive regulation of focal adhesion assembly,GO:0055007~cardiac muscle cell differentiation,GO:0090630~activation of GTPase activity,GO:0090650~cellular response to oxygen-glucose deprivation,GO:1901214~regulation of neuron death,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0016020~membrane,GO:0030027~lamellipodium,GO:0030426~growth cone,GO:0033596~TSC1-TSC2 complex,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0030695~GTPase regulator activity,GO:0032794~GTPase activating protein binding,GO:0047485~protein N-terminus binding,GO:0051087~chaperone binding,	IPR007483:Hamartin,IPR016024:Armadillo-type fold,	hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04910:Insulin signaling pathway,hsa05231:Choline metabolism in cancer,	191100~Tuberous sclerosis-1,606690~Lymphangioleiomyomatosis,607341~Focal cortical dysplasia, Taylor balloon cell type,			3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,Epilepsy,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Tumor suppressor,	chain:Hamartin,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Ser,modified residue,sequence variant,
TSC2	tuberous sclerosis 2(TSC2)	Homo sapiens		h_mtorPathway:mTOR Signaling Pathway,h_vdrPathway:Control of Gene Expression by Vitamin D Receptor,		GO:0001843~neural tube closure,GO:0006469~negative regulation of protein kinase activity,GO:0006606~protein import into nucleus,GO:0006897~endocytosis,GO:0007050~cell cycle arrest,GO:0007507~heart development,GO:0008104~protein localization,GO:0008285~negative regulation of cell proliferation,GO:0014067~negative regulation of phosphatidylinositol 3-kinase signaling,GO:0016032~viral process,GO:0016192~vesicle-mediated transport,GO:0030100~regulation of endocytosis,GO:0030178~negative regulation of Wnt signaling pathway,GO:0032007~negative regulation of TOR signaling,GO:0043491~protein kinase B signaling,GO:0043547~positive regulation of GTPase activity,GO:0046626~regulation of insulin receptor signaling pathway,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0050918~positive chemotaxis,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051726~regulation of cell cycle,GO:0051898~negative regulation of protein kinase B signaling,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0016020~membrane,GO:0033596~TSC1-TSC2 complex,GO:0048471~perinuclear region of cytoplasm,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0019902~phosphatase binding,GO:0031267~small GTPase binding,GO:0042803~protein homodimerization activity,	IPR000331:Rap GTPase activating proteins domain,IPR003913:Tuberin,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR018515:Tuberin-type domain,IPR024584:Tuberin, N-terminal,	hsa04115:p53 signaling pathway,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04910:Insulin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa05231:Choline metabolism in cancer,	606690~Lymphangioleiomyomatosis, somatic,613254~Tuberous sclerosis-2,			Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,GTPase activation,Host-virus interaction,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Tumor suppressor,Ubl conjugation,	chain:Tuberin,domain:Rap-GAP,modified residue,mutagenesis site,region of interest:Required for interaction with TSC1,sequence conflict,sequence variant,splice variant,
UBR5	ubiquitin protein ligase E3 component n-recognin 5(UBR5)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0006281~DNA repair,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006974~cellular response to DNA damage stimulus,GO:0008283~cell proliferation,GO:0033160~positive regulation of protein import into nucleus, translocation,GO:0035413~positive regulation of catenin import into nucleus,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0050847~progesterone receptor signaling pathway,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1901315~negative regulation of histone H2A K63-linked ubiquitination,GO:2000780~negative regulation of double-strand break repair,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0003723~RNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0034450~ubiquitin-ubiquitin ligase activity,GO:0043130~ubiquitin binding,	IPR000569:HECT,IPR002004:Polyadenylate-binding protein/Hyperplastic disc protein,IPR003126:Zinc finger, N-recognin,IPR009091:Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II,IPR024725:E3 ubiquitin ligase EDD, ubiquitin-associated domain,	hsa04120:Ubiquitin mediated proteolysis,			SM00119:HECTc,SM00396:ZnF_UBR1,SM00517:PolyA,	3D-structure,Acetylation,Alternative splicing,Complete proteome,DNA damage,DNA repair,Membrane,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,Ubl conjugation pathway,Zinc,Zinc-finger,	active site:Glycyl thioester intermediate,chain:E3 ubiquitin-protein ligase UBR5,compositionally biased region:Arg/Asp-rich (mixed charge),compositionally biased region:Arg/Glu-rich (mixed charge),compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Poly-Ala,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,domain:HECT,domain:PABC,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,turn,zinc finger region:UBR-type,
USP8	ubiquitin specific peptidase 8(USP8)	Homo sapiens				GO:0000281~mitotic cytokinesis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007032~endosome organization,GO:0008283~cell proliferation,GO:0016579~protein deubiquitination,GO:0038128~ERBB2 signaling pathway,GO:0070536~protein K63-linked deubiquitination,GO:0071108~protein K48-linked deubiquitination,GO:0098609~cell-cell adhesion,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0019897~extrinsic component of plasma membrane,GO:0030496~midbody,GO:0031313~extrinsic component of endosome membrane,	GO:0004197~cysteine-type endopeptidase activity,GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0017124~SH3 domain binding,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR001763:Rhodanese-like domain,IPR015063:Domain of unknown function DUF1873,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,	hsa04144:Endocytosis,				3D-structure,Alternative splicing,Cell cycle,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Endosome,Hydrolase,Membrane,Nucleus,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,SH3-binding,Thiol protease,Ubl conjugation,Ubl conjugation pathway,	chain:Ubiquitin carboxyl-terminal hydrolase 8,domain:Rhodanese,helix,modified residue,sequence conflict,sequence variant,short sequence motif:SH3-binding,strand,turn,
MYCL	v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog(MYCL)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0045607~regulation of auditory receptor cell differentiation,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046983~protein dimerization activity,	IPR002418:Transcription regulator Myc,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR012682:Transcription regulator Myc, N-terminal,				SM00353:HLH,	Alternative splicing,Complete proteome,Direct protein sequencing,DNA-binding,Nucleus,Polymorphism,Reference proteome,	chain:L-myc-1 proto-oncogene protein,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:Leucine-zipper,modified residue,sequence variant,splice variant,
MYCN	v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog(MYCN)	Homo sapiens				GO:0001502~cartilage condensation,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010942~positive regulation of cell death,GO:0030324~lung development,GO:0042733~embryonic digit morphogenesis,GO:0045607~regulation of auditory receptor cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048704~embryonic skeletal system morphogenesis,GO:0048712~negative regulation of astrocyte differentiation,GO:0048754~branching morphogenesis of an epithelial tube,GO:1903800~positive regulation of production of miRNAs involved in gene silencing by miRNA,GO:2000378~negative regulation of reactive oxygen species metabolic process,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0016021~integral component of membrane,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046983~protein dimerization activity,	IPR002418:Transcription regulator Myc,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR012682:Transcription regulator Myc, N-terminal,	hsa05202:Transcriptional misregulation in cancer,	164280~Feingold syndrome,	PIRSF001705:myc protein,	SM00353:HLH,	Activator,Complete proteome,Disease mutation,DNA-binding,Membrane,Nucleus,Phosphoprotein,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,	chain:N-myc proto-oncogene protein,compositionally biased region:Asp/Glu-rich (acidic),DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:Leucine-zipper,modified residue,sequence conflict,sequence variant,
VHL	von Hippel-Lindau tumor suppressor(VHL)	Homo sapiens		h_hifPathway:Hypoxia-Inducible Factor in the Cardiovascular System,h_vegfPathway:VEGF, Hypoxia, and Angiogenesis,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000902~cell morphogenesis,GO:0006355~regulation of transcription, DNA-templated,GO:0006508~proteolysis,GO:0008285~negative regulation of cell proliferation,GO:0016567~protein ubiquitination,GO:0043066~negative regulation of apoptotic process,GO:0045597~positive regulation of cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0050821~protein stabilization,GO:0061418~regulation of transcription from RNA polymerase II promoter in response to hypoxia,GO:0061428~negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0016020~membrane,GO:0030891~VCB complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019899~enzyme binding,GO:0061630~ubiquitin protein ligase activity,	IPR002714:Tumour suppressor protein, von Hippel-Lindau disease,IPR022772:von Hippel-Lindau disease tumour suppressor, beta/alpha domain,IPR024048:von Hippel-Lindau disease tumor suppressor, alpha domain,IPR024053:von Hippel-Lindau disease tumor suppressor,  beta domain,	hsa04066:HIF-1 signaling pathway,hsa04120:Ubiquitin mediated proteolysis,hsa05200:Pathways in cancer,hsa05211:Renal cell carcinoma,	144700~Renal cell carcinoma, somatic,171300~Pheochromocytoma,193300~von Hippel-Lindau syndrome,263400~Erythrocytosis, familial, 2,Hemangioblastoma, cerebellar, somatic~Hemangioblastoma, cerebellar, somatic,			3D-structure,Alternative initiation,Alternative splicing,Complete proteome,Congenital erythrocytosis,Cytoplasm,Disease mutation,Membrane,Nucleus,Polymorphism,Reference proteome,Repeat,Tumor suppressor,Ubl conjugation pathway,	chain:Von Hippel-Lindau disease tumor suppressor,helix,mutagenesis site,region of interest:8 X 5 AA tandem repeats of G-[PAVG]-E-E- [DAYSLE],region of interest:Interaction with Elongin BC complex,region of interest:Involved in binding to CCT complex,repeat:1,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,sequence variant,splice variant,strand,turn,
ZRSR2	zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2(ZRSR2)	Homo sapiens				GO:0000245~spliceosomal complex assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0008380~RNA splicing,	GO:0005689~U12-type spliceosomal complex,GO:0089701~U2AF,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0030628~pre-mRNA 3'-splice site binding,GO:0046872~metal ion binding,	IPR000504:RNA recognition motif domain,IPR000571:Zinc finger, CCCH-type,IPR003954:RNA recognition motif domain, eukaryote,IPR009145:U2 auxiliary factor small subunit,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00356:ZnF_C3H1,SM00361:RRM_1,	Coiled coil,Complete proteome,Metal-binding,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,RNA-binding,Spliceosome,Zinc,Zinc-finger,	chain:U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2,compositionally biased region:Poly-Glu,domain:RRM,modified residue,zinc finger region:C3H1-type 1,zinc finger region:C3H1-type 2,
ZFHX3	zinc finger homeobox 3(ZFHX3)	Homo sapiens			Transcription,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0007050~cell cycle arrest,GO:0007420~brain development,GO:0007517~muscle organ development,GO:0032922~circadian regulation of gene expression,GO:0045662~negative regulation of myoblast differentiation,GO:0045663~positive regulation of myoblast differentiation,GO:0045664~regulation of neuron differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0071559~response to transforming growth factor beta,GO:1904059~regulation of locomotor rhythm,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016604~nuclear body,GO:0043231~intracellular membrane-bounded organelle,	GO:0001046~core promoter sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0019899~enzyme binding,GO:0044212~transcription regulatory region DNA binding,	IPR001356:Homeodomain,IPR003604:Zinc finger, U1-type,IPR007087:Zinc finger, C2H2,IPR009057:Homeodomain-like,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,IPR017970:Homeobox, conserved site,	hsa04550:Signaling pathways regulating pluripotency of stem cells,	176807~Prostate cancer, susceptibility to, somatic,		SM00355:ZnF_C2H2,SM00389:HOX,SM00451:ZnF_U1,	3D-structure,Activator,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,DNA-binding,Homeobox,Isopeptide bond,Metal-binding,Myogenesis,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger homeobox protein 3,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,DNA-binding region:Homeobox 1,DNA-binding region:Homeobox 2,DNA-binding region:Homeobox 3,DNA-binding region:Homeobox 4,helix,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10; atypical,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 13,zinc finger region:C2H2-type 14,zinc finger region:C2H2-type 15,zinc finger region:C2H2-type 16,zinc finger region:C2H2-type 17,zinc finger region:C2H2-type 18; atypical,zinc finger region:C2H2-type 19,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 20,zinc finger region:C2H2-type 21,zinc finger region:C2H2-type 22,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5; atypical,zinc finger region:C2H2-type 6; degenerate,zinc finger region:C2H2-type 7; atypical,zinc finger region:C2H2-type 8; atypical,zinc finger region:C2H2-type 9; atypical,
